FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Salles, THC
   Volpe-Zanutto, F
   Sousa, IMD
   Machado, D
   Zanatta, AC
   Vilegas, W
   Lancellotti, M
   Foglio, MA
   d'Avila, MA
AF Costa Salles, Tais Helena
   Volpe-Zanutto, Fabiana
   de Oliveira Sousa, Ilza Maria
   Machado, Daisy
   Zanatta, Ana Caroline
   Vilegas, Wagner
   Lancellotti, Marcelo
   Foglio, Mary Ann
   d'Avila, Marcos Akira
TI Electrospun PCL-based nanofibers Arrabidaea chica Verlot - Pterodon
   pubescens Benth loaded: synergic effect in fibroblast formation
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE guided tissue regeneration; Arrabidaea chica; Pterodon pubescens; poly
   (epsilon-caprolactone)
ID CONTROLLED-RELEASE; IN-VITRO; ANTHOCYANINS; EXTRACT; SCAFFOLDS;
   MEMBRANE; DRUG; CO2
AB The guided tissue regeneration (GTR) technique can be applied in dentistry and other medical specializations, such as orthopedics. In modern dentistry, GTR has been used in periodontics and implantology to treat periodontal defects, to reconstruct lost, damaged and atrophied bone tissue in dental implant procedures, and to preserve alveolar bases after tooth extraction. In order to create and improve new therapies and to develop new biomaterials that restore, improve and prevent aggravation of compromised tissue function, poly (epsilon-caprolactone) (PCL) polymer membranes were obtained by the electrospinning process and were associated with two plant extracts: Pterodon pubescens Benth (P. pubescens) and Arrabidaea chica Verlot (A. chica) which are characterized by their pharmacological activities of anti-inflammatory and healing actions, respectively. Fiber morphology was analyzed using scanning electron microscopy (SEM), where fiber average diameter was measured from SEM images. Contact angle measurements were performed in order to evaluate the hydrophilicity of electrospun membranes containing vegetal extract. High-performance liquid chromatography was used to evaluate the ability to release active ingredients. Cytotoxicity and cell proliferation assays were performed in vitroon NIH-3T3 cells for 1, 3 and 7 d. Electrospun PCL membranes associated with plant extracts P. pubescensand/or A. chica presented a controlled release profile of the active compounds induced fibroblast formation, suggesting that they are promising and suitable for applications in GTR.
C1 [Costa Salles, Tais Helena; d'Avila, Marcos Akira] Univ Campinas UNICAMP, Sch Mech Engn, Dept Mfg & Mat Engn, Campinas, SP, Brazil.
   [Volpe-Zanutto, Fabiana] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland.
   [Volpe-Zanutto, Fabiana] Univ Estadual Campinas, Inst Biol, Grad Sch Biosci & Technol Bioact Prod, Campinas, Brazil.
   [de Oliveira Sousa, Ilza Maria] Univ Estadual Campinas UNICAMP, Fac Ciencias Med, Campinas, SP, Brazil.
   [Machado, Daisy; Lancellotti, Marcelo; Foglio, Mary Ann] Univ Estadual Campinas, Fac Pharmaceut Sci, Campinas, Brazil.
   [Zanatta, Ana Caroline; Vilegas, Wagner] Univ Estadual Paulista, Inst Biociencias, UNESP, Sao Vicente, SP, Brazil.
RP d'Avila, MA (corresponding author), Univ Campinas UNICAMP, Sch Mech Engn, Dept Mfg & Mat Engn, Campinas, SP, Brazil.
EM madavila@fem.unicamp.br
RI ; Volpe Zanutto, Fabiana/I-8543-2012
OI Zanatta, Ana C./0000-0003-0199-4521; Volpe Zanutto,
   Fabiana/0000-0003-0148-1080
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional do
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [42175/2016-9];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX The authors would like to thank the Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP), Conselho Nacional do Desenvolvimento
   Cientifico e Tecnologico (CNPq) Grant No. 42175/2016-9 and Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).
CR Aro AA, 2013, LIFE SCI, V92, P799, DOI 10.1016/j.lfs.2013.02.011
   Baker SC, 2009, BIOMATERIALS, V30, P1321, DOI 10.1016/j.biomaterials.2008.11.033
   Barve A, 2009, BIOPHARM DRUG DISPOS, V30, P356, DOI 10.1002/bdd.677
   Oliveira MB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/396894
   Castaneda-Ovando A, 2009, FOOD CHEM, V113, P859, DOI 10.1016/j.foodchem.2008.09.001
   Castro AGB, 2018, MAT SCI ENG C-MATER, V85, P154, DOI 10.1016/j.msec.2017.12.023
   Coelho LP, 2005, J ETHNOPHARMACOL, V98, P109, DOI 10.1016/j.jep.2005.01.014
   Elzubair A, 2006, J DENT, V34, P784, DOI 10.1016/j.jdent.2006.03.002
   Grando R, 2013, PAPEL NANOMATERAIS C
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   He M, 2017, J COLLOID INTERF SCI, V490, P270, DOI 10.1016/j.jcis.2016.11.062
   He M, 2015, APPL SURF SCI, V335, P121, DOI 10.1016/j.apsusc.2015.02.037
   Hoscheid J, 2015, ARTHRITIS, DOI 10.1155/2015/379459
   Houghton PJ, 2005, J ETHNOPHARMACOL, V100, P100, DOI 10.1016/j.jep.2005.07.001
   Iamaguti LS, 2008, PESQUISA VET BRASIL, V28, P195, DOI 10.1590/S0100-736X2008000400001
   Isaac C., 2010, REV MED, V89, P125, DOI DOI 10.11606/ISSN.1679-9836.V89I3/4P125-131
   Jorge MP, 2008, J ETHNOPHARMACOL, V118, P361, DOI 10.1016/j.jep.2008.04.024
   Kim SY, 2015, J COLLOID INTERF SCI, V442, P147, DOI 10.1016/j.jcis.2014.11.044
   Lam CXF, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034108
   Montero RB, 2012, ACTA BIOMATER, V8, P1778, DOI 10.1016/j.actbio.2011.12.008
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nucci C, 2012, J ETHNOPHARMACOL, V143, P170, DOI 10.1016/j.jep.2012.06.020
   Oliveira LAR, 2017, REV BRAS FARMACOGN, V27, P663, DOI 10.1016/j.bjp.2017.05.014
   Paula JT, 2014, J SUPERCRIT FLUID, V86, P100, DOI 10.1016/j.supflu.2013.12.008
   Paula JT, 2013, J SUPERCRIT FLUID, V81, P33, DOI 10.1016/j.supflu.2013.04.009
   Paulesini W, 2008, REV ODONTOL U CID SA, V20, P181
   Sabino KCC, 1999, TOXICOL LETT, V108, P27, DOI 10.1016/S0378-4274(99)00110-1
   Scalbert A, 2005, AM J CLIN NUTR, V81, p215S, DOI 10.1093/ajcn/81.1.215S
   Shakhssalim N, 2013, INT J ARTIF ORGANS, V36, P113, DOI 10.5301/ijao.5000175
   Sousa I M O, 2013, THESIS
   Spindola Humberto M., 2010, BMC Pharmacology, V10, P1, DOI 10.1186/1471-2210-10-1
   Spindola HM, 2011, EUR J PHARMACOL, V656, P45, DOI 10.1016/j.ejphar.2011.01.025
   Sultanova Z, 2016, INT J PHARMACEUT, V505, P133, DOI 10.1016/j.ijpharm.2016.03.032
   Taffarello D, 2013, QUIM NOVA, V36, P431, DOI 10.1590/S0100-40422013000300014
   Tammaro L, 2015, INT J PHARMACEUT, V490, P32, DOI 10.1016/j.ijpharm.2015.04.070
   Vieira CR, 2008, PHYTOMEDICINE, V15, P528, DOI 10.1016/j.phymed.2007.08.003
   Wu Y, 2018, ULTRASON SONOCHEM, V48, P311, DOI 10.1016/j.ultsonch.2018.06.016
   Zamani M, 2010, EUR J PHARM BIOPHARM, V75, P179, DOI 10.1016/j.ejpb.2010.02.002
   Zanutto FV, 2019, J PHARM SCI-US, V108, P1177, DOI 10.1016/j.xphs.2018.10.007
   Zorn B, 2001, PHYTOCHEMISTRY, V56, P831, DOI 10.1016/S0031-9422(01)00038-3
NR 40
TC 0
Z9 0
U1 12
U2 12
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD NOV
PY 2020
VL 15
IS 6
AR 065001
DI 10.1088/1748-605X/ab9bb1
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NV7ZS
UT WOS:000574535200001
PM 32955022
DA 2020-11-30
ER

PT J
AU Sakata, RP
   Antoniolli, G
   Lancellotti, M
   Kawano, DF
   Barbosa, EG
   Almeida, WP
AF Sakata, Renata P.
   Antoniolli, Giorgio
   Lancellotti, Marcelo
   Kawano, Daniel Fabio
   Barbosa, Euzebio Guimaraes
   Almeida, Wanda P.
TI Synthesis and biological evaluation of 2 '-Aminochalcone: A multi-target
   approach to find drug candidates to treat Alzheimer's disease
SO BIOORGANIC CHEMISTRY
LA English
DT Article
DE BACE-1; 2 '-Aminochalcones; Alzhemeir's disease; beta-Amyloid
ID ACETYLCHOLINESTERASE INHIBITORS; DESIGN; GENERATION; DISCOVERY; DOCKING;
   AGENTS; PERMEABILITY; OPTIMIZATION; DERIVATIVES; CHALCONES
AB Alzheimer's disease (AD) is a neurodegenerative process that compromises cognitive functions. The physiopathology of AD is multifactorial and is mainly supported by the cholinergic and amyloid hypotheses, which allows the identification the fundamental role of some markers, such as the enzymes acetylcholinesterase (AChE) and beta-secretase (BACE-1), and the beta-amyloid peptide (A beta). In this work, we prepared a series of chalcones and 2'-aminochalcones, which were tested against AChE and BACE-1 enzymes and on the aggregation of A beta. All compounds inhibited AChE activity with different potencies. We have found that the majority of chalcones having the amino group are able to inhibit BACE-1, which was not observed for chalcones without this group. The most active compound is the one derived from 2,3-dichlorobenzaldeyde, having an IC50, value of 2.71 mu M. A molecular docking study supported this result, showing a good interaction of the amino group with aspartic acid residues of the catalytic diade of BACE-1. Thioflavin-T fluorescence emission is reduced in 30 - 40%, when A beta(42) is incubated in the presence of some chalcones under aggregation conditions. In vitro cytotoxicity and in silico prediction of pharmacokinetic properties were also conducted in this study.
C1 [Sakata, Renata P.; Antoniolli, Giorgio; Almeida, Wanda P.] Univ Estadual Campinas, Inst Chem, Campinas, Brazil.
   [Sakata, Renata P.] Porphirio da Paz High Sch, Campinas, SP, Brazil.
   [Lancellotti, Marcelo; Kawano, Daniel Fabio; Almeida, Wanda P.] Univ Estadual Campinas, Fac Pharmaceut Sci, 200 Candido Portinari, BR-13083871 Campinas, SP, Brazil.
   [Barbosa, Euzebio Guimaraes] Univ Rio Grande do Norte, Dept Farm CCS Fed, Natal, RN, Brazil.
RP Almeida, WP (corresponding author), Univ Estadual Campinas, Inst Chem, Campinas, Brazil.; Almeida, WP (corresponding author), Univ Estadual Campinas, Fac Pharmaceut Sci, 200 Candido Portinari, BR-13083871 Campinas, SP, Brazil.
EM walmeida@unicamp.br
FU Sao Paulo Foundation of Science (Fapesp) [2018/02879-3]; University of
   Campinas Research Fund (Faepex) [3154/18]
FX Authors are grateful to Sao Paulo Foundation of Science (Fapesp,
   2018/02879-3) and University of Campinas Research Fund (Faepex, 3154/18)
   for support.
CR Abel M., 2006, NONCOVALENT INTERACT, P101
   Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   Agatonovic-Kustrin S, 2018, BIOMED PHARMACOTHER, V106, P553, DOI 10.1016/j.biopha.2018.06.147
   Allouche AR, 2011, J COMPUT CHEM, V32, P174, DOI 10.1002/jcc.21600
   ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U
   Bai P, 2019, EUR J MED CHEM, V183, DOI 10.1016/j.ejmech.2019.111737
   Bajda M, 2013, INT J MOL SCI, V14, P5608, DOI 10.3390/ijms14035608
   Barman A, 2013, J MOL GRAPH MODEL, V40, P1, DOI 10.1016/j.jmgm.2012.12.010
   Bunce RA, 2011, J HETEROCYCLIC CHEM, V48, P991, DOI 10.1002/jhet.672
   Choubdar N, 2019, BIOORG CHEM, V91, DOI 10.1016/j.bioorg.2019.103164
   Claisen L., 1881, CHEM BER, V14, P2460, DOI 10.1002/cber
   Cong L, 2019, EUR J MED CHEM, V166, P11, DOI 10.1016/j.ejmech.2019.01.039
   Crivori P, 2000, J MED CHEM, V43, P2204, DOI 10.1021/jm990968+
   Cummings Jeffrey, 2019, Alzheimers Dement (N Y), V5, P272, DOI 10.1016/j.trci.2019.05.008
   Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Gasteiger J., 1990, TETRAHEDRON COMPUT M, V3, P537, DOI DOI 10.1016/0898-5529(90)90156-3
   Gaugler J, 2019, ALZHEIMERS DEMENT, V15, P321, DOI 10.1016/j.jalz.2019.01.010
   Ghose AK, 1999, J COMB CHEM, V1, P55, DOI 10.1021/cc9800071
   Gonzalez JF, 2019, EXPERT OPIN DRUG DIS, V14, P879, DOI 10.1080/17460441.2019.1623201
   Ha ZY, 2020, CURR PROTEIN PEPT SC, V21, P99, DOI 10.2174/1389203720666191107094949
   Ishikawa M, 2011, J MED CHEM, V54, P1539, DOI 10.1021/jm101356p
   Jackisch R, 2009, J ALZHEIMERS DIS, V16, P635, DOI 10.3233/JAD-2009-1008
   Jiang N, 2019, BIOORG CHEM, V89, DOI 10.1016/j.bioorg.2019.103027
   Kaur H, 2018, CURR TOP MED CHEM, V18, P844, DOI 10.2174/1568026618666180626095714
   KAYE PT, 1994, S AFR J CHEM-S-AFR T, V47, P21
   KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799
   Klinkenberg I, 2011, BEHAV BRAIN RES, V221, P430, DOI 10.1016/j.bbr.2010.11.033
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881
   Li Q, 2017, EUR J MED CHEM, V132, P294, DOI 10.1016/j.ejmech.2017.03.062
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Liu HR, 2015, CHEM BIOL DRUG DES, V86, P517, DOI 10.1111/cbdd.12514
   Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x
   Ma L, 2011, J ENZYM INHIB MED CH, V26, P643, DOI 10.3109/14756366.2010.543420
   Mahapatra DK, 2015, EUR J MED CHEM, V101, P496, DOI 10.1016/j.ejmech.2015.06.052
   Moussa-Pacha NM, 2019, MED RES REV, DOI 10.1002/med.21622
   NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8
   Nordberg Agneta, 2013, Prim Care Companion CNS Disord, V15, DOI 10.4088/PCC.12r01412
   Pereda AE, 2014, NAT REV NEUROSCI, V15, P250, DOI 10.1038/nrn3708
   Polo E, 2019, BIOORG CHEM, V90, DOI 10.1016/j.bioorg.2019.103034
   Prati F, 2018, J MED CHEM, V61, P619, DOI 10.1021/acs.jmedchem.7b00393
   Qin HL, 2020, EUR J MED CHEM, V193, DOI 10.1016/j.ejmech.2020.112215
   Rajasekhar K, 2018, RSC ADV, V8, P23780, DOI 10.1039/c8ra03620a
   Roque A.C., 2000, LIGAND MACROMOLECULA, P13
   Sakata RP, 2017, MED CHEM, V13, P654, DOI 10.2174/1573406413666170525125730
   Sang ZP, 2019, EUR J MED CHEM, V180, P238, DOI 10.1016/j.ejmech.2019.07.021
   Selassie C.D., 2003, BURGERS MED CHEM DRU, P39
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Seong SH, 2017, BIOORGAN MED CHEM, V25, P3964, DOI 10.1016/j.bmc.2017.05.033
   Stewart JJP, 2013, J MOL MODEL, V19, P1, DOI 10.1007/s00894-012-1667-x
   Stierand K, 2006, BIOINFORMATICS, V22, P1710, DOI 10.1093/bioinformatics/btl150
   Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200
   Tadano G, 2019, J MED CHEM, V62, P9331, DOI 10.1021/acs.jmedchem.9b01140
   THOMPSON M, 2004, ACS M PHIL PA, V172, P42
   Torres FC, 2016, J BRAZIL CHEM SOC, V27, P1541, DOI 10.5935/0103-5053.20160033
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735
   Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n
   Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465
   Wang H, 2019, ACS CHEM NEUROSCI, V10, P852, DOI 10.1021/acschemneuro.8b00391
   Wang L, 2017, BIOORGAN MED CHEM, V25, P360, DOI 10.1016/j.bmc.2016.11.002
   Wang Y, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121188
   Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x
   Zhang XY, 2019, BIOORG CHEM, V87, P395, DOI 10.1016/j.bioorg.2019.03.043
   Zhang X, 2018, BIOORG CHEM, V80, P86, DOI 10.1016/j.bioorg.2018.06.009
   Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816
NR 67
TC 0
Z9 0
U1 3
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0045-2068
EI 1090-2120
J9 BIOORG CHEM
JI Bioorganic Chem.
PD OCT
PY 2020
VL 103
AR 104201
DI 10.1016/j.bioorg.2020.104201
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA NX6AQ
UT WOS:000575792000015
PM 32890999
DA 2020-11-30
ER

PT J
AU Neto, XAD
   Alves, ACS
   Dias, RA
   Rodrigues, RP
   Lancellotti, M
   Almeida, WP
   Kawano, DF
AF Neto, Xisto Antonio de Oliveira
   Alves, Anna Carolina Schneider
   Dias Junior, Reinaldo Antonio
   Rodrigues, Ricardo Pereira
   Lancellotti, Marcelo
   Almeida, Wanda Pereira
   Kawano, Daniel Fabio
TI Molecular Docking Reveals the Binding Modes of Anticancer
   Alkylphospholipids and Lysophosphatidylcholine within the Catalytic
   Domain of Cytidine Triphosphate: Phosphocholine Cytidyltransferase
SO EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY
LA English
DT Article
DE alkylphospholipids; apoptosis; cancer; cytidine triphosphate;
   phosphocholine cytidyltransferase; edelfosine
ID PLATELET-ACTIVATING-FACTOR; FATTY-ACID SYNTHASE; PHOSPHATIDYLCHOLINE
   BIOSYNTHESIS; LIPID RAFTS; CYTIDYLYLTRANSFERASE ACTIVITY; IN-VITRO; CTP;
   APOPTOSIS; HEXADECYLPHOSPHOCHOLINE; CELLS
AB Alkylphospholipids are synthetic analogues of endogenous phosphatidylcholines with a remarkable ability: induce the selective apoptosis of exponentially growing tumor cells. One hypothesis concerning their mechanism of action is the inhibition of cytidine triphosphate:phosphocholine cytidyltransferase (CCT), which would significantly suppress the phosphatidylcholine biosynthesis to trigger apoptosis. Herein, homology modeling, docking simulations, and the analyses of molecular interaction fields are used to suggest the most probable binding modes of four alkylphospholipids (edelfosine, erucylphosphocholine, perifosine, and miltefosine) and lysophosphatidylcholine at the catalytic domain of human CCT. All compounds display bind modes in agreement with the corresponding groups found in the CCT substrate, phosphocholine, while their binding strengths are increased because of the interaction of the alkyl chains with hydrophobic residues from the M domain of the protein. Analyses of the geometry of the CCT binding-site also suggest that small groups, such as benzyl/2-phenylethyl ethers or equivalent heterocycles, could replace the O-methyl group in edelfosine to yield even better inhibitors. It is believed this study can guide the development of new alkylphospholipids with an improved profile for the inhibition of phosphatidylcholine biosynthesis, a critical component for cell cycle progression that can be explored in cancer chemotherapy. Practical Applications: Studies focusing on the interactions between small ligands and their protein targets are decisive for the comprehension of how conformational changes in the macromolecular structure dictates the biological activity and, consequently, how they can be explored in drug discovery. Most of the current studies on alkylphospholipids focuses on their physicochemical interactions with cholesterol and sphingolipids in lipid rafts that, because of the variability and complexity of the membrane phases, hardly can provide structural data in the X-ray crystallography assays necessary for molecular modeling studies. Therefore, by exploring the inhibition of human cytidine triphosphate:phosphocholine cytidyltransferase as an alternative and, probably, complementary hypothesis to the membrane rafts, a helpful strategy can be provided to overcome the clinical limitations of alkylphospholipids.
C1 [Neto, Xisto Antonio de Oliveira; Alves, Anna Carolina Schneider; Lancellotti, Marcelo; Almeida, Wanda Pereira; Kawano, Daniel Fabio] Univ Campinas UNICAMP, Fac Pharmaceut Sci, BR-13083871 Campinas, SP, Brazil.
   [Dias Junior, Reinaldo Antonio; Kawano, Daniel Fabio] Univ Campinas UNICAMP, Inst Chem, BR-13083970 Campinas, SP, Brazil.
   [Rodrigues, Ricardo Pereira] Univ Espirito Santo UFES, Hlth Sci Ctr CCS, Dept Pharmaceut Sci, BR-29047105 Vitoria, ES, Brazil.
RP Kawano, DF (corresponding author), Univ Campinas UNICAMP, Fac Pharmaceut Sci, BR-13083871 Campinas, SP, Brazil.; Kawano, DF (corresponding author), Univ Campinas UNICAMP, Inst Chem, BR-13083970 Campinas, SP, Brazil.
EM dkawano@unicamp.br
RI Neto, Xisto Antonio Oliveira/AAY-5023-2020; Rodrigues,
   Ricardo/AAZ-9616-2020
OI Neto, Xisto Antonio Oliveira/0000-0003-4415-1065; Schneider Alves, Anna
   Carolina/0000-0001-8161-7421
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil
   (CAPES)CAPES [001]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2017/05876-2, 2018/08585-1, 2018/22817-2]; PRP-UNICAMP (Pro-Reitoria de
   Pesquisa da Unicamp) [2081/16, 3008/16, 2641/17, 2038/18, 3347/19]
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior-Brasil (CAPES)-Finance Code 001. The authors
   thank the funding agencies FAPESP (Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo, Grants N. 2017/05876-2, 2018/08585-1 and
   2018/22817-2) and PRP-UNICAMP (Pro-Reitoria de Pesquisa da Unicamp,
   Grants N. (2081/16, 3008/16, 2641/17, 2038/18 and 3347/19) for the
   financial support.
CR Accelrys, 2013, DISC STUD VIS REL 4
   ANDREESEN R, 1978, CANCER RES, V38, P3894
   Artese A, 2013, WIRES COMPUT MOL SCI, V3, P594, DOI 10.1002/wcms.1150
   Barratt E, 2005, J AM CHEM SOC, V127, P11827, DOI 10.1021/ja0527525
   BAUCHINGER M, 1983, MUTAT RES, V121, P225, DOI 10.1016/0165-7992(83)90207-5
   Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715
   Boggs K, 1998, BBA-LIPID LIPID MET, V1389, P1, DOI 10.1016/S0005-2760(97)00145-8
   BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757
   Bourne P. E., 2003, STRUCTURAL BIOINFORM, V44
   CORNELL R, 1989, J BIOL CHEM, V264, P9077
   Cornell RB, 2016, BBA-MOL CELL BIOL L, V1861, P847, DOI 10.1016/j.bbalip.2015.12.022
   Cornell RB, 2015, PROG LIPID RES, V59, P147, DOI 10.1016/j.plipres.2015.07.001
   Cramer C. J., 2004, ESSENTIALS COMPUTATI
   Cruciani F, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9445
   Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668
   Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c
   Dennis MK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201715
   EIBL H, 1990, CANCER TREAT REV, V17, P233, DOI 10.1016/0305-7372(90)90053-I
   Gasteiger J., 1990, TETRAHEDRON COMPUT M, V3, P537, DOI DOI 10.1016/0898-5529(90)90156-3
   GEILEN CC, 1992, J BIOL CHEM, V267, P6719
   Ghersi D, 2009, BIOINFORMATICS, V25, P3185, DOI 10.1093/bioinformatics/btp562
   Harpsoe K, 2008, J MOL GRAPH MODEL, V26, P874, DOI 10.1016/j.jmgm.2007.06.002
   Hewitt M, 2007, J CHEM INF MODEL, V47, P1460, DOI 10.1021/ci700016d
   HOFFMAN DR, 1984, BLOOD, V63, P545
   Jimenez-Lopez JM, 2002, EUR J BIOCHEM, V269, P4649, DOI 10.1046/j.1432-1033.2002.03169.x
   Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897
   Kagami LP, 2017, MOL DIVERS, V21, P677, DOI 10.1007/s11030-017-9745-8
   Kang DW, 2014, MOL BIOSYST, V10, P1998, DOI 10.1039/c4mb00147h
   Kawano DF, 2013, MINI-REV MED CHEM, V13, P997
   Kawano DF, 2011, MEM I OSWALDO CRUZ, V106, P957, DOI 10.1590/S0074-02762011000800010
   KING MT, 1981, CANCER LETT, V12, P217, DOI 10.1016/0304-3835(81)90071-9
   Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5
   Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363
   LOHMEYER M, 1995, BRIT J CANCER, V72, P277, DOI 10.1038/bjc.1995.325
   Lykidis A, 2001, BIOCHEMISTRY-US, V40, P494, DOI 10.1021/bi002140r
   Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222
   Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146
   Muley L, 2010, J MED CHEM, V53, P2126, DOI 10.1021/jm9016416
   MUNDER PG, 1990, CHEM IMMUNOL, V49, P206
   Nolan T., 2000, LIGAND MACROMOLECULA
   Oliveira SHP, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-197
   Pachioni JD, 2013, J PHARM PHARM SCI, V16, P742
   Patrick G. L., 2013, INTRO MED CHEM
   Ramirez de Molina A, 2004, CANCER RES, V64, P6732, DOI 10.1158/0008-5472.CAN-04-0489
   Ramirez de Molina A, 2008, INT J BIOCHEM CELL B, V40, P1753, DOI 10.1016/j.biocel.2008.01.013
   Ramos B, 2002, MOL PHARMACOL, V62, P1068, DOI 10.1124/mol.62.5.1068
   Renner S, 2008, J CHEM INF MODEL, V48, P319, DOI 10.1021/ci7003626
   RICHARDS B, 2010, FASEB J, V24
   Rodrigues RP, 2015, J CHEM EDUC, V92, P827, DOI 10.1021/ed500195d
   Alves ACS, 2018, CURR MED CHEM, V25, P2082, DOI 10.2174/0929867325666180111100601
   Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1
   van Blitterswijk WJ, 2008, CURR PHARM DESIGN, V14, P2061, DOI 10.2174/138161208785294636
   Van der Luit AH, 2003, BIOCHEM J, V374, P747, DOI 10.1042/BJ20030179
   van der Luit AH, 2002, J BIOL CHEM, V277, P39541, DOI 10.1074/jbc.M203176200
   van der Luit AH, 2007, MOL CANCER THER, V6, P2337, DOI 10.1158/1535-7163.MCT-07-0202
   Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465
   Vogler WR, 1996, LEUKEMIA RES, V20, P947, DOI 10.1016/S0145-2126(96)00070-7
   VOGLER WR, 1987, LIPIDS, V22, P919, DOI 10.1007/BF02535555
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   WEINHOLD PA, 1991, J BIOL CHEM, V266, P6093
   Wieder T, 1998, J BIOL CHEM, V273, P11025, DOI 10.1074/jbc.273.18.11025
   WIEDER T, 1995, LIPIDS, V30, P389, DOI 10.1007/BF02536296
   Wiese M., 2002, DRUG MEMBRANE INTERA
   Williams DH, 2004, ANGEW CHEM INT EDIT, V43, P6596, DOI 10.1002/anie.200300644
   Young D., 2009, COMPUTATIONAL DRUG D
NR 66
TC 1
Z9 1
U1 4
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1438-7697
EI 1438-9312
J9 EUR J LIPID SCI TECH
JI Eur. J. Lipid Sci. Technol.
PD JUL
PY 2020
VL 122
IS 7
AR 1900422
DI 10.1002/ejlt.201900422
EA JUN 2020
PG 12
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA MH7SV
UT WOS:000539599200001
DA 2020-11-30
ER

PT J
AU Machado-Paula, MM
   Corat, MAF
   Lancellotti, M
   Mi, G
   Marciano, FR
   Vega, ML
   Hidalgo, AA
   Webster, TJ
   Lobo, AO
AF Machado-Paula, M. M.
   Corat, M. A. F.
   Lancellotti, M.
   Mi, G.
   Marciano, F. R.
   Vega, M. L.
   Hidalgo, A. A.
   Webster, T. J.
   Lobo, A. O.
TI A comparison between electrospinning and rotary-jet spinning to produce
   PCL fibers with low bacteria colonization
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Poly epsilon-caprolactone; Electrospinning; Rotary jet spinning;
   Bacteria colonization; Cytotoxicity; Nanotechnology
ID TISSUE; ADHESION; BIOMATERIALS; INFECTIONS; ADSORPTION; ATTACHMENT;
   NANOFIBERS; TOLERANCE; SCAFFOLDS; ROUGHNESS
AB One of the important components in tissue engineering is material structure, providing a model for fixing and the development of cells and tissues, which allows for the transport of nutrients and regulatory molecules to and from cells. The community claims the need for new materials with better properties for use in the clinic. Poly (epsilon-caprolactone) (PCL) is a biodegradable polymer, semi crystalline, with superior mechanical properties and has attracted an increasing interest due to its usefulness in various biomedical applications. Herein, two different methods (electrospinning versus rotary jet spinning) with different concentrations of PCL produced ultra thinfibers each with particular characteristics, verified and analyzed by morphology, wettability, thermal and cytotoxicity features and for bacteria colonization. Different PCL scaffold morphologies were found to be dependent on the fabrication method used. All PCL scaffolds showed greater mammalian cell interactions. Most impressively, rotary-jet spun fibers showed that a special rough surface decreased bacteria colonization, emphasizing that no nanoparticle or antibiotic was used; maybe this effect is related with physical (scaffold) and/or biological mechanisms. Thus, this study showed that rotary jet spun fibers possess a special topography compared to electrospun fibers to reduce bacteria colonization and present no cytotoxicity when in contact with mammalian cells.
C1 [Machado-Paula, M. M.] Univ Vale Paraiba, Programa Posgrad Engn Biomed, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
   [Machado-Paula, M. M.; Mi, G.; Marciano, F. R.; Webster, T. J.; Lobo, A. O.] Northeastern Univ, Dept Chem Engn, Nanomed Labs, Boston, MA 02115 USA.
   [Corat, M. A. F.] Univ Estadual Campinas, Multidisciplinary Ctr Biol Res, BR-13083877 Campinas, SP, Brazil.
   [Lancellotti, M.] Univ Estadual Campinas, Fac Pharmaceut Sci, Lab Biotechnol, BR-13083877 Campinas, SP, Brazil.
   [Marciano, F. R.] UFPI Fed Univ Piaui, Dept Phys, BR-64049550 Teresina, PI, Brazil.
   [Vega, M. L.; Hidalgo, A. A.] UFPI Fed Univ Piaui, Dept Phys, Mat & Bionanotechnol Lab, BR-64049550 Teresina, PI, Brazil.
   [Lobo, A. O.] UFPI Fed Univ Piaui, Dept Mat Engn, LIMAV Interdisciplinary Lab Adv Mat, BR-64049550 Teresina, PI, Brazil.
RP Webster, TJ; Lobo, AO (corresponding author), Northeastern Univ, Dept Chem Engn, Nanomed Labs, Boston, MA 02115 USA.
EM th.webster@northeastern.edu; lobo@ufpi.edu.br
RI Lobo, Anderson Oliveira/B-2893-2011; Vega, Maria Leticia/F-9344-2015
OI Lobo, Anderson Oliveira/0000-0002-2544-0438; Vega, Maria
   Leticia/0000-0003-2517-8465
FU Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES [88881.068048/2014-01]; CAPESCAPES [88887.116351/2016-00];
   Northeastern University; Brazilian National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq) [465572/2014-6]; Sao Paulo Research
   Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2014/50869-6, 2014/16295-2, 2011/17877-7, 2011/20345-7,
   2015/08523-8, 2015/09697-0, 2016/00576-1]; CAPES (Education Ministry)
   via the projects of the National Institute for Science and Technology on
   Organic Electronics (INEO) [23038.000776/201754]
FX The authors would like to thank the Sao Paulo Research Foundation
   (FAPESP: 2014/16295-2, 2011/17877-7, 2011/20345-7, 2015/08523-8,
   2015/09697-0 and 2016/00576-1), the Coordination for the Improvement of
   Higher Education Personnel (CAPES, grant 88881.068048/2014-01), a
   scholarship from CAPES (88887.116351/2016-00), and Northeastern
   University for funding. This study was partially supported by the
   Brazilian National Council for Scientific and Technological Development
   (CNPq) (process number: 465572/2014-6), the Sao Paulo Research
   Foundation (FAPESP) (2014/50869-6), and CAPES (Education Ministry)
   (23038.000776/201754) via the projects of the National Institute for
   Science and Technology on Organic Electronics (INEO).
CR Abedini F, 2012, INT J NANOMED, V7, P4159, DOI [10.2147/IJN.S29823, 10.2147/IJN.S30434]
   Abrigo M, 2015, ACS APPL MATER INTER, V7, P7644, DOI 10.1021/acsami.5b00453
   Anselme K, 2010, P I MECH ENG H, V224, P1487, DOI 10.1243/09544119JEIM901
   Arciola CR, 2015, ADV EXP MED BIOL, V830, P29, DOI 10.1007/978-3-319-11038-7_2
   Armentano I, 2014, SCI WORLD J, DOI 10.1155/2014/410423
   Asghari F, 2017, ARTIF CELL NANOMED B, V45, P185, DOI 10.3109/21691401.2016.1146731
   Badrossamay MR, 2014, BIOMATERIALS, V35, P3188, DOI 10.1016/j.biomaterials.2013.12.072
   Badrossamay MR, 2010, NANO LETT, V10, P2257, DOI 10.1021/nl101355x
   Band VI, 2015, ANTIBIOTICS-BASEL, V4, P18, DOI 10.3390/antibiotics4010018
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Beyth N, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/246012
   Bixler GD, 2012, PHILOS T R SOC A, V370, P2381, DOI 10.1098/rsta.2011.0502
   Bobbert F., 2017, J MAT CHEM B
   Carman ML, 2006, BIOFOULING, V22, P11, DOI 10.1080/08927010500484854
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Christman KL, 2019, SCIENCE, V363, P340, DOI 10.1126/science.aar2955
   Damodaran Vinod B, 2016, Biomater Res, V20, P18, DOI 10.1186/s40824-016-0064-4
   Desai TA, 2000, MED ENG PHYS, V22, P595, DOI 10.1016/S1350-4533(00)00087-4
   Ercan B, 2013, INT J NANOMED, V8, P75, DOI 10.2147/IJN.S47286
   Evans ND, 2006, MATER TODAY, V9, P26, DOI 10.1016/S1369-7021(06)71740-0
   Gentleman MM, 2014, INT MATER REV, V59, P417, DOI 10.1179/1743280414Y.0000000038
   Gonzalez GM, 2017, MACROMOL MATER ENG, V302, DOI 10.1002/mame.201600365
   Gu H, 2014, FRONT CHEM SCI ENG, V8, P20, DOI 10.1007/s11705-014-1412-3
   Guo SS, 2017, MAT SCI ENG C-MATER, V70, P1163, DOI 10.1016/j.msec.2016.03.074
   Hall CW, 2017, FEMS MICROBIOL REV, V41, P276, DOI [10.1093/femsre/fux010, 10.1093/femsre/f]
   Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Kar K. K., 2014, HDB POLYM NANOCOMPOS
   Kasalkova N.S., 2015, WETTING WETTABILITY
   Kaur N., 2013, INT J PHARM BIO SCI, V4, P957
   Khang D, 2007, BIOMATERIALS, V28, P4756, DOI 10.1016/j.biomaterials.2007.07.018
   Khorshidi S, 2016, J TISSUE ENG REGEN M, V10, P715, DOI 10.1002/term.1978
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kostakova EK, 2017, J NANOMATER, V2017, DOI 10.1155/2017/8952390
   Li BY, 2018, J ORTHOP RES, V36, P22, DOI 10.1002/jor.23656
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Malikmammadov E, 2018, J BIOMAT SCI-POLYM E, V29, P863, DOI 10.1080/09205063.2017.1394711
   Mann EE, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-28
   Mellado P, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662015
   Nir S, 2016, CURR OPIN BIOTECH, V39, P48, DOI 10.1016/j.copbio.2015.12.012
   Nishimoto S, 2013, RSC ADV, V3, P671, DOI 10.1039/c2ra21260a
   Percival SL, 2015, J MED MICROBIOL, V64, P323, DOI 10.1099/jmm.0.000032
   Piacenza E., 2017, MICROBIAL BIOTECHNOL
   Pogodin S, 2013, BIOPHYS J, V104, P835, DOI 10.1016/j.bpj.2012.12.046
   Pu X, 2016, BIOL OPEN, V5, P389, DOI 10.1242/bio.016899
   Ray SS, 2016, RSC ADV, V6, P85495, DOI 10.1039/c6ra14952a
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rodriguez-Hernandez J., 2017, BACTERIAL INFECT FEW, P13
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Scardino AJ, 2008, BIOFOULING, V24, P45, DOI 10.1080/08927010701784391
   Schneider RP, 1996, J COLLOID INTERF SCI, V182, P204, DOI 10.1006/jcis.1996.0452
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Seltmann G., 2013, BACTERIAL CELL WALL
   Shakibaie M, 2015, J TRACE ELEM MED BIO, V29, P235, DOI 10.1016/j.jtemb.2014.07.020
   Singh Shriti, 2017, Open Microbiol J, V11, P53, DOI 10.2174/1874285801711010053
   Stojanovska E, 2016, RSC ADV, V6, P83783, DOI 10.1039/c6ra16986d
   Teterycz D, 2010, INT J INFECT DIS, V14, pE913, DOI 10.1016/j.ijid.2010.05.014
   Valizadeh A, 2016, ARTIF CELL NANOMED B, V44, P504, DOI 10.3109/21691401.2014.965310
   van de Lagemaat M, 2017, ACTA BIOMATER, V59, P139, DOI 10.1016/j.actbio.2017.06.042
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893, DOI 10.1128/AEM.53.8.1893-1897.1987
   Vunjak-Novakovic G, 2006, TISSUE ENG, V12, P3261, DOI 10.1089/ten.2006.12.3261
   Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Xu Q, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0300
   Yuan Y, 2017, RSC ADV, V7, P14254, DOI 10.1039/c7ra01571b
   Zhang XX, 2013, RSC ADV, V3, P12003, DOI 10.1039/c3ra40497h
NR 66
TC 1
Z9 1
U1 6
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN
PY 2020
VL 111
AR 110706
DI 10.1016/j.msec.2020.110706
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA LF4NO
UT WOS:000527396600003
PM 32279777
DA 2020-11-30
ER

PT J
AU Cefali, LC
   Vazquez, C
   Ataide, JA
   Figueiredo, MC
   Ruiz, ALTG
   Foglio, MA
   Lancellotti, M
   Mazzola, PG
AF Cefali, Leticia Caramori
   Vazquez, Carolina
   Ataide, Janaina Artem
   Figueiredo, Mariana Cecchetto
   Ruiz, Ana Lucia Tasca Gois
   Foglio, Mary Ann
   Lancellotti, Marcelo
   Mazzola, Priscila Gava
TI In vitro activity and formulation of a flavonoid-containing cashew pulp
   extract for the topical treatment of acne and the protection of skin
   against premature aging
SO NATURAL PRODUCT RESEARCH
LA English
DT Article; Early Access
DE Acne; aging; antioxidant; cashew; flavonoids
AB The cashew nut is an important product in Brazil, both for consumption and export, with the pulp of the cashew fruit being considered a by-product despite its high flavonoid content. In this study, the use of cashew pulp extract as a treatment for acne and in the prevention of early skin damage was investigated. Its flavonoid content was determined using spectrophotometric identification, and its effects on cell and bacterial viability, the migration of keratinocytes, and antioxidant activity in vitro were evaluated. Furthermore, it was incorporated into an emulsion for topical administration, and the physical-chemical stability parameters of the formulation were determined. The cashew pulp contained flavonoids with healing and antioxidant activity, and was not toxic to keratinocyte cells in a viability test. The flavonoid-rich formulation was stable, indicating that this is a promising formulation for use in the treatment of acne and protection of skin against premature damage.
C1 [Cefali, Leticia Caramori] Univ Campinas UNICAMP, Inst Biol, Grad Program Biosci & Technol Bioact Prod, Campinas, SP, Brazil.
   [Vazquez, Carolina; Ataide, Janaina Artem; Ruiz, Ana Lucia Tasca Gois; Foglio, Mary Ann; Lancellotti, Marcelo; Mazzola, Priscila Gava] Univ Campinas UNICAMP, Fac Pharmaceut Sci, Candido Portinari St 200,Cidade Univ Zeferino Vaz, BR-13083871 Campinas, SP, Brazil.
   [Figueiredo, Mariana Cecchetto] Univ Campinas UNICAMP, Sch Med Sci, Grad Program Med Sci, Campinas, SP, Brazil.
RP Ataide, JA (corresponding author), Univ Campinas UNICAMP, Fac Pharmaceut Sci, Candido Portinari St 200,Cidade Univ Zeferino Vaz, BR-13083871 Campinas, SP, Brazil.
EM janaina.a.ataide@gmail.com
RI Ruiz, Ana Lucia Tasca Gois/C-2249-2012; Ataide, Janaina
   Artem/I-6604-2018
OI Ruiz, Ana Lucia Tasca Gois/0000-0002-0844-8702; Ataide, Janaina
   Artem/0000-0002-1929-9474
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/25533-7];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
   [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) (number 2015/25533-7), and partial financial support
   by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
   (Finance Code 001) and Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq).
CR Abreu CRA, 2009, ACTA HORTIC, V841, P451
   Agostini-Costa Tânia da Silveira, 2004, Cienc. Rural, V34, P1075, DOI 10.1590/S0103-84782004000400017
   Martin MA, 2010, J NUTR BIOCHEM, V21, P196, DOI 10.1016/j.jnutbio.2008.10.009
   Bhat M. G., 2010, Journal of Horticultural Sciences, V5, P1
   Cefali LC, 2016, INT J COSMETIC SCI, V38, P346, DOI 10.1111/ics.12316
   Cefali LC, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8100443
   Cefali LC, 2015, BRAZ J PHARM SCI, V51, P579, DOI 10.1590/S1984-82502015000300010
   Chiari BG, 2014, IND CROP PROD, V52, P389, DOI 10.1016/j.indcrop.2013.11.011
   Dornas W. C., 2007, Revista de Ciencias Farmaceuticas Basica e Aplicada, V28, P241
   Farmacopeia ANDVS, 2010, FARMACOPEIA BRASILEI
   Feldmann KA, 2001, CURR OPIN PLANT BIOL, V4, P162, DOI 10.1016/S1369-5266(00)00154-0
   Filho W, 2016, TECNOL CIEN AGROPEC, V10, P6
   Hirata LL, 2004, ACTA FARM BONAER, V23, P418
   Kanlayavattanakul M, 2011, INT J COSMETIC SCI, V33, P289, DOI 10.1111/j.1468-2494.2011.00647.x
   Lotito SB, 2006, FREE RADICAL BIO MED, V41, P1727, DOI 10.1016/j.freeradbiomed.2006.04.033
   MANN J, 1987, SECONDARY METABOLISM
   Masaki H, 2010, J DERMATOL SCI, V58, P85, DOI 10.1016/j.jdermsci.2010.03.003
   Melo EA, 2006, BRAZ J FOOD TECHNOL, V9, P89
   Michodjehoun-Mestres L, 2009, FOOD CHEM, V112, P851, DOI 10.1016/j.foodchem.2008.06.056
   Moura C. F. H., 2001, Revista Brasileira de Fruticultura, V23, P537, DOI 10.1590/S0100-29452001000300017
   Nugroho A. E., 2013, International Food Research Journal, V20, P299
   Paiva FA, 2000, EMBRAPA AGROINDUSTRI, P74
   PEREZILZARBE J, 1991, Z LEBENSM UNTERS FOR, V192, P551, DOI 10.1007/BF01202512
   Pitz HS, 2016, OXID MED CELL LONGEV, V2016, P1
   Prochazkova D, 2011, FITOTERAPIA, V82, P513, DOI 10.1016/j.fitote.2011.01.018
   Rivera AE, 2008, J AM ACAD DERMATOL, V59, P659, DOI 10.1016/j.jaad.2008.05.029
   Seo GY, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.167
   Silva ME, 2007, BRAZ J CHEM ENG, V24, P163, DOI 10.1590/S0104-66322007000200001
   Tan A U, 2018, Int J Womens Dermatol, V4, P56, DOI 10.1016/j.ijwd.2017.10.006
   Toyoda Masahiko, 2001, Medical Electron Microscopy, V34, P29, DOI 10.1007/s007950100002
   Cavalcanti JJV, 2007, CROP BREED APPL BIOT, V7, P186, DOI 10.12702/1984-7033.v07n02a11
   Xu L, 2013, ANN PLAS SURG, V71, P415, DOI 10.1097/SAP.0b013e31824ca62b
   Yeh SL, 2005, J NUTR BIOCHEM, V16, P729, DOI 10.1016/j.jnutbio.2005.03.012
NR 33
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-6419
EI 1478-6427
J9 NAT PROD RES
JI Nat. Prod. Res.
DI 10.1080/14786419.2020.1747454
EA APR 2020
PG 7
WC Chemistry, Applied; Chemistry, Medicinal
SC Chemistry; Pharmacology & Pharmacy
GA LH0GF
UT WOS:000528466900001
PM 32323575
DA 2020-11-30
ER

PT J
AU Delafiori, J
   Lima, ED
   Dabaja, MZ
   Dias-Audibert, FL
   de Oliveira, DN
   Melo, CFOR
   Morishita, KN
   Sales, GM
   Ruiz, ALTG
   da Silva, GG
   Lancellotti, M
   Catharino, RR
AF Delafiori, Jeany
   Lima, Estela de Oliveira
   Dabaja, Mohamed Ziad
   Dias-Audibert, Flavia Luisa
   de Oliveira, Diogo Noin
   Rodrigues Melo, Carlos Fernando Odir
   Morishita, Karen Noda
   Sales, Geovana Manzan
   Tasca Gois Ruiz, Ana Lucia
   da Silva, Gisele Goulart
   Lancellotti, Marcelo
   Catharino, Rodrigo Ramos
TI Molecular signatures associated with prostate cancer cell line (PC-3)
   exposure to inactivated Zika virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NRF2; METHYLTRANSFERASE; GLYCOSYLATION; REPLICATION; PROGRESSION;
   MODULATION; MECHANISMS; PREVENTION; INFECTION; PROTEINS
AB The recent outbreak of Zika virus (ZIKV) infection associated with microcephaly cases has elicited much research on the mechanisms involved in ZIKV-host cell interactions. It has been described that Zika virus impairs cell growth, raising a hypothesis about its oncolytic potential against cancer cells. ZIKV tumor cell growth inhibition was later confirmed for glioblastoma. It was also demonstrated that an inactivated ZIKV prototype (ZVp) based on bacterial outer membrane vesicles has antiproliferative activity upon other cancer cell lines, such as PC-3 prostate cancer cell. This study aims at understanding the pathways that might be involved with the antiproliferative effect of Zika virus against prostate cancer cells. A metabolomic approach based on high-resolution mass spectrometry analysis led to the identification of 21 statistically relevant markers of PC-3 cells treated with ZVp. The markers were associated with metabolic alterations that trigger lipid remodeling, endoplasmic reticulum stress, inflammatory mediators, as well as disrupted porphyrin and folate metabolism. These findings highlight molecular signatures of ZVp-induced response that may be involved on cellular pathways triggered by its antiproliferative effect. To our knowledge, this is the first reported metabolomic assessment of ZIKV effect on prostate cancer cells, a promising topic for further research.
C1 [Delafiori, Jeany; Dabaja, Mohamed Ziad; Dias-Audibert, Flavia Luisa; de Oliveira, Diogo Noin; Rodrigues Melo, Carlos Fernando Odir; Morishita, Karen Noda; Sales, Geovana Manzan; Catharino, Rodrigo Ramos] Univ Estadual Campinas, Sch Pharmaceut Sci, Innovare Biomarkers Lab, UNICAMP, Campinas, SP, Brazil.
   [Lima, Estela de Oliveira] Sao Paulo State Univ UNESP, Med Sch, Botucatu, SP, Brazil.
   [Tasca Gois Ruiz, Ana Lucia] Univ Estadual Campinas, Sch Pharmaceut Sci, UNICAMP, Campinas, SP, Brazil.
   [Tasca Gois Ruiz, Ana Lucia; da Silva, Gisele Goulart] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, UNICAMP, Piracicaba, SP, Brazil.
   [Lancellotti, Marcelo] Univ Estadual Campinas, Sch Pharmaceut Sci, Lab Biotechnol, UNICAMP, Campinas, SP, Brazil.
RP Catharino, RR (corresponding author), Univ Estadual Campinas, Sch Pharmaceut Sci, Innovare Biomarkers Lab, UNICAMP, Campinas, SP, Brazil.
EM rodrigo.catharino@fcf.unicamp.br
RI de Oliveira, Diogo Noin/C-3939-2013; Lima, Estela/W-5105-2019; Ruiz, Ana
   Lucia Tasca Gois/C-2249-2012
OI de Oliveira, Diogo Noin/0000-0002-2725-476X; Lima,
   Estela/0000-0003-0479-0364; Ruiz, Ana Lucia Tasca
   Gois/0000-0002-0844-8702; Melo, Carlos/0000-0003-0334-1065; Delafiori,
   Jeany/0000-0003-2481-0465
FU OCRC (Obesity Comorbidities Research Center) CEPID: CMPO - Centro
   Multidisciplinar de Pesquisa em Obesidade e Doencas Associadas (FAPESP)
   [13/07607-8]; Coordination for the Improvement of Higher Education
   Personnel (CAPES)CAPES [88882.305824/2013-01]; National Council for
   Scientific and Technological Development (CNPQ)National Council for
   Scientific and Technological Development (CNPq) [141200/2018-9,
   1578388]; Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2016/17066-2, 2018/14657-5]
FX This work was supported by the OCRC (Obesity Comorbidities Research
   Center) CEPID: CMPO - Centro Multidisciplinar de Pesquisa em Obesidade e
   Doencas Associadas (FAPESP number: 13/07607-8). The members of Innovare
   Biomarkers Laboratory would like to thank Professor Edson Durigon for
   providing the ZIKV strain. This research was funded by Coordination for
   the Improvement of Higher Education Personnel (CAPES) for the fellowship
   granted for DO (PNPD No. 88882.305824/2013-01) and scholarships of JD
   and MD; by the National Council for Scientific and Technological
   Development (CNPQ) grant numbers 141200/2018-9 and 1578388 (PNPD) for
   FD-A and EL fellowship, respectively; and by the Sao Paulo Research
   Foundation (FAPESP) grant number 2016/17066-2 for CM fellowship and
   2018/14657-5 for research funding.
CR Alves D, 2013, J VACCINES VACCIN, DOI [10.4172/2157-7560.1000196, DOI 10.4172/2157-7560.1000196]
   Arboleda G, 2009, BRAIN RES REV, V59, P333, DOI 10.1016/j.brainresrev.2008.10.001
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brys M, 2013, MOL CELL BIOCHEM, V372, P149, DOI 10.1007/s11010-012-1455-z
   Bylund J, 2000, CYTOCHROME P450 ENZY
   Chen HX, 2016, FRONT BIOSCI-LANDMRK, V21, P1084
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Dabaja MZ, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0243-1
   Dando I, 2019, BIOL REV, V94, P1530, DOI 10.1111/brv.12513
   Dean Wendy, 2005, Birth Defects Res C Embryo Today, V75, P98, DOI 10.1002/bdrc.20037
   El Kalamouni C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010002
   Frohlich DA, 2008, ONCOGENE, V27, P4353, DOI 10.1038/onc.2008.79
   GOTTLIEB C, 1988, FERTIL STERIL, V49, P322
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heger Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep33379
   Jadoon S, 2018, BIOCH PHARM ANGEL, V7, P2167, DOI [10.4172/2167-0501.1000246, DOI 10.4172/2167-0501.1000246]
   Janssens S, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00210-17
   Jayakumar S, 2014, BBA-GEN SUBJECTS, V1840, P485, DOI 10.1016/j.bbagen.2013.10.006
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x
   Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Kurosu M, 2018, J MOL PHARM ORGANIC, V6, DOI [10.4172/2329-9053.1000141, DOI 10.4172/2329-9053.1000141]
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Leier HC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006952
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lima ED, 2018, J MASS SPECTROM, V53, P257, DOI 10.1002/jms.4058
   Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y
   Majumdar S, 2011, CURR GENOMICS, V12, P486, DOI 10.2174/138920211797904061
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martins P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26508-z
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02373
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01954
   Milkovic L, 2017, REDOX BIOL, V12, P727, DOI 10.1016/j.redox.2017.04.013
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Moon EJ, 2015, FREE RADICAL BIO MED, V79, P292, DOI 10.1016/j.freeradbiomed.2014.11.009
   Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Mueller E, 2000, P NATL ACAD SCI USA, V97, P10990, DOI 10.1073/pnas.180329197
   Nakano T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198345
   No Jae Hong, 2014, J Cancer Prev, V19, P111, DOI 10.15430/JCP.2014.19.2.111
   Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377
   Paschos A, 2013, PROSTATE CANCER P D, V16, P217, DOI 10.1038/pcan.2013.13
   Perez-Garcia LA, 2017, CURR PROTEIN PEPT SC, V18, P1090, DOI 10.2174/1389203717666160813161729
   Rockenfeller P, 2015, CELL DEATH DIFFER, V22, P499, DOI 10.1038/cdd.2014.219
   Roman WA, 2017, REV BRAS FARMACOGN, V27, P592, DOI 10.1016/j.bjp.2017.05.007
   Simanjuntak Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006854
   Song YH, 2011, MODERN PATHOL, V24, P1272, DOI 10.1038/modpathol.2011.76
   Spencer JL, 2018, J INFECT DIS, V217, P538, DOI 10.1093/infdis/jix436
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   Strating JRPM, 2017, CURR OPIN CELL BIOL, V47, P24, DOI 10.1016/j.ceb.2017.02.005
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073
   Xu Yi, 2014, Biomed J, V37, P112, DOI 10.4103/2319-4170.131378
   Yang X, 2015, INT J MOL SCI, V16, P25865, DOI 10.3390/ijms161025865
   Yu SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008579
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
   2008, VITAM HORM, V79, P1
NR 63
TC 0
Z9 0
U1 2
U2 5
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 25
PY 2019
VL 9
AR 15351
DI 10.1038/s41598-019-51954-8
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JH5RK
UT WOS:000492825800061
PM 31653965
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU De Almeida, JR
   Mendes, B
   Lancellotti, M
   Franchi, G
   Vale, N
   Gomes, PAC
   Da Silva, SL
AF De Almeida, Jose Rafael
   Mendes, Bruno
   Lancellotti, Marcelo
   Franchi, Gilberto
   Vale, Nuno
   Carvalho Gomes, Paula Alexandra
   Da Silva, Saulo Luis
TI EFFECT OF LEUCINE TO PHENYLALANINE SUBSTITUTION ON ANTIBACTERIAL AND
   ANTITUMORAL PROPERTIES OF BIOMIMETIC PEPTIDES DERIVED FROM VENOM TOXINS
SO TOXICON
LA English
DT Meeting Abstract
CT 15th Congress of the Brazilian-Society-of-Toxinology
CY MAY 26-29, 2019
CL Sao Pedro, BRAZIL
SP Brazilian Soc Toxinol
C1 [De Almeida, Jose Rafael] Univ Reg Amazon Ikiam, Tena, AL, Brazil.
   [Mendes, Bruno; Lancellotti, Marcelo; Franchi, Gilberto] Univ Estadual Campinas, Campinas, SP, Brazil.
   [Vale, Nuno; Carvalho Gomes, Paula Alexandra] Univ Porto, Porto, Portugal.
   [Da Silva, Saulo Luis] Univ Cuenca, Cuenca, Ecuador.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD OCT 5
PY 2019
VL 168
SU 1
MA 070
BP S30
EP S30
DI 10.1016/j.toxicon.2019.06.125
PG 1
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA NI2UD
UT WOS:000565210200102
DA 2020-11-30
ER

PT J
AU Pereira, RFC
   Mofatto, LS
   Silva, ACA
   Alves, DA
   Machado, D
   Theizen, TH
   Pereira, GAG
   Levy, CE
   de Hollanda, LM
   Carazzolle, MF
   Lancellotti, M
AF Pereira, Rafaella F. C.
   Mofatto, Luciana S.
   Silva, Ana C. A.
   Alves, Danilo A.
   Machado, Daisy
   Theizen, Thais H.
   Pereira, Goncalo A. G.
   Levy, Carlos E.
   de Hollanda, Luciana M.
   Carazzolle, Marcelo F.
   Lancellotti, Marcelo
TI Draft Whole-Genome Sequences of Haemophilus influenzae Biogroup
   aegyptius Strains Isolated from Five Brazilian Purpuric Fever Cases and
   One Conjunctivitis Case
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
ID CLONE
AB Brazilian purpuric fever is a febrile hemorrhagic pediatric disease caused by Haemophilus influenzae biogroup aegyptius, a bacterium which was formerly associated with only self-limited purulent conjunctivitis. Here, we present draft genomes of strains from five Brazilian purpuric fever cases and one conjunctivitis case.
C1 [Pereira, Rafaella F. C.; Machado, Daisy; Theizen, Thais H.; de Hollanda, Luciana M.; Lancellotti, Marcelo] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil.
   [Mofatto, Luciana S.; Pereira, Goncalo A. G.; Carazzolle, Marcelo F.] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Campinas, SP, Brazil.
   [Silva, Ana C. A.; Alves, Danilo A.; Lancellotti, Marcelo] Univ Estadual Campinas, Fac Pharmaceut Sci, Campinas, SP, Brazil.
   [Levy, Carlos E.] Univ Estadual Campinas, Sch Med Sci, Dept Clin Pathol, Campinas, SP, Brazil.
   [de Hollanda, Luciana M.] Tiradentes Univ UNIT, Inst Technol & Res ITP, Aracaju, SE, Brazil.
RP Pereira, RFC (corresponding author), Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil.
EM rafaella.carneirop@gmail.com
RI Mofatto, Luciana S/A-8914-2011; Carazzolle, Marcelo
   Falsarella/C-6503-2012; Machado, Daisy/ABA-3731-2020; UNICAMP, CCES
   -/J-7787-2015; Levy, Carlos/AAN-7226-2020; Hollanda, Luciana Maria
   de/F-7893-2011; Levy, Carlos/L-2116-2013
OI Mofatto, Luciana S/0000-0002-2087-7251; Carazzolle, Marcelo
   Falsarella/0000-0002-5474-2830; Machado, Daisy/0000-0002-6435-6159;
   Hollanda, Luciana Maria de/0000-0002-6047-4043; Levy,
   Carlos/0000-0002-4862-8900
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2011/01319-5, 2012/15046-3]
FX This work was financed by the Sao Paulo Research Foundation (FAPESP;
   grant no. 2011/01319-5 and 2012/15046-3).
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75
   BRENNER DJ, 1988, J CLIN MICROBIOL, V26, P1524, DOI 10.1128/JCM.26.8.1524-1534.1988
   Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365
   Harrison LH, 2008, CLIN MICROBIOL REV, V21, P594, DOI 10.1128/CMR.00020-08
   Jolley Keith A, 2018, Wellcome Open Res, V3, P124, DOI 10.12688/wellcomeopenres.14826.1
   Kroll JS, 2002, PLASMID, V48, P38, DOI 10.1016/S0147-619X(02)00020-3
   Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226
   Santana-Porto EA, 2009, EMERG INFECT DIS, V15, P675, DOI 10.3201/eid1504.090014
   Strouts FR, 2012, EMERG INFECT DIS, V18, P449, DOI 10.3201/eid1803.110728
   Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569
   Wilson K, 2001, CURR PROTOC MOL BIOL, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
NR 13
TC 1
Z9 1
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD JUL
PY 2019
VL 8
IS 30
AR e00642-19
DI 10.1128/MRA.00642-19
PG 3
WC Microbiology
SC Microbiology
GA IL8ZC
UT WOS:000477574000021
PM 31346025
OA Green Published, Other Gold
DA 2020-11-30
ER

PT J
AU Costa, JSR
   Medeiros, M
   Yamashiro-Kanashiro, EH
   Rocha, MC
   Cotrim, PC
   Stephano, MA
   Lancellotti, M
   Tavares, GD
   Oliveira-Nascimento, L
AF Ribeiro Costa, Juliana Souza
   Medeiros, Marilia
   Yamashiro-Kanashiro, Edite Harumi
   Rocha, Mussya Cisotto
   Cotrim, Paulo Cesar
   Stephano, Marco Antonio
   Lancellotti, Marcelo
   Tavares, Guilherme Diniz
   Oliveira-Nascimento, Laura
TI Biodegradable nanocarriers coated with polymyxin B: Evaluation of
   leishmanicidal and antibacterial potential
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID POLYALKYLCYANOACRYLATE NANOPARTICLES; CUTANEOUS LEISHMANIASIS;
   SENSITIVITY
AB Most treatments of leishmaniasis require hospitalization and present side effects or parasite resistance; innovations in drug formulation/reposition can overcome these barriers and must be pursued to increase therapeutic alternatives. Therefore, we tested polymyxin B (polB) potential to kill Leishmania amazonensis, adsorbed or not in PBCA nanoparticles (PBCAnp), which could augment polB internalization in infected macrophages. PBCAnps were fabricated by anionic polymerization and analyzed by Dynamic Light Scattering (size, potential), Nanoparticle Tracking Analysis (size/concentration), vertical diffusion cell (release rate), drug incorporation (indirect method, protein determination) and in vitro cell viability. Nanoparticles coated with polB (PBCAnp-polB) presented an adequate size of 261.5 25.9 nm, low PDI and of 1.79 +/- 0.17 mV (stable for 45 days, at least). The 50% drug release from PBCAnp-polB was 6-7 times slower than the free polB, which favors a prolonged and desired release profile. Concerning in vitro evaluations, polB alone reduced in vitro amastigote infection of macrophages (10 g/mL) without complete parasite elimination, even at higher concentrations. This behavior limits its future application to adjuvant leishmanicidal therapy or antimicrobial coating of carriers. The nanocarrier PBCAnp also presented leishmanicidal effect and surpassed polB activity; however, no antimicrobial activity was detected. PolB maintained its activity against E. coli, Pseudomonas and Klebsiella, adding antimicrobial properties to the nanoparticles. Thus, this coated drug delivery system, described for the first time, demonstrated antileishmanial and antimicrobial properties. The bactericidal feature helps with concomitant prevention/treatment of secondary infections that worst ulcers induced by cutaneous L. amazonensis, ultimately ending in disfiguring or disabling lesions.
   Author summary Cutaneous leishmaniasis form disfiguring lesions that leads to depression and social isolation. Both consequences result often in economic and education loss for communities already short on resources. The actual treatment aims to eliminate the protozoa disease-vector. Yet, it presents undesired effects or parasite resistance, besides the need for intravenous infusions and hospitalization. There is a few topical leishmanicidals but none with prolonged action. As highlighted, no ideal therapy exists; we must keep searching for alternatives, which includes new drugs, vehicles or therapies. For drugs, the most cost-effective way comprises testing approved molecules for other diseases, such as the antimicrobial polymyxin B (polB). Repositioning a drug has the added benefit of known safety profile and drawbacks, shortening and narrowing the research path. In turn, carriers can decrease side-effects and multiple dosing. They shield and/or improve drug targeting, which in this case means delivering inside macrophages infected with Leishmania. An example is poly (n-butyl cyanoacrylate) nanoparticles (PBCAnp), shown as an efficient carrier for targeting an extended drug release. Therefore, this work aimed to evaluate leishmanicidal and adjuvant properties of polB, alone and absorbed onto PBCAnp.
C1 [Ribeiro Costa, Juliana Souza; Lancellotti, Marcelo; Oliveira-Nascimento, Laura] Univ Estadual Campinas, Biol Inst, Dept Biochem & Tissue Biol, Campinas, SP, Brazil.
   [Ribeiro Costa, Juliana Souza; Medeiros, Marilia; Lancellotti, Marcelo; Oliveira-Nascimento, Laura] Univ Estadual Campinas, Fac Pharmaceut Sci, Campinas, SP, Brazil.
   [Yamashiro-Kanashiro, Edite Harumi; Rocha, Mussya Cisotto; Cotrim, Paulo Cesar] Univ Sao Paulo, Trop Med Inst, Sao Paulo, SP, Brazil.
   [Stephano, Marco Antonio] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, SP, Brazil.
   [Tavares, Guilherme Diniz] Univ Estadual Campinas, Campinas, SP, Brazil.
RP Oliveira-Nascimento, L (corresponding author), Univ Estadual Campinas, Biol Inst, Dept Biochem & Tissue Biol, Campinas, SP, Brazil.; Oliveira-Nascimento, L (corresponding author), Univ Estadual Campinas, Fac Pharmaceut Sci, Campinas, SP, Brazil.
EM lauraon@unicamp.br
RI Costa, Juliana Souza Ribeiro/AAW-1517-2020; Tavares,
   Guilherme/AAQ-7583-2020; Stephano, Marco Antonio/H-3980-2013
OI Costa, Juliana Souza Ribeiro/0000-0002-2211-4493; Yamashiro-Kanashiro,
   Edite/0000-0002-8050-7658; Stephano, Marco Antonio/0000-0003-2927-0584;
   de Oliveira Nascimento, Laura/0000-0002-4741-8493; Tavares,
   Guilherme/0000-0001-6276-0994
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/16588-7]; Fundo
   de Amparo ao Ensino, Pesquisa e Extensao da UNICAMP (FAEPEX);
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil
   (CAPES)CAPES [001]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP), Grant number: 2013/16588-7 (http://www.fapesp.br)
   and Fundo de Amparo ao Ensino, Pesquisa e Extensao da UNICAMP (FAEPEX).
   Juliana Souza Ribeiro Costa was financed by the Fundo de Amparo ao
   Ensino, Pesquisa e Extensao da UNICAMP (FAEPEX) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) - Finance
   Code 001 (http://www.capes.gov.br/bolsas). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], 2015, J POLIT PHILOS, V23, P481
   Bootz A, 2004, EUR J PHARM BIOPHARM, V57, P369, DOI 10.1016/S0939-6411(03)00193-0
   Cabeza L, 2015, INT J NANOMED, V10, P1291, DOI 10.2147/IJN.S74378
   Cardoso LS, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-1
   Clinical and Laboratory Standards Institute, 2015, METH DIL ANT SUSC TE
   COUVREUR P, 1991, J CONTROL RELEASE, V17, P187, DOI 10.1016/0168-3659(91)90058-L
   Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI [10.1128/CMR.19.1.111-126.2006, 10.4103/0974-777X.62887]
   Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004
   Goncalves EDD, 2009, REV SOC BRAS MED TRO, V42, P219, DOI 10.1590/S0037-86822009000200027
   Duque Beltran S, 1992, BIOMED BOGOTA, V12, P68
   Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2
   Gales AC, 2001, J CLIN MICROBIOL, V39, P183, DOI 10.1128/JCM.39.1.183-190.2001
   GASPAR R, 1992, ANN TROP MED PARASIT, V86, P41, DOI 10.1080/00034983.1992.11812629
   Honary S, 2013, TROP J PHARM RES, V12, P255, DOI 10.4314/tjpr.v12i2.19
   Horikoshi S., 2013, MICROWAVES NANOPARTI
   Kisich KO, 2007, INT J PHARM, V345, P154, DOI 10.1016/j.ijpharm.2007.05.062
   Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512
   Lourenco C, 1996, INT J PHARM, V138, P1, DOI 10.1016/0378-5173(96)04486-9
   McDermott Alison M, 2004, Ocul Surf, V2, P229
   Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev
   Monteiro LM, 2017, INT J ANTIMICROB AG, V50, P88, DOI 10.1016/j.ijantimicag.2017.01.033
   Nguyen LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012684
   OrganizacAo Mundial da Saude, 2010, 1 ORG MUND SAUD
   Rivas L, 2009, BBA-BIOMEMBRANES, V1788, P1570, DOI 10.1016/j.bbamem.2008.11.002
   Rogero Sizue Ota, 2003, Mat. Res., V6, P317, DOI 10.1590/S1516-14392003000300003
   STORM DR, 1977, ANNU REV BIOCHEM, V46, P723, DOI 10.1146/annurev.bi.46.070177.003451
   Sutariya VB, 2015, BIOINTERACTIONS OF NANOMATERIALS, P1
   Tavares GD, 2013, NANOPARTICULAS POLI
   Urban C, 2011, ANTIMICROB AGENTS CH, V55, P388, DOI 10.1128/AAC.01088-10
   Van der Vliet D, 2006, AM J TROP MED HYG, V75, P270, DOI 10.4269/ajtmh.2006.75.270
   Vermeersch M, 2009, ANTIMICROB AGENTS CH, V53, P3855, DOI 10.1128/AAC.00548-09
   Verrest L, 2017, CLIN PHARMACOKINET, V56, P583, DOI 10.1007/s40262-016-0467-3
   WHO, 2016, LEISH SIT TRENDS
   Wikler M., 2009, METHODS DILUTION ANT
   Yeaman MR, 2002, ANTIMICROB AGENTS CH, V46, P3883, DOI 10.1128/AAC.46.12.3883-3891.2002
   Zauli-Nascimento RC, 2010, TROP MED INT HEALTH, V15, P68, DOI 10.1111/j.1365-3156.2009.02414.x
   Zazo H, 2016, J CONTROL RELEASE, V224, P86, DOI 10.1016/j.jconrel.2016.01.008
   Zhang Q, 1998, INT J PHARM, V164, P21, DOI 10.1016/S0378-5173(97)00395-5
NR 38
TC 3
Z9 3
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2019
VL 13
IS 5
AR e0007388
DI 10.1371/journal.pntd.0007388
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IB3ST
UT WOS:000470188100048
PM 31042710
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Vit, FF
   Oliveira, AF
   Rodriguez, DAO
   de Carvalho, HF
   Lancellotti, M
   de la Torre, LG
AF Vit, Franciele Flores
   Oliveira, Aline Furtado
   Osorio Rodriguez, Daniel Andres
   de Carvalho, Hernandes F.
   Lancellotti, Marcelo
   de la Torre, Lucimara Gaziola
TI Perfusion microbioreactor system with permeable membranes to monitor
   bacterial growth
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE microfluidics; bacteria; bioprocess; microbioreactors; microdevices
ID ESCHERICHIA-COLI; INHIBITORY CONCENTRATION; MICROFLUIDIC DEVICE;
   DIFFUSION; CHEMOTAXIS; GRADIENTS; STREPTOMYCIN; CULTIVATION; GENERATION;
   TRANSPORT
AB BACKGROUND Microfluidics offers itself as a potential platform for optimizing microbial growth in different substrate concentrations using a single assay. The aim of this study was to construct a reversible microfluidic device for monitoring the bacterial growth in chambers with different substrate concentrations with its respective technical triplicates. The convective concentration gradient generator (CCG) system was constructed with three inlets for solutions with different concentrations that distributed them to the sequential cultivation chambers (CCs). A perfusion microbioreactor system (PM) was constructed using a commercial polydimethylsiloxane (PDMS) sheet and glass, with an adapted semi-permeable membrane system to constrain the cells within the CC. Cell growth of a fluorescent Escherichia coli JM109 was monitored by fluorescence microscope with time-lapse technique. RESULTS The growth profile of E. coli with different streptomycin concentrations and its specific growth rates (mu(x)) in the microfluidics device (mu(x) of 0.0088 and 0.0092 h(-1)) were compared in batch cultivations, which show no significant difference between the two methods. In addition, the half maximal inhibitory concentration (IC50) values indicate that continuous perfusion surpasses consumption of the tested drug. CONCLUSION The results demonstrate the efficiency of the microfluidic device for cell cultivation and its applicability in industrial biotechnology, allowing rapid screening of multiple parameters. (c) 2018 Society of Chemical Industry
C1 [Vit, Franciele Flores; Oliveira, Aline Furtado; de la Torre, Lucimara Gaziola] Univ Estadual Campinas, Sch Chem Engn, Dept Bioproc & Mat Engn, Albert Einstein Ave 500, BR-13083852 Campinas, SP, Brazil.
   [Osorio Rodriguez, Daniel Andres; de Carvalho, Hernandes F.] Univ Estadual Campinas, Inst Biol, Dept Cell Biol, Campinas, SP, Brazil.
   [Lancellotti, Marcelo] Univ Estadual Campinas, Sch Pharmaceut Sci, Dept Pharmaceut Sci, Campinas, SP, Brazil.
RP de la Torre, LG (corresponding author), Univ Estadual Campinas, Sch Chem Engn, Dept Bioproc & Mat Engn, Albert Einstein Ave 500, BR-13083852 Campinas, SP, Brazil.
EM latorre@feq.unicamp.br
RI de la Torre, Lucimara G/C-7896-2012; de la Torre, Lucimara/Y-3414-2019;
   Oliveira, Aline/Q-6008-2017
OI de la Torre, Lucimara G/0000-0002-8179-1160; de la Torre,
   Lucimara/0000-0002-8179-1160; Osorio Rodriguez, Daniel
   Andres/0000-0001-5026-8441; Vit, Franciele/0000-0002-0047-8384;
   Oliveira, Aline/0000-0003-0317-7816
FU Fundacao de Amparo a pesquisa do Estado de Sao Paulo (Sao Paulo Research
   Foundation FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2015/26701-0]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES)CAPES [001]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq - National Council for Scientific and
   Technological Development)National Council for Scientific and
   Technological Development (CNPq) [310735/2016-5]
FX We would like to thank the financial support from Fundacao de Amparo a
   pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation FAPESP -
   process number 2015/26701-0) and Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES) finance code 001 (Coordination for the
   Improvement of Higher Education Personnel). We also thank CNPEM -The
   Laboratory of Microfabrication (LMF), Professor Dr Jose Alberto Fracassi
   and INCT-INFABIC for the use of equipment and data acquisition. The
   authors would like to thank Dr Anupam Aich and Mr. Erico G Baroni for
   providing English language revision. LGT thanks Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq - National Council for
   Scientific and Technological Development, productivity grant
   310735/2016-5).
CR Abu-Lail NI, 2003, ENVIRON SCI TECHNOL, V37, P2173, DOI 10.1021/es026159o
   Ahmed T, 2010, INTEGR BIOL-UK, V2, P604, DOI 10.1039/c0ib00049c
   Ahmed T, 2010, NANO LETT, V10, P3379, DOI 10.1021/nl101204e
   Amselem G, 2016, LAB CHIP, V16, P4200, DOI 10.1039/c6lc00968a
   Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163
   Atencia J, 2012, LAB CHIP, V12, P309, DOI 10.1039/c1lc20829b
   Bower DM, 2012, BIOTECHNOL BIOENG, V109, P1976, DOI 10.1002/bit.24498
   BRYAN LE, 1976, ANTIMICROB AGENTS CH, V9, P928, DOI 10.1128/AAC.9.6.928
   Canning J, 2014, NANOMATERIALS-BASEL, V4, P157, DOI 10.3390/nano4010157
   Chang WJ, 2003, BIOMED MICRODEVICES, V5, P281, DOI 10.1023/A:1027301628547
   Cira NJ, 2012, LAB CHIP, V12, P1052, DOI 10.1039/c2lc20887c
   Englert DL, 2009, APPL ENVIRON MICROB, V75, P4557, DOI 10.1128/AEM.02952-08
   Failing K, 2006, DEUT TIERARZTL WOCH, V113, P412
   FERNANDEZ RO, 1987, ANTIMICROB AGENTS CH, V31, P1627, DOI 10.1128/AAC.31.10.1627
   Friedlander RS, 2013, P NATL ACAD SCI USA, V110, P5624, DOI 10.1073/pnas.1219662110
   Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI 10.2217/NNM.10.12
   Hol FJH, 2014, SCIENCE, V346, P438, DOI 10.1126/science.1251821
   Hou SY, 2011, LANGMUIR, V27, P2686, DOI 10.1021/la1046194
   Hou ZN, 2014, LAB CHIP, V14, P3409, DOI 10.1039/c4lc00451e
   Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b
   Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712
   JINHO S, 1985, BIOTECHNOL BIOENG, V27, P1668
   JUNG G, 1988, ANN INST PASTEUR MIC, V139, P129, DOI 10.1016/0769-2609(88)90100-7
   Kijanka GS, 2015, ANAL CHIM ACTA, V872, P95, DOI 10.1016/j.aca.2014.12.035
   Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049
   Leclerc E, 2003, BIOMED MICRODEVICES, V5, P109, DOI 10.1023/A:1024583026925
   Lecuyer S, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/3/030401
   Lin F, 2004, LAB CHIP, V4, P164, DOI 10.1039/b313600k
   Netrabukkana R, 1996, IND ENG CHEM RES, V35, P458, DOI 10.1021/ie950200x
   Oliveira AF, 2016, BIOCHEM ENG J, V105, P288, DOI 10.1016/j.bej.2015.09.015
   Oliveira AF, 2016, BIOTECHNOL PROGR, V32, P1372, DOI 10.1002/btpr.2350
   Park JY, 2009, LAB CHIP, V9, P2194, DOI 10.1039/b822006a
   Patino T, 2016, LAB CHIP, V16, P3626, DOI 10.1039/c6lc90088g
   RIESENBERG D, 1991, J BIOTECHNOL, V20, P17, DOI 10.1016/0168-1656(91)90032-Q
   Rusconi R, 2014, NAT PHYS, V10, P212, DOI 10.1038/NPHYS2883
   Sambrook J., 2001, MOL CLONING LAB MANU
   Somaweera H, 2016, ANAL CHIM ACTA, V907, P7, DOI 10.1016/j.aca.2015.12.008
   Tirella A, 2008, TOXICOL IN VITRO, V22, P1957, DOI 10.1016/j.tiv.2008.09.016
   Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784
   Wang SY, 2009, J PHARMACEUT BIOMED, V49, P806, DOI 10.1016/j.jpba.2008.12.021
NR 40
TC 3
Z9 3
U1 2
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-2575
EI 1097-4660
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD MAR
PY 2019
VL 94
IS 3
BP 712
EP 720
DI 10.1002/jctb.5814
PG 9
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA HK9FL
UT WOS:000458295400006
DA 2020-11-30
ER

PT J
AU Amstalden, MCK
   Oliveira, JD
   Strauss, M
   Mazali, IO
   Machado, D
   Theisen, TH
   Lancellotti, M
AF Amstalden, Maria-Cecilia Krahenbuehl
   Oliveira, Jose Diogo
   Strauss, Mathias
   Mazali, Italo Odone
   Machado, Daisy
   Theisen, Thais Holtz
   Lancellotti, Marcelo
TI Analysis of the effects of mesoporous silica particles SBA-15 and SBA-16
   in Streptococcus pneumoniae transformation process
SO FOLIA MICROBIOLOGICA
LA English
DT Article
ID RESPIRATORY-INFECTIONS; DRUG-DELIVERY; AIR-POLLUTION; NANOPARTICLES;
   COMPETENCE; EXPOSURE
AB Streptococcus pneumoniae are natural competent bacteria which requires the presence of a pheromone-like molecule to do the transformation process. This study verified the influence of mesoporous silica (SBA-15 and SBA-16) on the transformation process in S. pneumoniae using a donor DNA obtained from a mutant strain of this microorganism (Sp360luxS). The results showed that mesoporous silica SBA-15 and SBA-16 particles doubled the transformation ratio frequency compared with negative control (without nanoparticles) in using SBA-15 (ratio 1.81 +/- 0.04) and SBA-16 (ratio 2.18 +/- 0.22). We demonstrated the how mesoporous silica nanoparticles were able to increase the pneumococcus transformations, which could possibly lead to the acquisition of virulence factor genes and resistance of antibiotics.
C1 [Amstalden, Maria-Cecilia Krahenbuehl; Oliveira, Jose Diogo; Machado, Daisy; Theisen, Thais Holtz; Lancellotti, Marcelo] Univ Estadual Campinas, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil.
   [Amstalden, Maria-Cecilia Krahenbuehl; Lancellotti, Marcelo] Univ Estadual Campinas, Fac Pharmaceut Sci, Campinas, SP, Brazil.
   [Strauss, Mathias] Natl Ctr Res Energy & Mat, Brazilian Nanotechnol Natl Lab, Campinas, SP, Brazil.
   [Strauss, Mathias] Univ Estadual Campinas, Inst Chem, Funct Mat Lab, Campinas, SP, Brazil.
RP Lancellotti, M (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil.; Lancellotti, M (corresponding author), Univ Estadual Campinas, Fac Pharmaceut Sci, Campinas, SP, Brazil.
EM marcelo.lancellotti@fcf.unicamp.br
RI Mazali, Italo O/C-5217-2012; Machado, Daisy/ABA-3731-2020
OI Mazali, Italo O/0000-0001-5698-5273; Machado, Daisy/0000-0002-6435-6159
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); Coordination for the
   Improvement of Higher Education Personnel (CAPES)CAPES; Sao Paulo
   Research FoundationFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2011/14079-2, 2013/22127-2, 2014/50906-9]; National Council
   for Scientific and Technological DevelopmentNational Council for
   Scientific and Technological Development (CNPq) [307494/2016-0]
FX This work was funded by the National Council for Scientific and
   Technological Development (CNPq), Sao Paulo Research Foundation
   (FAPESP), and Coordination for the Improvement of Higher Education
   Personnel (CAPES). This study was funded by Sao Paulo Research
   Foundation (2011/14079-2; 2013/22127-2; 2014/50906-9) and National
   Council for Scientific and Technological Development (307494/2016-0).
CR Blossom DB, 2007, MICROB DRUG RESIST, V13, P21, DOI 10.1089/mdr.2006.9993
   Brauer M, 2002, AM J RESP CRIT CARE, V166, P1092, DOI 10.1164/rccm.200108-007OC
   Chen WH, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001206
   Silva JMDE, 2011, J MATER CHEM, V21, P15678, DOI 10.1039/c1jm11476j
   Ezzati M, 2001, ENVIRON HEALTH PERSP, V109, P481, DOI 10.2307/3454706
   Hausdorff WP, 2001, LANCET, V357, P950, DOI 10.1016/S0140-6736(00)04222-7
   Hollanda LM, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-28
   Joloba ML, 2010, INT J ANTIMICROB AG, V36, P124, DOI 10.1016/j.ijantimicag.2010.03.024
   Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g
   Mamaeva V, 2013, ADV DRUG DELIVER REV, V65, P689, DOI 10.1016/j.addr.2012.07.018
   Mattos IB, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-53
   Meynen V, 2009, MICROPOR MESOPOR MAT, V125, P170, DOI 10.1016/j.micromeso.2009.03.046
   Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996
   Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012
   Slowing II, 2007, ADV FUNCT MATER, V17, P1225, DOI 10.1002/adfm.200601191
   Steinmoen H, 2003, J BACTERIOL, V185, P7176, DOI 10.1128/JB.185.24.7176-7183.2003
   Stevens KE, 2011, MBIO, V2, DOI 10.1128/mBio.00071-11
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   teWaterNaude JM, 2006, OCCUP ENVIRON MED, V63, P187, DOI 10.1136/oem.2004.018614
   Varela JN, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-14
   Xia TA, 2009, ACS NANO, V3, P3273, DOI 10.1021/nn900918w
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
NR 22
TC 0
Z9 0
U1 1
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0015-5632
EI 1874-9356
J9 FOLIA MICROBIOL
JI Folia Microbiol.
PD JAN
PY 2019
VL 64
IS 1
BP 127
EP 132
DI 10.1007/s12223-018-0631-2
PG 6
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA HH7MW
UT WOS:000455916000016
PM 30008055
DA 2020-11-30
ER

PT J
AU Nascimento, V
   Franca, C
   Hernandez-Montelongo, J
   Machado, D
   Lancellotti, M
   Cotta, M
   Landers, R
   Beppu, M
AF Nascimento, Vicente
   Franca, Carla
   Hernandez-Montelongo, Jacobo
   Machado, Daisy
   Lancellotti, Marcelo
   Cotta, Monica
   Landers, Richard
   Beppu, Marisa
TI Influence of pH and ionic strength on the antibacterial effect of
   hyaluronic acid/chitosan films assembled layer-by-layer
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE Natural polymers; Layer-by-layer; pH; Ionic strength; Antibacterial
   effect
ID MULTILAYER FILMS; POLYELECTROLYTE MULTILAYERS; CHITOSAN; CD44; ACID;
   CONSTRUCTION; BIOFILMS; BUILDUP
AB Hyaluronic acid (HA)/chitosan (CHI) films were assembled by LbL using different conditions of pH and ionic strength (IS) in order to obtain stable surfaces to avoid the adhesion and proliferation of Pseudomonas aeruginosa and Staphylococcus aureus. The results showed that pH and IS were key synthesis variables for obtaining different features, such as wettability, thickness and the availability of functional groups. The antibacterial effect was more effective against S. aureus with a reduction of approximately 3, 4, and 1.5 log reduction after 4, 8 and 24 h of culture time, respectively. In the case of P. aeruginosa, the films presented a lower bacterial reduction: 1 log reduction in times evaluated. In conclusion, the results of the antibacterial effect against S. aureus after 24 h, suggest that the HA/CHI films assembled by LbL can protect several substrates, such as biomedical devices, against bacterial proliferation.
C1 [Nascimento, Vicente; Franca, Carla; Beppu, Marisa] Univ Estadual Campinas, Fac Engn Quim, BR-13083852 Campinas, SP, Brazil.
   [Hernandez-Montelongo, Jacobo; Cotta, Monica; Landers, Richard] Univ Estadual Campinas, Inst Fis Gleb Wataghin, BR-13083859 Campinas, SP, Brazil.
   [Hernandez-Montelongo, Jacobo] Univ Catolica Temuco, Fac Ingn, Dept Ciencias Matemat & Fis, Araucania 4813302, Chile.
   [Machado, Daisy; Lancellotti, Marcelo] Univ Estadual Campinas, Inst Biol, BR-13083862 Campinas, SP, Brazil.
RP Nascimento, V (corresponding author), Univ Estadual Campinas, Fac Engn Quim, BR-13083852 Campinas, SP, Brazil.
EM vicente.qmc@gmail.com
RI Machado, Daisy/ABA-3731-2020; Hernandez-Montelongo, Jacobo/H-2717-2013;
   Franca, Carla Giometti/AAM-9298-2020; Cotta, Monica A/H-3505-2012
OI Machado, Daisy/0000-0002-6435-6159; Franca, Carla
   Giometti/0000-0003-3527-7563; 
FU FAPEAM; CNPqNational Council for Scientific and Technological
   Development (CNPq); CAPESCAPES
FX The authors acknowledge the support from Multi-User Lab (LAMULT) from
   Institute of Physics "Gleb Wataghin" at UNICAMP, which provided
   invalu-able access to their equipments. This work was financially
   supported FAPEAM, CNPq, and CAPES.
CR Almodovar J, 2011, BIOMACROMOLECULES, V12, P2755, DOI 10.1021/bm200519y
   Brown MB, 2005, J EUR ACAD DERMATOL, V19, P308, DOI 10.1111/j.1468-3083.2004.01180.x
   Brunot C, 2007, BIOMATERIALS, V28, P632, DOI 10.1016/j.biomaterials.2006.09.026
   Chang SH, 2015, CARBOHYD POLYM, V134, P74, DOI 10.1016/j.carbpol.2015.07.072
   Chua PH, 2008, J BIOMED MATER RES A, V87A, P1061, DOI 10.1002/jbm.a.31854
   Chung YC, 2008, BIORESOURCE TECHNOL, V99, P2806, DOI 10.1016/j.biortech.2007.06.044
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cui D, 2010, ADV FUNCT MATER, V20, P3303, DOI 10.1002/adfm.201000601
   CULTY M, 1992, J CELL BIOL, V116, P1055, DOI 10.1083/jcb.116.4.1055
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   De Kievit TR, 2001, APPL ENVIRON MICROB, V67, P1865, DOI 10.1128/AEM.67.4.1865-1873.2001
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Elzbieciak M, 2009, LANGMUIR, V25, P3255, DOI 10.1021/la803988k
   Elzbieciak M, 2008, COLLOID SURFACE A, V321, P258, DOI 10.1016/j.colsurfa.2008.01.036
   Fanni D, 2013, RENAL FAILURE, V35, P967, DOI 10.3109/0886022X.2013.808955
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Habib SB, 2010, J VAC SCI TECHNOL A, V28, P476, DOI 10.1116/1.3374738
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   Hernandez-Montelongo J, 2017, MAT SCI ENG C-MATER, V71, P718, DOI 10.1016/j.msec.2016.10.064
   Hernandez-Montelongo J, 2016, COLLOID SURFACE B, V141, P499, DOI 10.1016/j.colsurfb.2016.02.028
   Hernandez-Montelongo J, 2014, CARBOHYD POLYM, V110, P238, DOI 10.1016/j.carbpol.2014.04.002
   Hernandez-Montelongo J, 2016, CARBOHYD POLYM, V136, P1, DOI 10.1016/j.carbpol.2015.08.076
   Lawrie G, 2007, BIOMACROMOLECULES, V8, P2533, DOI 10.1021/bm070014y
   Li ZH, 2015, INT J BIOL MACROMOL, V75, P378, DOI 10.1016/j.ijbiomac.2015.01.056
   Lichter JA, 2009, LANGMUIR, V25, P7686, DOI 10.1021/la900349c
   Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022
   Lopez BGC, 2015, J APPL MICROBIOL, V119, P677, DOI 10.1111/jam.12874
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Picart C, 2005, ADV FUNCT MATER, V15, P1771, DOI 10.1002/adfm.200400588
   Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004
   Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5
   Swiston AJ, 2008, NANO LETT, V8, P4446, DOI 10.1021/nl802404h
   Wang BL, 2013, ACS APPL MATER INTER, V5, P4136, DOI 10.1021/am4000547
NR 37
TC 6
Z9 6
U1 6
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD DEC
PY 2018
VL 109
BP 198
EP 205
DI 10.1016/j.eurpolymj.2018.09.038
PG 8
WC Polymer Science
SC Polymer Science
GA HG4WD
UT WOS:000454974800022
DA 2020-11-30
ER

PT J
AU Dabaja, MZ
   Lima, ED
   de Oliveira, DN
   Guerreiro, TM
   Melo, CFOR
   Morishita, KN
   Lancellotti, M
   Ruiz, ALTG
   Goulart, G
   Duarte, DA
   Catharino, RR
AF Dabaja, Mohamed Ziad
   Lima, Estela de Oliveira
   de Oliveira, Diogo Noin
   Guerreiro, Tatiane Melina
   Odir Rodrigues Melo, Carlos Fernando
   Morishita, Karen Noda
   Lancellotti, Marcelo
   Tasca Gois Ruiz, Ana Lucia
   Goulart, Gisele
   Duarte, Diego Andreazzi
   Catharino, Rodrigo Ramos
TI Metabolic alterations induced by attenuated Zika virus in glioblastoma
   cells
SO CELL AND BIOSCIENCE
LA English
DT Article
DE Zika virus; Outer membrane vesicle; Prototype; Mass spectrometry; Cancer
   research
ID NF-KAPPA-B; ANTICANCER DRUG SCREEN; NITRIC-OXIDE SYNTHASE;
   TUMOR-NECROSIS-FACTOR; NEURAL STEM-CELLS; LYSOPHOSPHATIDIC ACID;
   IN-VIVO; METHIONINE SYNTHASE; HYDROGEN-PEROXIDE; FOLIC-ACID
AB Background: Zika virus (ZIKV) has recently become a major matter of concern since its association with microcephaly cases in newborns was determined. From then on, ZIKV has been untiringly studied, and several scientific data have shown the virus' tropism to neural cells. Previous studies have proposed that ZIKV induced glioblastoma cells death, suggesting that ZIKV and ZIKV-associated molecules might induce intracellular biochemical alterations, and thereby be alternatives for neural cancer management. In this sense, the present contribution presents a prospective approach for glioblastomas management: producing a ZIKV-based therapy that stimulates glioblastoma control. We developed an attenuated ZIKV prototype based on bacterial outer membrane vesicles (OMV). The attenuated ZIKV was applied on glioblastoma cells, where cytopathic and cytostatic effects were evaluated. Glioblastoma cells, with and without treatment, were submitted to mass spectrometry analysis.
   Results: Microscopic analysis showed cytopathic effects induced by ZIKV prototype on glioblastoma cells after 24 and 48 h post-treatment. DNA fragmentation assay and TNF-alpha expression were indicative that ZVp induced cell damage and death. The metabolomics investigation elected 5 different biomarkers that might be associated with cell cytopathic effects, highlighting intracellular biochemical modifications induced by the attenuated ZIKV. The remarkable evidence of cell death in glioblastoma stimulated further studies that rendered a preliminary screening with other tumor cell lineages, though anti-proliferative activity test. Among the 11 tumors evaluated, prostate and ovarian tumors were the most affected by ZIKV prototype, and other 6 cell lines also presented cytostatic effects.
   Conclusions: Results ultimately demonstrated that this prototype not only emerges as a potential alternative for glioblastoma management, but may also be an important tool against other important tumors.
C1 [Dabaja, Mohamed Ziad; Lima, Estela de Oliveira; de Oliveira, Diogo Noin; Guerreiro, Tatiane Melina; Odir Rodrigues Melo, Carlos Fernando; Morishita, Karen Noda; Catharino, Rodrigo Ramos] Univ Estadual Campinas, UNICAMP, Sch Pharmaceut Sci, Innovare Biomarkers Lab, Campinas, SP, Brazil.
   [Lancellotti, Marcelo] Univ Estadual Campinas, UNICAMP, Sch Pharmaceut Sci, Lab Biotechnol, Campinas, SP, Brazil.
   [Tasca Gois Ruiz, Ana Lucia; Goulart, Gisele] Univ Estadual Campinas, UNICAMP, Fac Pharmaceut Sci, BR-13081970 Campinas, SP, Brazil.
   [Duarte, Diego Andreazzi] Univ Estadual Campinas, UNICAMP, Fac Med Sci, Renal Pathophysiol Lab, Campinas, SP, Brazil.
RP Catharino, RR (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Pharmaceut Sci, Innovare Biomarkers Lab, Campinas, SP, Brazil.
EM rrc@g.unicamp.br
RI de Oliveira Lima, Estela/G-7375-2015; de Oliveira, Diogo
   Noin/C-3939-2013; Lima, Estela/W-5105-2019; Ruiz, Ana Lucia Tasca
   Gois/C-2249-2012
OI de Oliveira Lima, Estela/0000-0003-0479-0364; de Oliveira, Diogo
   Noin/0000-0002-2725-476X; Lima, Estela/0000-0003-0479-0364; Ruiz, Ana
   Lucia Tasca Gois/0000-0002-0844-8702; Melo, Carlos/0000-0003-0334-1065
FU OCRC (Obesity Comorbidities Research Center) CEPID: CMPO - Centro
   Multidisciplinar de Pesquisa em Obesidade e Doencas Associadas (FAPESP)
   [13/07607-8]; National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [134522/2016-8]; Coordination for the Improvement of Higher Level
   Personnel (CAPES)CAPES [PNPD: 1578388, PROEX: 1489740]; Sao Paulo
   Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [11/50400-0, 15/06809-1, 18/14657-5, 16/17066-2];
   Plano Nacional de Enfrentamento ao Aedes aegypti e a Microcefalia
   [Brazilian Plan for Fighting Aedes aegypti and Microcephaly]
   [88887.137889/2017-00]
FX This work was supported by the OCRC (Obesity Comorbidities Research
   Center) CEPID: CMPO - Centro Multidisciplinar de Pesquisa em Obesidade e
   Doencas Associadas (FAPESP number: 13/07607-8); the National Council for
   Scientific and Technological Development (134522/2016-8) for the
   fellowship from MZD; the Coordination for the Improvement of Higher
   Level Personnel (CAPES) for the fellowships from EOL (PNPD: 1578388) and
   TMG (PROEX: 1489740); by Sao Paulo Research Foundation (FAPESP, Process
   Nos. 11/50400-0, 15/06809-1 and 18/14657-5 for RRC, and 16/17066-2 for
   CFORM); and by Plano Nacional de Enfrentamento ao Aedes aegypti e a
   Microcefalia [Brazilian Plan for Fighting Aedes aegypti and
   Microcephaly] for the fellowship under process No. 88887.137889/2017-00
   for DNO.
CR Alves D, 2013, J VACCINES VACCIN, DOI [10.4172/2157-7560.1000196, DOI 10.4172/2157-7560.1000196]
   Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522
   Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628
   BANERJEE RV, 1990, FASEB J, V4, P1450
   BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X
   BOYER CS, 1995, BIOCHEM PHARMACOL, V50, P753, DOI 10.1016/0006-2952(95)00195-6
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault S, 2007, AM J PHYSIOL-REG I, V292, pR1174, DOI 10.1152/ajpregu.00619.2006
   CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666
   Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000
   CHAO CC, 1995, CRIT REV NEUROBIOL, V9, P189
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Danishpajooh IO, 2001, J BIOL CHEM, V276, P27296, DOI 10.1074/jbc.M104043200
   DAS AK, 1989, LIPIDS, V24, P329, DOI 10.1007/BF02535172
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Dean Wendy, 2005, Birth Defects Res C Embryo Today, V75, P98, DOI 10.1002/bdrc.20037
   Dello Russo C, 2009, BIOCHEM PHARMACOL, V78, P1242, DOI 10.1016/j.bcp.2009.06.097
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   Dong YZ, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/2754756
   ELIAS L, 1991, LEUKEMIA, V5, P879
   Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084
   FADOK VA, 1992, J IMMUNOL, V148, P2207
   GU XX, 1991, ANAL BIOCHEM, V196, P311, DOI 10.1016/0003-2697(91)90472-6
   GUO HY, 1993, CANCER RES, V53, P5676
   JAMES SJ, 1992, CARCINOGENESIS, V13, P2471, DOI 10.1093/carcin/13.12.2471
   JAMES SJ, 1994, CELL PROLIFERAT, V27, P395, DOI 10.1111/j.1365-2184.1994.tb01471.x
   Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1
   KOPROWSKI H, 1993, P NATL ACAD SCI USA, V90, P3024, DOI 10.1073/pnas.90.7.3024
   Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lima ED, 2018, J MASS SPECTROM, V53, P257, DOI 10.1002/jms.4058
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01954
   MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757
   Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801
   NATARAJAN V, 1993, J BIOL CHEM, V268, P930
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589
   Polumuri SK, 2007, J IMMUNOL, V179, P236, DOI 10.4049/jimmunol.179.1.236
   Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7
   Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422
   Roman WA, 2017, REV BRAS FARMACOGN, V27, P592, DOI 10.1016/j.bjp.2017.05.007
   Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287
   Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951
   SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107
   Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TIGYI G, 1995, AM J PHYSIOL-HEART C, V268, pH2048
   Tuck-Muller CM, 2000, CYTOGENET CELL GENET, V89, P121, DOI 10.1159/000015590
   Weichhart T, 2008, ANN RHEUM DIS, V67, P70, DOI 10.1136/ard.2008.098459
   WRIGHT SC, 1992, J CELL BIOCHEM, V48, P344, DOI 10.1002/jcb.240480403
   Xia J, 2016, CURR PROTOC BIOINFOR, V55
   Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319
   Yaddanapudi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026766
   Zeyaullah M, 2012, PATHOL ONCOL RES, V18, P771, DOI 10.1007/s12253-012-9548-2
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 60
TC 1
Z9 1
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-3701
J9 CELL BIOSCI
JI Cell Biosci.
PD SEP 4
PY 2018
VL 8
AR 47
DI 10.1186/s13578-018-0243-1
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GS4PP
UT WOS:000443631100001
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Franca, CG
   Nascimento, VF
   Hernandez-Montelongo, J
   Machado, D
   Lancellotti, M
   Beppu, MM
AF Franca, Carla Giometti
   Nascimento, Vicente Franco
   Hernandez-Montelongo, Jacobo
   Machado, Daisy
   Lancellotti, Marcelo
   Beppu, Marisa Masumi
TI Synthesis and Properties of Silk Fibroin/Konjac Glucomannan Blend Beads
SO POLYMERS
LA English
DT Article
DE biopolymers; silk fibroin; konjac glucomannan; porous beads; scaffolds;
   tissue engineering
ID KONJAC GLUCOMANNAN; PHYSICAL-PROPERTIES; HYDROXYAPATITE; DEGRADATION;
   FABRICATION; COMPOSITE; MEMBRANES
AB Silk fibroin (SF) and konjac glucomannan (KGM) are promising materials in the biomedical field due to their low toxicity, biocompatibility, biodegradability and low immune response. Beads of these natural polymers are interesting scaffolds for biomedical applications, but their fabrication is a challenge due to their low stability and the necessary adaptation of their chemical and mechanical properties to be successfully applied. In that sense, this study aimed to synthesize a blend of silk fibroin and konjac glucomannan (SF/KGM) in the form of porous beads obtained through dripping into liquid nitrogen, with a post-treatment using ethanol. Intermolecular hydrogen bonds promoted the integration of SF and KGM. Treated beads showed higher porous size, crystallinity, and stability than untreated beads. Characterization analyses by Fourier-transform infrared spectroscopy (FTIR), thermogravimetric (TGA), and X-ray diffraction (XDR) evidenced that ethanol treatment allows a conformational transition from silk I to silk II in SF and an increase in the KGM deacetylation. Those chemical changes significantly enhanced the mechanical resistance of SF/KGM beads in comparison to pure SF and KGM beads. Moreover, samples showed cytocompatibility with HaCaT and BALB/c 3T3 cells.
C1 [Franca, Carla Giometti; Nascimento, Vicente Franco; Beppu, Marisa Masumi] Univ Estadual Campinas, Fac Engn Quim, BR-13083852 Campinas, SP, Brazil.
   [Hernandez-Montelongo, Jacobo] Univ Catolica Temuco, Fac Ingn, Dept Ciencias Matemat & Fis, Temuco 4813302, Chile.
   [Hernandez-Montelongo, Jacobo] Univ Catolica Temuco, Fac Ingn, Nucleo Invest Bioprod & Mat Avanzados BioMa, Temuco 4813302, Chile.
   [Machado, Daisy; Lancellotti, Marcelo] Univ Estadual Campinas, Inst Biol, Lab Biotecnol, BR-13083862 Campinas, SP, Brazil.
RP Hernandez-Montelongo, J (corresponding author), Univ Catolica Temuco, Fac Ingn, Dept Ciencias Matemat & Fis, Temuco 4813302, Chile.; Hernandez-Montelongo, J (corresponding author), Univ Catolica Temuco, Fac Ingn, Nucleo Invest Bioprod & Mat Avanzados BioMa, Temuco 4813302, Chile.
EM carlagfranca@gmail.com; vicente.qmc@gmail.com; jacobo.hernandez@uct.cl;
   daisy.machado@gmail.com; mlancell@unicamp.br; beppu@feq.unicamp.br
RI Franca, Carla Giometti/AAM-9298-2020; Hernandez-Montelongo,
   Jacobo/H-2717-2013; Machado, Daisy/A-4891-2013
OI Franca, Carla Giometti/0000-0003-3527-7563; Machado,
   Daisy/0000-0002-6435-6159; Hernandez-Montelongo,
   Jacobo/0000-0002-1510-3470
FU Brazilian National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX This study was financially supported by the Brazilian National Council
   for Scientific and Technological Development (CNPq).
CR Alonso-Sande M, 2009, EUR J PHARM BIOPHARM, V72, P453, DOI 10.1016/j.ejpb.2008.02.005
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Alvarez-Mancenido F, 2008, INT J PHARMACEUT, V349, P11, DOI 10.1016/j.ijpharm.2007.07.015
   CANEVAROLO JR S. V., 2003, TECNICAS CARACTERIZA
   Chen X, 1997, J POLYM SCI POL PHYS, V35, P2293, DOI 10.1002/(SICI)1099-0488(199710)35:14<2293::AID-POLB9>3.0.CO;2-X
   Chen XD, 2014, BIOMACROMOLECULES, V15, P2166, DOI 10.1021/bm500327m
   Chua M, 2012, CARBOHYD POLYM, V87, P2202, DOI 10.1016/j.carbpol.2011.10.053
   de Alteriis R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12634
   Enomoto-Rogers Y, 2013, CARBOHYD POLYM, V92, P1827, DOI 10.1016/j.carbpol.2012.11.043
   Gong ZG, 2009, CHEM COMMUN, P7506, DOI 10.1039/b914218e
   Guang S., 2015, J APPL POLYM SCI, V132
   Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012
   Hernandez-Montelongo J, 2017, MAT SCI ENG C-MATER, V71, P718, DOI 10.1016/j.msec.2016.10.064
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   International Organization for Standardization, 2009, 109935 ISO
   Jin WP, 2015, FOOD HYDROCOLLOID, V48, P320, DOI 10.1016/j.foodhyd.2015.02.007
   Jin WP, 2014, CARBOHYD POLYM, V99, P270, DOI 10.1016/j.carbpol.2013.08.029
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Lautrup B., 2011, PHYS CONTINUOUS MATT, P696
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lee KG, 2004, J APPL POLYM SCI, V93, P2174, DOI 10.1002/app.20714
   Li J, 2014, FOOD HYDROCOLLOID, V40, P9, DOI 10.1016/j.foodhyd.2014.02.001
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   LIANG CX, 1992, J APPL POLYM SCI, V45, P1937, DOI 10.1002/app.1992.070451108
   Ling SJ, 2011, BIOMACROMOLECULES, V12, P3344, DOI 10.1021/bm2006032
   Lv Q, 2005, J APPL POLYM SCI, V96, P2168, DOI 10.1002/app.21682
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Mori H, 2000, J Biotechnol, V74, P95
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Park SJ, 1999, J APPL POLYM SCI, V74, P2571, DOI 10.1002/(SICI)1097-4628(19991209)74:11<2571::AID-APP2>3.0.CO;2-A
   Qu J., 2013, J BIOMATER NANOBIOTE, V4, P84
   Rusa CC, 2005, MACROMOLECULES, V38, P5640, DOI 10.1021/ma050340a
   Sepulveda P, 2000, J BIOMED MATER RES, V50, P27, DOI 10.1002/(SICI)1097-4636(200004)50:1<27::AID-JBM5>3.0.CO;2-6
   Shang SM, 2013, CARBOHYD POLYM, V93, P561, DOI 10.1016/j.carbpol.2012.12.038
   She ZD, 2008, POLYM DEGRAD STABIL, V93, P1316, DOI 10.1016/j.polymdegradstab.2008.04.001
   Sun LJ, 2015, BIOCHEM ENG J, V96, P46, DOI 10.1016/j.bej.2014.12.012
   Teimouri A, 2015, INT J BIOL MACROMOL, V76, P292, DOI 10.1016/j.ijbiomac.2015.02.023
   Teimouri A, 2015, RSC ADV, V5, P27558, DOI 10.1039/c5ra01018g
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Wang L, 2012, LANGMUIR, V28, P459, DOI 10.1021/la2041373
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Xu X, 2007, CARBOHYD POLYM, V70, P192, DOI 10.1016/j.carbpol.2007.03.017
   Yang G, 2000, J MEMBRANE SCI, V177, P153, DOI 10.1016/S0376-7388(00)00467-1
   Yin AL, 2013, J BIOMED MATER RES A, V101, P1292, DOI 10.1002/jbm.a.34434
   Yu HQ, 2007, CARBOHYD POLYM, V69, P29, DOI 10.1016/j.carbpol.2006.08.024
   Zhang H, 2001, BIOPOLYMERS, V59, P38, DOI 10.1002/1097-0282(200107)59:1<38::AID-BIP1004>3.0.CO;2-A
NR 47
TC 6
Z9 6
U1 1
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD AUG
PY 2018
VL 10
IS 8
AR 923
DI 10.3390/polym10080923
PG 14
WC Polymer Science
SC Polymer Science
GA GU6HG
UT WOS:000445410200116
PM 30960848
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Martins, P
   Machado, D
   Theizen, TH
   Guarnieri, JPO
   Bernardes, BG
   Gomide, GP
   Corat, MAF
   Abbehausen, C
   Modena, JLP
   Melo, CFOR
   Morishita, KN
   Catharino, RR
   Arns, CW
   Lancellotti, M
AF Martins, Paula
   Machado, Daisy
   Theizen, Thais Holtz
   Oliveira Guarnieri, Joao Paulo
   Bernardes, Bruno Gaia
   Gomide, Gabriel Piccirillo
   Finzi Corat, Marcus Alexandre
   Abbehausen, Camilla
   Proenca Modena, Jose Luiz
   Odir Rodrigues Melo, Carlos Fernando
   Morishita, Karen Noda
   Catharino, Rodrigo Ramos
   Arns, Clarice Weis
   Lancellotti, Marcelo
TI Outer Membrane Vesicles from Neisseria Meningitidis (Proteossome) Used
   for Nanostructured Zika Virus Vaccine Production
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PSEUDOMONAS-AERUGINOSA; RESISTANCE; INFECTION; EPIDEMIC; BACTERIA;
   SPREAD
AB The increase of Zika virus (ZIKV) infections in Brazil in the last two years leaves a prophylactic measures on alert for this new and emerging pathogen. Concerning of our positive experience, we developed a new prototype using Neisseria meningitidis outer membrane vesicles (OMV) on ZIKV cell growth in a fusion of OMV in the envelope of virus particles. The fusion of nanoparticles resulting from outer membrane vesicles of N. meningitidis with infected C6/36 cells line were analyzed by Nano tracking analysis (NTA), zeta potential, differential light scattering (DLS), scan and scanning transmission eletronic microscopy (SEM and STEM) and high resolution mass spectometry (HRMS) for nanostructure characterization. Also, the vaccination effects were viewed by immune response in mice protocols immunization (ELISA and inflammatory chemokines) confirmed by Zika virus soroneutralization test. The results of immunizations in mice showed that antibody production had a titer greater than 1: 160 as compared to unvaccinated mice. The immune response of the adjuvant and non-adjuvant formulation activated the cellular immune response TH1 and TH2. In addition, the serum neutralization was able to prevent infection of virus particles in the glial tumor cell model (M059J). This research shows efficient strategies without recombinant technology or DNA vaccines.
C1 [Martins, Paula; Oliveira Guarnieri, Joao Paulo; Bernardes, Bruno Gaia; Gomide, Gabriel Piccirillo; Lancellotti, Marcelo] Univ Campinas UNICAMP, Fac Pharmaceut Sci FCF, Campinas, SP, Brazil.
   [Machado, Daisy; Theizen, Thais Holtz; Lancellotti, Marcelo] Univ Campinas UNICAMP, Inst Biol, Biochem & Tissue Biol Dept, Biotechnol Lab,LABIOTEC, Campinas, SP, Brazil.
   [Finzi Corat, Marcus Alexandre] Univ Estadual Campinas, Multidisciplinary Ctr Biol Res, Campinas, SP, Brazil.
   [Proenca Modena, Jose Luiz; Arns, Clarice Weis] Univ Campinas UNICAMP, Inst Biol, Genet Mol Biol & Bioagents Dept, Campinas, SP, Brazil.
   [Abbehausen, Camilla] Univ Campinas UNICAMP, Inst Chem, Inorgan Dept, Campinas, SP, Brazil.
   [Odir Rodrigues Melo, Carlos Fernando; Morishita, Karen Noda; Catharino, Rodrigo Ramos] Univ Campinas UNICAMP, Fac Pharmaceut Sci FCF, INNOVARE Biomarkers Lab, Campinas, SP, Brazil.
RP Lancellotti, M (corresponding author), Univ Campinas UNICAMP, Fac Pharmaceut Sci FCF, Campinas, SP, Brazil.; Lancellotti, M (corresponding author), Univ Campinas UNICAMP, Inst Biol, Biochem & Tissue Biol Dept, Biotechnol Lab,LABIOTEC, Campinas, SP, Brazil.
EM marcelo.lancellotti@fcf.unicamp.br
RI Corat, Marcus/AAH-2882-2020; Machado, Daisy/ABA-3731-2020; Modena, Jose
   Luiz Proenca/C-8231-2014; Proenca-Modena, Jose Luiz/AAU-7622-2020;
   Abbehausen, Camilla/AAA-7975-2019; Abbehausen, Camilla/X-9527-2019;
   Abbehausen, Camilla/AAD-3050-2020
OI Machado, Daisy/0000-0002-6435-6159; Modena, Jose Luiz
   Proenca/0000-0002-4996-3153; Proenca-Modena, Jose
   Luiz/0000-0002-4996-3153; Abbehausen, Camilla/0000-0002-8410-2252; Melo,
   Carlos/0000-0003-0334-1065
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2014/14457-5, 2016/17066-2, 2017/12719-0]
FX Thanks for Beatriz Jacyntho Siqueira, Prof. Dr. Daniel F. Kawano for the
   moral support for develop this article. Special acknowledgements for
   Prof. Dr. Glaucia Maria Pastore from the initiative for ZIKA Task Force
   in UNICAMP. Thanks for Prof. Dr. Eneida de Paula for use of NTA
   equipment (FAPESP 2014/14457-5), Carlos Fernando Odir Rodrigues de Melo
   (fellowship FAPESP 2016/17066-2), Prof. Dr. Camila Abbehausen in the
   acquisition and STEM images interpretation (FAPESP 2017/12719-0).
   Special thanks for the technician Hugo Campos Loureiro for disponibility
   in perfomed in short time the electronic microscopy images.
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Collins B. S., 2016, DISCOV MED, V12, P7
   da Silva SR, 2016, J MED VIROL, V88, P1657, DOI 10.1002/jmv.24582
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Ferreiros C M, 1991, FEMS Microbiol Lett, V67, P123
   Furuta N, 2009, INFECT IMMUN, V77, P4761, DOI 10.1128/IAI.00841-09
   GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987
   Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071
   Jung R, 2000, CLIN CHEM LAB MED, V38, P833, DOI 10.1515/CCLM.2000.120
   Kadurugamuwa JL, 1996, J BACTERIOL, V178, P2767, DOI 10.1128/jb.178.10.2767-2774.1996
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843
   Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lappann M, 2013, J BACTERIOL, V195, P4425, DOI 10.1128/JB.00625-13
   Lappann M, 2013, MOL MICROBIOL, V89, P433, DOI 10.1111/mmi.12288
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Mashburn-Warren L, 2008, GEOBIOLOGY, V6, P214, DOI 10.1111/j.1472-4669.2008.00157.x
   Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x
   MAYRAND D, 1989, CAN J MICROBIOL, V35, P607, DOI 10.1139/m89-097
   McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x
   McCaig WD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149132
   McCaig WD, 2013, J BACTERIOL, V195, P1120, DOI 10.1128/JB.02007-12
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nagaputra JC, 2014, CLIN VACCINE IMMUNOL, V21, P234, DOI 10.1128/CVI.00561-13
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   PARSONS NJ, 1985, J GEN MICROBIOL, V131, P601
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0
   Sahiner F, 2016, MIKROBIYOL BUL, V50, P333, DOI 10.5578/mb.24167
   Schooling SR, 2006, J BACTERIOL, V188, P5945, DOI 10.1128/JB.00257-06
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   THOMPSON BG, 1981, CAN J MICROBIOL, V27, P729, DOI 10.1139/m81-111
   van der Pol L, 2015, BIOTECHNOL J, V10, P1689, DOI 10.1002/biot.201400395
   Virginio VG, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2016.e00225
   Warner JM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.178101
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J., 2016, J VIROL, V91
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Xia J., 2016, CURRENT PROTOCOLS BI, V14, P91
   Zollinger WD, 1997, INFECT IMMUN, V65, P1053, DOI 10.1128/IAI.65.3.1053-1060.1997
NR 47
TC 4
Z9 4
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 29
PY 2018
VL 8
AR 8290
DI 10.1038/s41598-018-26508-z
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GH3GQ
UT WOS:000433290900021
PM 29844457
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Almeida, JR
   Mendes, B
   Lancellotti, M
   Marangoni, S
   Vale, N
   Passos, O
   Ramos, MJ
   Fernandes, PA
   Gomes, P
   Da Silva, SL
AF Almeida, Jose R.
   Mendes, Bruno
   Lancellotti, Marcelo
   Marangoni, Sergio
   Vale, Nuno
   Passos, Oscar
   Ramos, Maria J.
   Fernandes, Pedro A.
   Gomes, Paula
   Da Silva, Saulo L.
TI A novel synthetic peptide inspired on Lys49 phospholipase A(2) from
   Crotalus oreganus abyssus snake venom active against multidrug-resistant
   clinical isolates
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
DE Antibacterial activity; Biomimetic peptide; Snake venom; Phospholipase
   A(2)
ID C-TERMINAL REGION; INCREASED ANTIMICROBIAL ACTIVITY; SOLID-PHASE
   SYNTHESIS; PSEUDOMONAS-AERUGINOSA; FUTURE-DIRECTIONS; COLOR TEST;
   ANTIBACTERIAL; MECHANISMS; HOMOLOGS; INSIGHTS
AB Currently, the evolving and complex mechanisms of bacterial resistance to conventional antibiotics are increasing, while alternative medicines are drying up, which urges the need to discover novel agents able to kill antibiotic-resistant bacteria. Lys49 phospholipase A(2)s (PLA(2)s) from snake venoms are multifunctional toxins able to induce a huge variety of therapeutic effects and consequently serve as templates for new drug leads. Hence, the present study was aimed at the synthesis of oligopeptides mimicking regions of the antibacterial Lys49 PLA(2) toxin (CoaTx-II), recently isolated from Crotalus oreganus abyssus snake venom, to identify small peptides able to reproduce the therapeutic action of the toxin. Five peptides, representing major regions of interest within CoaTx-II, were synthesized and screened for their antibacterial properties. The 13-mer peptide pC-CoaTxII, corresponding to residues 115-129 of CoaTx-II, was able to reproduce the promising bactericidal effect of the toxin against multi-resistant clinical isolates. Peptide pC-CoaTxII is mainly composed by positively charged and hydrophobic amino acids, a typical trait in most antimicrobial peptides, and presented no defined secondary structure in aqueous environment. The physicochemical properties of pC-CoaTxII are favorable towards a strong interaction with anionic lipid membranes as those in bacteria. Additional in silico studies suggest formation of a water channel across the membrane upon peptide insertion, eventually leading to bacterial cell disruption and death. Overall, our findings confirm the valuable potential of snake venom toxins towards design and synthesis of novel antimicrobials, thus representing key insights towards development of alternative efficient antimicrobials to fight bacterial resistance to current antibiotics. (C) 2018 Elsevier Masson SAS. All rights reserved.
C1 [Almeida, Jose R.; Da Silva, Saulo L.] Univ Reg Amazon, Ikiam, Km 7 Via Muyuna, Tena, Napo, Ecuador.
   [Almeida, Jose R.; Mendes, Bruno; Lancellotti, Marcelo; Marangoni, Sergio] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Bioquim & Biol Tecidual, Campinas, SP, Brazil.
   [Vale, Nuno] Univ Porto, Fac Farm, Dept Ciencias Medicamento, UCIBIO REQUIMTE,Lab Farmacol, Porto, Portugal.
   [Passos, Oscar; Ramos, Maria J.; Fernandes, Pedro A.] Univ Porto, Fac Ciencias, Dept Quim & Bioquim, UCIBIO REQUIMTE, Porto, Portugal.
   [Gomes, Paula] Univ Porto, Fac Ciencias, Dept Quim & Bioquim, LAQV REQUIMTE, Porto, Portugal.
RP Almeida, JR (corresponding author), Univ Reg Amazon, Ikiam, Km 7 Via Muyuna, Tena, Napo, Ecuador.
EM rafael.dealmeida@ikiam.edu.ec
RI Almeida, Jose Rafael/D-1472-2016; Ramos, Maria J/D-6183-2013; Fernandes,
   Pedro A/D-6327-2013; Gomes, Paula A. C./C-6698-2008
OI Almeida, Jose Rafael/0000-0002-4637-4468; Ramos, Maria
   J/0000-0002-7554-8324; Fernandes, Pedro A/0000-0003-2748-4722; Gomes,
   Paula A. C./0000-0002-6018-4724; Mendes, Bruno/0000-0002-3756-6425; Da
   Silva, Saulo Luis/0000-0002-7029-2016
FU Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES; National Counsel of Technological and Scientific
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq); Fundacao para a Ciencia e a Tecnologia (FCT,
   Portugal)Portuguese Foundation for Science and Technology; FEDER
   (European Union)European Union (EU) [UID/Multi/04378/2013,
   IF/00092/2014]; FCT, IF position; Fundacao Manuel Antonio da Mota (FMAM,
   Portugal)
FX The authors gratefully acknowledge to the Coordination for the
   Improvement of Higher Education Personnel (CAPES) for doctoral
   scholarship and the National Counsel of Technological and Scientific
   Development (CNPq) for doctoral-sandwich scholarship and financial
   support. NV thanks support from Fundacao para a Ciencia e a Tecnologia
   (FCT, Portugal) and FEDER (European Union), through projects
   UID/Multi/04378/2013 and IF/00092/2014. NV thanks also FCT by IF
   position and Fundacao Manuel Antonio da Mota (FMAM, Portugal) by support
   to Nuno Vale Lab.
CR Adessi C, 2002, CURR MED CHEM, V9, P963, DOI 10.2174/0929867024606731
   Almeida JR, 2017, CURR MED CHEM, V24, P3254, DOI 10.2174/0929867323666161028155611
   Almeida JR, 2016, TOXICON, V120, P147, DOI 10.1016/j.toxicon.2016.08.007
   Bauer A.W., 1966, TECH B REG MED TECH, V36, P49
   Behrendt R, 2016, J PEPT SCI, V22, P4, DOI 10.1002/psc.2836
   Biovia D. S., 2016, DISCOVERY STUDIO MOD
   Bluhm MEC, 2015, EUR J MED CHEM, V103, P574, DOI 10.1016/j.ejmech.2015.09.022
   Falcao CB, 2015, J MED CHEM, V58, P8553, DOI 10.1021/acs.jmedchem.5b01142
   Cardozo VF, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-12
   Case D. A., 2017, AMBER 2017
   Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006
   Chen YY, 2017, INT J BIOL MACROMOL, V96, P177, DOI 10.1016/j.ijbiomac.2016.11.082
   Correa EA, 2016, TOXICON, V115, P13, DOI 10.1016/j.toxicon.2016.02.021
   Costa TR, 2008, PEPTIDES, V29, P1645, DOI 10.1016/j.peptides.2008.05.021
   Costa TR, 2015, INT J BIOL MACROMOL, V80, P489, DOI 10.1016/j.ijbiomac.2015.07.004
   Cury GG, 2009, BRAZ J INFECT DIS, V13, P165, DOI 10.1590/S1413-86702009000300002
   da Silva SL, 2009, EUR J MED CHEM, V44, P312, DOI 10.1016/j.ejmech.2008.02.043
   de Oliveira NG, 2013, CELL MOL LIFE SCI, V70, P4645, DOI 10.1007/s00018-013-1345-x
   Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003
   Bergamini FRG, 2012, RSC ADV, V2, P10372, DOI 10.1039/c2ra21433d
   Henninot A, 2018, J MED CHEM, V61, P1382, DOI 10.1021/acs.jmedchem.7b00318
   Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945
   KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6
   KAISER E, 1980, ANAL CHIM ACTA, V118, P149, DOI 10.1016/S0003-2670(01)93726-2
   Kaspar AA, 2013, DRUG DISCOV TODAY, V18, P807, DOI 10.1016/j.drudis.2013.05.011
   Kolmel DK, 2014, EUR J MED CHEM, V79, P231, DOI 10.1016/j.ejmech.2014.03.078
   Lainson J. C., 2017, ACS MED CHEM LETT
   Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09
   Lomonte B, 2003, TOXICON, V42, P307, DOI 10.1016/S0041-0101(03)00149-1
   Lomonte B, 2012, TOXICON, V60, P520, DOI 10.1016/j.toxicon.2012.02.007
   Lomonte B, 2010, CURR PHARM DESIGN, V16, P3224, DOI 10.2174/138161210793292456
   Lomonte B, 2009, PROTEIN PEPTIDE LETT, V16, P860, DOI 10.2174/092986609788923356
   MacKerell AD, 2001, COMPUTATIONAL BIOCHEMISTRY AND BIOPHYSICS, P7
   Mojsoska B, 2015, PHARMACEUTICALS, V8, P366, DOI 10.3390/ph8030366
   Norrby S. A., 2005, LANCET INFECT DIS, V52
   Oliveira G A, 2001, Braz J Infect Dis, V5, P163, DOI 10.1590/S1413-86702001000400001
   Paramo L, 1998, EUR J BIOCHEM, V253, P452, DOI 10.1046/j.1432-1327.1998.2530452.x
   Paramo L, 1998, EUR J BIOCH, V253
   Pedron CN, 2017, EUR J MED CHEM, V126, P456, DOI 10.1016/j.ejmech.2016.11.040
   Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   ROTILIE CA, 1975, ANTIMICROB AGENTS CH, V7, P311, DOI 10.1128/AAC.7.3.311
   Samy RP, 2017, BIOCHEM PHARMACOL, V134, P127, DOI 10.1016/j.bcp.2017.03.005
   Santamaria C, 2005, TOXICON, V45, P807, DOI 10.1016/j.toxicon.2004.09.012
   Santamaria C, 2005, ANTIMICROB AGENTS CH, V49, P1340, DOI 10.1128/AAc.49.4.1340-1345.2005
   Santos NA, 2015, TOXICON, V103, P160, DOI 10.1016/j.toxicon.2015.07.004
   Soares MJD, 2001, J MED MICROBIOL, V50, P732, DOI 10.1099/0022-1317-50-8-732
   Sudharshan S, 2015, J VENOM ANIM TOXINS, V21, DOI 10.1186/s40409-015-0014-y
   Ullah A, 2012, INT J BIOL MACROMOL, V51, P209, DOI 10.1016/j.ijbiomac.2012.05.006
   Vale N, 2017, BIOORG MED CHEM LETT, V27, P2898, DOI 10.1016/j.bmcl.2017.04.086
NR 50
TC 8
Z9 8
U1 3
U2 24
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD APR 10
PY 2018
VL 149
BP 248
EP 256
DI 10.1016/j.ejmech.2018.02.055
PG 9
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA GB6NW
UT WOS:000429186900022
PM 29501945
DA 2020-11-30
ER

PT J
AU Monteiro, JHSK
   Machado, D
   de Hollanda, LM
   Lancellotti, M
   Sigoli, FA
   de Bettencourt-Dias, A
AF Monteiro, J. H. S. K.
   Machado, D.
   de Hollanda, L. M.
   Lancellotti, M.
   Sigoli, F. A.
   de Bettencourt-Dias, A.
TI Selective cytotoxicity and luminescence imaging of cancer cells with a
   dipicolinato-based Eu-III complex
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID BLOOD-BRAIN-BARRIER; LANTHANIDE COMPLEXES; PHOTOPHYSICAL PROPERTIES;
   IN-VIVO; NANOPARTICLES; NANOPROBE; BIOPROBES; EUROPIUM;
   TRIS(DIPICOLINATES); NANOCRYSTALS
AB Four new species [Ln(dipicNH(2))(3)](3-) (Ln = La-III, Eu-III, Gd-III, Tb-III), with the ligand dipicNH(2)(2-) (dipic = dipicolinato), were synthesized. Incubation of the Eu-III complex with glioma NG97 and pancreatic cancer PANC1 cells showed that it penetrates the cell membrane and can be used to image the cells, while also being moderately cytotoxic.
C1 [Monteiro, J. H. S. K.; Sigoli, F. A.] Univ Estadual Campinas, Inst Chem, Sao Paulo, Brazil.
   [Monteiro, J. H. S. K.; de Bettencourt-Dias, A.] Univ Nevada, Dept Chem, Reno, NV 89557 USA.
   [Machado, D.; de Hollanda, L. M.; Lancellotti, M.] Univ Estadual Campinas, Inst Biol, Sao Paulo, Brazil.
RP Sigoli, FA (corresponding author), Univ Estadual Campinas, Inst Chem, Sao Paulo, Brazil.; de Bettencourt-Dias, A (corresponding author), Univ Nevada, Dept Chem, Reno, NV 89557 USA.
EM fsigoli@iqm.unicamp.br; abd@unr.edu
RI Machado, Daisy/ABA-3731-2020; Sigoli, Fernando A/AAA-6744-2019; Sigoli,
   Fernando A/C-5225-2012; de Bettencourt-Dias, Ana/J-4398-2019
OI Machado, Daisy/0000-0002-6435-6159; de Bettencourt-Dias,
   Ana/0000-0001-5162-2393; Sigoli, Fernando A/0000-0003-1285-6765;
   Monteiro, Jorge/0000-0002-9622-3537
FU NSF-CHENational Science Foundation (NSF) [1363325]; FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/53868-0,
   2012/15064-3]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [303433/2014-0]
FX Financial support from NSF-CHE 1363325 (AdBD), FAPESP 08/53868-0 (FAS),
   CNPq 303433/2014-0 (FAS and AdBD), FAPESP 2012/15064-3 (ML) is
   gratefully acknowledged. The authors thank Prof. Carlos Lenz Cesar, for
   access to equipment and assistance provided by INFABIC at the University
   of Campinas.
CR Andres J, 2013, PHYS CHEM CHEM PHYS, V15, P15981, DOI 10.1039/c3cp52279b
   Andres J, 2011, INORG CHEM, V50, P10082, DOI 10.1021/ic200983y
   Atkinson P, 2006, ORG BIOMOL CHEM, V4, P3166, DOI 10.1039/b608528h
   Banerjee J, 2016, DRUG DISCOV TODAY, V21, P1367, DOI 10.1016/j.drudis.2016.05.020
   Bourdolle A, 2011, INORG CHEM, V50, P4987, DOI 10.1021/ic200227b
   BRAYSHAW PA, 1995, INORG CHEM, V34, P2068, DOI 10.1021/ic00112a019
   Bunzli JCG, 2015, COORDIN CHEM REV, V293, P19, DOI 10.1016/j.ccr.2014.10.013
   Bunzli JCG, 2010, CHEM REV, V110, P2729, DOI 10.1021/cr900362e
   Bunzli JCG, 2005, CHEM SOC REV, V34, P1048, DOI 10.1039/b406082m
   CARPENTIERI U, 1988, BIOL TRACE ELEM RES, V16, P165, DOI 10.1007/BF02797101
   Chamas ZE, 2010, DALTON T, V39, P7091, DOI 10.1039/c002982c
   Chauvin AS, 2009, INORG CHEM, V48, P10687, DOI 10.1021/ic901424w
   Chauvin AS, 2004, SPECTROSC LETT, V37, P517, DOI 10.1081/SL-120039700
   D'Aleo A, 2008, INORG CHEM, V47, P10258, DOI 10.1021/ic8012969
   Danihelova Martina, 2013, Interdiscip Toxicol, V6, P209, DOI 10.2478/intox-2013-0031
   de Bettencourt-Dias A, 2012, J AM CHEM SOC, V134, P6987, DOI 10.1021/ja209572m
   de Bettencourt-Dias A, 2010, INORG CHEM, V49, P8848, DOI 10.1021/ic101034y
   DeBettencourtDias A, 2014, Luminescence of Lanthanide Ions in Coordination Compounds and Nanomaterials, P1, DOI 10.1002/9781118682760
   Devaraj NK, 2009, ANGEW CHEM INT EDIT, V48, P7013, DOI 10.1002/anie.200903233
   Eliseeva SV, 2010, J PHYS CHEM B, V114, P2932, DOI 10.1021/jp9090206
   Gassner AL, 2008, INORG CHEM, V47, P7802, DOI 10.1021/ic800842f
   Georgieva JV, 2012, ANGEW CHEM INT EDIT, V51, P8339, DOI 10.1002/anie.201202001
   He XY, 2017, CHEM COMMUN, V53, P9438, DOI 10.1039/c7cc05142e
   Huang BH, 2003, J AM CHEM SOC, V125, P14518, DOI 10.1021/ja037895a
   Jing H, 2016, THERANOSTICS, V6, P862, DOI 10.7150/thno.12890
   Ju Q, 2012, J AM CHEM SOC, V134, P1323, DOI 10.1021/ja2102604
   Karpenko IA, 2015, J AM CHEM SOC, V137, P405, DOI 10.1021/ja5111267
   Kim D, 2017, CHEM COMMUN, V53, P9474, DOI 10.1039/c7cc05236g
   Kostova I., 2005, CURR MED CHEM, P591
   Kostova I, 2010, J RARE EARTH, V28, P40, DOI 10.1016/S1002-0721(10)60367-5
   Kostova I, 2010, J TRACE ELEM MED BIO, V24, P7, DOI 10.1016/j.jtemb.2009.06.004
   LAMTURE JB, 1995, INORG CHEM, V34, P864, DOI 10.1021/ic00108a017
   Liu B, 2017, ADV MATER, V29, DOI 10.1002/adma.201605434
   Liu Q, 2011, J AM CHEM SOC, V133, P17122, DOI 10.1021/ja207078s
   Liu Z, 2012, CHEM COMMUN, V48, P5142, DOI 10.1039/c2cc18048k
   Miller-Shakesby DM, 2016, CRYSTENGCOMM, V18, P4977, DOI 10.1039/c6ce00209a
   Mizukami S, 2011, ANGEW CHEM INT EDIT, V50, P8750, DOI 10.1002/anie.201103775
   Monteiro JHSK, 2017, INORG CHEM, V56, P709, DOI 10.1021/acs.inorgchem.6b02637
   Montgomery CP, 2009, ACCOUNTS CHEM RES, V42, P925, DOI 10.1021/ar800174z
   Pereira R. F. C., 2014, Br. Pat., Patent No. [2011003016A2, 2011003016]
   Qiao RR, 2012, ACS NANO, V6, P3304, DOI 10.1021/nn300240p
   Rajendran M, 2014, INORG CHEM, V53, P1839, DOI 10.1021/ic4018739
   Reji TFAF, 2013, J RARE EARTH, V31, P1009, DOI 10.1016/S1002-0721(13)60022-8
   Schick I, 2014, J AM CHEM SOC, V136, P2473, DOI 10.1021/ja410787u
   Steel HL, 2015, CHEM COMMUN, V51, P11441, DOI 10.1039/c5cc04003e
   Supkowski RM, 2002, INORG CHIM ACTA, V340, P44, DOI 10.1016/S0020-1693(02)01022-8
   Tang ZJ, 2017, ANAL CHEM, V89, P4238, DOI 10.1021/acs.analchem.7b00284
   Tyagi N, 2017, J COLLOID INTERF SCI, V498, P364, DOI 10.1016/j.jcis.2017.03.057
   Wang LY, 2017, ACS APPL MATER INTER, V9, P3873, DOI 10.1021/acsami.6b12591
   Wu SC, 2015, J AM CHEM SOC, V137, P14726, DOI 10.1021/jacs.5b08685
   Yan HH, 2012, ACS NANO, V6, P410, DOI 10.1021/nn203749v
   Yim YS, 2012, CHEM COMMUN, V48, P61, DOI 10.1039/c1cc15113d
   Yuan W, 2016, ADV FUNCT MATER, V26, P8631, DOI 10.1002/adfm.201603907
   Zhang XD, 2013, J AM CHEM SOC, V135, P18, DOI 10.1021/ja308249k
   Zhao ZL, 2014, J AM CHEM SOC, V136, P11220, DOI 10.1021/ja5029364
NR 55
TC 21
Z9 21
U1 1
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PD NOV 7
PY 2017
VL 53
IS 86
BP 11818
EP 11821
DI 10.1039/c7cc06753d
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA FK9XZ
UT WOS:000413866900020
PM 29038814
DA 2020-11-30
ER

PT J
AU Severino, P
   Silveira, EF
   Loureiro, K
   Chaud, MV
   Antonini, D
   Lancellotti, M
   Sarmento, VH
   da Silva, CF
   Santana, MHA
   Souto, EB
AF Severino, Patricia
   Silveira, Elisania F.
   Loureiro, Kahynna
   Chaud, Marco V.
   Antonini, Danilo
   Lancellotti, Marcelo
   Sarmento, Victor Hugo
   da Silva, Classius F.
   Santana, Maria Helena A.
   Souto, Eliana B.
TI Antimicrobial activity of polymyxin-loaded solid lipid nanoparticles
   (PLX-SLN): Characterization of physicochemical properties and in vitro
   efficacy
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Solid lipid nanoparticles; Polymyxin B sulphate; Anti-microbial drugs;
   Anti-microbial activity; Pseudomonas aeruginosa
ID PSEUDOMONAS-AERUGINOSA; ACINETOBACTER-BAUMANNII; DELIVERY; FORMULATION;
   CLOTRIMAZOLE; NANOCARRIER; PERMEATION; RESISTANCE; TOXICITY; CARRIERS
AB Antimicrobial resistance is a current public health concern, limiting the available therapeutic options used for the treatment of common bacterial infections. The development of new drug entities via biotechnological processes is however expensive and time-consuming. Therefore, old antimicrobial agents have been recovered for clinical use. An example of these drugs is polymyxin, which is known for its serious adverse side effects, such as nephrotoxicity, neurotoxicity and promotion of skin pigmentation. To overcome these limitations, the use of biodegradable nanoparticles has been proposed to allow site-specific targeting, increasing the drug's bioavailability and decreasing its side effects. The aim of this work was the development of an optimized pharmaceutical formulation composed of solid lipid nanoparticles (SLN) loading polymyxin B sulphate (PLX) for the treatment of bacterial infections. The PLX-loaded SLN were produced by a double emulsion method (w/o/w), obtaining particles with a mean size of approximately 200 nm, polydispersity of 0.3 and zeta potential of -30 mV. The encapsulation efficiency reached values above 90% for all developed formulations. SLN remained stable for a period of 6 months of storage at room temperature. The occlusive properties of the SLN was shown to be dependent on the type of lipid, while the antimicrobial properties of PLX-loaded SLN were effective against resistant strains of Pseudomonas aerttginosa. Results from the differential scanning calorimetry (DSC), wide angle Xray diffraction (WAXD) and small angle X-ray scattering (SAXS) analyses confirmed the crystallinity of the inner SLN matrices, suggesting the capacity of these particles to modify the release profile of the loaded drug.
C1 [Severino, Patricia; Silveira, Elisania F.; Loureiro, Kahynna] Univ Tiradentes Unit, Lab Nanotechnol & Nanomed LNMed, Av Murilo Dantas 300, BR-49010390 Aracaju, Brazil.
   [Severino, Patricia; Silveira, Elisania F.; Loureiro, Kahynna] Inst Technol & Res ITP, Av Murilo Dantas 300, BR-49010390 Aracaju, Brazil.
   [Chaud, Marco V.] Univ Sorocaba, Lab Biomat & Nanotechnol Dev & Evaluat Bioact Sub, Rd Raposo Tavares Km 92-5, BR-18023000 Sorocaba, SP, Brazil.
   [Antonini, Danilo; Lancellotti, Marcelo] Univ Fed Sergipe, Dept Chem, BR-49500000 Itabaiana, SE, Brazil.
   [Sarmento, Victor Hugo] Univ Fed Sao Paulo, Inst Environm Chem & Pharmaceut Sci, Diadema, Brazil.
   [da Silva, Classius F.] State Univ Campinas UNICAMP, Biol Inst, Biochem Dept, Campinas, SP, Brazil.
   [Santana, Maria Helena A.] State Univ Campinas UNICAMP, Sch Chem Engn, Lab Dev Biotechnol Proc, Campinas, SP, Brazil.
   [Souto, Eliana B.] Univ Coimbra FFUC, Fac Pharm, Dept Pharmaceut Technol, Polo Ciencias Saude, P-3000548 Coimbra, Portugal.
   [Souto, Eliana B.] Univ Coimbra, Fac Pharm, Grp Pharmaceut Technol, REQUIMTE LAQV, Coimbra, Portugal.
   Tiradentes Univ UNIT Aracaju, Inst Technol & Res ITP, Lab Nanotechnol & Nanomed LNMED, Program Ind Biotechnol, Av Murilo Dantas 300, Aracaju, Sergipe, Brazil.
RP Souto, EB (corresponding author), Univ Coimbra FFUC, Fac Pharm, Dept Pharmaceut Technol, Polo Ciencias Saude, P-3000548 Coimbra, Portugal.; Severino, P (corresponding author), Tiradentes Univ UNIT Aracaju, Inst Technol & Res ITP, Lab Nanotechnol & Nanomed LNMED, Program Ind Biotechnol, Av Murilo Dantas 300, Aracaju, Sergipe, Brazil.
EM patricia_severino@itp.org.br; ebsouto@ff.uc.pt
RI Santana, Maria Helena/F-6437-2013; Sarmento, Victor Hugo/AAL-1496-2020;
   Chaud, Marco Vinicius/C-7690-2012; da Silva, Classius/E-3706-2010;
   Souto, Eliana B./T-1645-2019; Loureiro, Kahynna/AAD-7846-2019
OI Sarmento, Victor Hugo/0000-0001-6882-002X; Chaud, Marco
   Vinicius/0000-0003-3618-8415; Souto, Eliana B./0000-0002-9737-6017;
   Loureiro, Kahynna/0000-0002-0877-4591; da Silva,
   Classius/0000-0001-9937-5598
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/21219-5]; CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)National
   Council for Scientific and Technological Development (CNPq)
   [443238/2014-6, 470388/2014-5]; FAPITEC (Fundacao de Apoio a Pesquisa e
   a Inovacao Tecnologica do Estado de Sergipe); Portuguese Science and
   Technology Foundation (FCT/MCT); European Funds (PRODER/COMPETE)
   [M-ERA-NET/0004/2015, UID/QUI/50006/2013]; FEDEREuropean Union (EU)
   [PT2020]
FX The authors wish to acknowledge the sponsorship of the FAPESP (Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo, #2012/21219-5), CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico,
   #443238/2014-6, #470388/2014-5) and FAPITEC (Fundacao de Apoio a
   Pesquisa e a Inovacao Tecnologica do Estado de Sergipe). Therefore, we
   are grateful Croda/Brazil, Cristalia/Brazil and Professor PhD Cristiano
   Oliveira, University of Sao Paulo (USP). The authors would like to thank
   the financial support received from Portuguese Science and Technology
   Foundation (FCT/MCT) and from European Funds (PRODER/COMPETE) under the
   projects M-ERA-NET/0004/2015 and UID/QUI/50006/2013, and co-financed by
   FEDER, under the Partnership Agreement PT2020.
CR Alipour M, 2014, THER DELIV, V5, P409, DOI [10.4155/TDE.14.13, 10.4155/tde.14.13]
   Almeida AJ, 2007, ADV DRUG DELIVER REV, V59, P478, DOI 10.1016/j.addr.2007.04.007
   Arnold T.M., 2007, AM J HLTH SYST PHARM, V64
   Balbino T.A., 2016, MICROFLUIDIC ASSEMBL
   Brandenburg KS, 2012, PHARM DEV TECHNOL, V17, P654, DOI 10.3109/10837450.2011.572893
   Grando CRC, 2013, J COLLOID SCI BIOTEC, V2, P140, DOI 10.1166/jcsb.2013.1044
   Clinical and Laboratory Standards Institute (CLSI), 2006, PERF STAND ANT DISK
   Das S, 2011, COLLOID SURFACE B, V88, P483, DOI 10.1016/j.colsurfb.2011.07.036
   Diniz F., 2017, CHARACTERIZATION POL
   Dwivedi G.R., 2016, CURR TOP MED CHEM
   Fangueiro JF, 2013, PHARM DEV TECHNOL, V18, P545, DOI 10.3109/10837450.2011.591804
   Gallarate M, 2009, J MICROENCAPSUL, V26, P394, DOI 10.1080/02652040802390156
   Gallardo-Godoy A, 2016, J MED CHEM, V59, P1068, DOI 10.1021/acs.jmedchem.5b01593
   Golmohammadzadeh S, 2012, BRAZ J PHARM SCI, V48, P683, DOI 10.1590/S1984-82502012000400012
   Gothwal S, 2016, INDIAN J PEDIATR, V83, P179, DOI 10.1007/s12098-015-1798-z
   Guo F, 2015, J MATER SCI-MATER M, V26, P1, DOI DOI 10.1007/S10856-015-5487-2
   Gupta A., 2016, F1000 RES, P5
   Han SB, 2014, INT J COSMETIC SCI, V36, P588, DOI 10.1111/ics.12160
   Harm S., 2016, INNATE IMMUN
   Heming N, 2016, EXPERT OPIN EMERG DR, V21, P27, DOI 10.1517/14728214.2016.1132700
   Henao MP, 2016, ANN ALLERG ASTHMA IM, V116, P372, DOI 10.1016/j.anai.2016.01.014
   Kasongo KW, 2011, J PHARM SCI-US, V100, P5185, DOI 10.1002/jps.22711
   Kim HJ, 2016, ANN LAB MED, V36, P15, DOI 10.3343/alm.2016.36.1.15
   Kushwaha AK, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/584549
   Labarca JA, 2016, CRIT REV MICROBIOL, V42, P276, DOI 10.3109/1040841X.2014.940494
   Lambadi PR, 2015, INT J NANOMED, V10, P2155, DOI 10.2147/IJN.S72923
   MacVane S.H., 2016, J INTENSIVE CARE MED
   Mattos K.P., 2016, PIGMENT CELL MELANOM
   Moreno-Sastre M, 2016, INT J PHARMACEUT, V498, P263, DOI 10.1016/j.ijpharm.2015.12.028
   Muller RH, 2002, ADV DRUG DELIVER REV, V54, pS131, DOI 10.1016/S0169-409X(02)00118-7
   Myint T, 2016, J INVEST MED HIGH IM, V4, DOI 10.1177/2324709616638362
   Nicastro MC, 2016, BIOPHYS CHEM, V208, P9, DOI 10.1016/j.bpc.2015.07.010
   nostructured lipid carriers (NLC), ADV DRUG DELIV REV, V54, pS131
   de Souza ALR, 2014, INT J PHARMACEUT, V463, P31, DOI 10.1016/j.ijpharm.2013.12.022
   Richards Derek, 2006, Evid Based Dent, V7, P106, DOI 10.1038/sj.ebd.6400452
   Rigatto MH, 2016, ANTIMICROB AGENTS CH, V60, P2443, DOI 10.1128/AAC.02634-15
   Severino P, 2015, PHARMAZIE, V70, P693, DOI 10.1691/ph.2015.5073
   Severino P., 2015, J NANOMATER UNPUB
   Severino P, 2015, COLLOID SURFACE B, V129, P191, DOI 10.1016/j.colsurfb.2015.03.049
   Severino P, 2015, EUR J PHARM SCI, V66, P78, DOI 10.1016/j.ejps.2014.09.021
   Severino P, 2014, EUR J MED CHEM, V81, P28, DOI 10.1016/j.ejmech.2014.04.084
   Severino P, 2011, COLLOID SURFACE B, V86, P125, DOI 10.1016/j.colsurfb.2011.03.029
   Shah RM, 2016, APPL MATER TODAY, V5, P118, DOI 10.1016/j.apmt.2016.09.010
   Shah RM, 2014, J COLLOID INTERF SCI, V428, P286, DOI 10.1016/j.jcis.2014.04.057
   Singh S, 2010, CHEM PHARM BULL, V58, P650, DOI 10.1248/cpb.58.650
   Souto EB, 2004, INT J PHARMACEUT, V278, P71, DOI 10.1016/j.ijpharm.2004.02.032
   Teeranachaideekul V, 2008, J CONTROL RELEASE, V128, P134, DOI 10.1016/j.jconrel.2008.02.011
   Wilder M.A., 2005, PERFORMANCE STANDARD
   Wissing SA, 2001, J COSMET SCI, V52, P313
   Xia JF, 2016, BIOSCI TRENDS, V10, P14, DOI 10.5582/bst.2016.01020
NR 50
TC 22
Z9 22
U1 2
U2 24
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0928-0987
EI 1879-0720
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD AUG 30
PY 2017
VL 106
BP 177
EP 184
DI 10.1016/j.ejps.2017.05.063
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FC6YW
UT WOS:000406988600020
PM 28576561
DA 2020-11-30
ER

PT J
AU Salles, THC
   Sendyk, DI
   de Oliveira, NK
   Machado, D
   Lancellotti, M
   Deboni, MCZ
   Kiang, CT
   d'Avila, MA
AF Costa Salles, Tais Helena
   Sendyk, Daniel Isaac
   de Oliveira, Natacha Kalline
   Machado, Daisy
   Lancellotti, Marcelo
   Zindel Deboni, Maria Cristina
   Kiang, Chang Tien
   d'Avila, Marcos Akira
TI In vitro and in vivo evaluation of electrospun membranes of poly
   (epsilon-caprolactone) and poly (rotaxane)
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
ID TISSUE; FABRICATION; PROLIFERATION; POLYROTAXANES; SCAFFOLDS; GROWTH
C1 [Costa Salles, Tais Helena; d'Avila, Marcos Akira] Univ Estadual Campinas, Sch Mech Engn, Dept Mfg & Mat Engn, Rua Mendeleyev 200, BR-13083860 Campinas, SP, Brazil.
   [Sendyk, Daniel Isaac; de Oliveira, Natacha Kalline; Zindel Deboni, Maria Cristina] Univ Sao Paulo, Dept Oral & Maxillofacial Surg, Fac Dent, Sao Paulo, Brazil.
   [Machado, Daisy; Lancellotti, Marcelo] Univ Estadual Campinas, Inst Biol, Biotechnol Lab, Campinas, SP, Brazil.
   [Kiang, Chang Tien] Nucl & Energy Res Inst IPEN, Chem & Environm Ctr CQMA, Sao Paulo, Brazil.
RP d'Avila, MA (corresponding author), Univ Estadual Campinas, Sch Mech Engn, Dept Mfg & Mat Engn, Rua Mendeleyev 200, BR-13083860 Campinas, SP, Brazil.
EM tais_helenacs@yahoo.com.br; dsendyk@usp.br; natachakalline@hotmail.com;
   daisy.machado@gmail.com; lancellottim@gmail.com; mczdebon@usp.br;
   chang.kiang@gmail.com; madavila@fem.unicamp.br
RI de Oliveira, Natacha K/N-4664-2014; Machado, Daisy/ABA-3731-2020;
   Deboni, Maria Cristina Zindel/G-1859-2010; Salles, Tais/R-5441-2017
OI de Oliveira, Natacha K/0000-0003-0157-7891; Machado,
   Daisy/0000-0002-6435-6159; Deboni, Maria Cristina
   Zindel/0000-0002-2966-6039; 
FU CNPq - Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq) [308660/2015-3, 401297/2014-4]; CAPES - Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES [1199553]; Fundacao de
   Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [FAPESP 15/15055-0]
FX The authors thank the financial support from CNPq - Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (308660/2015-3 and
   401297/2014-4), CAPES - Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (1199553) and FAPESP 15/15055-0 (Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo).
CR Annen BM, 2011, EUR J ORAL IMPLANTOL, V4, P87
   Araki J, 2007, SOFT MATTER, V3, P1456, DOI 10.1039/b705688e
   Bassi A. K., 2011, J TISSUE ENG, P615328
   Becker J, 2009, CLIN ORAL IMPLAN RES, V20, P742, DOI 10.1111/j.1600-0501.2008.01689.x
   Changotade S, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/283796
   Ciardelli G, 2005, BIOMACROMOLECULES, V6, P1961, DOI 10.1021/bm0500805
   Deboni M., 2016, CLIN ORAL IMPLANTS R, V27
   Garg K., 2014, BIOMICROFLUIDICS, P13403
   Gautam S, 2013, MAT SCI ENG C-MATER, V33, P1228, DOI 10.1016/j.msec.2012.12.015
   Ghanaati S, 2010, ACTA BIOMATER, V6, P4476, DOI 10.1016/j.actbio.2010.07.006
   Ghorani B, 2015, FOOD HYDROCOLLOID, V51, P227, DOI 10.1016/j.foodhyd.2015.05.024
   Gong XS, 2015, CARBOHYD RES, V412, P7, DOI 10.1016/j.carres.2015.04.021
   Joung Yoon Ki, 2007, [Biomaterials Research, 생체재료학회지], V11, P162
   Kulkarni A, 2010, POLYM-PLAST TECHNOL, V49, P427, DOI 10.1080/03602550903414019
   LIPATOVA TE, 1982, DOKL AKAD NAUK SSSR+, V263, P1379
   Meng ZX, 2010, MAT SCI ENG C-MATER, V30, P1014, DOI 10.1016/j.msec.2010.05.003
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   OKUMURA Y, 2001, ADV MAT, V13
   Oster M., MACROMOL RAPID COMMU, P292
   Polimeni G., HISTOPATHOLOGICAL OB, P99, DOI [10.1111/j.1708-8208.2007.00067.x., DOI 10.1111/J.1708-8208.2007.00067.X.]
   Prabhakaran MP, 2008, TISSUE ENG PT A, V14, P1787, DOI 10.1089/ten.tea.2007.0393
   Sela M.N., 1995, ENZYMATIC DEGRADATIO, P263
   Seyednejad H, 2011, ACTA BIOMATER, V7, P1999, DOI 10.1016/j.actbio.2011.01.018
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI 10.1016/S0142-9612(03)00251-5
   Wang J, 2016, BROADB MULT SYST BRO, P1
   Wang PJ, 2012, POLYMER, V53, P2361, DOI 10.1016/j.polymer.2012.03.060
   Webb K., 2009, NIH PUBLIC ACCESS, V41, P422
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Xue JJ, 2015, COLLOID SURFACE B, V135, P846, DOI 10.1016/j.colsurfb.2015.03.031
   Zhang YF, 2010, ACTA BIOMATER, V6, P3021, DOI 10.1016/j.actbio.2010.02.030
   Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0
   Zhu X., 2008, ELECTROSPUN FIBROUS, P1795
   Zhu YX, 2009, J MATER SCI-MATER M, V20, P799, DOI 10.1007/s10856-008-3636-6
NR 33
TC 4
Z9 4
U1 1
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2017
VL 77
BP 912
EP 919
DI 10.1016/j.msec.2017.03.190
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA EX6VW
UT WOS:000403381200103
PM 28532110
DA 2020-11-30
ER

PT J
AU Rodrigues, DM
   Moreira, JCD
   Lancellotti, M
   Gilioli, R
   Corat, MAF
AF Rodrigues, Daniele Masselli
   de Oliveira Moreira, Joselia Cristina
   Lancellotti, Marcelo
   Gilioli, Rovilson
   Finzi Corat, Marcus Alexandre
TI Murine norovirus infection in Brazilian animal facilities
SO EXPERIMENTAL ANIMALS
LA English
DT Article
DE Brazil; mouse; murine norovirus; RT-PCR
ID MOLECULAR CHARACTERIZATION; MURINE-NOROVIRUS-1 INFECTION; ENTERIC
   CALICIVIRUSES; LABORATORY MICE; CECUM CONTENTS; MOUSE MODEL; PCR ASSAY;
   GENOGROUP; DIVERSITY; RECOMBINATION
AB Murine norovirus (MNV) is a single-stranded positive-sense RNA virus of the Caliciviridae family. MNV has been reported to infect laboratory mice with the ability to cause lethal infections in strains lacking components of the innate immune response. Currently, MNV is considered the most prevalent infectious agent detected in laboratory mouse facilities. In this study, mice in 22 laboratory animal facilities within Brazil were analyzed for MNV infection. Using primers targeting a conserved region of the viral capsid, MNV was detected by RT-PCR in 137 of 359 mice from all 22 facilities. Nucleotide sequencing and phylogenetic analysis of the capsid region from the viral genome showed identity ranging from 87% to 99% when compared to reported MNV sequences. In addition, RAW264.7 cells inoculated with a mouse fecal suspension displayed cytopathic effect after the fifth passage. This study represents the first report of MNV in mouse colonies in Brazilian laboratory animal facilities, emphasizing the relevance of a health surveillance program in such environments.
C1 [Rodrigues, Daniele Masselli; de Oliveira Moreira, Joselia Cristina; Gilioli, Rovilson; Finzi Corat, Marcus Alexandre] Univ Campinas UNICAMP, Anim Hlth Lab, Multidisciplinary Ctr Biol Res Lab Anim Sci CEMIB, Campinas, SP, Brazil.
   [Lancellotti, Marcelo] Univ Estadual Campinas, Inst Biol, Dept Biochem, BR-13083970 Campinas, SP, Brazil.
RP Rodrigues, DM (corresponding author), Cidade Univ Zeferino Vaz,Rua 5 Junho, BR-13083970 Campinas, SP, Brazil.
RI Corat, Marcus/AAH-2882-2020
CR Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025
   Barron EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021435
   Caddy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081596
   Goto K, 2009, EXP ANIM TOKYO, V58, P135, DOI 10.1538/expanim.58.135
   Green K. Y., 2007, FIELDS VIROLOGY, V1, P949
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hanaki KI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098108
   Henderson KS, 2008, LAB ANIMAL, V37, P314, DOI 10.1038/laban0708-314
   Hsu CC, 2005, CLIN DIAGN LAB IMMUN, V12, P1145, DOI 10.1128/CDLI.12.10.1145-1151.2005
   Hsu CC, 2006, COMPARATIVE MED, V56, P247
   Hsu CC, 2007, VIRUS GENES, V34, P147, DOI 10.1007/s11262-006-0060-1
   Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147
   Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905
   Karst SM, 2015, J PATHOL, V235, P206, DOI 10.1002/path.4463
   Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015
   Katayama K, 2002, VIROLOGY, V299, P225, DOI 10.1006/viro.2002.1568
   Kelmenson JA, 2009, COMPARATIVE MED, V59, P27
   Kim JR, 2011, J VET MED SCI, V73, P687, DOI 10.1292/jvms.10-0226
   Kitajima M, 2009, MICROBIOL IMMUNOL, V53, P531, DOI 10.1111/j.1348-0421.2009.00152.x
   Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5
   Lencioni KC, 2008, COMPARATIVE MED, V58, P522
   Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312
   Martella V, 2008, EMERG INFECT DIS, V14, P1306, DOI 10.3201/eid1408.080062
   Martella V, 2007, EMERG INFECT DIS, V13, P1071, DOI 10.3201/eid1307.070268
   McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413
   Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861
   Muller B, 2007, ARCH VIROL, V152, P1709, DOI 10.1007/s00705-007-0989-y
   Mumphrey SM, 2007, J VIROL, V81, P3251, DOI 10.1128/JVI.02096-06
   Ohsugi T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00012
   Oliver SL, 2003, J VIROL, V77, P2789, DOI 10.1128/JVI.77.4.2789-2798.2003
   Paik J, 2010, COMPARATIVE MED, V60, P189
   Perdue KA, 2007, J AM ASSOC LAB ANIM, V46, P39
   Pritchett-Corning KR, 2009, LAB ANIM-UK, V43, P165, DOI 10.1258/la.2008.008009
   Smith DB, 2012, J GEN VIROL, V93, P259, DOI 10.1099/vir.0.036392-0
   Sugieda M, 2002, VIRUS RES, V87, P165, DOI 10.1016/S0168-1702(02)00107-7
   Sugieda M, 1998, ARCH VIROL, V143, P1215, DOI 10.1007/s007050050369
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Taylor NS, 2007, J CLIN MICROBIOL, V45, P2166, DOI 10.1128/JCM.00137-07
   Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07
   Thepaut M, 2015, VET RES, V46, DOI 10.1186/s13567-015-0239-3
   Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14
   Wang QH, 2007, VACCINE, V25, P5453, DOI 10.1016/j.vaccine.2006.12.032
   Ward JM, 2006, TOXICOL PATHOL, V34, P708, DOI 10.1080/01926230600918876
   Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432
   Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05
   Wolf S, 2009, VET MICROBIOL, V133, P184, DOI 10.1016/j.vetmic.2008.06.019
   Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535
   Zenner L, 2000, LAB ANIM, V34, P76, DOI 10.1258/002367700780577957
   Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015
NR 49
TC 1
Z9 1
U1 0
U2 9
PU INT PRESS EDITING CENTRE INC
PI TOKYO
PA 1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN
SN 1341-1357
EI 1881-7122
J9 EXP ANIM TOKYO
JI Exp. Anim.
PD APR
PY 2017
VL 66
IS 2
BP 115
EP 124
DI 10.1538/expanim.16-0027
PG 10
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA ES9FU
UT WOS:000399862500005
PM 28049885
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Nakahata, DH
   Ribeiro, MA
   Corbi, PP
   Machado, D
   Lancellotti, M
   Lustri, WR
   Ferreira, AMD
   Formiga, ALB
AF Nakahata, Douglas H.
   Ribeiro, Marcos A.
   Corbi, Pedro P.
   Machado, Daisy
   Lancellotti, Marcelo
   Lustri, Wilton R.
   da Costa Ferreira, Ana M.
   Formiga, Andre L. B.
TI Synthesis, characterization and preliminary antimicrobial assays of
   copper(II) complexes with 2-(imidazole-2-yl)heteroaryl ligands
SO INORGANICA CHIMICA ACTA
LA English
DT Article
DE Copper(II) complexes; Imidazole; Structure elucidation; Antimicrobial
   agents
ID CRYSTAL-STRUCTURES; SPECTROSCOPIC CHARACTERIZATION;
   COORDINATION-COMPOUNDS; ANTIFUNGAL ACTIVITY; DNA-BINDING; BASIS-SETS;
   CU(II); 1,10-PHENANTHROLINE; ANTIBACTERIAL; MECHANISMS
AB The coordination chemistry and antimicrobial profiles of three copper(II) complexes with 2-(imidazole-2yl)heteroaryl ligands, named impy, impz and impm, have been investigated. Based on X-ray structure determination the complexes present square planar geometry with coordination formulas [CuCl2(impx)], where x = y, z or m. Elemental analysis and mass spectrometric results are in agreement with the proposed compositions. Vibrational spectroscopy and molecular modeling provided further evidences that the [CuCl2(impz)] complex, which did not have its structure solved by X-ray diffraction, adopts a similar geometry of the other two complexes. Electronic spectroscopic data indicated that all three ligands led to a hypsochromic shift of the d-d band when compared to CuCl2.2H(2)O and that the electronic structure of the ligands are significantly altered upon coordination to Cu(II). Electronic paramagnetic resonance studies in solution showed that the compounds present similar coordination environments. The MIC values of the complexes over E. coli and S. aureus was 17.8 mu mol.mL(-1), thus no distinction was found between the complexes and the tested strain. The complexes were inactive over three tested fungal strains under the considered experimental conditions. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Nakahata, Douglas H.; Ribeiro, Marcos A.; Corbi, Pedro P.; Formiga, Andre L. B.] Univ Campinas UNICAMP, Inst Chem, POB 6154, BR-13083970 Campinas, SP, Brazil.
   [Machado, Daisy; Lancellotti, Marcelo] Univ Campinas UNICAMP, Inst Biol, Biotechnol Lab, Campinas, SP, Brazil.
   [Lustri, Wilton R.] Centro Univ Araraquara, Biol & Hlth Sci Dept, BR-14801320 Araraquara, SP, Brazil.
   [da Costa Ferreira, Ana M.] Univ Sao Paulo, Inst Chem, BR-05508000 Sao Paulo, SP, Brazil.
RP Formiga, ALB (corresponding author), Univ Campinas UNICAMP, Inst Chem, POB 6154, BR-13083970 Campinas, SP, Brazil.
EM formiga@iqm.unicamp.br
RI Machado, Daisy/ABA-3731-2020; Corbi, Pedro P/B-7639-2012; Da Costa
   Ferreira, Ana Maria/C-2244-2012; Lustri, Wilton Rogerio/AAG-3992-2020;
   Nakahata, Douglas H/D-8073-2019; Formiga, Andre/G-9755-2011
OI Machado, Daisy/0000-0002-6435-6159; Corbi, Pedro P/0000-0002-7478-0877;
   Da Costa Ferreira, Ana Maria/0000-0001-9898-1692; Nakahata, Douglas
   H/0000-0003-3859-6463; Lustri, Wilton Rogerio/0000-0001-6627-4758;
   Formiga, Andre/0000-0001-6773-8083
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de sao Paulo)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/25114-4]; CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)National
   Council for Scientific and Technological Development (CNPq)
   [402627/2012-1, 131013/2014-9, 442123/2014-0, 165799/2015-3]; CAPES
   (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)CAPES
   [0580/2013]; CENAPAD-SP (Centro Nacional de Processamento de Alto
   Desempenho em sao Paulo) [487]
FX This study was supported by grants from FAPESP (Fundacao de Amparo a
   Pesquisa do Estado de sao Paulo, grant 2015/25114-4), CNPq (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico, grants
   402627/2012-1, 131013/2014-9, 442123/2014-0 and 165799/2015-3), CAPES
   (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, grant
   0580/2013), CENAPAD-SP (Centro Nacional de Processamento de Alto
   Desempenho em sao Paulo, Project Number 487) for computational time. We
   thank MSc Eduardo Guimaraes Ratier Arruda for the fruitful discussions
   on the syntheses of the ligands and Ph.D Marcos Alberto de Carvalho for
   Raman measurements.
CR Adamo C, 1999, J CHEM PHYS, V110, P6158, DOI 10.1063/1.478522
   Agotegaray MA, 2012, POLYHEDRON, V34, P74, DOI 10.1016/j.poly.2011.12.005
   Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890
   AMUNDSEN AR, 1977, J AM CHEM SOC, V99, P6730, DOI 10.1021/ja00462a042
   Arjmand F, 2005, EUR J MED CHEM, V40, P1103, DOI 10.1016/j.ejmech.2005.05.005
   Arjmand F, 2012, J PHOTOCH PHOTOBIO B, V114, P15, DOI 10.1016/j.jphotobiol.2012.05.003
   Barnett SM, 2012, NAT CHEM, V4, P498, DOI [10.1038/NCHEM.1350, 10.1038/nchem.1350]
   Bin Ou Z., 2013, J COORD CHEM, V66, P2152
   Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z
   Borkow G, 2005, CURR MED CHEM, V12, P2163, DOI 10.2174/0929867054637617
   Caglar S, 2013, INORG CHIM ACTA, V408, P131, DOI 10.1016/j.ica.2013.09.013
   Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI
   Conry R. R., 2006, ENCY INORG CHEM
   CORNILSEN BC, 1974, J INORG NUCL CHEM, V36, P2467, DOI 10.1016/0022-1902(74)80455-0
   Coronado E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1827
   Coyle B, 2003, BIOMETALS, V16, P321, DOI 10.1023/A:1020695923788
   Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726
   Gaetke LM, 2014, ARCH TOXICOL, V88, P1929, DOI 10.1007/s00204-014-1355-y
   Galani A, 2014, INORG CHIM ACTA, V423, P207, DOI 10.1016/j.ica.2014.08.005
   GEARY WJ, 1971, COORDIN CHEM REV, V7, P81, DOI 10.1016/S0010-8545(00)80009-0
   Hathaway B. J., 1987, COMPREHENSIVE COORDI, V5
   ISCI H, 1974, INORG CHEM, V13, P1175, DOI 10.1021/ic50135a032
   Izsak R, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3646921
   Janiak C, 2000, J CHEM SOC DALTON, P3885, DOI 10.1039/b003010o
   JEFFREY GA, 1985, INT J BIOL MACROMOL, V7, P336, DOI 10.1016/0141-8130(85)90048-0
   KLAEHN DD, 1984, INORG CHEM, V23, P483, DOI 10.1021/ic00172a021
   Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028
   Lever ABP, 1984, INORGANIC ELECT SPEC
   LEVER BP, 1971, INORG CHEM, V10, P817
   Lewis A, 2016, J INORG BIOCHEM, V157, P52, DOI 10.1016/j.jinorgbio.2016.01.014
   Lide D. R., 2005, CRC HDB CHEM PHYS RE
   Liu HH, 2013, INORG CHIM ACTA, V405, P387, DOI 10.1016/j.ica.2013.06.029
   Loganathan R, 2012, INORG CHEM, V51, P5512, DOI 10.1021/ic2017177
   Marinelli M, 2016, CURR TOP MED CHEM, V16, P2995, DOI 10.2174/1568026616666160506145408
   Medina JJM, 2014, J MOL STRUCT, V1058, P298, DOI 10.1016/j.molstruc.2013.11.014
   Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81
   Pavia D. L., 2009, INTRO SPECTROSCOPY G
   Pitie M, 2003, EUR J INORG CHEM, P528
   Prosser KE, 2017, J INORG BIOCHEM, V167, P89, DOI 10.1016/j.jinorgbio.2016.11.006
   Rubino JT, 2012, J INORG BIOCHEM, V107, P129, DOI 10.1016/j.jinorgbio.2011.11.024
   SAITO Y, 1972, INORG CHEM, V11, P2003, DOI 10.1021/ic50115a004
   SAKAGUCHI U, 1979, J CHEM SOC DALTON, P600, DOI 10.1039/dt9790000600
   Sanchez-Guadarrama O, 2009, J INORG BIOCHEM, V103, P1204, DOI 10.1016/j.jinorgbio.2009.05.018
   Santini C, 2014, CHEM REV, V114, P815, DOI 10.1021/cr400135x
   Satterfield M, 2001, INORG CHEM, V40, P5393, DOI 10.1021/ic010356r
   Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930
   Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI 10.1107/S2053229614024218
   Steiner T, 1996, CRYSTALLOGR REV, V6, P1, DOI DOI 10.1080/08893119608035394
   SUD IJ, 1981, J INVEST DERMATOL, V76, P438, DOI 10.1111/1523-1747.ep12521036
   Tantirungrotechai Y, 2006, J MOL STRUC-THEOCHEM, V760, P189, DOI 10.1016/j.theochem.2005.12.007
   Voss ME, 2008, TETRAHEDRON, V64, P645, DOI 10.1016/j.tet.2007.11.009
   Walther W, 2014, LETT DRUG DES DISCOV, V11, P825, DOI 10.2174/1570180811666140529004102
   Weigend F, 2003, J CHEM PHYS, V119, P12753, DOI 10.1063/1.1627293
   Weigend F, 1998, CHEM PHYS LETT, V294, P143, DOI 10.1016/S0009-2614(98)00862-8
   Wende C, 2014, EUR J INORG CHEM, P2597, DOI 10.1002/ejic.201400032
   WILDE RE, 1973, J INORG NUCL CHEM, V35, P1017, DOI 10.1016/0022-1902(73)80474-9
   Yang L, 2007, DALTON T, P955, DOI 10.1039/b617136b
   Zanvettor NT, 2016, INORG CHIM ACTA, V443, P304, DOI 10.1016/j.ica.2016.01.011
NR 58
TC 10
Z9 10
U1 0
U2 32
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0020-1693
EI 1873-3255
J9 INORG CHIM ACTA
JI Inorg. Chim. Acta
PD MAR 24
PY 2017
VL 458
BP 224
EP 232
DI 10.1016/j.ica.2017.01.015
PG 9
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA EL5AI
UT WOS:000394633400025
DA 2020-11-30
ER

PT J
AU Hernandez-Montelongo, J
   Lucchesi, EG
   Nascimento, VF
   Franca, CG
   Gonzalez, I
   Macedo, WAA
   Machado, D
   Lancellotti, M
   Moraes, AM
   Beppu, MM
   Cotta, MA
AF Hernandez-Montelongo, J.
   Lucchesi, E. G.
   Nascimento, V. F.
   Franca, C. G.
   Gonzalez, I.
   Macedo, W. A. A.
   Machado, D.
   Lancellotti, M.
   Moraes, A. M.
   Beppu, M. M.
   Cotta, M. A.
TI Antibacterial and non-cytotoxic ultra-thin polyethylenimine film
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Ultra-thin film; Polyethylenimine; Antibacterial; Non-cytotoxic
ID LAYER-BY-LAYER; POLYELECTROLYTE MULTILAYERS; PSEUDOMONAS-AERUGINOSA;
   SURFACE MODIFICATION; NANOPARTICLES; POLYMER; CONSTRUCTION; NANOTUBES;
   BACTERIAL; DELIVERY
AB In recent years, a common strategy, to obtain more uniform and controlled synthesis of polyelectrolytes multi layers (PEMs), relies on a previous polyethylenimine (PEI) coating of the substrate surface. PEI is a synthetic cationic polymer which provides a positive charge distribution on the materials to be covered with PEMs. Despite being an important step, this pre-layer deposition is frequently overlooked and no comprehensive characterizations or deep discussions are reported in literature. In that sense, this work reports on the synthesis of a typical PEI film that works as a precursor for PEMs, and its detailed physicochemical characterization. As many PEMs are produced for antibacterial and biomedical applications, the cytotoxicity of the film was also tested using fibroblasts, and its antibacterial activity was studied using Staphylococcus aureus and Pseudomonas aeruginosa. Our results present the formation of an ultra-thin film of PEI with a thickness around 3.5 nm, and with a significant percent of NH3+ (35% of the total amount of N) in its chemical structure; NH3+ is a key chemical group because it is considered an important bacterial killer agent. The film was stable and did not present important cytotoxic effect for fibroblasts up to 7 days, contrary to other reports. Finally, the PEI film showed high antibacterial activity against the S. aureus strain: reductions in cell density were higher than 95% up to 24 h. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Hernandez-Montelongo, J.; Cotta, M. A.] Univ Estadual Campinas, Inst Fis Gleb Wataghin, Dept Fis Aplicada, BR-13083859 Campinas, SP, Brazil.
   [Lucchesi, E. G.] Itibanyl Produtos Especiais LTDA, BR-13240000 Jarinu, SP, Brazil.
   [Nascimento, V. F.; Franca, C. G.; Moraes, A. M.; Beppu, M. M.] Univ Estadual Campinas, Fac Engn Quim, BR-13083852 Campinas, SP, Brazil.
   [Gonzalez, I.; Macedo, W. A. A.] Ctr Desenvolvimento Tecnol Nucl, BR-31270901 Belo Horizonte, MG, Brazil.
   [Machado, D.; Lancellotti, M.] Univ Estadual Campinas, Inst Biol, Lab Biotecnol, BR-13083862 Campinas, SP, Brazil.
RP Hernandez-Montelongo, J (corresponding author), Univ Estadual Campinas, Inst Fis Gleb Wataghin, Dept Fis Aplicada, BR-13083859 Campinas, SP, Brazil.
EM jacobo@ifi.unicamp.br
RI Machado, Daisy/ABA-3731-2020; Moraes, Angela Maria/K-5181-2012; Macedo,
   Waldemar A A/C-4950-2013; Cotta, Monica A/H-3505-2012;
   Hernandez-Montelongo, Jacobo/H-2717-2013; Franco, Vicente/B-8750-2017;
   Franca, Carla Giometti/AAM-9298-2020
OI Machado, Daisy/0000-0002-6435-6159; Moraes, Angela
   Maria/0000-0002-5813-332X; Macedo, Waldemar A A/0000-0001-5451-9965;
   Franca, Carla Giometti/0000-0003-3527-7563; Hernandez-Montelongo,
   Jacobo/0000-0002-1510-3470
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2010/51748-7, 2013/02300-1];
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [307139/2015-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES; Fundacao de Amparo a Pesquisa do Estado de Minas
   GeraisMinas Gerais State Research Foundation (FAPEMIG); FAPESPFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); FAPEAM
FX This work was financially supported by Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (grant numbers 2010/51748-7 and 2013/02300-1),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (307139/2015-8), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais. J.
   Hernandez-Montelongo and V. Nascimento acknowledge FAPESP and FAPEAM
   scholarships, respectively.
CR Azevedo MM, 2014, J MED MICROBIOL, V63, P1167, DOI 10.1099/jmm.0.069609-0
   BAHULEKAR R, 1991, ENZYME MICROB TECH, V13, P858, DOI 10.1016/0141-0229(91)90101-F
   Beyth N, 2010, P NATL ACAD SCI USA, V107, P22038, DOI 10.1073/pnas.1010341107
   Borges J, 2014, CHEM REV, V114, P8883, DOI 10.1021/cr400531v
   Brunot C, 2007, BIOMATERIALS, V28, P632, DOI 10.1016/j.biomaterials.2006.09.026
   Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440
   Cado G, 2013, ADV FUNCT MATER, V23, P4801, DOI 10.1002/adfm.201300416
   Chen SG, 2014, CHEM ENG J, V256, P238, DOI 10.1016/j.cej.2014.07.006
   Chen SG, 2011, COLLOID SURFACE B, V85, P323, DOI 10.1016/j.colsurfb.2011.03.004
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Ciofani G, 2008, BIOTECHNOL BIOENG, V101, P850, DOI 10.1002/bit.21952
   Deege MPD, 2011, CURR PHARM BIOTECHNO, V12, P2062
   Demadis KD, 2011, IND ENG CHEM RES, V50, P5873, DOI 10.1021/ie102546g
   Forrest ML, 2003, BIOCONJUGATE CHEM, V14, P934, DOI 10.1021/bc034014g
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Fu JH, 2006, J BIOMED MATER RES A, V79A, P665, DOI 10.1002/jbm.a.30819
   Garza JM, 2005, LANGMUIR, V21, P12372, DOI 10.1021/la051465b
   Ghosh D. S., 2013, BASICS ULTRATHIN MET, P11
   Gong XZ, 2014, RSC ADV, V4, P24653, DOI 10.1039/c4ra02247e
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   He W, 2005, BIOMATERIALS, V26, P2983, DOI 10.1016/j.biomaterials.2004.08.021
   Helander IM, 1997, MICROBIOL-UK, V143, P3193, DOI 10.1099/00221287-143-10-3193
   Hernandez-Montelongo J, 2016, COLLOID SURFACE B, V141, P499, DOI 10.1016/j.colsurfb.2016.02.028
   Hernandez-Montelongo J, 2014, CARBOHYD POLYM, V110, P238, DOI 10.1016/j.carbpol.2014.04.002
   Hernandez-Montelongo J, 2016, CARBOHYD POLYM, V136, P1, DOI 10.1016/j.carbpol.2015.08.076
   Hoque J, 2015, ACS APPL MATER INTER, V7, P1804, DOI 10.1021/am507482y
   Janissen R, 2015, SCI REP-UK, V5, DOI 10.1038/srep09856
   Junthip J., 2016, J BIOMED MATER RES A, V104, P1
   Lopez BGC, 2015, J APPL MICROBIOL, V119, P677, DOI 10.1111/jam.12874
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   MacDonald IA, 2013, J BACTERIOL, V195, P2971, DOI 10.1128/JB.02267-12
   Mark J. E., 2009, POLYM DATA HDB
   Martins TD, 2015, APPL SURF SCI, V329, P287, DOI 10.1016/j.apsusc.2014.12.010
   Naveas N, 2014, COLLOID SURFACE B, V115, P310, DOI 10.1016/j.colsurfb.2013.11.026
   Naveas N, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/4/045009
   Nishimoto S, 2013, RSC ADV, V3, P671, DOI 10.1039/c2ra21260a
   Okon E.U., 2014, INT J INNOV APPL STU, V5, P192
   Sheppard NC, 2014, INT IMMUNOL, V26, P531, DOI 10.1093/intimm/dxu055
   Taubenberger AV, 2014, TISSUE ENG PART B-RE, V20, P40, DOI 10.1089/ten.TEB.2013.0125
   Tian XK, 2015, MICROPOR MESOPOR MAT, V207, P46, DOI 10.1016/j.micromeso.2014.12.031
   Vancha AR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-23
   Zanin H, 2014, MAT SCI ENG C-MATER, V39, P359, DOI 10.1016/j.msec.2014.03.016
NR 42
TC 9
Z9 9
U1 6
U2 53
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2017
VL 71
BP 718
EP 724
DI 10.1016/j.msec.2016.10.064
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA EG3TI
UT WOS:000390967200085
PM 27987765
DA 2020-11-30
ER

PT J
AU Virginio, VG
   Bandeira, NC
   Leal, FMD
   Lancellotti, M
   Zaha, A
   Ferreira, HB
AF Virginio, Veridiana Gomes
   Bandeira, Natalia Costantin
   dos Anjos Leal, Fernanda Munhoz
   Lancellotti, Marcelo
   Zaha, Arnaldo
   Ferreira, Henrique Bunselmeyer
TI Assessment of the adjuvant activity of mesoporous silica nanoparticles
   in recombinant Mycoplasma hyopneumoniae antigen vaccines
SO HELIYON
LA English
DT Article
DE Microbiology; Biotechnology; Immunology
ID IMMUNE-RESPONSES; CHIMERIC PROTEIN; SBA-15; CARRIERS; SWINE
AB The adjuvant potential of two mesoporous silica nanoparticles (MSNs), SBa-15 and SBa-16, was assessed in combination with a recombinant HSP70 surface polypeptide domain from Mycoplasma hyopneumoniae, the etiological agent of porcine enzootic pneumonia (PEP). The recombinant antigen (HSP70(212-600)), previously shown as immunogenic in formulation with classic adjuvants, was used to immunize BALB/c mice in combination with SBa-15 or SBa-16 MSNs, and the effects obtained with these formulations were compared to those obtained with alum, the adjuvant traditionally used in anti-PEP bacterins. The HSP70(212-600) + SBa-15 vaccine elicited a strong humoral immune response, with high serum total IgG levels, comparable to those obtained using HSP70(212-600) + alum. The HSP70(212-600) + SBa-16 vaccine elicited a moderate humoral immune response, with lower levels of total IgG. The cellular immune response was assessed by the detection of IFN-gamma, IL-4 and IL-10 in splenocyte culture supernatants. The HSP70(212-600) + SBa-15 vaccine increased IFN-gamma, IL-4 and IL-10 levels, while no stimulation was detected with the HSP70(212-600) Sfla-16 vaccine. The HSP70(212-600) + SBa-15 vaccine induced a mixed Thl/Th2-type response, with an additional IL-10 mediated anti-inflammatory effect, both of relevance for an anti-PEP vaccine. Alum adjuvant controls stimulated an unspecific cellular immune response, with similar levels of cytokines detected in mice immunized either with HSP70(212-600) + alum or with the adjuvant alone. The better humoral and cellular immune responses elicited in mice indicated that SBa-15 has adjuvant potential, and can be considered as an alternative to the use of alum in veterinary vaccines. The use of SBa-15 with HSP70(212-600) is also promising as a potential anti-PEP subunit vaccine formulation.
C1 [Virginio, Veridiana Gomes; Bandeira, Natalia Costantin; dos Anjos Leal, Fernanda Munhoz; Zaha, Arnaldo; Ferreira, Henrique Bunselmeyer] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Genom Estrutural & Func, Porto Alegre, RS, Brazil.
   [Virginio, Veridiana Gomes; dos Anjos Leal, Fernanda Munhoz; Zaha, Arnaldo; Ferreira, Henrique Bunselmeyer] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil.
   [Zaha, Arnaldo; Ferreira, Henrique Bunselmeyer] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Biol Mol & Biotecnol, Porto Alegre, RS, Brazil.
   [Lancellotti, Marcelo] Univ Estadual Campinas, Dept Bioquim, Inst Biol, Lab Biotecnol, Campinas, SP, Brazil.
   [Lancellotti, Marcelo] Univ Estadual Campinas, Fac Ciencias Farmaceut, Campinas, SP, Brazil.
RP Ferreira, HB (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Caixa Postal 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM henrique@cbiot.ufrgs.br
RI Ferreira, Henrique B/H-4189-2012; Zaha, Arnaldo/D-3165-2013
OI Ferreira, Henrique B/0000-0003-3611-6040; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do
   Sul (FAPERGS, PqG) [1975-2551/13-3]; DTI1/FAPERGS postdoctoral
   fellowship; PIBITI/CNPq fellowship; CNPq Ph.D. fellowship
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do
   Estado do Rio Grande do Sul (FAPERGS, PqG no 1975-2551/13-3). Veridiana
   G. Virginio was a recipient of a DTI1/FAPERGS postdoctoral fellowship.
   Natalia C. Bandeira was a recipient of a PIBITI/CNPq fellowship.
   Fernanda M. A. Leal is a recipient of a CNPq Ph.D. fellowship.
CR Alves D. A., 2013, J VACCINES VACCIN, V4, P6
   Bargieri DY, 2008, VACCINE, V26, P6132, DOI 10.1016/j.vaccine.2008.08.070
   Carvalho LV, 2010, VACCINE, V28, P7829, DOI 10.1016/j.vaccine.2010.09.087
   Delany I, 2014, EMBO MOL MED, V6, P708, DOI 10.1002/emmm.201403876
   Delves PJ, 2000, NEW ENGL J MED, V343, P108, DOI 10.1056/NEJM200007133430207
   Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223
   Feng ZX, 2013, VET MICROBIOL, V167, P417, DOI 10.1016/j.vetmic.2013.08.012
   FROST L, 1985, ALLERGY, V40, P368, DOI 10.1111/j.1398-9995.1985.tb00249.x
   Galliher-Beckley A, 2015, VACCINE, V33, P2903, DOI 10.1016/j.vaccine.2015.04.065
   GUPTA RK, 1993, VACCINE, V11, P293, DOI 10.1016/0264-410X(93)90190-9
   Hakimi H, 2014, INFLAMMATION, V37, P818, DOI 10.1007/s10753-013-9801-1
   Hartono SB, 2012, ACS NANO, V6, P2104, DOI 10.1021/nn2039643
   Hudson SP, 2008, BIOMATERIALS, V29, P4045, DOI 10.1016/j.biomaterials.2008.07.007
   Jones LS, 2005, J BIOL CHEM, V280, P13406, DOI 10.1074/jbc.M500687200
   Jorge S, 2014, COMP IMMUNOL MICROB, V37, P229, DOI 10.1016/j.cimid.2014.07.001
   Kinzenbaw DA, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.149
   Kunzmann A, 2011, BBA-GEN SUBJECTS, V1810, P361, DOI 10.1016/j.bbagen.2010.04.007
   Lee NH, 2012, CLIN EXP VACCINE RES, V1, P18, DOI 10.7774/cevr.2012.1.1.18
   Lee SH, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-43
   Leroux-Roels I, 2015, VACCINE, V33, P577, DOI 10.1016/j.vaccine.2013.10.052
   Li XR, 2011, EUR J PHARM BIOPHARM, V78, P107, DOI 10.1016/j.ejpb.2010.12.017
   Maes D, 2008, VET MICROBIOL, V126, P297, DOI 10.1016/j.vetmic.2007.09.008
   Mahony D, 2013, SMALL, V9, P3138, DOI 10.1002/smll.201300012
   Marchioro SB, 2014, VACCINE, V32, P4689, DOI 10.1016/j.vaccine.2014.05.072
   Marchioro SB, 2014, VET MICROBIOL, V173, P166, DOI 10.1016/j.vetmic.2014.07.009
   MARK A, 1995, VACCINE, V13, P669, DOI 10.1016/0264-410X(94)00017-H
   Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510
   Mella JR, 2014, SHOCK, V42, P337, DOI 10.1097/SHK.0000000000000222
   Mercuri LP, 2006, SMALL, V2, P254, DOI 10.1002/smll.200500274
   Mody KT, 2013, NANOSCALE, V5, P5167, DOI 10.1039/c3nr00357d
   Morrison DF, 2000, INFECT IMMUN, V68, P4752, DOI 10.1128/IAI.68.8.4752-4758.2000
   O'Hagan DT, 2015, VACCINE, V33, pB14, DOI 10.1016/j.vaccine.2015.01.088
   Pinto PM, 2007, VET MICROBIOL, V121, P83, DOI 10.1016/j.vetmic.2006.11.018
   Scaramuzzi K, 2016, NANOMED-NANOTECHNOL, V12, P2241, DOI 10.1016/j.nano.2016.06.003
   Skrastina D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114006
   SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127
   Souza KC, 2009, J MATER SCI-MATER M, V20, P507, DOI 10.1007/s10856-008-3592-1
   Srinivasan NR, 2016, FARADAY DISCUSS, V186, P353, DOI 10.1039/c5fd00126a
   Thacker E. L., 2010, DIS SWINE, P779
   Thacker EL, 2000, AM J VET RES, V61, P1384, DOI 10.2460/ajvr.2000.61.1384
   Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005
   Villarreal I, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-2
   Virginio VG, 2014, VACCINE, V32, P5832, DOI 10.1016/j.vaccine.2014.08.008
   Virginio VG, 2003, CLIN EXP IMMUNOL, V132, P309, DOI 10.1046/j.1365-2249.2003.02123.x
   Wang TY, 2012, INT J PHARMACEUT, V436, P351, DOI 10.1016/j.ijpharm.2012.06.028
   Woolley LK, 2014, VACCINE, V32, P4333, DOI 10.1016/j.vaccine.2014.06.008
   Xia TA, 2009, ACS NANO, V3, P3273, DOI 10.1021/nn900918w
   Xiong QY, 2014, VACCINE, V32, P3445, DOI 10.1016/j.vaccine.2014.03.071
   Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069
NR 49
TC 12
Z9 13
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD JAN
PY 2017
VL 3
IS 1
AR e00225
DI 10.1016/j.heliyon.2016.e00225
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GF5NW
UT WOS:000432015800014
PM 28194450
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Bergamini, FRG
   Ribeiro, MA
   Lancellotti, M
   Machado, D
   Miranda, PCML
   Cuin, A
   Formiga, ALB
   Corbi, PP
AF Bergamini, F. R. G.
   Ribeiro, M. A.
   Lancellotti, M.
   Machado, D.
   Miranda, P. C. M. L.
   Cuin, A.
   Formiga, A. L. B.
   Corbi, P. P.
TI Synthesis, spectroscopic characterizations, crystal structures and DFT
   studies of nalidixic acid carbonyl hydrazones derivatives
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article
DE Nalidixic acid; Carbonyl hydrazones; Crystal structure; Antimicrobial;
   DFT; NMR
ID BIOLOGICAL EVALUATION; PROTEIN-BINDING; DNA; ANTIOXIDANT; COMPLEXES;
   MECHANISM; GYRASE; NI(II)
AB This article describes the synthesis and characterization of the 1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carbohydrazide (hzd) and six carbonyl hydrazones derivatives of the nalidixic with 1H-pyrrol-2-ylmethylidene (hpyrr), 1H-imidazol-2-ylmethylidene (h2imi), pyridin-2-ylmethylidene (h2py), pyridin-3-ylmethylidene (h3py), pyridin-4-ylmethylidene(h4py) and (2-hydroxyphenyl)methylidene (hsali). The carbonyl hydrazones were characterized by elemental and ESI-QTOF-MS analyses, IR and detailed NMR spectroscopic measurements. The 2D NMR experiments allowed the unambiguous assignment of the hydrogen, carbon and nitrogen atoms, which have not been reported for nalidixic acid carbonyl hydrazone derivatives so far. Crystal structures of hzd and the new carbonyl hydrazones h2imi, hpyrr and h3py were determined by X-ray diffraction studies. Although the synthesis of hzd was reported decades ago, the hzd crystal structure have not been reported yet. Geometric optimizations of all the characterized structures were performed with the aid of DFT studies. Despite the fact that the hydrazones with 2-pyridine carboxylic acid (h2py) and salicyl aldehyde (hsali) were already reported by literature, a detailed spectroscopic study followed by DFT studies are also reported for such compounds in this manuscript. Antimicrobial studies of the compounds are also presented. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Bergamini, F. R. G.; Ribeiro, M. A.; Formiga, A. L. B.; Corbi, P. P.] Univ Campinas UNICAMP, Inst Chem, Dept Inorgan Chem, POB 6154, BR-13083970 Campinas, SP, Brazil.
   [Lancellotti, M.; Machado, D.] Univ Campinas UNICAMP, Inst Biol, Biotechnol Lab, POB 6154, BR-13083970 Campinas, SP, Brazil.
   [Miranda, P. C. M. L.] Univ Campinas UNICAMP, Inst Chem, Dept Organ Chem, POB 6154, BR-13083970 Campinas, SP, Brazil.
   [Cuin, A.] Univ Fed Juiz de Fora, LQBin Lab Quim BioInorgan, Dept Quim, BR-36036330 Juiz de Fora, MG, Brazil.
RP Bergamini, FRG; Corbi, PP (corresponding author), Univ Campinas UNICAMP, Inst Chem, POB 6154, BR-13083970 Campinas, SP, Brazil.
EM bergamini.frg@gmail.com; ppcorbi@iqm.unicamp.br
RI Machado, Daisy/ABA-3731-2020; Miranda, Paulo/B-8868-2013; Corbi, Pedro
   P/B-7639-2012; Cuin, Alexandre/H-3548-2015; Ribeiro, Marcos
   A/D-2420-2015; Cuin, Alexandre/V-2997-2019; Bergamini, Fernando
   Rodrigues Goulart/B-8168-2013; Formiga, Andre/G-9755-2011
OI Machado, Daisy/0000-0002-6435-6159; Miranda, Paulo/0000-0002-6418-3614;
   Corbi, Pedro P/0000-0002-7478-0877; Cuin, Alexandre/0000-0002-5444-5027;
   Ribeiro, Marcos A/0000-0002-9350-6419; Bergamini, Fernando Rodrigues
   Goulart/0000-0002-8357-3044; Formiga, Andre/0000-0001-6773-8083
FU Brazilian Agency FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2012/08230-2]; Brazilian Agency CAPESCAPES; Brazilian
   Agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico, Brazil) [140707/2013-1, 442123/2014-0]
FX This study was supported by grants from the Brazilian Agencies FAPESP
   (grant # 2012/08230-2) CAPES and CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Brazil - grant #140707/2013-1
   and #442123/2014-0). The authors are also grateful to CENAPAD-SP for
   computer time and to Dr. Deborah Simoni for X-ray crystallographic data
   acquisitions.
CR Aboul-Fadl T, 2010, EUR J MED CHEM, V45, P4578, DOI 10.1016/j.ejmech.2010.07.020
   Adamo C, 1999, J CHEM PHYS, V110, P6158, DOI 10.1063/1.478522
   Aggarwal N, 2010, J AGR FOOD CHEM, V58, P3056, DOI 10.1021/jf904144e
   [Anonymous], 2009, TOPAS R VERSION 4 2
   Bhat MA, 2013, MED CHEM RES, V22, P4522, DOI 10.1007/s00044-012-0458-3
   Bin-Jubair F. A. S., 2010, THESIS
   Caneva C, 2015, MOL DIVERS, V19, P669, DOI 10.1007/s11030-015-9597-z
   CARROLL FI, 1981, J HETEROCYCLIC CHEM, V18, P941, DOI 10.1002/jhet.5570180519
   Coelho AA, 2000, J APPL CRYSTALLOGR, V33, P899, DOI 10.1107/S002188980000248X
   Coelho AA, 2003, J APPL CRYSTALLOGR, V36, P86, DOI 10.1107/S0021889802019878
   Deeba F, 2013, ASIAN J CHEM, V25, P8351, DOI 10.14233/ajchem.2013.14738
   Deeba F, 2009, ACTA CRYSTALLOGR E, V65, pO3152, DOI 10.1107/S1600536809048739
   Deeba F, 2009, ACTA CRYSTALLOGR E, V65, pO860, DOI 10.1107/S1600536809009167
   Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726
   Eichkorn K, 1997, THEOR CHEM ACC, V97, P119, DOI 10.1007/s002140050244
   Emmerson AM, 2003, J ANTIMICROB CHEMOTH, V51, P13, DOI 10.1093/jac/dkg208
   Izsak R, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3646921
   Kratz F, 1998, J PHARM SCI-US, V87, P338, DOI 10.1021/js970246a
   Krishnamoorthy P, 2012, DALTON T, V41, P4423, DOI 10.1039/c2dt11938b
   Lidicky O, 2015, MOLECULES, V20, P19849, DOI 10.3390/molecules201119664
   Moksharagni B., 2015, INT J PHARM BIO SCI, V6, P11
   Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81
   PAWLEY GS, 1981, J APPL CRYSTALLOGR, V14, P357, DOI 10.1107/S0021889881009618
   Ramakrishnan A, 2015, RSC ADV, V5, P55938, DOI 10.1039/c5ra05574a
   Rollas S, 2008, OPEN DRUG DELIV J, V2, P77, DOI DOI 10.2174/1874126600802010077
   Rollas S, 2007, MOLECULES, V12, P1910, DOI 10.3390/12081910
   Sathyadevi P, 2012, POLYHEDRON, V31, P294, DOI 10.1016/j.poly.2011.09.021
   Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930
   Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI 10.1107/S2053229614024218
   SHEN LL, 1985, P NATL ACAD SCI USA, V82, P307, DOI 10.1073/pnas.82.2.307
   Spek AL, 2009, ACTA CRYSTALLOGR D, V65, P148, DOI 10.1107/S090744490804362X
   Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U
   SUGINO A, 1977, P NATL ACAD SCI USA, V74, P4767, DOI 10.1073/pnas.74.11.4767
   Vicini P, 2002, EUR J MED CHEM, V37, P553, DOI 10.1016/S0223-5234(02)01378-8
   WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665
   Webber MA, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg050
   Young R.A., 1981, IUCR MONOGRAPH, V5
NR 37
TC 4
Z9 4
U1 1
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2860
EI 1872-8014
J9 J MOL STRUCT
JI J. Mol. Struct.
PD SEP 15
PY 2016
VL 1120
BP 115
EP 124
DI 10.1016/j.molstruc.2016.05.025
PG 10
WC Chemistry, Physical
SC Chemistry
GA DP4FZ
UT WOS:000378453100012
DA 2020-11-30
ER

PT J
AU Almeida, JR
   Lancellotti, M
   Soares, AM
   Calderon, LA
   Ramirez, D
   Gonzalez, W
   Marangoni, S
   Da Silva, SL
AF Almeida, J. R.
   Lancellotti, M.
   Soares, A. M.
   Calderon, L. A.
   Ramirez, D.
   Gonzalez, W.
   Marangoni, S.
   Da Silva, S. L.
TI CoaTx-II, a new dimeric Lys49 phospholipase A(2) from Crotalus oreganus
   abyssus snake venom with bactericidal potential: Insights into its
   structure and biological roles
SO TOXICON
LA English
DT Article
DE Snake venom; Lys49 phospholipase A(2); Crotalus oreganus abyssus;
   Myotoxicity; Antibacterial effect
ID LOCAL TISSUE-DAMAGE; MYOTOXIN-II; FUNCTIONAL-CHARACTERIZATION;
   SEQUENCE-ANALYSIS; HOMOLOG; PURIFICATION; PEPTIDES; RATTLESNAKE;
   PROTEINS; REGION
AB Snake venoms are rich and intriguing sources of biologically-active molecules that act on target cells, modulating a diversity of physiological functions and presenting promising pharmacological applications. Lys49 phospholipase A(2) is one of the multifunctional proteins present in these complex secretions and, although catalytically inactive, has a variety of biological activities, including cytotoxic, antibacterial, inflammatory, antifungal activities. Herein, a Lys49 phospholipase A(2), denominated CoaTx-II from Crotalus oreganus abyssus, was purified and structurally and pharmacologically characterized. CoaTx-II was isolated with a high degree of purity by a combination of two chromatographic steps; molecular exclusion and reversed-phase high performance liquid chromatography. This toxin is dimeric with a mass of 13868.2 Da (monomeric form), as determined by mass spectrometry. CoaTx-II is rich in Arg and Lys residues and displays high identity with other Lys49 PLA(2) homologues, which have high isoelectric points. The structural model of dimeric CoaTx-II shows that the toxin is non-covalently stabilized. Despite its enzymatic inactivity, in vivo CoaTx-II caused local muscular damage, characterized by increased plasma creatine kinase and confirmed by histological alterations, in addition to an inflammatory activity, as demonstrated by mice paw edema induction and pro-inflammatory cytokine IL-6 elevation. CoaTx-II also presents antibacterial activity against gram negative (Pseudomonas aeruginosa 31NM, Escherichia coli ATCC 25922) and positive (Staphyloccocus aureus BEC9393 and Rib1) bacteria. Therefore, data show that this newly purified toxin plays a central role in mediating the degenerative events associated with envenomation, in addition to demonstrating antibacterial properties, with potential for use in the development of strategies for antivenom therapy and combating antibiotic-resistant bacteria. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Almeida, J. R.; Da Silva, S. L.] IKIAM Univ Reg Amazon, Km 7 Via Muyuna, Tena, Napo, Ecuador.
   [Almeida, J. R.; Lancellotti, M.; Marangoni, S.] Campinas State Univ UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil.
   [Soares, A. M.; Calderon, L. A.] Oswaldo Cruz Fdn FIOCRUZ, Fiocruz Rondonia, CEBio, Porto Velho, RO, Brazil.
   [Soares, A. M.; Calderon, L. A.] Fed Univ Rondonia, Porto Velho, RO, Brazil.
   [Ramirez, D.; Gonzalez, W.] Univ Talca, CBSM, 2 Norte 685,Casilla 721, Talca, Chile.
   [Almeida, J. R.; Soares, A. M.; Calderon, L. A.; Gonzalez, W.; Da Silva, S. L.] Int Network Ecuadorian Snakes Venoms Studies RIEV, Tena, Napo, Ecuador.
RP Almeida, JR (corresponding author), IKIAM Univ Reg Amazon, Km 7 Via Muyuna, Tena, Napo, Ecuador.
EM rafaeldealmeida@ikiam.edu.ec
RI Ramirez, David/X-4233-2019; Almeida, Jose Rafael/D-1472-2016; Ramirez,
   David/Q-9537-2018; Soares, Andreimar M/K-5556-2014; de A Calderon,
   Leonardo/K-8515-2012
OI Ramirez, David/0000-0003-0002-1189; Almeida, Jose
   Rafael/0000-0002-4637-4468; Ramirez, David/0000-0003-0002-1189; de A
   Calderon, Leonardo/0000-0003-2669-092X; Soares,
   Andreimar/0000-0003-1032-2188; Da Silva, Saulo Luis/0000-0002-7029-2016;
   de Almeida, Jose Rafael/0000-0002-0688-7648; Gonzalez,
   Wendy/0000-0002-7535-6883
FU Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES; National Counsel of Technological and Scientific
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq)
FX The authors gratefully acknowledge to the Coordination for the
   Improvement of Higher Education Personnel (CAPES) and the National
   Counsel of Technological and Scientific Development (CNPq) for financial
   support.
CR Almeida JR, 2016, TOXICON, V117, P1, DOI 10.1016/j.toxicon.2016.03.008
   Angulo Y, 2005, TOXICON, V46, P291, DOI 10.1016/j.toxicon.2005.03.025
   Angulo Y, 2002, INT J BIOCHEM CELL B, V34, P1268, DOI 10.1016/S1357-2725(02)00060-2
   Angulo Y, 2009, TOXICON, V54, P949, DOI 10.1016/j.toxicon.2008.12.014
   Ben Bacha A, 2013, INT J BIOL MACROMOL, V57, P156, DOI 10.1016/j.ijbiomac.2013.03.020
   Brahma RK, 2015, TOXICON, V93, P1, DOI 10.1016/j.toxicon.2014.10.022
   Buke C, 2007, INFECT CONT HOSP EP, V28, P1255, DOI 10.1086/522678
   Calgarotto AK, 2008, TOXICON, V51, P1509, DOI 10.1016/j.toxicon.2008.03.030
   Calvete JJ, 2007, J MASS SPECTROM, V42, P1405, DOI 10.1002/jms.1242
   Cardozo VF, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-12
   Carvalho BMA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/153045
   Correa EA, 2016, TOXICON, V115, P13, DOI 10.1016/j.toxicon.2016.02.021
   Cury GG, 2009, BRAZ J INFECT DIS, V13, P165, DOI 10.1590/S1413-86702009000300002
   da Silva SL, 2009, EUR J MED CHEM, V44, P312, DOI 10.1016/j.ejmech.2008.02.043
   Da Silva SL, 2011, INT J PEPT RES THER, V17, P165, DOI 10.1007/s10989-011-9254-z
   de Oliveira NG, 2013, CELL MOL LIFE SCI, V70, P4645, DOI 10.1007/s00018-013-1345-x
   de Sousa MV, 1998, BBA-PROTEIN STRUCT M, V1384, P204, DOI 10.1016/S0167-4838(98)00023-5
   DeAraujo HSS, 1996, TOXICON, V34, P1237, DOI 10.1016/S0041-0101(96)00111-0
   deAraujo HSS, 1996, ARCH BIOCHEM BIOPHYS, V326, P21, DOI 10.1006/abbi.1996.0042
   Delatorre P, 2011, BIOCHIMIE, V93, P513, DOI 10.1016/j.biochi.2010.11.003
   dos Santos JI, 2011, PROTEINS, V79, P61, DOI 10.1002/prot.22858
   EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283
   Falconi M, 2000, J MOL RECOGNIT, V13, P14, DOI 10.1002/(SICI)1099-1352(200001/02)13:1<14::AID-JMR484>3.0.CO;2-F
   Fernandes CAH, 2010, J STRUCT BIOL, V171, P31, DOI 10.1016/j.jsb.2010.03.019
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   Bergamini FRG, 2012, RSC ADV, V2, P10372, DOI 10.1039/c2ra21433d
   Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005
   Gutierrez JM, 2008, TOXICON, V51, P80, DOI 10.1016/j.toxicon.2007.08.007
   Higuchi DA, 2007, BIOCHIMIE, V89, P319, DOI 10.1016/j.biochi.2006.10.010
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   Holzer M, 1996, TOXICON, V34, P1149, DOI 10.1016/0041-0101(96)00057-8
   Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613
   Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d
   KIHARA H, 1992, BIOCHEM INT, V28, P895
   KOCHVA E, 1987, TOXICON, V25, P65, DOI 10.1016/0041-0101(87)90150-4
   Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098
   Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008
   Lomonte B, 2003, TOXICON, V42, P307, DOI 10.1016/S0041-0101(03)00149-1
   Lomonte B, 2012, TOXICON, V60, P520, DOI 10.1016/j.toxicon.2012.02.007
   Lomonte B, 2010, CURR PHARM DESIGN, V16, P3224, DOI 10.2174/138161210793292456
   Lomonte B, 2009, PROTEIN PEPTIDE LETT, V16, P860, DOI 10.2174/092986609788923356
   Mackessy SP, 2010, TOXICON, V55, P1463, DOI 10.1016/j.toxicon.2010.02.028
   Gutierrez JM, 2013, TOXICON, V62, P27, DOI 10.1016/j.toxicon.2012.09.006
   Gutierrez JM, 2009, TOXICON, V54, P958, DOI 10.1016/j.toxicon.2009.01.038
   Martins W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/654170
   McCleary RJR, 2013, TOXICON, V62, P56, DOI 10.1016/j.toxicon.2012.09.008
   Montecucco C, 2008, CELL MOL LIFE SCI, V65, P2897, DOI 10.1007/s00018-008-8113-3
   Murakami MT, 2007, TOXICON, V49, P378, DOI 10.1016/j.toxicon.2006.10.011
   Mamede CCN, 2013, PROTEIN PEPTIDE LETT, V20, P192
   Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6
   Nunez V, 2004, TOXICON, V44, P91, DOI 10.1016/j.toxicon.2004.04.013
   Oliveira CD, 2009, TOXICON, V53, P560, DOI 10.1016/j.toxicon.2008.12.025
   Paramo L, 1998, EUR J BIOCHEM, V253, P452, DOI 10.1046/j.1432-1327.1998.2530452.x
   Ponce-Soto L.A., 2007, BIOCH BIOPHYS ACTA, V1770, P585
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   Rokyta DR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-394
   Salvador GHM, 2013, TOXICON, V72, P52, DOI 10.1016/j.toxicon.2013.06.013
   Samy RP, 2012, CURR MED CHEM, V19, P6150
   Santamaria C, 2005, TOXICON, V45, P807, DOI 10.1016/j.toxicon.2004.09.012
   Santamaria C, 2005, ANTIMICROB AGENTS CH, V49, P1340, DOI 10.1128/AAc.49.4.1340-1345.2005
   Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   Smart BP, 2004, BIOORGAN MED CHEM, V12, P1737, DOI 10.1016/j.bmc.2004.01.022
   Soares MJD, 2001, J MED MICROBIOL, V50, P732, DOI 10.1099/0022-1317-50-8-732
   Stabeli RG, 2006, COMP BIOCHEM PHYS C, V142, P371, DOI 10.1016/j.cbpc.2005.11.020
   Sudharshan S, 2015, J VENOM ANIM TOXINS, V21, DOI 10.1186/s40409-015-0014-y
   Teixeira CFP, 2003, TOXICON, V42, P947, DOI 10.1016/j.toxicon.2003.11.006
   Tsai IH, 2001, ARCH BIOCHEM BIOPHYS, V394, P236, DOI 10.1006/abbi.2001.2524
   Tsai SH, 2007, TOXICON, V50, P914, DOI 10.1016/j.toxicon.2007.06.025
   Ullah A, 2012, INT J BIOL MACROMOL, V51, P209, DOI 10.1016/j.ijbiomac.2012.05.006
   VAN DEENENL, 1963, Biochim Biophys Acta, V70, P538
   Azevedo FVP, 2016, INT J BIOL MACROMOL, V82, P671, DOI 10.1016/j.ijbiomac.2015.10.080
   Ward RJ, 2002, BIOCHEM J, V362, P89, DOI 10.1042/0264-6021:3620089
   Wei JF, 2006, BIOCHIMIE, V88, P1331, DOI 10.1016/j.biochi.2006.05.003
NR 78
TC 17
Z9 18
U1 1
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD SEP 15
PY 2016
VL 120
BP 147
EP 158
DI 10.1016/j.toxicon.2016.08.007
PG 12
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA DW7IJ
UT WOS:000383824100020
PM 27530662
OA Bronze
DA 2020-11-30
ER

PT J
AU Alves, DA
   Machado, D
   Melo, A
   Pereira, RFC
   Severino, P
   de Hollanda, LM
   Araujo, DR
   Lancellotti, M
AF Alves, Danilo Antonini
   Machado, Daisy
   Melo, Adriana
   Carneiro Pereira, Rafaella Fabiana
   Severino, Patricia
   de Hollanda, Luciana Maria
   Araujo, Daniele Ribeiro
   Lancellotti, Marcelo
TI Preparation of Thermosensitive Gel for Controlled Release of
   Levofloxacin and Their Application in the Treatment of
   Multidrug-Resistant Bacteria
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID LOCALIZED LIDOCAINE RELEASE; THERMORESPONSIVE HYDROGELS; GENE
   TRANSFECTION; BINARY HYDROGELS; DRUG-DELIVERY; NANOPARTICLES;
   MICELLIZATION; QUINOLONE; MECHANISMS; COPOLYMERS
AB Levofloxacin is a synthetic broad-spectrum antibacterial agent for oral or intravenous administration. Chemically, levofloxacin is the levorotatory isomer (L-isomer) of racemate ofloxacin, a fluoroquinolone antibacterial agent. Quinolone derivatives rapidly and specifically inhibit the synthesis of bacterial DNA. Levofloxacin has in vitro activity against a broad range of aerobic and anaerobic Gram-positive and Gram-negative bacteria. However, formulation of combined poloxamers thermoregulated (as Pluronic (R) F127) and levofloxacin for use in multiresistant bacterial treatment were poorly described in the current literature. Thus, the aim of the present work is to characterize poloxamers for levofloxacin controlled release and their use in the treatment of multidrug bacterial resistance. Micelles were produced in colloidal dispersions, with a diameter between 5 and 100 nm, which form spontaneously from amphiphilic molecules under certain conditions as concentration and temperature. Encapsulation of levofloxacin into nanospheres showed efficiency and enhancement of antimicrobial activity against Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae when compared with only levofloxacin. Furthermore, all formulations were not cytotoxic for NIH/3T3 cell lineage. In conclusion, poloxamers combined with levofloxacin have shown promising results, better than alone, decreasing the minimal inhibitory concentration of the studied bacterial multiresistance strains. In the future, this new formulation will be used after being tested in animal models in patients with resistant bacterial strains.
C1 [Alves, Danilo Antonini; Machado, Daisy; Melo, Adriana; Carneiro Pereira, Rafaella Fabiana; Lancellotti, Marcelo] Univ Estadual Campinas, UNICAMP, Inst Biol, Lab Biotechnol LABIOTEC, Campinas, SP, Brazil.
   [Severino, Patricia] Inst Technol & Res ITP, Lab Nanotechnol & Nanomed LNMed, Aracaju, SE, Brazil.
   [Severino, Patricia; de Hollanda, Luciana Maria] Tiradentes Univ UNIT, Aracaju, SE, Brazil.
   [Araujo, Daniele Ribeiro] Fed Univ ABC UFABC, Ctr Nat Sci & Humanities, Santo Andre, SP, Brazil.
   [Lancellotti, Marcelo] Univ Estadual Campinas, UNICAMP, Fac Pharmaceut Sci, Campinas, SP, Brazil.
RP Lancellotti, M (corresponding author), Univ Estadual Campinas, UNICAMP, Inst Biol, Lab Biotechnol LABIOTEC, Campinas, SP, Brazil.; Lancellotti, M (corresponding author), Univ Estadual Campinas, UNICAMP, Fac Pharmaceut Sci, Campinas, SP, Brazil.
EM lancellottim@gmail.com
RI de Melo, Adriana/B-3670-2015; Machado, Daisy/ABA-3731-2020; Pereira,
   Rafaella F C/M-4418-2017
OI de Melo, Adriana/0000-0002-3925-0707; Machado,
   Daisy/0000-0002-6435-6159; Pereira, Rafaella F C/0000-0003-4928-7631
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2011/21822-3, 2011/21685-6, 2014/14457-5]
FX The authors would like to thank FAPESP (2011/21822-3, 2011/21685-6,
   2014/14457-5) for the financial support. Also the authors thank Dr. Ana
   Lucia da Costa Darini from FCFRP-USP for gifting them with the reference
   resistant strains for this study.
CR Aldred KJ, 2014, BIOCHEMISTRY-US, V53, P1565, DOI 10.1021/bi5000564
   Anderson VR, 2008, DRUGS, V68, P535, DOI 10.2165/00003495-200868040-00011
   Andriole VT, 2005, CLIN INFECT DIS, V41, pS113, DOI 10.1086/428051
   Anes J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00587
   Baym M, 2016, SCIENCE, V351, DOI 10.1126/science.aad3292
   Carbon C, 2001, CHEMOTHERAPY, V47, P9, DOI 10.1159/000057839
   Catauro M, 2004, J MATER SCI-MATER M, V15, P991, DOI 10.1023/B:JMSM.0000042684.13247.38
   Cavalieri SJ, 2005, MANUAL ANTIMICROBIAL
   Chaibundit C, 2007, LANGMUIR, V23, P9229, DOI 10.1021/la701157j
   Chana J, 2015, NANOMED-NANOTECHNOL, V11, P89, DOI 10.1016/j.nano.2014.07.012
   Chen PC, 2004, J BIOMED MATER RES A, V70A, P412, DOI 10.1002/jbm.a.30086
   Chen PC, 2004, J BIOMED MATER RES A, V70A, P459, DOI 10.1002/jbm.a.30101
   CLSI, 2006, STAND NCFCL
   Daniels S, 2009, EUR J CLIN PHARMACOL, V65, P343, DOI 10.1007/s00228-009-0614-y
   de Araujo DR, 2010, PHARM RES-DORDR, V27, P1677, DOI 10.1007/s11095-010-0151-5
   Dumortier G, 2006, PHARM RES-DORDR, V23, P2709, DOI 10.1007/s11095-006-9104-4
   Emmerson AM, 2003, J ANTIMICROB CHEMOTH, V51, P13, DOI 10.1093/jac/dkg208
   Farias DF, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/263509, 10.1155/2013/605831, 10.1155/2013/340605, 10.1155/2013/510736]
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Ferreira TH, 2015, J BIOMED MATER RES A, V103, P2176, DOI 10.1002/jbm.a.35333
   Fisher A, 2010, INT J CLIN PHARM TH, V48, P138
   FLORENCE AT, 1998, PHYSICOCHEMICAL PRIN
   Geethalakshmi R, 2013, IND CROP PROD, V51, P107, DOI 10.1016/j.indcrop.2013.08.055
   Giedraitiene A, 2011, MEDICINA-LITHUANIA, V47, P137
   Gong P, 2007, NANOTECHNOLOGY, V18, P28
   Guilhelmelli F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00353
   Harrison WJ, 2005, LANGMUIR, V21, P6170, DOI 10.1021/la050297k
   Hollanda LM, 2014, MAT SCI ENG C-MATER, V39, P288, DOI 10.1016/j.msec.2014.03.002
   Hooper DC, 1999, DRUGS, V58, P6, DOI 10.2165/00003495-199958002-00002
   Islan GA, 2015, INT J PHARMACEUT, V496, P953, DOI 10.1016/j.ijpharm.2015.10.050
   Kamboj V. K., 2015, PHARM LETT, V7, P264
   Khameneh B, 2016, MICROB PATHOGENESIS, V95, P32, DOI 10.1016/j.micpath.2016.02.009
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Klouda L, 2015, EUR J PHARM BIOPHARM, V97, P338, DOI 10.1016/j.ejpb.2015.05.017
   Kwon GS, 1996, ADV DRUG DELIVER REV, V21, P107, DOI 10.1016/S0169-409X(96)00401-2
   LESHER GY, 1962, J MED PHARMACEUT CH, V5, P1063, DOI 10.1021/jm01240a021
   Levaquin, 2016, LEVAQUIN HIGHLIGHTS
   Li C, 2014, ACTA OTO-LARYNGOL, V134, P468, DOI 10.3109/00016489.2013.878473
   Lorente M, 2013, JAMA DERMATOL, V149, P1111, DOI 10.1001/jamadermatol.2013.4365
   Machado D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054269
   dos Santos ACM, 2015, INT J NANOMED, V10, P2391, DOI 10.2147/IJN.S72337
   Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q
   Moffitt M, 1996, NATO ADV SCI INST SE, V327, P53
   Moffitt M, 1996, ACCOUNTS CHEM RES, V29, P95, DOI 10.1021/ar940080+
   Moghimi SM, 2000, TRENDS BIOTECHNOL, V18, P412, DOI 10.1016/S0167-7799(00)01485-2
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   NCCLS, 2004, M11 A6 METH ANT SUSC
   Nebert DW, 2008, DRUG METAB REV, V40, P187, DOI [10.1080/03602530801952864, 10.1080/03602530801952864 ]
   Newby GE, 2009, J COLLOID INTERF SCI, V329, P54, DOI 10.1016/j.jcis.2008.09.054
   Nischal PM, 2014, NATL MED J INDIA, V27, P241
   Noel GJ, 2009, CLIN MED INSIGHTS-TH, V1, P433
   Oshiro A, 2014, LANGMUIR, V30, P13689, DOI 10.1021/la503021c
   Paavola A, 1998, J CONTROL RELEASE, V52, P169, DOI 10.1016/S0168-3659(97)00206-X
   Paavola A, 1995, PHARM RES-DORDR, V12, P1997, DOI 10.1023/A:1016264527738
   Paavola A, 2000, INT J PHARMACEUT, V199, P85, DOI 10.1016/S0378-5173(00)00376-8
   Park YJ, 2003, INT J PHARM, V263, P105, DOI 10.1016/S0378-5173(03)00362-4
   PATON JH, 1991, DRUG SAFETY, V6, P8, DOI 10.2165/00002018-199106010-00002
   Pazian G. M., 2007, REV CESUMAR CIENCIAS, V11, P157
   Ricardo NMPS, 2005, INT J PHARMACEUT, V300, P22, DOI 10.1016/j.ijpharm.2005.04.023
   Ricci EJ, 2005, INT J PHARMACEUT, V288, P235, DOI 10.1016/j.ijpharm.2004.09.028
   Ricci EJ, 2002, EUR J PHARM SCI, V17, P161, DOI 10.1016/S0928-0987(02)00166-5
   Riley MA, 2012, BIOCHEM SOC T, V40, P1438, DOI 10.1042/BST20120179
   SCHMOLKA IR, 1972, J BIOMED MATER RES, V6, P571, DOI 10.1002/jbm.820060609
   Severino P, 2015, COLLOID SURFACE B, V129, P191, DOI 10.1016/j.colsurfb.2015.03.049
   STEIN GE, 1988, PHARMACOTHERAPY, V8, P301
   Torchilin VP, 2007, PHARM RES, V24, P2333, DOI 10.1007/s11095-007-9463-5
   Torchilin VP, 2007, AAPS J, V9, pE128, DOI 10.1208/aapsj0902015
   Turcu I, 2012, J PHYS CHEM B, V116, P6488, DOI 10.1021/jp3034215
   Yin QQ, 2009, ACTA ANAESTH SCAND, V53, P1207, DOI 10.1111/j.1399-6576.2009.02030.x
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zanin H, 2014, MAT SCI ENG C-MATER, V39, P359, DOI 10.1016/j.msec.2014.03.016
NR 71
TC 5
Z9 5
U1 1
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2016
VL 2016
AR 9702129
DI 10.1155/2016/9702129
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA DW3AF
UT WOS:000383513500001
PM 27689094
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Profirio, DD
   De Paiva, REF
   Abbehausen, C
   Cuin, A
   Masciocchi, N
   Machado, D
   Lancellotti, M
   Corbi, PP
   Formiga, ALB
AF Profirio, Daniel De Moraes
   Ferraz De Paiva, Raphael Enoque
   Abbehausen, Camilla
   Cuin, Alexandre
   Masciocchi, Norberto
   Machado, Daisy
   Lancellotti, Marcelo
   Corbi, Pedro Paulo
   Barboza Formiga, Andre Luiz
TI Crystal structure and cytotoxic activities of a bis(pyrrolyl-imine)
   gold(III) complex
SO JOURNAL OF COORDINATION CHEMISTRY
LA English
DT Article
DE Pyrrolyl-imine; gold(III); DFT; cytotoxic activity; DNA
ID MOLECULAR-ORBITAL METHODS; DNA-BINDING PROPERTIES; GAUSSIAN-TYPE BASIS;
   IN-VITRO; GOLD COMPOUNDS; BASIS-SETS; LIGANDS; NICKEL(II); CHEMISTRY;
   PYRROLE
AB A gold(III) complex with N,N-ethylenebis(pyrrol-2-yl-methyleneamine) (H(2)pyren) was synthesized and characterized by physicochemical and spectroscopic measurements. Density functional theory (DFT) studies and cytotoxic assays were performed. Infrared, mass spectrometry, and H-1, C-13, and {N-15,H-1} nuclear magnetic resonance analyses indicate that pyren is deprotonated and gold(III) is four coordinate in a square planar environment, with the pyrrole and imine nitrogens as donors. The structure was confirmed by powder X-ray diffraction and confirmed as a minimum of the potential energy surface by DFT. Cytotoxic activity of [Au(pyren)](+) was active against three tumorigenic cell lines with IC50 values of 35M. Interaction studies with CT-DNA by fluorescence and competition with ethidium bromide (EB) showed a quenching of the emission band of DNA with a Stern-Volmer quenching constant value of (3.0 +/- 0.1)x10(4)M(-1) and a decrease in fluorescence quenching of EB-DNA system, respectively, confirming that DNA is a possible target for the complex via an intercalative binding, which was confirmed by DNA conformational changes observed with circular dichroism spectroscopy.
   [GRAPHICS]
C1 [Profirio, Daniel De Moraes; Ferraz De Paiva, Raphael Enoque; Abbehausen, Camilla; Corbi, Pedro Paulo; Barboza Formiga, Andre Luiz] Univ Estadual Campinas, Inst Chem, Campinas, SP, Brazil.
   [Cuin, Alexandre] Univ Fed Juiz de Fora, Dept Chem, Juiz De Fora, Brazil.
   [Masciocchi, Norberto] Univ Insubria, Dipartimento Sci & Alta Tecnol, Como, Italy.
   [Machado, Daisy; Lancellotti, Marcelo] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil.
RP Formiga, ALB (corresponding author), Univ Estadual Campinas, Inst Chem, Campinas, SP, Brazil.
EM formiga@iqm.unicamp.br
RI Abbehausen, Camilla/AAD-3050-2020; Machado, Daisy/ABA-3731-2020;
   Abbehausen, Camilla/X-9527-2019; Cuin, Alexandre/V-2997-2019;
   Abbehausen, Camilla/AAA-7975-2019; Paiva, Raphael EF/B-7634-2012; Cuin,
   Alexandre/H-3548-2015; Enrique, Colacio/L-6020-2014; Corbi, Pedro
   P/B-7639-2012; Masciocchi, Norberto/K-4400-2015; Formiga,
   Andre/G-9755-2011
OI Abbehausen, Camilla/0000-0002-8410-2252; Machado,
   Daisy/0000-0002-6435-6159; Paiva, Raphael EF/0000-0003-2549-0344; Cuin,
   Alexandre/0000-0002-5444-5027; Enrique, Colacio/0000-0002-6745-9241;
   Corbi, Pedro P/0000-0002-7478-0877; Masciocchi,
   Norberto/0000-0001-9921-2350; Formiga, Andre/0000-0001-6773-8083
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/08230-2]; CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)National
   Council for Scientific and Technological Development (CNPq)
   [130697/2012-5, 402627/2012-1, 442123/2014-0]
FX This work was supported by grants from FAPESP (Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo, proc. no. 2012/08230-2) and CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, proc.
   no. 130697/2012-5, 402627/2012-1 and 442123/2014-0).
CR Adamo C, 1999, J CHEM PHYS, V110, P6158, DOI 10.1063/1.478522
   Akerman MP, 2013, J LABELLED COMPD RAD, V56, P530, DOI 10.1002/jlcr.3068
   [Anonymous], 2005, TOPAS R SOFTW VERS 3
   Arsenijevic M, 2012, MED CHEM, V8, P2, DOI 10.2174/157340612799278469
   Bacchi A, 2003, INORG CHIM ACTA, V342, P229, DOI 10.1016/S0020-1693(02)01077-0
   Barnard PJ, 2007, COORDIN CHEM REV, V251, P1889, DOI 10.1016/j.ccr.2007.04.006
   Barnard PJ, 2004, J INORG BIOCHEM, V98, P1642, DOI 10.1016/j.jinorgbio.2004.05.011
   Batterham T. J., 1973, NMR SPECTRA SIMPLE H
   Berners-Price SJ, 2011, METALLOMICS, V3, P863, DOI 10.1039/c1mt00062d
   Bindoli A, 2009, COORDIN CHEM REV, V253, P1692, DOI 10.1016/j.ccr.2009.02.026
   Blackburn GM, 2006, NUCLEIC ACIDS IN CHEMISTRY AND BIOLOGY, THIRD EDITION, pV, DOI 10.1039/9781847555380-FP005
   Bruijnincx PCA, 2008, CURR OPIN CHEM BIOL, V12, P197, DOI 10.1016/j.cbpa.2007.11.013
   Calamai P, 1999, INORG CHIM ACTA, V285, P309, DOI 10.1016/S0020-1693(98)00350-8
   Chang YM, 2012, INT J MOL SCI, V13, P3394, DOI 10.3390/ijms13033394
   Chen JM, 2008, SPECTROCHIM ACTA A, V71, P191, DOI 10.1016/j.saa.2007.12.007
   Chen QG, 1999, ANALYST, V124, P901, DOI 10.1039/a901174i
   Chen ZF, 2012, J BIOL INORG CHEM, V17, P247, DOI 10.1007/s00775-011-0846-z
   Coelho AA, 2000, J APPL CRYSTALLOGR, V33, P899, DOI 10.1107/S002188980000248X
   Coelho AA, 2003, J APPL CRYSTALLOGR, V36, P86, DOI 10.1107/S0021889802019878
   Cuin A, 2011, BIOMED PHARMACOTHER, V65, P334, DOI 10.1016/j.biopha.2011.04.012
   Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105
   DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902
   Fantin VR, 2002, CANCER CELL, V2, P29, DOI 10.1016/S1535-6108(02)00082-X
   Franceschi F, 2001, CHEM-EUR J, V7, P1468, DOI 10.1002/1521-3765(20010401)7:7<1468::AID-CHEM1468>3.0.CO;2-A
   FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267
   Gay M, 2005, J INORG BIOCHEM, V99, P2387, DOI 10.1016/j.jinorgbio.2005.09.006
   Glii B. D., 2012, DALTON T, V41, P6887
   GRUENWEDEL DW, 1993, J INORG BIOCHEM, V52, P251, DOI 10.1016/0162-0134(93)80029-9
   HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485
   HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527
   Holland JP, 2009, INORG CHIM ACTA, V362, P402, DOI 10.1016/j.ica.2008.04.031
   HOLTZER ME, 1992, BIOPOLYMERS, V32, P1675, DOI 10.1002/bip.360321209
   Ihmels H, 2005, PHOTOCHEM PHOTOBIOL, V81, P1107, DOI 10.1562/2005-01-25-IR-427
   Jaroudi S. S. A., 2013, POLYHEDRON, V50, P434, DOI [10.1016/j.poly.2012.11.034, DOI 10.1016/J.POLY.2012.11.034]
   JONES CJ, 1971, J CHEM SOC A, P1052, DOI 10.1039/j19710001052
   KELLER E, 1986, CHEM UNSERER ZEIT, V20, P178, DOI 10.1002/ciuz.19860200603
   Khandar AA, 2010, INORG CHIM ACTA, V363, P4080, DOI 10.1016/j.ica.2010.08.019
   Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026
   Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, DOI [10.1007/978-0-387-46312-4., DOI 10.1007/978-0-387-46312-4, 10.1007/978-0-387-46312-4]
   Li W, 2007, J RAMAN SPECTROSC, V38, P483, DOI 10.1002/jrs.1670
   Liang LC, 2004, J ORGANOMET CHEM, V689, P947, DOI 10.1016/j.jorganchem.2003.12.035
   McKeage MJ, 2000, CANCER CHEMOTH PHARM, V46, P343, DOI 10.1007/s002800000166
   Mehboob M. M. U., 2013, POLYHEDRON, V61, P225, DOI [10.1016/j.poly.2013.05.054, DOI 10.1016/J.POLY.2013.05.054]
   Merrick JP, 2007, J PHYS CHEM A, V111, P11683, DOI 10.1021/jp073974n
   Messori L, 2004, BIOORGAN MED CHEM, V12, P6039, DOI 10.1016/j.bmc.2004.09.014
   Milacic V, 2009, COORDIN CHEM REV, V253, P1649, DOI 10.1016/j.ccr.2009.01.032
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Munro O. Q., 2012, Patent Number, Patent No. [WO2011158176, 2011158176]
   Munro OQ, 2003, ACTA CRYSTALLOGR C, V59, pO672, DOI 10.1107/S0108270103023230
   Nakamoto K., 2009, INFRARED RAMAN SPE A
   NGUYEN HN, 1992, CANCER CHEMOTH PHARM, V30, P37, DOI 10.1007/BF00686483
   Nobili S, 2010, MED RES REV, V30, P550, DOI 10.1002/med.20168
   Ott I, 2009, COORDIN CHEM REV, V253, P1670, DOI 10.1016/j.ccr.2009.02.019
   Pacheco E. A., 2009, GOLD CHEM APPL FUTUR
   Patra AK, 2012, CHEM SCI, V3, P364, DOI 10.1039/c1sc00582k
   Roy LE, 2008, J CHEM THEORY COMPUT, V4, P1029, DOI 10.1021/ct8000409
   Sanders BC, 2013, J INORG BIOCHEM, V118, P115, DOI 10.1016/j.jinorgbio.2012.08.026
   SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112
   Shahabadi N., 2011, BIOINORG CHEM APPL, V124, P1
   Shan XF, 2008, TETRAHEDRON, V64, P5577, DOI 10.1016/j.tet.2008.03.077
   Shan XF, 2007, EUR J INORG CHEM, P3315, DOI 10.1002/ejic.200700352
   Shaw CF, 1999, CHEM REV, V99, P2589, DOI 10.1021/cr980431o
   Silverstein R.M., 2005, SPECTROMETRIC IDENTI
   Stern C, 2000, J ORGANOMET CHEM, V593, P86, DOI 10.1016/S0022-328X(99)00356-3
   Sun RWY, 2010, CHEM-EUR J, V16, P3097, DOI 10.1002/chem.200902741
   Sun RWY, 2009, COORDIN CHEM REV, V253, P1682, DOI 10.1016/j.ccr.2009.02.017
   Tiekink ERT, 2002, CRIT REV ONCOL HEMAT, V42, P225, DOI 10.1016/S1040-8428(01)00216-5
   To YF, 2009, INT J CANCER, V124, P1971, DOI 10.1002/ijc.24130
   Wang Y, 2005, CANCER RES, V65, P11553, DOI 10.1158/0008-5472.CAN-05-2867
   Wang YB, 2008, COLLOID SURFACE A, V329, P44, DOI 10.1016/j.colsurfa.2008.06.041
   Wang Y, 2008, BIOORG MED CHEM LETT, V18, P298, DOI 10.1016/j.bmcl.2007.10.085
   Wang Y, 2010, J COORD CHEM, V63, P147, DOI 10.1080/00958970903295836
   Wu ZK, 2003, ANGEW CHEM INT EDIT, V42, P3271, DOI 10.1002/anie.200350908
   Xiang HF, 2005, CHEM COMMUN, P1408, DOI 10.1039/b415711g
   Yang LY, 2004, EUR J INORG CHEM, P1478, DOI 10.1002/ejic.200300639
   Yang LY, 2003, TETRAHEDRON, V59, P10037, DOI 10.1016/j.tet.2003.10.049
   Young R. A., 1981, RIETVELD METHOD
   Yuan QH, 2006, CHEM-EUR J, V12, P2808, DOI 10.1002/chem.200500844
   Zhang Peilin, 2003, Mol Cancer, V2, P1
NR 79
TC 1
Z9 1
U1 1
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0095-8972
EI 1029-0389
J9 J COORD CHEM
JI J. Coord. Chem.
PY 2016
VL 69
IS 18
BP 2707
EP 2722
DI 10.1080/00958972.2016.1214949
PG 16
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA DW9GK
UT WOS:000383964300007
DA 2020-11-30
ER

PT J
AU Sousa, LM
   Corbi, PP
   Formiga, ALB
   Lancellotti, M
   Marzano, IM
   Pereira-Maia, EC
   Von Poelhsitz, G
   Guerra, W
AF Sousa, L. M.
   Corbi, P. P.
   Formiga, A. L. B.
   Lancellotti, Marcelo
   Marzano, I. M.
   Pereira-Maia, E. C.
   Von Poelhsitz, G.
   Guerra, W.
TI Spectroscopic characterization and molecular modeling of novel
   palladium(II) complexes with carbazates and hydrazides
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article
DE Palladium(II) complexes; Carbazate; Hydrazide; Solid-state NMR;
   Molecular modeling
ID GAUSSIAN-TYPE BASIS; ACID HYDRAZIDES; ORBITAL METHODS; ANTIMICROBIAL
   ACTIVITY; VIBRATIONAL-SPECTRA; BIOLOGICAL-ACTIVITY; TAUTOMERISM;
   PLATINUM
AB Palladium(II) complexes of the type trans-[Pd(L)(2)Cl-2], where L = 4-methoxybenzylcarbazate (4-MC), benzyl carbazate (BC), 4-fluorophenoxyacetic acid hydrazide (4-FM), 3-methoxybenzoic acid hydrazide (3-MH), ethyl carbazate (EC) and tert-butyl carbazate (TC) were synthesized by the slow addition of the ligand to K2PdCl4 previously dissolved in water or ethanol. These complexes were characterized by elemental analyses, conductivity measurements, TG/DTA, FT-IR, mass spectrometric and NMR spectroscopy (solution and solid-state). All coordination compounds exhibit a square planar coordination geometry in which the palladium(II) ion coordinates to two nitrogen atoms and two chlorine atoms. The structures of the palladium(II) complexes were optimized and theoretical data show that the trans isomer is more stable, in accordance with the experimental data. Preliminary in vitro tests of some these new palladium complexes in a chronic myelogenous leukemia cell line (k562 cells) are also reported. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Sousa, L. M.; Von Poelhsitz, G.; Guerra, W.] Univ Fed Uberlandia, Inst Quim, BR-38400902 Uberlandia, MG, Brazil.
   [Corbi, P. P.; Formiga, A. L. B.] Univ Estadual Campinas, Inst Quim, BR-13083970 Campinas, SP, Brazil.
   [Lancellotti, Marcelo] Univ Estadual Campinas, Biotechnol Lab, Inst Biol, UNICAMP, Campinas, SP, Brazil.
   [Marzano, I. M.; Pereira-Maia, E. C.] Univ Fed Minas Gerais, Dept Quim, BR-31270901 Belo Horizonte, MG, Brazil.
RP Guerra, W (corresponding author), Univ Fed Uberlandia, Inst Quim, Av Joao Naves Avila 2121,Campus Santa Monica, BR-38400902 Uberlandia, MG, Brazil.
EM wg@iqufu.ufu.br
RI Corbi, Pedro P/B-7639-2012; Guerra, Wendell/S-8338-2019; Maia, Elene
   Pereira/A-6837-2008; Von Poelhsitz, Gustavo/A-3668-2013; Formiga,
   Andre/G-9755-2011
OI Corbi, Pedro P/0000-0002-7478-0877; Maia, Elene
   Pereira/0000-0003-2699-6232; Von Poelhsitz, Gustavo/0000-0003-1329-2260;
   Sousa, Luana/0000-0001-7411-069X; Formiga, Andre/0000-0001-6773-8083;
   Guerra, Wendell/0000-0001-6979-8557
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); RMQ (Rede Mineira de Quimica); FAPEMIG (Fundacao de Amparo a
   Pesquisa de Minas Gerais, Brazil)Minas Gerais State Research Foundation
   (FAPEMIG); CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP); FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
   [APQ-00330-14]
FX This work was supported by CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Brazil), RMQ (Rede Mineira de Quimica), and
   FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais, Brazil). A.L.B.F
   would like to acknowledge CENAPAD for computational time and CNPq and
   FAPESP for financial support. W.G. gratefully acknowledges to the Grupo
   de Materiais Inorganicos do Triangulo - GMIT research group supported by
   FAPEMIG (APQ-00330-14).
CR Adamo C, 1999, J CHEM PHYS, V110, P6158, DOI 10.1063/1.478522
   Bonacin JA, 2007, VIB SPECTROSC, V44, P133, DOI 10.1016/j.vibspec.2006.10.007
   CYMERMANCRAIG J, 1955, NATURE, V176, P34, DOI 10.1038/176034a0
   de Jong JC, 2004, BIOORG MED CHEM LETT, V14, P1741, DOI 10.1016/j.bmcl.2004.01.038
   de Souza GD, 2013, CENT EUR J CHEM, V11, P290, DOI 10.2478/s11532-012-0156-5
   de Souza GD, 2012, LAT AM J PHARM, V31, P620
   de Souza GD, 2013, CROAT CHEM ACTA, V86, P201, DOI 10.5562/cca2151
   Dekeyser MA, 2003, CHIMIA, V57, P702, DOI 10.2533/000942903777678533
   DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902
   DODOFF N, 1994, J INORG BIOCHEM, V54, P221, DOI 10.1016/0162-0134(94)80015-4
   DODOFF N, 1995, J INORG BIOCHEM, V60, P257, DOI 10.1016/0162-0134(95)00025-9
   FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267
   Galal SA, 2009, EUR J MED CHEM, V44, P1500, DOI 10.1016/j.ejmech.2008.07.013
   Garoufis A, 2009, COORDIN CHEM REV, V253, P1384, DOI 10.1016/j.ccr.2008.09.011
   GEARY WJ, 1971, COORDIN CHEM REV, V7, P81, DOI 10.1016/S0010-8545(00)80009-0
   Guerra W, 2005, J INORG BIOCHEM, V99, P2348, DOI 10.1016/j.jinorgbio.2005.09.001
   Guerra W, 2005, QUIM NOVA, V28, P809, DOI 10.1590/S0100-40422005000500015
   HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485
   HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI 10.1063/1.448975
   HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527
   Judge V, 2012, MED CHEM RES, V21, P3940, DOI 10.1007/s00044-011-9948-y
   KERRISON SJS, 1977, J CHEM SOC CHEM COMM, P861, DOI 10.1039/c39770000861
   Kushev D, 2009, CROAT CHEM ACTA, V82, P607
   Mahalingam V, 2009, POLYHEDRON, V28, P1532, DOI 10.1016/j.poly.2009.03.023
   MALHOTRA R, 1993, INDIAN J CHEM A, V32, P457
   Milenkovic M, 2014, POLYHEDRON, V80, P47, DOI 10.1016/j.poly.2014.01.022
   Milenkovic M, 2013, INORG CHIM ACTA, V395, P33, DOI 10.1016/j.ica.2012.09.043
   MUHIELDEEN Z, 1992, EUR J MED CHEM, V27, P101, DOI 10.1016/0223-5234(92)90097-K
   Nakamoto K., 1997, INFRARED RAMAN SPECT
   NARANG KK, 1993, SYN REACT INORG MET, V23, P971, DOI 10.1080/15533179308016876
   Rollas S, 2007, MOLECULES, V12, P1910, DOI 10.3390/12081910
   SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112
   Silva PP, 2014, J INORG BIOCHEM, V132, P67, DOI 10.1016/j.jinorgbio.2013.09.014
   Sousa EHS, 2014, J INORG BIOCHEM, V140, P236, DOI 10.1016/j.jinorgbio.2014.08.002
   Sousa EHS, 2012, J BIOL INORG CHEM, V17, P275, DOI 10.1007/s00775-011-0848-x
   Singh B, 2000, SYN REACT INORG MET, V30, P1175
   SUR P, 1995, CANCER LETT, V94, P27, DOI 10.1016/0304-3835(95)03819-I
   Tantirungrotechai Y, 2006, J MOL STRUC-THEOCHEM, V760, P189, DOI 10.1016/j.theochem.2005.12.007
   Timm RA, 2008, J BRAZIL CHEM SOC, V19, P287, DOI 10.1590/S0103-50532008000200013
   UI Q., 2013, SPECTROCHIM ACTA A, V115, P683
NR 40
TC 17
Z9 17
U1 0
U2 40
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-2860
EI 1872-8014
J9 J MOL STRUCT
JI J. Mol. Struct.
PD OCT 5
PY 2015
VL 1097
BP 15
EP 22
DI 10.1016/j.molstruc.2015.05.012
PG 8
WC Chemistry, Physical
SC Chemistry
GA CN6PC
UT WOS:000358555700003
DA 2020-11-30
ER

PT J
AU Lopez, BGC
   de Lourenco, CC
   Alves, DA
   Machado, D
   Lancellotti, M
   Sawaya, ACHF
AF Lopez, B. G. C.
   de Lourenco, C. C.
   Alves, D. A.
   Machado, D.
   Lancellotti, M.
   Sawaya, A. C. H. F.
TI Antimicrobial and cytotoxic activity of red propolis: an alert for its
   safe use
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
DE antimicrobial activity; bioactive natural products; cytotoxicity; red
   propolis; UHPLC-MS
ID ENTEROCOCCUS-FAECALIS; BRAZILIAN PROPOLIS; NATURAL-PRODUCTS;
   CHEMICAL-COMPOSITION; BEE PRODUCTS; IN-VITRO; CONSTITUENTS; ANTIOXIDANT;
   POLYPHENOLS; ANTIBACTERIAL
AB AimsRed propolis is a resinous product popularly consumed in Brazil as it improves health, and it is considered a nutraceutical. The objective of this study was to test the antimicrobial activity of eight samples of red propolis from Brazil and Cuba to assess the possibility of application of this natural product as an antimicrobial agent, along with a study of its cytotoxic activity against non-tumor cell lines to evaluate at which concentrations it could be safely used.
   Methods and ResultsThe chemical profile of the samples was evaluated by UHPLC-MS. All the samples presented antimicrobial activity which was tested using agar diffusion and serial dilution methods; and these samples displayed a better activity against most Gram-negative bacteria with minimum inhibitory concentration (MIC) in the range between 625gml(-1) and 500gml(-1). However our studies also revealed an inherent cytotoxic effect against HaCaT human keratinocytes and BALBc 3T3.
   ConclusionsTo have a noncytotoxic and safe use of red propolis, it is necessary to use a concentration below the IC50 cytotoxic values.
   Significance and Impact of the StudyThe traditional use of propolis does not necessarily guarantee its safety. The evaluation of the safety of bioactive natural products should always be considered together with the evaluation of the activity.
C1 [Lopez, B. G. C.; Alves, D. A.; Lancellotti, M.; Sawaya, A. C. H. F.] State Univ Campinas UNICAMP, Inst Biol, Dept Plant Biol, Pharm Course,Biosci & Technol Bioact Prod Postgra, Campinas, SP, Brazil.
   [de Lourenco, C. C.] State Univ Campinas UNICAMP, Inst Biol, Plant Biol Postgrad Program, Dept Plant Biol, Campinas, SP, Brazil.
   [Alves, D. A.; Machado, D.; Lancellotti, M.] Univ Estadual Campinas, UNICAMP, LABIOTEC Biotechnol Lab, Dept Biochem,Inst Biol, Campinas, SP, Brazil.
RP Sawaya, ACHF (corresponding author), Univ Estadual Campinas, Inst Biol, Bloco J Terreo,Ciadade Univ Zeferino Vaz, BR-13083970 Campinas, SP, Brazil.
EM achfsawa@unicamp.br
RI Sawaya, Alexandra C H F/F-3999-2012; Machado, Daisy/A-4891-2013;
   Machado, Daisy/ABA-3731-2020
OI Sawaya, Alexandra C H F/0000-0001-7524-6628; Machado,
   Daisy/0000-0002-6435-6159; Machado, Daisy/0000-0002-6435-6159
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013-20313-3]; CAPESCAPES
FX The authors thank FAPESP (2013-20313-3) and CAPES for their financial
   support. Special thanks also to Edimel Apiaries (Edivaldo F. Pacheco
   Filho) for a sample of red propolis from Paraiba, Brazil, Jose Marinho
   de Lima for the propolis samples from Alagoas, Brazil and Dr.Osmany
   Cuesta-Rubio for the Cuban sample.
CR Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005
   Awale S, 2008, BIOORGAN MED CHEM, V16, P181, DOI 10.1016/j.bmc.2007.10.004
   Ayres DC, 2007, MEM I OSWALDO CRUZ, V102, P215, DOI 10.1590/S0074-02762007005000020
   Bankova VS, 2000, APIDOLOGIE, V31, P3, DOI 10.1051/apido:2000102
   Betz JM, 2002, FUN FO NUTR SERIES, P367
   Biesalski H. K., 2001, NUTRACEUTICALS HLTH
   Bispo Junior W., 2012, Semina: Ciencias Biologicas e da Saude (Londrina), V33, P3, DOI 10.5433/1679-0367.2012v33n1p3
   BONTEN MJM, 1993, NEW ENGL J MED, V328, P209, DOI 10.1056/NEJM199301213280311
   BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3
   Bueno-Silva B, 2013, J AGR FOOD CHEM, V61, P4546, DOI 10.1021/jf305468f
   Butler MS, 2006, BIOCHEM PHARMACOL, V71, P919, DOI 10.1016/j.bcp.2005.10.012
   de Albuquerque RLC, 2009, INT J MORPHOL, V27, P1106
   Nunes LCC, 2009, REV BRAS FARMACOGN, V19, P524, DOI 10.1590/S0102-695X2009000400003
   Frozza COD, 2013, FOOD CHEM TOXICOL, V52, P137, DOI 10.1016/j.fct.2012.11.013
   Daleprane JB, 2012, J NUTR, V142, P441, DOI 10.3945/jn.111.150706
   Daleprane JB, 2012, J NUTR BIOCHEM, V23, P557, DOI 10.1016/j.jnutbio.2011.02.012
   dasSilva J. L. D. C, 2013, AFR J PHARM PHARMACO, V7, P2006
   Daugsch A, 2008, EVID-BASED COMPL ALT, V5, P435, DOI 10.1093/ecam/nem057
   Fitzgerald-Hughes D, 2012, FEMS IMMUNOL MED MIC, V65, P399, DOI 10.1111/j.1574-695X.2012.00954.x
   Franchi GC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/918956
   GONNET M, 1968, Annales de l'Abeille (Paris), V11, P105, DOI 10.1051/apido:19680202
   GUZMAN CA, 1989, INFECT IMMUN, V57, P1834
   Hancock REW, 2000, DRUG RESIST UPDATE, V3, P247, DOI 10.1054/drup.2000.0152
   Iio A, 2012, PHYTOMEDICINE, V19, P383, DOI 10.1016/j.phymed.2011.10.007
   Iio A, 2010, PHYTOMEDICINE, V17, P974, DOI 10.1016/j.phymed.2010.03.001
   Izuta H, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-45
   Izuta H, 2009, BIOL PHARM BULL, V32, P1947, DOI 10.1248/bpb.32.1947
   Kamiya T, 2012, J AGR FOOD CHEM, V60, P11065, DOI 10.1021/jf303004n
   Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657
   Kujumgiev A, 1999, J ETHNOPHARMACOL, V64, P235, DOI 10.1016/S0378-8741(98)00131-7
   Lam KS, 2007, TRENDS MICROBIOL, V15, P279, DOI 10.1016/j.tim.2007.04.001
   Ledon N, 1996, REV CUBANA FARM, V30, P274
   Li F, 2008, BIOORGAN MED CHEM, V16, P5434, DOI 10.1016/j.bmc.2008.04.016
   Lopez BGC, 2014, FOOD CHEM, V146, P174, DOI 10.1016/j.foodchem.2013.09.063
   Lotti C, 2011, REV BRAS FARMACOGN, V21, P901, DOI 10.1590/S0102-695X2011005000142
   Love RM, 2001, INT ENDOD J, V34, P399, DOI 10.1046/j.1365-2591.2001.00437.x
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   Marcucci M. C., 2011, REV PESQ INOV FARM, V3, P9
   Mendonca L. S., 2011, SCI PLENA, V7, P1
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s
   Novak EM, 2014, J FUNCT FOODS, V11, P91, DOI 10.1016/j.jff.2014.09.008
   Oldoni TLC, 2011, SEP PURIF TECHNOL, V77, P208, DOI 10.1016/j.seppur.2010.12.007
   Oliveira RN, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42129
   Cabral ISR, 2009, QUIM NOVA, V32, P1523, DOI 10.1590/S0100-40422009000600031
   Righi AA, 2011, J SCI FOOD AGR, V91, P2363, DOI 10.1002/jsfa.4468
   Rodriguez S, 1997, PHARMACOL RES, V35, P1, DOI 10.1006/phrs.1996.9998
   Sawaya ACHF, 2004, ANALYST, V129, P739, DOI 10.1039/b403873h
   Sforcin J. M., 2001, Journal of Venomous Animals and Toxins, V7, P139, DOI 10.1590/S0104-79302001000100009
   Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032
   Silici S, 2005, J PHARMACOL SCI, V99, P39, DOI 10.1254/jphs.FPE05002X
   Silva BB, 2008, EVID-BASED COMPL ALT, V5, P313, DOI 10.1093/ecam/nem059
   Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016
   Siqueira JF, 2002, J ENDODONT, V28, P168, DOI 10.1097/00004770-200203000-00006
   Suma B, 2012, INT J CLIN MED, V3, P159, DOI [DOI 10.4236/IJCM.2012, 10.4236/ijcm.2012.33033]
   Tilden J, 1996, AM J PUBLIC HEALTH, V86, P1142, DOI 10.2105/AJPH.86.8_Pt_1.1142
   Tosi EA, 2007, FOOD CHEM, V104, P1025, DOI 10.1016/j.foodchem.2007.01.011
   Trusheva B, 2006, EVID-BASED COMPL ALT, V3, P249, DOI 10.1093/ecam/nel006
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Wikler M, 2005, PERFORMANCE STANDARD, V25, P1
NR 60
TC 25
Z9 25
U1 0
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1364-5072
EI 1365-2672
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD SEP
PY 2015
VL 119
IS 3
BP 677
EP 687
DI 10.1111/jam.12874
PG 11
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA CP9RA
UT WOS:000360231000007
PM 26086953
OA Bronze
DA 2020-11-30
ER

PT J
AU Ferreira, TH
   Hollanda, LM
   Lancellotti, M
   de Sousa, EMB
AF Ferreira, T. H.
   Hollanda, L. M.
   Lancellotti, M.
   de Sousa, E. M. B.
TI Boron nitride nanotubes chemically functionalized with glycol chitosan
   for gene transfection in eukaryotic cell lines
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE BNNT; functionalization; nanovector; cell and gene transfection
ID MULTIWALLED CARBON NANOTUBES; IN-VITRO; DELIVERY; NANOPARTICLES;
   NANOMATERIALS; TOXICITY; CYTOCOMPATIBILITY; PROLIFERATION; STABILITY;
   PROTEINS
AB Nanostructured materials have been widely studied concerning their potential biomedical applications, primarily to selectively carry specific drugs or molecules within a tissue or organ. In this context, boron nitride nanotubes (BNNTs) have generated considerable interest in the scientific community because of their unique properties, presenting good chemical inertness and high thermal stability. Among the many applications proposed for BNNTs in the biomedical field in recent years, the most important include their use as biosensors, nanovectors for the delivery of proteins, drugs, and genes. In the present study, BNNTs were synthesized, purified, and functionalized with glycol chitosan through a chemical process, yielding the BNNT-GC. The size of BNNT-GC was reduced using an ultrasound probe. Two samples with different sizes were selected for in vitro assays. The nanostructures were characterized by transmission electron microscopy (TEM), Fourier transform infrared spectroscopy (FTIR), thermal analysis (TGA), and dynamic light scattering (DLS). The in vitro assays MTT and neutral red (NR) were performed with NIH-3T3 and A549 cell lines and demonstrated that this material is not cytotoxic. Furthermore, the BNNT-GC was applied in gene transfection of plasmid pIRES containing a gene region that express a green fluorescent protein (GFP) in NIH-3T3 and A549 cell lines. The gene transfection was characterized by fluorescent protein produced in the cells and pictured by fluorescent microscopy. Our results suggest that BNNT-GC has moderate stability and presents great potential as a gene carrier agent in nonviral-based therapy, with low cytotoxicity and good transfection efficiency. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2176-2185, 2015.
C1 [Ferreira, T. H.; de Sousa, E. M. B.] CDTN CNEN, Ctr Desenvolvimento Tecnol Nucl, SENAN, BR-30270901 Belo Horizonte, MG, Brazil.
   [Hollanda, L. M.; Lancellotti, M.] Univ Estadual Campinas, Dept Bioquim, LABIOTEC, BR-13083862 Campinas, SP, Brazil.
RP de Sousa, EMB (corresponding author), CDTN CNEN, Ctr Desenvolvimento Tecnol Nucl, SENAN, Ave Presidente Antonio Carlos 6627,Campus UFMG, BR-30270901 Belo Horizonte, MG, Brazil.
EM sousaem@cdtn.br
RI Ferreira, Tiago/C-3725-2016; DE HOLLANDA, LUCIANA MARIA/F-7893-2011
OI DE HOLLANDA, LUCIANA MARIA/0000-0002-6047-4043
FU FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)Minas
   Gerais State Research Foundation (FAPEMIG); CNPQ (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico)National Council for Scientific
   and Technological Development (CNPq); FAPESP (Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo)Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP) [processo numero 2011/17195-3]; CAPES (Comissao
   Aperfeicoamento de Pessoal de Nivel Superior)CAPES
FX Contract grant sponsor: FAPEMIG (Fundacao de Amparo a Pesquisa do Estado
   de Minas Gerais); Contract grant sponsor: CNPQ (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico); Contract grant sponsor:
   FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); contract
   grant number: processo numero 2011/17195-3; Contract grant sponsor:
   CAPES (Comissao Aperfeicoamento de Pessoal de Nivel Superior)
CR Ahmad J, 2012, TOXICOL APPL PHARM, V259, P160, DOI 10.1016/j.taap.2011.12.020
   Andrade GF, 2013, MICROPOR MESOPOR MAT, V168, P102, DOI 10.1016/j.micromeso.2012.09.034
   Bhattacharya R, 2008, ADV DRUG DELIVER REV, V60, P1289, DOI 10.1016/j.addr.2008.03.013
   Borenfreund E., 1985, J TISS CULT METHODS, V9, P7, DOI DOI 10.1007/BF01666038
   Borm PJA, 2006, PART FIBRE TOXICOL, V3, DOI 10.1186/1743-8977-3-11
   Casals E, 2003, CHEM PHYS LIPIDS, V125, P139, DOI 10.1016/S0009-3084(03)00086-0
   Chen X, 2009, J AM CHEM SOC, V131, P890, DOI 10.1021/ja807334b
   Ciofani G, 2010, INT J NANOMED, V5, P285
   Ciofani G, 2008, BIOTECHNOL BIOENG, V101, P850, DOI 10.1002/bit.21952
   Ciofani G, 2012, J COLLOID INTERF SCI, V374, P308, DOI 10.1016/j.jcis.2012.01.049
   Ciofani G, 2010, BIOCHEM BIOPH RES CO, V394, P405, DOI 10.1016/j.bbrc.2010.03.035
   Ciofani G, 2009, NANO TODAY, V4, P8, DOI 10.1016/j.nantod.2008.09.001
   Ciofani G, 2008, J NANOSCI NANOTECHNO, V8, P6223, DOI 10.1166/jnn.2008.339
   Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875
   Durrieu MC, 2004, J MATER SCI-MATER M, V15, P779, DOI 10.1023/B:JMSM.0000032818.09569.d9
   Soares DCF, 2012, INT J PHARMACEUT, V423, P489, DOI 10.1016/j.ijpharm.2011.12.002
   Ferreira T. H., 2011, J BIOMATER NANOBIOTE, V2, P426, DOI DOI 10.4236/jbnb.2011.24052
   Ferreira TH, 2013, MAT SCI ENG C-MATER, V33, P4616, DOI 10.1016/j.msec.2013.07.024
   Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908
   Foley S, 2002, BIOCHEM BIOPH RES CO, V294, P116, DOI 10.1016/S0006-291X(02)00445-X
   Gao ZH, 2012, RSC ADV, V2, P6200, DOI 10.1039/c2ra20765f
   Golberg D, 2007, ADV MATER, V19, P2413, DOI 10.1002/adma.200700179
   Hirano S, 1999, POLYM INT, V48, P732, DOI 10.1002/(SICI)1097-0126(199908)48:8<732::AID-PI211>3.3.CO;2-L
   Hollanda LM, 2014, MAT SCI ENG C-MATER, V39, P288, DOI 10.1016/j.msec.2014.03.002
   Horvath L, 2011, ACS NANO, V5, P3800, DOI 10.1021/nn200139h
   Jain S, 2011, CHEM RES TOXICOL, V24, P2028, DOI 10.1021/tx2003728
   Juzenas P, 2008, ADV DRUG DELIVER REV, V60, P1600, DOI 10.1016/j.addr.2008.08.004
   Khazaei A, 2010, INT J NANOMED, V5, P639, DOI 10.2147/IJN.S11146
   Kong H, 2004, MACROMOLECULES, V37, P4022, DOI 10.1021/ma049694c
   Lacerda L, 2007, NANO TODAY, V2, P38, DOI 10.1016/S1748-0132(07)70172-X
   Lacerda L, 2008, J MATER CHEM, V18, P17, DOI 10.1039/b711554g
   Lahiri D, 2011, J MECH BEHAV BIOMED, V4, P44, DOI 10.1016/j.jmbbm.2010.09.005
   Li RB, 2011, CARBON, V49, P1797, DOI 10.1016/j.carbon.2011.01.003
   Liu XH, 2013, COLLOID SURFACE B, V111, P224, DOI 10.1016/j.colsurfb.2013.06.010
   Liu Z, 2011, MATER TODAY, V14, P316, DOI 10.1016/S1369-7021(11)70161-4
   Machado CML, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-13
   Mastrobattista E, 2006, NAT REV DRUG DISCOV, V5, P115, DOI 10.1038/nrd1960
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nakamura M, 2010, COLLOID SURFACE B, V79, P19, DOI 10.1016/j.colsurfb.2010.03.008
   Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021
   Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   Pantarotto D., 2004, ANGEW CHEM, V116, P5354, DOI DOI 10.1002/ANGE.200460437
   Prato M, 2008, ACCOUNTS CHEM RES, V41, P60, DOI 10.1021/ar700089b
   Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645
   Raffa V, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/7/075104
   Ryoo SR, 2010, ACS NANO, V4, P6587, DOI 10.1021/nn1018279
   Shi XH, 2011, NAT NANOTECHNOL, V6, P714, DOI [10.1038/nnano.2011.151, 10.1038/NNANO.2011.151]
   Unak G, 2012, COLLOID SURFACE B, V90, P217, DOI 10.1016/j.colsurfb.2011.10.027
   Yang L, 2011, ADV DRUG DELIVER REV, V63, P1361, DOI 10.1016/j.addr.2011.10.002
   Zangmeister RA, 2007, LANGMUIR, V23, P6252, DOI 10.1021/la063109e
   Zanin H, 2014, MAT SCI ENG C-MATER, V39, P359, DOI 10.1016/j.msec.2014.03.016
   Zheng MT, 2008, SCI CHINA SER B, V51, P205, DOI 10.1007/s11426-008-0026-3
   Zhi C, 2005, J AM CHEM SOC, V127, P17144, DOI 10.1021/ja055989+
   Zhi C, 2007, CHEM-ASIAN J, V2, P1581, DOI 10.1002/asia.200700246
   Zhou X, 2012, NANO RES, V5, P703, DOI 10.1007/s12274-012-0254-x
NR 55
TC 29
Z9 30
U1 2
U2 65
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2015
VL 103
IS 6
BP 2176
EP 2185
DI 10.1002/jbm.a.35333
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CH4SV
UT WOS:000354024100029
PM 25231734
DA 2020-11-30
ER

PT J
AU Melo, A
   Amadeu, MS
   Lancellotti, M
   de Hollanda, LM
   Machado, D
AF Melo, Adriana
   Amadeu, Marcela Seragiotto
   Lancellotti, Marcelo
   de Hollanda, Luciana Maria
   Machado, Daisy
TI THE ROLE OF NANOMATERIALS IN COSMETICS: NATIONAL AND INTERNATIONAL
   LEGISLATIVE ASPECTS
SO QUIMICA NOVA
LA English
DT Article
DE nanotechnology; cosmetics; legislation
AB Nanotechnology is currently one of the fastest growing scientific fields. The products of this science have become part of our everyday lives. However, to date, regulatory agencies have not yet established a single definition for nanomaterials and nanotechnology. Therefore, each country has its own definitions and legislation to control products containing nanomaterials. Being relatively new materials, there are no long-term studies showing their impact on human health and the environment. Consequently, countries control the amount of nanomaterials present in cosmetics, allowing the end consumer to choose which cosmetic to use, by choosing products with or without nanomaterials. Therefore, the primary objective of this study was to identify the most used nanomaterials in cosmetics and verify whether these formulations are in accordance with the laws in force in the United States, the European Union and Brazil, thereby determining if the cosmetics on the market are in line with the existing laws in these three economic powers. This study is unique and will contribute to furthering the discussion on existing laws pertinent to the use of nanotechnology in cosmetics.
C1 [Melo, Adriana; Amadeu, Marcela Seragiotto; Lancellotti, Marcelo; de Hollanda, Luciana Maria; Machado, Daisy] Univ Estadual Campinas, Inst Biol, Dept Bioquim & Biol Tecidual, BR-13083862 Campinas, SP, Brazil.
   [Lancellotti, Marcelo] Univ Estadual Campinas, Fac Ciencias Farmaceut, BR-13083862 Campinas, SP, Brazil.
RP Melo, A (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Bioquim & Biol Tecidual, BR-13083862 Campinas, SP, Brazil.
EM daisy.machado@gmail.com
RI Machado, Daisy/ABA-3731-2020; de Melo, Adriana/B-3670-2015; Lobo,
   Diele/I-9106-2012; Hollanda, Luciana Maria de/F-7893-2011
OI Machado, Daisy/0000-0002-6435-6159; de Melo,
   Adriana/0000-0002-3925-0707; Hollanda, Luciana Maria
   de/0000-0002-6047-4043
CR Alvarez-Roman R, 2004, PHARM RES-DORDR, V21, P1818, DOI 10.1023/B:PHAM.0000045235.86197.ef
   [Anonymous], 2011, POLICY PRINCIPLES US
   Baril M.B., 2012, VISAO ACAD, V1, P45
   Cadioli L., 2006, EXATAS TECNOL, V1, P98
   Capek I, 2004, ADV COLLOID INTERFAC, V107, P125, DOI 10.1016/S0001-8686(03)00115-5
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Fronza T., 2007, NANOCOSMETICOS DIREC
   Gwinn MR, 2012, ADVERSE EFFECTS OF ENGINEERED NANOMATERIALS: EXPOSURE, TOXICOLOGY, AND IMPACT ON HUMAN HEALTH, P97, DOI 10.1016/B978-0-12-386940-1.00006-4
   Kim J, 2006, ANGEW CHEM INT EDIT, V45, P7754, DOI 10.1002/anie.200602471
   Kimbrel G. A., 2007, GLOBAL REGULATORY IS, V1, P117
   Knopp D, 2009, ANAL CHIM ACTA, V647, P14, DOI 10.1016/j.aca.2009.05.037
   Neves K., 2008, COSMET TOILETRIES, V20, P22
   Oberdorster E., 2004, ENV HLTH PERSPECT, V112
   Zanetti-Ramos B. G., 2008, REV BRASILEIRA FARMA, V89, P95
NR 14
TC 8
Z9 8
U1 0
U2 31
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0100-4042
EI 1678-7064
J9 QUIM NOVA
JI Quim. Nova
PD MAY
PY 2015
VL 38
IS 4
BP 599
EP 603
DI 10.5935/0100-4042.20150042
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA CL0EB
UT WOS:000356610900022
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Lima, FL
   Joazeiro, PP
   Lancellotti, M
   de Hollanda, LM
   Lima, BD
   Linares, E
   Augusto, O
   Brocchi, M
   Giorgio, S
AF Lima, Flavia Luna
   Joazeiro, Paulo Pinto
   Lancellotti, Marcelo
   de Hollanda, Luciana Maria
   Lima, Bruna de Araujo
   Linares, Edlaine
   Augusto, Ohara
   Brocchi, Marcelo
   Giorgio, Selma
TI Effects of hyperbaric oxygen on Pseudomonas aeruginosa susceptibility to
   imipenem and macrophages
SO FUTURE MICROBIOLOGY
LA English
DT Article
DE free radicals; hyperbaric oxygen; imipenem; macrophages; Pseudomonas
   aeruginosa; superoxide anion
ID INHIBITION; MECHANISMS; ANTIBIOTICS; ENHANCEMENT; SUPEROXIDE;
   RESISTANCE; HYPEROXIA; BACTERIA; THERAPY; GROWTH
AB Background: The seriousness to treat burn wounds infected with Pseudomonas aeruginosa led us to examine whether the effect of the carbapenem antibiotic imipenem is enhanced by hyperbaric oxygen (HBO). Materials & methods: The effects of HBO (100% O-2, 3 ATA, 5 h) in combination with imipenen on bacterial counts of six isolates of P. aeruginosa and bacterial ultrastructure were investigated. Infected macrophages were exposed to HBO (100% O-2, 3 ATA, 90 min) and the production of reactive oxygen species monitored. Results: HBO enhanced the effects of imipenen. HBO increased superoxide anion production by macrophages and likely kills bacteria by oxidative mechanisms. Conclusion: HBO in combination with imipenem
C1 [Lima, Flavia Luna; Giorgio, Selma] Univ Estadual Campinas, Dept Anim Biol, Inst Biol, Campinas, SP, Brazil.
   [Joazeiro, Paulo Pinto] Univ Estadual Campinas, Dept Histol & Embriol, Inst Biol, Campinas, SP, Brazil.
   [Lancellotti, Marcelo; de Hollanda, Luciana Maria] Univ Estadual Campinas, Dept Biochem, Inst Biol, Campinas, SP, Brazil.
   [Lima, Bruna de Araujo; Brocchi, Marcelo] Univ Estadual Campinas, Dept Genet Evolut & Bioagents, Inst Biol, Campinas, SP, Brazil.
   [Linares, Edlaine; Augusto, Ohara] Univ Sao Paulo, Dept Biochem, Inst Chem, BR-05508 Sao Paulo, SP, Brazil.
RP Giorgio, S (corresponding author), Univ Estadual Campinas, Dept Anim Biol, Inst Biol, Campinas, SP, Brazil.
EM sgiorgio@unicamp.br
RI Augusto, Ohara/D-3839-2012; Brocchi, Marcelo/E-3723-2012; Giorgio,
   Selma/A-6701-2013; DE HOLLANDA, LUCIANA MARIA/F-7893-2011; de Araujo
   Lima, Bruna/A-5961-2013; Linares, Edlaine/AAR-8753-2020
OI Augusto, Ohara/0000-0002-7220-4286; DE HOLLANDA, LUCIANA
   MARIA/0000-0002-6047-4043; Linares, Edlaine/0000-0001-8164-3013
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, BrazilNational Council for
   Scientific and Technological Development (CNPq)
FX This work was supported by grants of Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico, Brazil. EL and OA are members of the CEPID Redoxoma
   (FAPESP # 2013/07937-8). The authors have no other relevant affiliations
   or financial involvement with any organization or entity with a
   financial interest in or financial conflict with the subject matter or
   materials discussed in the manuscript apart from those disclosed.
CR Al-Waili Noori S, 2006, Technol Health Care, V14, P489
   Almzaiel AJ, 2013, LIFE SCI, V93, P125, DOI 10.1016/j.lfs.2013.06.003
   Alvarez-Ortega C, 2011, VIRULENCE, V2, P144, DOI 10.4161/viru.2.2.15014
   Arrais-Silva WW, 2005, PARASITOL INT, V54, P1, DOI 10.1016/j.parint.2004.07.002
   Babior BM, 2002, ISRAEL MED ASSOC J, V4, P1023
   Battistoni A, 2004, INT J IMMUNOPATH PH, V17, P71, DOI 10.1177/039463200401700110
   BORNSIDE GH, 1975, ANTIMICROB AGENTS CH, V7, P682, DOI 10.1128/AAC.7.5.682
   BROWN OR, 1968, APPL MICROBIOL, V16, P260, DOI 10.1128/AEM.16.2.260-262.1968
   Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006
   Cimsit M, 2009, EXPERT REV ANTI-INFE, V7, P1015, DOI [10.1586/eri.09.76, 10.1586/ERI.09.76]
   CLARK JM, 1971, INFECT IMMUN, V4, P488, DOI 10.1128/IAI.4.4.488-491.1971
   Degrossoli A, 2011, SCAND J IMMUNOL, V74, P165, DOI 10.1111/j.1365-3083.2011.02566.x
   Fernandes DC, 2005, FREE RADICAL BIO MED, V38, P189, DOI 10.1016/j.freeradbiomed.2004.09.027
   Fournier D, 2013, J ANTIMICROB CHEMOTH, V68, P1772, DOI 10.1093/jac/dkt098
   Gimbel M, 1999, HYPERBARIC MEDICINE, P205
   Gurdol F, 2008, PHYSIOL RES, V57, P41
   Hancock REW, 2000, DRUG RESIST UPDATE, V3, P247, DOI 10.1054/drup.2000.0152
   Hind J, 1996, J ANTIMICROB CHEMOTH, V37, P253, DOI 10.1093/jac/37.2.253
   Hink J, 2001, MED HYPOTHESES, V57, P764, DOI 10.1054/mehy.2001.1488
   Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053
   Kaide CG, 2008, EMERG MED CLIN N AM, V26, P571, DOI 10.1016/j.emc.2008.01.005
   KENWARD MA, 1980, MICROBIOS, V28, P47
   KESADO T, 1980, ANTIMICROB AGENTS CH, V17, P912, DOI 10.1128/AAC.17.6.912
   Matsunami T, 2011, INT J CLIN EXP PATHO, V4, P255
   Morrow DMP, 2007, FREE RADICAL BIO MED, V42, P1338, DOI 10.1016/j.freeradbiomed.2007.01.031
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nagaveni S, 2011, INDIAN J MICROBIOL, V51, P2, DOI 10.1007/s12088-011-0062-0
   PAKMAN LM, 1971, INFECT IMMUN, V4, P479, DOI 10.1128/IAI.4.4.479-487.1971
   Park M., 1999, HYPERBARIC MED PRACT, P205
   PARK MK, 1991, ANTIMICROB AGENTS CH, V35, P691, DOI 10.1128/AAC.35.4.691
   PARK MK, 1992, CLIN INFECT DIS, V14, P720, DOI 10.1093/clinids/14.3.720
   Shandley S, 2012, J ORTHOP RES, V30, P203, DOI 10.1002/jor.21522
   Speit G, 2002, MUTAT RES-REV MUTAT, V512, P111, DOI 10.1016/S1383-5742(02)00045-5
   Stehling EG, 2010, BRAZ J INFECT DIS, V14, P462, DOI 10.1590/S1413-86702010000500007
   Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf
   Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008
   Turhan V, 2009, J SURG RES, V155, P111, DOI 10.1016/j.jss.2008.08.031
   WEISLOW OS, 1974, INFECT IMMUN, V10, P546, DOI 10.1128/IAI.10.3.546-552.1974
   Widiyanti P., 2011, INDONES J TROP INFEC, V2, P49
   Zanon V, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-24
   Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473
NR 41
TC 10
Z9 10
U1 0
U2 7
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0913
EI 1746-0921
J9 FUTURE MICROBIOL
JI Future Microbiol.
PY 2015
VL 10
IS 2
BP 179
EP 189
DI 10.2217/FMB.14.111
PG 11
WC Microbiology
SC Microbiology
GA CB7UH
UT WOS:000349833000006
PM 25689530
DA 2020-11-30
ER

PT J
AU Cury, GCG
   Pereira, RFC
   de Hollanda, LM
   Lancellotti, M
AF Gentile Cury, Gisele Cristiane
   Carneiro Pereira, Rafaella Fabiana
   de Hollanda, Luciana Maria
   Lancellotti, Marcelo
TI Inflammatory response of Haemophilus influenzae biotype aegyptius
   causing Brazilian Purpuric Fever
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Brazilian purpuric fever; Haemophilus influenzae biogroup aegyptius;
   genetic transfer; Neisseria meningitidis; Haemophilus influenzae
ID NEISSERIA-MENINGITIDIS; BIOGROUP AEGYPTIUS; STRAINS
AB The Brazilian Purpuric Fever (BPF) is a systemic disease with many clinical features of meningococcal sepsis and is usually preceded by purulent conjunctivitis. The illness is caused by Haemophilus influenza biogroup aegyptius, which was associated exclusively with conjunctivitis. In this work construction of the las gene, hypothetically responsible for this virulence, were fusioned with ermAM cassette in Neisseria meningitidis virulent strains and had its DNA transfer to non BPF H. influenzae strains. The effect of the las transfer was capable to increase the cytokines TNF alpha and IL10 expression in Hec-1B cells line infected with these transformed mutants (in eight log scale of folding change RNA expression). This is the first molecular study involving the las transfer to search an elucidation of the pathogenic factors by horizontal intergeneric transfer from meningococci to H. influenzae.
C1 [Gentile Cury, Gisele Cristiane; Carneiro Pereira, Rafaella Fabiana; de Hollanda, Luciana Maria; Lancellotti, Marcelo] Univ Estadual Campinas, Inst Biol, Dept Biochem, Biotechnol Lab, Campinas, SP, Brazil.
RP Lancellotti, M (corresponding author), 13083 970 State Univ Campinas, Dept Biochem, Inst Biol, Rua Monteiro Lobato S-N,Caixa Postal 6109, Campinas, SP, Brazil.
EM mlancell@unicamp.br
RI DE HOLLANDA, LUCIANA MARIA/F-7893-2011; Pereira, Rafaella F
   C/M-4418-2017
OI DE HOLLANDA, LUCIANA MARIA/0000-0002-6047-4043; Pereira, Rafaella F
   C/0000-0003-4928-7631
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2008/56777-5]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [575313/2008-0]
FX All the authors declare have no conflicts of interest in this work. This
   work was supported by FAPESP (number 2008/56777-5) and CNPq (number
   575313/2008-0). Thanks for the English revision for Julia N. Varela.
CR [Anonymous], 1987, LANCET, V31, P2
   Bjerre A, 2004, CRIT CARE MED, V32, P433, DOI 10.1097/01.CCM.0000104950.52577.97
   Brandtzaeg P, 2001, J ENDOTOXIN RES, V7, P401, DOI 10.1177/09680519010070060401
   BRENNER DJ, 1988, J CLIN MICROBIOL, V26, P1524, DOI 10.1128/JCM.26.8.1524-1534.1988
   Centers for Disease Control (CDC), 1986, MMWR Morb Mortal Wkly Rep, V35, P553
   Centers for Disease Control (CDC), 1985, MMWR Morb Mortal Wkly Rep, V34, P217
   Davis J, 2001, J BACTERIOL, V183, P4626, DOI 10.1128/JB.183.15.000-000.2001
   HARRISON LH, 1987, LANCET, V2, P761
   Hollanda LM, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-28
   JACOBS RF, 1990, SCAND J INFECT DIS, P7
   Kroll JS, 1998, P NATL ACAD SCI USA, V95, P12381, DOI 10.1073/pnas.95.21.12381
   Lancellotti M, 2008, BRAZ J INFECT DIS, V12, P430, DOI 10.1590/S1413-86702008000500015
   Li MS, 2003, MOL MICROBIOL, V47, P1101, DOI 10.1046/j.1365-2958.2003.03359.x
   Mattos IB, J NANOBIOTECHNOLOGY, V9, P53
   MCINTYRE P, 1987, LANCET, V2, P112
   Overbergh L, 2005, CYTOKINE, V31, P454, DOI 10.1016/j.cyto.2005.07.002
   Pereira RFC AD, 2011, J BACTERIOL PARASITO, V2, P5
   PITTMAN M, 1950, J BACTERIOL, V59, P413, DOI 10.1128/JB.59.3.413-426.1950
   QUINN FD, 1995, INFECT IMMUN, V63, P2317, DOI 10.1128/IAI.63.6.2317-2322.1995
   RUBIN LG, 1993, INFECT IMMUN, V61, P650, DOI 10.1128/IAI.61.2.650-655.1993
   Santana-Porto EA, 2009, EMERG INFECT DIS, V15, P675, DOI 10.3201/eid1504.090014
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Strouts FR, 2012, EMERG INFECT DIS, V18, P449, DOI 10.3201/eid1803.110728
   Taha MK, 1998, MOL MICROBIOL, V28, P1153, DOI 10.1046/j.1365-2958.1998.00876.x
   Taha MK, 2000, CYTOKINE, V12, P21, DOI 10.1006/cyto.1999.0506
   Virata M, 1998, CLIN INFECT DIS, V27, P1238, DOI 10.1086/514988
   WEYANT RS, 1994, J INFECT DIS, V169, P430, DOI 10.1093/infdis/169.2.430
NR 27
TC 1
Z9 1
U1 0
U2 1
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD OCT-DEC
PY 2014
VL 45
IS 4
BP 1449
EP 1454
DI 10.1590/S1517-83822014000400040
PG 6
WC Microbiology
SC Microbiology
GA CC2UM
UT WOS:000350200100040
PM 25763053
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Martins, LJ
   Ferreira, BRV
   Almeida, WP
   Lancellotti, M
   Coelho, F
AF Martins, Lucimara J.
   Ferreira, Bruno R. V.
   Almeida, Wanda P.
   Lancellotti, Marcelo
   Coelho, Fernando
TI An easy access to halogenated and non-halogenated spiro-hexadienones
SO TETRAHEDRON LETTERS
LA English
DT Article
DE Morita-Baylis-Hillman; Spiro-hexadienones; Heck reaction; Hypervalent
   iodine; Brominated compounds
ID BAYLIS-HILLMAN REACTION; CYCLIZATION; DERIVATIVES;
   SPIROCYCLOHEXADIENONES; CONSTRUCTION; CHEMISTRY; ACID
AB We describe an improved protocol for the synthesis of spiro-hexadienones from Morita-Baylis-Hillman adducts. Solvent modification and temperature resulted in a significant increase in the yield. This protocol was used to synthesize mono- and dibrominated spiro-hexadienones in good overall yields. This report is the first to describe the synthesis of halogenated spiro-hexadienones from Morita-Baylis-Hillman adducts. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Martins, Lucimara J.; Ferreira, Bruno R. V.; Almeida, Wanda P.; Coelho, Fernando] Univ Estadual Campinas, Inst Chem, BR-13083970 Campinas, SP, Brazil.
   [Lancellotti, Marcelo] Univ Estadual Campinas, Inst Biol, BR-13083862 Campinas, SP, Brazil.
RP Coelho, F (corresponding author), Univ Estadual Campinas, Inst Chem, POB 6154, BR-13083970 Campinas, SP, Brazil.
EM coelho@iqm.unicamp.br
RI Ferreira, Bruno/AAJ-4971-2020; Coelho, Fernando/B-7602-2012; Almeida,
   Waldemar S/N-4641-2015
OI Coelho, Fernando/0000-0003-1800-1549; Almeida, Waldemar
   S/0000-0002-7382-8373; Almeida, Wanda Pereira/0000-0002-7154-4668
FU National Council for Scientific and Technological Development (CNPq -
   Brazil)National Council for Scientific and Technological Development
   (CNPq); Sao Paulo Research Foundation (FAPESP - Brazil)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/20033-5,
   2009/51602-5, 2009/18390-4]
FX W. P. A., M. L. and F. C. are grateful to the National Council for
   Scientific and Technological Development (CNPq - Brazil) for financial
   support and research fellowships. F. C. and L. J. M. are grateful to Sao
   Paulo Research Foundation (FAPESP - Brazil) for Grants (2011/20033-5;
   2009/51602-5) and fellowship (2009/18390-4), respectively.
CR Almeida WP, 1998, TETRAHEDRON LETT, V39, P8609, DOI 10.1016/S0040-4039(98)01927-3
   Alonso DA, 2002, ADV SYNTH CATAL, V344, P172, DOI 10.1002/1615-4169(200202)344:2<172::AID-ADSC172>3.0.CO;2-9
   Amarante GW, 2008, TETRAHEDRON LETT, V49, P3744, DOI 10.1016/j.tetlet.2008.04.040
   Amarante GW, 2010, TETRAHEDRON LETT, V51, P2597, DOI 10.1016/j.tetlet.2010.02.169
   Andrez JC, 2010, ORG LETT, V12, P4368, DOI 10.1021/ol101851z
   Appel TR, 2003, EUR J ORG CHEM, V2003, P47
   Asmanidou A, 2000, MOLECULES, V5, P874, DOI 10.3390/50600874
   Barontini M, 2013, MED CHEM RES, V22, P674, DOI 10.1007/s00044-012-0052-8
   Basavaiah D, 2012, CHEM SOC REV, V41, P68, DOI 10.1039/c1cs15174f
   Basavaiah D, 2010, CHEM REV, V110, P5447, DOI 10.1021/cr900291g
   Beil W, 1998, TETRAHEDRON, V54, P7273, DOI 10.1016/S0040-4020(98)00158-6
   Canesi S, 2002, TETRAHEDRON LETT, V43, P5193, DOI 10.1016/S0040-4039(02)00949-8
   Catellani M, 1999, J ORGANOMET CHEM, V584, P63, DOI 10.1016/S0022-328X(99)00093-5
   Coelho F, 2002, TETRAHEDRON, V58, P7437, DOI 10.1016/S0040-4020(02)00822-0
   Coelho F, 2000, QUIM NOVA, V23, P98, DOI 10.1590/S0100-40422000000100017
   de Turiso FGL, 2005, ORG LETT, V7, P151, DOI 10.1021/ol0477226
   Dohi T, 2005, ANGEW CHEM INT EDIT, V44, P6193, DOI 10.1002/anie.200501688
   Dohi T, 2010, TETRAHEDRON, V66, P5775, DOI 10.1016/j.tet.2010.04.116
   Ferreira BRV, 2009, TETRAHEDRON, V65, P7712, DOI 10.1016/j.tet.2009.06.084
   Fujioka H, 2010, CHEM COMMUN, V46, P4133, DOI 10.1039/b925687c
   Glushkov VA, 2010, TETRAHEDRON, V66, P721, DOI 10.1016/j.tet.2009.11.055
   HARA H, 1992, TETRAHEDRON LETT, V33, P6491, DOI 10.1016/S0040-4039(00)79023-X
   HEY DH, 1971, J CHEM SOC C, P116, DOI 10.1039/j39710000116
   KONIG GM, 1990, J NAT PROD, V53, P1615, DOI 10.1021/np50072a041
   KONIG GM, 1993, HETEROCYCLES, V36, P1351
   Li CW, 2007, J ORG CHEM, V72, P9203, DOI 10.1021/jo701504m
   Miyazawa E, 2003, J ORG CHEM, V68, P5429, DOI 10.1021/jo034318w
   MORIARTY RM, 2001, ORG REACTIONS, V57, P327, DOI DOI 10.1002/0471264180.OR057.02
   Nifontov YV, 2003, RUSS CHEM B+, V52, P437, DOI 10.1023/A:1023479420744
   Oliveira DD, 2001, TETRAHEDRON LETT, V42, P6793, DOI 10.1016/S0040-4039(01)01401-0
   Pereira J, 2007, ORG LETT, V9, P3101, DOI 10.1021/ol0712576
   Pirovani RV, 2009, SYNLETT, P2333, DOI 10.1055/s-0029-1217725
   Shi M, 2011, RSC CATAL SER, P1
   Su B, 2013, ORG LETT, V15, P1606, DOI 10.1021/ol400388j
   WULFF WD, 1985, J AM CHEM SOC, V107, P503, DOI 10.1021/ja00288a040
   Yoshida M, 2012, TETRAHEDRON-ASYMMETR, V23, P859, DOI 10.1016/j.tetasy.2012.05.026
   Zhdankin VV, 2002, CHEM REV, V102, P2523, DOI 10.1021/cr010003+
NR 37
TC 8
Z9 8
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0040-4039
J9 TETRAHEDRON LETT
JI Tetrahedron Lett.
PD SEP 17
PY 2014
VL 55
IS 38
BP 5264
EP 5267
DI 10.1016/j.tetlet.2014.07.114
PG 4
WC Chemistry, Organic
SC Chemistry
GA AO7SD
UT WOS:000341552000010
DA 2020-11-30
ER

PT J
AU Hollanda, LM
   Lobo, AO
   Lancellotti, M
   Berni, E
   Corat, EJ
   Zanin, H
AF Hollanda, L. M.
   Lobo, A. O.
   Lancellotti, M.
   Berni, E.
   Corat, E. J.
   Zanin, H.
TI Graphene and carbon nanotube nanocomposite for gene transfection
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Graphene oxide; Gene transfer; Carbon nanotubes; Composite; Cell
   viability; Plasma
ID MS/MS PROTEOME ANALYSIS; HEPATOMA HEPG2 CELLS; OXIDATIVE STRESS;
   DRUG-DELIVERY; CYTOTOXICITY; TOXICITY; DNA; OXIDE; BINDING; MICE
AB Graphene and carbon nanotube nanocomposite (GCN) was synthesised and applied in gene transfection of pIRES plasmid conjugated with green fluorescent protein (GFP) in NIH-3T3 and NG97 cell lines. The tips of the multi-walled carbon nanotubes (MWCNTs) were exfoliated by oxygen plasma etching, which is also known to attach oxygen content groups on the MWCNT surfaces, changing their hydrophobicity. The nanocomposite was characterised by high resolution scanning electron microscopy; energy-dispersive X-ray, Fourier transform infrared. and Raman spectroscopies, as well as zeta potential and particle size analyses using dynamic light scattering. BET adsorption isotherms showed the GCN to have an effective surface area of 38.5 m(2)/g. The GCN and pIRES plasmid conjugated with the GFP gene, forming it-stacking when dispersed in water by magnetic stirring, resulting in a helical wrap. The measured zeta potential confirmed that the plasmid was connected to the nanocomposite. The NIH-3T3 and NG97 cell lines could phagocytize this wrap. The gene transfection was characterised by fluorescent protein produced in the cells and pictured by fluorescent microscopy. Before application, we studied GCN cell viability in NIH-3T3 and NG97 line cells using both MTT and Neutral Red uptake assays. Our results suggest that GCN has moderate stability behaviour as colloid solution and has great potential as a gene carrier agent in non-viral based therapy, with low cytotoxicity and good transfection efficiency. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Hollanda, L. M.; Lancellotti, M.] Univ Estadual Campinas, Inst Biol, Dept Biochem, Biotechnol Lab, BR-13083862 Campinas, SP, Brazil.
   [Lobo, A. O.] UNIVAP, Inst Res & Dev, Lab Biomed Nanotechnol, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
   [Berni, E.] Univ Estadual Campinas, Inst Chem, Dept Phys Chem, Biol Chem Lab, BR-13083970 Campinas, SP, Brazil.
   [Corat, E. J.; Zanin, H.] INPE, Associated Lab Sensors & Mat, BR-12227010 Sao Jose Dos Campos, Brazil.
RP Zanin, H (corresponding author), INPE, Associated Lab Sensors & Mat, Av Astronautas 1758, BR-12227010 Sao Jose Dos Campos, Brazil.
EM hudsonzanin@gmail.com
RI Corat, Evaldo J./D-9584-2012; Lobo, Anderson Oliveira/B-2893-2011;
   zanin, hudson/A-8408-2015; DE HOLLANDA, LUCIANA MARIA/F-7893-2011;
   Zanin, Hudson/AAC-8962-2019
OI Corat, Evaldo J./0000-0003-3011-5522; Lobo, Anderson
   Oliveira/0000-0002-2544-0438; zanin, hudson/0000-0002-7295-4378; DE
   HOLLANDA, LUCIANA MARIA/0000-0002-6047-4043; Zanin,
   Hudson/0000-0002-7295-4378
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [202439/2012-7]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2011/17195-3, 2011/17877-7]
FX The authors would like to thank Brazilians agencies CNPq
   (202439/2012-7); FAPESP (2011/17195-3) and (2011/17877-7) for financial
   support. We also thank the researchers Dr. Silvia Mika Shishido and Dr.
   Daisy Machado for constructive discussion. Special thanks for Maria
   Helena Andrade Santana and Daniela Araujo for the ZetaSizerNano
   analysis, Elaine Minatel for the help in transfection assay, and Alene
   Alder-Rangel for reviewing the English language of this manuscript.
CR Antunes EF, 2006, CARBON, V44, P2202, DOI 10.1016/j.carbon.2006.03.003
   Bhirde AA, 2010, NANOMEDICINE-UK, V5, P1535, DOI [10.2217/nnm.10.90, 10.2217/NNM.10.90]
   Borenfreund E., 1985, J TISS CULT METHODS, V9, P7, DOI DOI 10.1007/BF01666038
   Bottini M, 2006, TOXICOL LETT, V160, P121, DOI 10.1016/j.toxlet.2005.06.020
   Casey A, 2007, CARBON, V45, P1425, DOI 10.1016/j.carbon.2007.03.033
   Casey A, 2007, CARBON, V45, P34, DOI 10.1016/j.carbon.2006.08.009
   Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104
   CHAN WCW, 2010, P ASME 1 GLOB C NAN, P111
   Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016
   Cheung W, 2010, ADV DRUG DELIVER REV, V62, P633, DOI 10.1016/j.addr.2010.03.007
   Compton OC, 2011, ACS NANO, V5, P4380, DOI 10.1021/nn1030725
   de Andrade LR, 2014, ECOTOX ENVIRON SAFE, V99, P92, DOI 10.1016/j.ecoenv.2013.10.013
   De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231
   De Nicola M., 2007, J PHYS-CONDENS MAT, P19
   Ding LH, 2005, NANO LETT, V5, P2448, DOI 10.1021/nl051748o
   Feazell RP, 2007, J AM CHEM SOC, V129, P8438, DOI 10.1021/ja073231f
   Firme CP, 2010, NANOMED-NANOTECHNOL, V6, P245, DOI 10.1016/j.nano.2009.07.003
   Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908
   Foldvari M, 2008, NANOMED-NANOTECHNOL, V4, P183, DOI 10.1016/j.nano.2008.04.003
   Ge CC, 2011, P NATL ACAD SCI USA, V108, P16968, DOI 10.1073/pnas.1105270108
   Ghosh S, 2009, ACS NANO, V3, P2667, DOI 10.1021/nn900368b
   Grinet M.A.V.M, J MAT CHEM B
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639
   Hu WB, 2010, ACS NANO, V4, P4317, DOI 10.1021/nn101097v
   Hurt RH, 2006, CARBON, V44, P1028, DOI 10.1016/j.carbon.2005.12.023
   Isobe H, 2006, ANGEW CHEM INT EDIT, V45, P6676, DOI 10.1002/anie.200601718
   Izidoro M.S.J., 2012, J BACTERIOL PARASITO, P3
   Jang H, 2010, ANGEW CHEM INT EDIT, V49, P5703, DOI 10.1002/anie.201001332
   Ju SY, 2008, NAT NANOTECHNOL, V3, P356, DOI 10.1038/nnano.2008.148
   Kalbacova M, 2007, CARBON, V45, P2266, DOI 10.1016/j.carbon.2007.06.025
   Kaya C, 2008, ADV ENG MATER, V10, P131, DOI 10.1002/adem.200700241
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   Liao KH, 2011, ACS APPL MATER INTER, V3, P2607, DOI 10.1021/am200428v
   Liu Y, 2005, ANGEW CHEM INT EDIT, V44, P4782, DOI 10.1002/anie.200500042
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Lobo AO, 2012, MAT SCI ENG C-MATER, V32, P648, DOI 10.1016/j.msec.2010.08.010
   Lobo AO, 2013, MAT SCI ENG C-MATER, V33, P4305, DOI 10.1016/j.msec.2013.06.032
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   MacDiarmid JA, 2007, CANCER CELL, V11, P431, DOI 10.1016/j.ccr.2007.03.012
   Machado CML, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-13
   Machado D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054269
   Mastrobattista E, 2006, NAT REV DRUG DISCOV, V5, P115, DOI 10.1038/nrd1960
   Maynard AD, 2004, J TOXICOL ENV HEAL A, V67, P87, DOI 10.1080/15287390490253688
   Misra SK, 2012, SMALL, V8, P131, DOI 10.1002/smll.201101640
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murray AR, 2009, TOXICOLOGY, V257, P161, DOI 10.1016/j.tox.2008.12.023
   Mwenifumbo S, 2007, J MATER CHEM, V17, P1894, DOI 10.1039/b617708e
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]
   Pacurari M, 2008, ENVIRON HEALTH PERSP, V116, P1211, DOI 10.1289/ehp.10924
   Park KH, 2003, J BIOL CHEM, V278, P50212, DOI 10.1074/jbc.M310216200
   Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645
   Ramalingam P, 2013, RSC ADV, V3, P2369, DOI 10.1039/c2ra22343k
   Ryoo SR, 2010, ACS NANO, V4, P6587, DOI 10.1021/nn1018279
   Sanchez-Pomales G, 2009, J NANOSCI NANOTECHNO, V9, P2175, DOI 10.1166/jnn.2009.SE47
   Sato Y, 2005, MOL BIOSYST, V1, P176, DOI 10.1039/b502429c
   Shim M, 2002, NANO LETT, V2, P285, DOI 10.1021/nl015692j
   Shvedova AA, 2012, TOXICOL APPL PHARM, V261, P121, DOI 10.1016/j.taap.2012.03.023
   Singh R, 2005, J AM CHEM SOC, V127, P4388, DOI 10.1021/ja0441561
   Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o
   Tejral G, 2009, J APPL BIOMED, V7, P1
   Vardharajula S, 2012, INT J NANOMED, V7, P5361, DOI 10.2147/IJN.S35832
   Wei H., 2013, NANO RES, P1
   Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c
   Yan LA, 2011, NANOSCALE, V3, P362, DOI 10.1039/c0nr00647e
   Yan XB, 2011, T NONFERR METAL SOC, V21, P1085, DOI 10.1016/S1003-6326(11)60826-1
   Yuan JF, 2012, TOXICOL SCI, V126, P149, DOI 10.1093/toxsci/kfr332
   Yuan JF, 2011, TOXICOL LETT, V207, P213, DOI 10.1016/j.toxlet.2011.09.014
   Zangmeister RA, 2007, LANGMUIR, V23, P6252, DOI 10.1021/la063109e
   Zanin H, 2014, MATER RES BULL, V49, P487, DOI 10.1016/j.materresbull.2013.09.033
   Zanin H., ACS APPL MAT IINTERF, V5, P12238
   Zanin H, 2013, J MATER CHEM B, V1, P4947, DOI 10.1039/c3tb20550a
   Zanin H, 2013, J APPL ELECTROCHEM, V43, P323, DOI 10.1007/s10800-012-0491-4
   Zanin H, 2012, MAT SCI ENG C-MATER, V32, P2340, DOI 10.1016/j.msec.2012.07.005
   Zhang DW, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/47/475102
   Zhang L, 2005, ELECTROANAL, V17, P630, DOI 10.1002/elan.200403091
   Zhang LM, 2011, SMALL, V7, P460, DOI 10.1002/smll.201001522
   Zhang YB, 2011, ACS NANO, V5, P7020, DOI 10.1021/nn2016259
   Zhang YG, 2012, ELECTROCHIM ACTA, V61, P185, DOI 10.1016/j.electacta.2011.12.003
   Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877
   Zhou X, 2012, NANO RES, V5, P703, DOI 10.1007/s12274-012-0254-x
NR 81
TC 41
Z9 42
U1 2
U2 99
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2014
VL 39
BP 288
EP 298
DI 10.1016/j.msec.2014.03.002
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AS0DS
UT WOS:000343949200038
PM 24863227
DA 2020-11-30
ER

PT J
AU Zanin, H
   Hollanda, LM
   Ceragioli, HJ
   Ferreira, MS
   Machado, D
   Lancellotti, M
   Catharino, RR
   Baranauskas, V
   Lobo, AO
AF Zanin, H.
   Hollanda, L. M.
   Ceragioli, H. J.
   Ferreira, M. S.
   Machado, D.
   Lancellotti, M.
   Catharino, R. R.
   Baranauskas, V.
   Lobo, A. O.
TI Carbon nanoparticles for gene transfection in eukaryotic cell lines
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Gene transfection; Cell viability; Metabolomic test; Carbon nanomaterial
ID HEPATOMA HEPG2 CELLS; GRAPHENE OXIDE; DRUG-DELIVERY; PROTEIN CORONA;
   NANOTUBES; TOXICITY; DNA; BINDING; ACID; BIOCOMPATIBILITY
AB For the first time, oxygen terminated cellulose carbon nanoparticles (CCN) was synthesised and applied in gene transfection of pIRES plasmid. The CCN was prepared from catalytic of polyaniline by chemical vapour deposition techniques. This plasmid contains one gene that encodes the green fluorescent protein (GFP) in eukaryotic cells, making them fluorescent. This new nanomaterial and pIRES plasmid formed pi-stacking when dispersed in water by magnetic stirring. The frequencies shift in zeta potential confirmed the plasmid strongly connects to the nanomaterial. In vitro tests found that this conjugation was phagocytised by NG97, NIH-3T3 and A549 cell lines making them fluorescent, which was visualised by fluorescent microscopy. Before the transfection test, we studied CCN in cell viability. Both MTT and Neutral Red uptake tests were carried out using NG97, NIH-3T3 and A549 cell lines. Further, we use metabolomics to verify if small amounts of nanomaterial would be enough to cause some cellular damage in NG97 cells. We showed two mechanisms of action by CCN-DNA complex, producing an exogenous protein by the transfected cell and metabolomic changes that contributed by better understanding of glioblastoma, being the major finding of this work. Our results suggested that this nanomaterial has great potential as a gene carrier agent in non-viral based therapy, with low cytotoxicity, good transfection efficiency, and low cell damage in small amounts of nanomaterials in metabolomic tests. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zanin, H.; Ceragioli, H. J.; Baranauskas, V.] Univ Estadual Campinas, Fac Engn Eletr & Comp, Dept Semicond Instrumentos & Foton, BR-13083852 Campinas, SP, Brazil.
   [Hollanda, L. M.; Machado, D.; Lancellotti, M.] Univ Estadual Campinas, Inst Biol, Dept Biochem, Biotechnol Lab, BR-13083862 Campinas, SP, Brazil.
   [Ferreira, M. S.; Catharino, R. R.] Univ Estadual Campinas, Innovare Biomarkers Lab, BR-13083877 Sao Paulo, Brazil.
   [Lobo, A. O.] Univ Vale Paraiba UNIVAP, Lab Biomed Nanotechnol NANOBIO, BR-12224000 Sao Jose Dos Campos, SP, Brazil.
RP Zanin, H (corresponding author), Univ Estadual Campinas, Fac Engn Eletr & Comp, Dept Semicond Instrumentos & Foton, BR-13083852 Campinas, SP, Brazil.
EM hudsonzanin@gmail.com; luciana.hollanda@gmail.com
RI Zanin, Hudson/AAC-8962-2019; zanin, hudson/A-8408-2015; DE HOLLANDA,
   LUCIANA MARIA/F-7893-2011; Catharino, Rodrigo/G-1487-2013; Lobo,
   Anderson Oliveira/B-2893-2011; Machado, Daisy/A-4891-2013; Machado,
   Daisy/ABA-3731-2020
OI Zanin, Hudson/0000-0002-7295-4378; zanin, hudson/0000-0002-7295-4378; DE
   HOLLANDA, LUCIANA MARIA/0000-0002-6047-4043; Catharino,
   Rodrigo/0000-0001-7219-2644; Lobo, Anderson
   Oliveira/0000-0002-2544-0438; Machado, Daisy/0000-0002-6435-6159;
   Machado, Daisy/0000-0002-6435-6159
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [202439/2012-7]; CAPESCAPES; FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2011/17195-3, 2011/17877-7]
FX The authors would like to thank Brazilians agencies CNPq
   (202439/2012-7); CAPES and FAPESP (2011/17195-3) and (2011/17877-7) for
   financial support Our sincere acknowledgements to Dr. Elaine Minatel,
   who helped us with the fluorescence images. The electron microscopy work
   was performed with a HRSEM (FEI-Inspect) microscope at the
   LME/LNLS-Campinas.
CR Abdelnur P.V., 2011, 10 EMBRAPA
   Alberghina M., 2010, B ACCAD GIOENIA SCI, V43, P1
   Antunes EF, 2006, CARBON, V44, P2202, DOI 10.1016/j.carbon.2006.03.003
   Bhirde AA, 2010, NANOMEDICINE-UK, V5, P1535, DOI [10.2217/nnm.10.90, 10.2217/NNM.10.90]
   Bottini M, 2006, TOXICOL LETT, V160, P121, DOI 10.1016/j.toxlet.2005.06.020
   Bu Q, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/12/125105
   Casey A, 2007, CARBON, V45, P1425, DOI 10.1016/j.carbon.2007.03.033
   Casey A, 2007, CARBON, V45, P34, DOI 10.1016/j.carbon.2006.08.009
   Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104
   Chan WCW, 2010, NEMB2010: PROCEEDINGS OF THE ASME FIRST GLOBAL CONGRESS ON NANOENGINEERING FOR MEDICINE AND BIOLOGY - 2010, P111
   Cheung W, 2010, ADV DRUG DELIVER REV, V62, P633, DOI 10.1016/j.addr.2010.03.007
   de Andrade LR, 2014, ECOTOX ENVIRON SAFE, V99, P92, DOI 10.1016/j.ecoenv.2013.10.013
   De C. Vos, 2008, EXPRESSION MULTIDISC, P573
   De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231
   de Oliveira DN, 2013, INT J COSMETIC SCI, V35, P467, DOI 10.1111/ics.12066
   de Oliveira DN, 2013, MATERIALS, V6, P1000, DOI 10.3390/ma6031000
   Ding LH, 2005, NANO LETT, V5, P2448, DOI 10.1021/nl051748o
   Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j
   Ellis DI, 2007, PHARMACOGENOMICS, V8, P1243, DOI 10.2217/14622416.8.9.1243
   Feazell RP, 2007, J AM CHEM SOC, V129, P8438, DOI 10.1021/ja073231f
   Feng JH, 2013, METABOLOMICS, V9, P874, DOI 10.1007/s11306-013-0499-8
   Firme CP, 2010, NANOMED-NANOTECHNOL, V6, P245, DOI 10.1016/j.nano.2009.07.003
   Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908
   Foldvari M, 2008, NANOMED-NANOTECHNOL, V4, P183, DOI 10.1016/j.nano.2008.04.003
   Garcia MC, 1998, J NEUROCHEM, V70, P24
   Ge CC, 2011, P NATL ACAD SCI USA, V108, P16968, DOI 10.1073/pnas.1105270108
   Ghosh S, 2009, ACS NANO, V3, P2667, DOI 10.1021/nn900368b
   Grinet MAVM, 2014, J MATER CHEM B, V2, P1196, DOI 10.1039/c3tb21525c
   Hadrup N, 2012, J APPL TOXICOL, V32, P929, DOI 10.1002/jat.2779
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639
   Hollanda LM, 2014, MAT SCI ENG C-MATER, V39, P288, DOI 10.1016/j.msec.2014.03.002
   Hu WB, 2010, ACS NANO, V4, P4317, DOI 10.1021/nn101097v
   Hurt RH, 2006, CARBON, V44, P1028, DOI 10.1016/j.carbon.2005.12.023
   Isobe H, 2006, ANGEW CHEM INT EDIT, V45, P6676, DOI 10.1002/anie.200601718
   Izidoro M.S.J., 2012, J BACTERIOL PARASITO, V3
   Jang H, 2010, ANGEW CHEM INT EDIT, V49, P5703, DOI 10.1002/anie.201001332
   Kaya C, 2008, ADV ENG MATER, V10, P131, DOI 10.1002/adem.200700241
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   Lei RH, 2008, TOXICOL APPL PHARM, V232, P292, DOI 10.1016/j.taap.2008.06.026
   Lin BC, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-236
   Lin HJ, 2012, CURR DRUG METAB, V13, P354, DOI 10.2174/138920012800166535
   Liu Y, 2005, ANGEW CHEM INT EDIT, V44, P4782, DOI 10.1002/anie.200500042
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Liu Z, 2011, MATER TODAY, V14, P316, DOI 10.1016/S1369-7021(11)70161-4
   Lobo AO, 2012, MAT SCI ENG C-MATER, V32, P648, DOI 10.1016/j.msec.2010.08.010
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   Machado CML, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-13
   Machado CML, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-291
   Machado D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054269
   Martin Clayton Antunes, 2006, Rev. Nutr., V19, P761, DOI 10.1590/S1415-52732006000600011
   Mastrobattista E, 2006, NAT REV DRUG DISCOV, V5, P115, DOI 10.1038/nrd1960
   Maynard AD, 2004, J TOXICOL ENV HEAL A, V67, P87, DOI 10.1080/15287390490253688
   Misra SK, 2012, SMALL, V8, P131, DOI 10.1002/smll.201101640
   Monteiro-Riviere NA, 2006, CARBON, V44, P1070, DOI 10.1016/j.carbon.2005.11.004
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murray AR, 2009, TOXICOLOGY, V257, P161, DOI 10.1016/j.tox.2008.12.023
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]
   Pacurari M, 2008, ENVIRON HEALTH PERSP, V116, P1211, DOI 10.1289/ehp.10924
   Park KH, 2003, J BIOL CHEM, V278, P50212, DOI 10.1074/jbc.M310216200
   Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645
   Ryoo SR, 2010, ACS NANO, V4, P6587, DOI 10.1021/nn1018279
   Sanchez-Pomales G, 2009, J NANOSCI NANOTECHNO, V9, P2175, DOI 10.1166/jnn.2009.SE47
   Sato Y, 2005, MOL BIOSYST, V1, P176, DOI 10.1039/b502429c
   SAWAMURA Y, 1990, J NEURO-ONCOL, V9, P125, DOI 10.1007/BF02427832
   Shim M, 2002, NANO LETT, V2, P285, DOI 10.1021/nl015692j
   Shvedova AA, 2012, TOXICOL APPL PHARM, V261, P121, DOI 10.1016/j.taap.2012.03.023
   Silva TA, 2014, ELECTROCHIM ACTA, V119, P114, DOI 10.1016/j.electacta.2013.12.024
   Singh R, 2005, J AM CHEM SOC, V127, P4388, DOI 10.1021/ja0441561
   Tan B, 2010, J LIPID RES, V51, P112, DOI 10.1194/jlr.M900198-JLR200
   Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o
   Tejral G, 2009, J APPL BIOMED, V7, P1
   Vardharajula S, 2012, INT J NANOMED, V7, P5361, DOI 10.2147/IJN.S35832
   VRIGNAUD P, 1986, CANCER RES, V46, P3258
   Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c
   Yan LA, 2011, NANOSCALE, V3, P362, DOI 10.1039/c0nr00647e
   Yan XB, 2011, T NONFERR METAL SOC, V21, P1085, DOI 10.1016/S1003-6326(11)60826-1
   Yuan JF, 2012, TOXICOL SCI, V126, P149, DOI 10.1093/toxsci/kfr332
   Yuan JF, 2011, TOXICOL LETT, V207, P213, DOI 10.1016/j.toxlet.2011.09.014
   Zangmeister RA, 2007, LANGMUIR, V23, P6252, DOI 10.1021/la063109e
   Zanin H, 2014, J ELECTROCHEM SOC, V161, pH290, DOI 10.1149/2.011405jes
   Zanin H, 2013, J MATER CHEM B, V1, P4947, DOI 10.1039/c3tb20550a
   Zanin H, 2013, J APPL ELECTROCHEM, V43, P323, DOI 10.1007/s10800-012-0491-4
   Zhang DW, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/47/475102
   Zhang L, 2005, ELECTROANAL, V17, P630, DOI 10.1002/elan.200403091
   Zhang LW, 2007, INT J TOXICOL, V26, P103, DOI 10.1080/10915810701225133
   Zhang LM, 2011, SMALL, V7, P460, DOI 10.1002/smll.201001522
   Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680
   Zhang YB, 2011, ACS NANO, V5, P7020, DOI 10.1021/nn2016259
   Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877
   Zhou X, 2012, NANO RES, V5, P703, DOI 10.1007/s12274-012-0254-x
NR 91
TC 14
Z9 16
U1 0
U2 59
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2014
VL 39
BP 359
EP 370
DI 10.1016/j.msec.2014.03.016
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA AS0DS
UT WOS:000343949200048
PM 24863237
DA 2020-11-30
ER

PT J
AU de Paiva, REF
   Abbehausen, C
   Bergamini, FRG
   Thompson, AL
   Alves, DA
   Lancellotti, M
   Corbi, PP
AF de Paiva, Raphael E. F.
   Abbehausen, Camilla
   Bergamini, Fernando R. G.
   Thompson, Andre L.
   Alves, Danilo A.
   Lancellotti, Marcelo
   Corbi, Pedro P.
TI Investigating the inclusion of the Ag(I)-nimesulide complex into
   beta-cyclodextrin: studies in solution and in the solid state
SO JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY
LA English
DT Article
DE Silver(I); Nimesulide; beta-Cyclodextrin; Inclusion chemistry; NOESY NMR
ID SILVER SULFADIAZINE; GAMMA-CYCLODEXTRIN; ALPHA-CYCLODEXTRIN; WATER;
   DERIVATIVES; DICHLORIDE; COMPOUND
AB The present work describes the preparation and characterization of inclusion systems involving beta-CD and the silver(I) nimesulide coordination complex (Ag-NMS), prepared by kneading (K) and co-evaporation (CE) methods. Solid state characterization by DSC, XRD and IR vibrational spectroscopic measurements provided remarkable evidences of the formation of true inclusion systems. Solution measurements provided information about the inclusion mode. The UV-Vis spectroscopy was used to obtain the association constants by the Scatchard method, and the value obtained was 370 +/- 2 L mol(-1). The 1 H NMR spectroscopic measurements indicate a total inclusion of the guest into the cavity. A 2D NOESY experiment was carried out for the inclusion complex. The spectrum shows that hydrogens 3-6 of the cyclodextrin clearly correlate with the protons of the phenoxy ring of nimesulide in the Ag-NMS coordination compound, which confirms the formation of the inclusion complex. The antibacterial activities of the Ag-NMS and CE-[(Ag-NMS)center dot beta-CD] inclusion system were evaluated by the well diffusion method over Escherichia coli and Pseudomonas aeruginosa (Gram-negative) and Staphylococcus aureus (Grampositive) pathogenic bacterial strains. The observed data shows the significant antibacterial activity of the Ag-NMS coordination complex, and no activity for the inclusion complex under the same considered conditions.
C1 [de Paiva, Raphael E. F.; Abbehausen, Camilla; Bergamini, Fernando R. G.; Thompson, Andre L.; Corbi, Pedro P.] Univ Campinas UNICAMP, Inst Chem, Dept Inorgan Chem, BR-13083970 Campinas, SP, Brazil.
   [Alves, Danilo A.; Lancellotti, Marcelo] Univ Estadual Campinas, UNICAMP, Biotechnol Lab, Inst Biol, BR-13083970 Campinas, SP, Brazil.
RP Corbi, PP (corresponding author), Univ Campinas UNICAMP, Inst Chem, Dept Inorgan Chem, POB 6154, BR-13083970 Campinas, SP, Brazil.
EM raphael.enoque@gmail.com; ppcorbi@iqm.unicamp.br
RI Abbehausen, Camilla/AAD-3050-2020; Paiva, Raphael EF/B-7634-2012;
   Abbehausen, Camilla/AAA-7975-2019; Abbehausen, Camilla/X-9527-2019;
   Corbi, Pedro P/B-7639-2012; Bergamini, Fernando Rodrigues
   Goulart/B-8168-2013
OI Abbehausen, Camilla/0000-0002-8410-2252; Paiva, Raphael
   EF/0000-0003-2549-0344; Corbi, Pedro P/0000-0002-7478-0877; Bergamini,
   Fernando Rodrigues Goulart/0000-0002-8357-3044
FU FAPESP (Sao Paulo State Research Foundation, Brazil)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [proc. 2012/08230-2];
   CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX This study was supported by grants from the Brazilian Agencies FAPESP
   (Sao Paulo State Research Foundation, Brazil-proc. 2012/08230-2), CAPES
   and CNPq. Professor Corbi is also grateful to Professors Celso A.
   Bertran and Andre L. B. Formiga from the Campinas State University,
   UNICAMP, Brazil, for technical support.
CR Braga SS, 2006, EUR J INORG CHEM, P1662, DOI 10.1002/ejic.200501006
   Braga SS, 2002, SUPRAMOL CHEM, V14, P359, DOI 10.1080/10610270290029308
   Braga SS, 2005, J ORGANOMET CHEM, V690, P2905, DOI 10.1016/j.jorganchem.2005.03.012
   Braga SS, 2002, J INCL PHENOM MACRO, V44, P261, DOI 10.1023/A:1023001105669
   Braga SS, 2006, INORG CHIM ACTA, V359, P4757, DOI 10.1016/j.ica.2006.03.017
   BUVARI A, 1988, J CHEM SOC PERK T 2, P543, DOI 10.1039/p29880000543
   Chen M, 2006, CHEMOSPHERE, V63, P522, DOI 10.1016/j.chemosphere.2005.08.033
   CLSI, 2007, PERF STAND ANT SUS S
   Cunha-Silva L, 2002, J ORGANOMET CHEM, V656, P281, DOI 10.1016/S0022-328X(02)01635-2
   de Paiva REF, 2012, POLYHEDRON, V36, P112, DOI 10.1016/j.poly.2012.02.002
   Demain AL, 2009, J ANTIBIOT, V62, P5, DOI 10.1038/ja.2008.16
   Fernandes JA, 2005, ORGANOMETALLICS, V24, P5673, DOI 10.1021/om050654m
   Ferreira P, 2000, ORGANOMETALLICS, V19, P1455, DOI 10.1021/om991033u
   FOX CL, 1968, ARCH SURG-CHICAGO, V96, P184
   FOX CL, 1974, ANTIMICROB AGENTS CH, V5, P582, DOI 10.1128/AAC.5.6.582
   Bergamini FRG, 2012, RSC ADV, V2, P10372, DOI 10.1039/c2ra21433d
   GREATBANKS D, 1987, MAGN RESON CHEM, V25, P208, DOI 10.1002/mrc.1260250306
   Hao HJ, 2011, CRYST GROWTH DES, V11, P3564, DOI 10.1021/cg200534x
   Harata K, 2002, CARBOHYD RES, V337, P537, DOI 10.1016/S0008-6215(02)00019-8
   Jin SW, 2011, J COORD CHEM, V64, P617, DOI 10.1080/00958972.2011.552603
   Kasbekar N, 2006, AM J HEALTH-SYST PH, V63, P1235, DOI 10.2146/ajhp050487
   Kasuga NC, 2012, INORG CHEM, V51, P1640, DOI 10.1021/ic201950p
   Kasuga NC, 2011, INORG CHIM ACTA, V368, P44, DOI 10.1016/j.ica.2010.12.044
   Legrand FX, 2011, NEW J CHEM, V35, P2061, DOI 10.1039/c1nj20200f
   Li B, 2011, DALTON T, V40, P788, DOI 10.1039/c0dt00949k
   Lima S, 2001, ORGANOMETALLICS, V20, P2191, DOI 10.1021/om001088s
   Lippold I, 2009, J INORG BIOCHEM, V103, P480, DOI 10.1016/j.jinorgbio.2008.12.014
   Maheshwari A, 2011, CARBOHYD RES, V346, P1809, DOI 10.1016/j.carres.2011.07.003
   Marques J, 2008, J ORGANOMET CHEM, V693, P3021, DOI 10.1016/j.jorganchem.2008.06.023
   MCCORMACK S, 1992, ELECTROCHIM ACTA, V37, P1939, DOI 10.1016/0013-4686(92)87106-A
   Meindersma GW, 2006, CHEM ENG PROCESS, V45, P175, DOI 10.1016/j.cep.2005.06.009
   Morales A, 2008, J INCL PHENOM MACRO, V60, P263, DOI 10.1007/s10847-007-9374-4
   Nalluri B.N., 2003, AAPS PHARMSCITECH, V4, DOI [10.1208/pt040102, DOI 10.1208/pt040102]
   Pettinari C, 2011, INORG CHEM, V50, P11173, DOI 10.1021/ic201714c
   Sanphui P, 2011, J PHARM SCI-US, V100, P2287, DOI 10.1002/jps.22464
   SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x
   Sengul A, 2011, STRUCT CHEM, V22, P925, DOI 10.1007/s11224-011-9778-z
   Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c
   SZEJTLI J, 1998, CYCLODEXTRIN TECHNOL
   Turel I, 1999, J INCL PHENOM MACRO, V35, P595, DOI 10.1023/A:1008026715964
   WENZ G, 1994, ANGEW CHEM INT EDIT, V33, P803, DOI 10.1002/anie.199408031
   Whittle BJR, 2003, FUND CLIN PHARMACOL, V17, P301, DOI 10.1046/j.1472-8206.2003.00135.x
   Wintgens V, 2012, BIOMACROMOLECULES, V13, P528, DOI 10.1021/bm201608n
   Yaghi OM, 1996, J AM CHEM SOC, V118, P295, DOI 10.1021/ja953438l
NR 44
TC 4
Z9 4
U1 0
U2 23
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-3127
EI 1573-1111
J9 J INCL PHENOM MACRO
JI J. Incl. Phenom. Macrocycl. Chem.
PD JUN
PY 2014
VL 79
IS 1-2
BP 225
EP 235
DI 10.1007/s10847-013-0348-4
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA AL6WH
UT WOS:000339273600022
DA 2020-11-30
ER

PT J
AU Varela, JN
   Amstalden, MCK
   Pereira, RFC
   de Hollanda, LM
   Ceragioli, HJ
   Baranauskas, V
   Lancellotti, M
AF Varela, Julia Nogueira
   Kraehenbuehl Amstalden, Maria Cecilia
   Carneiro Pereira, Rafaella Fabiana
   de Hollanda, Luciana Maria
   Ceragioli, Helder Jose
   Baranauskas, Vitor
   Lancellotti, Marcelo
TI Haemophilus influenzae porine ompP2 gene transfer mediated by graphene
   oxide nanoparticles with effects on transformation process and virulence
   bacterial capacity
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
DE Haemophilus influenzae; Graphene oxide; Bacterial transformation; Outer
   membrane protein; Virulence; Porin
ID OUTER-MEMBRANE PROTEIN; NEISSERIA-MENINGITIDIS TRANSFORMATION; WALLED
   CARBON NANOTUBES; MOLECULAR EPIDEMIOLOGY; ESCHERICHIA-COLI; PORE
   FUNCTION; RESISTANCE; P2; COMPETENCE; CHILDREN
AB Background: H. influenzae is a natural competent bacterium that can uptake DNA from the environment and recombine into bacterial genome. The outbreaks of Brazilian purpuric fever, heavily polluted areas of a different H. influenzae biogroup - aegyptius - as well as gene transference between Neisseria meningitis make the transformation process an important evolutionary factor. This work studied the horizontal transference of the ompP2 gene from a multiresistant strain of H. influenzae 07 (NTHi), under the influence of graphene oxide nanoparticles in order to mimic an atmosphere rich in suspended particles and this way verify if the CFU transformants number was increased.
   Material and methods: In this article the gene ompP2 was transformed into different strains of H. influenzae mediated or not by graphene oxide nanoparticles in suspension, followed by the adhesion tests in Hec-1B (human endometrium adenocarcinoma) and A549 (pulmonary epithelial carcinoma) cells lines. The transformation frequency and the adhesion capacity were determined in all the mutants to which the ompP2 gene was transferred and compared to their wild type strains.
   Results: The nanoparticles increased the transformation ratio of one particular strain isolated from a pneumonia case. The adhesion patterns to A549 and Hec1b cell lines of these mutated bacteria has their capacity increased when compared to the wild type.
   Conclusions: Graphene oxide nanoparticles aid the transformation process, helping to increase the number of CFUs, and the mutants generated with the ompP2 gene from a H. influenzae resistant strain not only present a chloramphenicol resistance but also have an increased adherence patterns in A549 and Hec1B cell lines.
C1 [Varela, Julia Nogueira; Kraehenbuehl Amstalden, Maria Cecilia; Carneiro Pereira, Rafaella Fabiana; de Hollanda, Luciana Maria; Lancellotti, Marcelo] Univ Campinas UNICAMP, Inst Biol, Dept Biochem, LABIOTEC Biotechnol Lab, BR-13083970 Campinas, SP, Brazil.
   [Ceragioli, Helder Jose; Baranauskas, Vitor] Univ Campinas UNICAMP, Inst Biol, Dept Semicond Instruments & Photon, NanoEng NanoEngn & Diamond Lab,Sch Elect & Comp E, BR-13083852 Campinas, SP, Brazil.
RP Lancellotti, M (corresponding author), Univ Campinas UNICAMP, Inst Biol, Dept Biochem, LABIOTEC Biotechnol Lab, CP6109, BR-13083970 Campinas, SP, Brazil.
EM mlancell@unicamp.br
RI Nogueira Varela, Julia/O-4302-2016; Pereira, Rafaella F C/M-4418-2017;
   DE HOLLANDA, LUCIANA MARIA/F-7893-2011
OI Pereira, Rafaella F C/0000-0003-4928-7631; DE HOLLANDA, LUCIANA
   MARIA/0000-0002-6047-4043
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2011/14079-2, 2011/21685-6, 2012/15046-3]; CAPESCAPES
FX Thanks for FAPESP (Grants 2011/14079-2, 2011/21685-6 and 2012/15046-3)
   and CAPES (fellowship grants for Varela JN) for the financial support
   for the LABIOTEC.
CR Arbing MA, 2002, J MEMBRANE BIOL, V189, P131, DOI 10.1007/s00232-002-1008-6
   BABICH H, 1986, ARCH ENVIRON CON TOX, V15, P31, DOI 10.1007/BF01055246
   Bae S, 2010, ANTIMICROB AGENTS CH, V54, P65, DOI 10.1128/AAC.00966-09
   BARENKAMP SJ, 1981, J INFECT DIS, V143, P668, DOI 10.1093/infdis/143.5.668
   BENSON SA, 1988, J MOL BIOL, V203, P961, DOI 10.1016/0022-2836(88)90121-0
   Booy R, 1997, LANCET, V349, P1197, DOI 10.1016/S0140-6736(96)06392-1
   BORENFREUND E, 1984, CELL BIOL TOXICOL, V1, P55, DOI 10.1007/BF00125565
   BURNS JL, 1985, ANTIMICROB AGENTS CH, V27, P46, DOI 10.1128/AAC.27.1.46
   Cerquetti M, 2004, CLIN INFECT DIS, V38, P1041, DOI 10.1086/382083
   Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844
   Dimopoulou ID, 1997, J ANTIMICROB CHEMOTH, V39, P303, DOI 10.1093/jac/39.3.303
   DIMOPOULOU ID, 1992, J INFECT DIS, V165, P1069, DOI 10.1093/infdis/165.6.1069
   Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172
   Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998
   Gazagne L, 1998, J CLIN MICROBIOL, V36, P3629, DOI 10.1128/JCM.36.12.3629-3635.1998
   Gilsdorf JR, 2004, INFECT IMMUN, V72, P2457, DOI 10.1128/IAI.72.5.2457-2461.2004
   Hollanda LM, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-28
   Holt JG, 1994, BERGEYS MANUAL DETER, P175
   KONOWALCHUK J, 1977, INFECT IMMUN, V18, P775, DOI 10.1128/IAI.18.3.775-779.1977
   KROLL JS, 1991, J BACTERIOL, V173, P7449, DOI 10.1128/jb.173.23.7449-7457.1991
   Kroll JS, 1998, P NATL ACAD SCI USA, V95, P12381, DOI 10.1073/pnas.95.21.12381
   Leaves NI, 2000, J ANTIMICROB CHEMOTH, V45, P599, DOI 10.1093/jac/45.5.599
   Mattos IB, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-53
   Maughan H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005854
   Maughan H, 2009, EVOLUTION, V63, P1852, DOI 10.1111/j.1558-5646.2009.00658.x
   MURPHY TF, 1988, INFECT IMMUN, V56, P2673, DOI 10.1128/IAI.56.10.2673-2679.1988
   MURPHY TF, 1988, INFECT IMMUN, V56, P1084, DOI 10.1128/IAI.56.5.1084-1089.1988
   Pereira RFC AD, 2011, J BACTERIOL PARASITO, V2, P4
   Rahman M, 2008, J INFECTION, V56, P191, DOI 10.1016/j.jinf.2007.12.008
   Regelink AG, 1999, ANTIMICROB AGENTS CH, V43, P226, DOI 10.1128/AAC.43.2.226
   Ribeiro H, 2002, ESTUD AV-SAO PAULO, V16, P24
   Rojas-Chapana J, 2005, LAB CHIP, V5, P536, DOI 10.1039/b500681c
   Sambrook J., 1989, MOL CLONING LAB MANU
   SCALETSKY ICA, 1984, INFECT IMMUN, V45, P534, DOI 10.1128/IAI.45.2.534-536.1984
   Spence JM, 2000, INFECT IMMUN, V68, P5002, DOI 10.1128/IAI.68.9.5002-5010.2000
   Takahata S, 2007, ANTIMICROB AGENTS CH, V51, P1589, DOI 10.1128/AAC.01545-06
   TURK DC, 1984, J MED MICROBIOL, V18, P1, DOI 10.1099/00222615-18-1-1
   Wang SR, 2005, SCAND J INFECT DIS, V37, P921, DOI 10.1080/00365540500262492
   Wolf J, 2007, PAEDIATR RESPIR REV, V8, P204, DOI 10.1016/j.prrv.2007.08.002
   Wolf J, 2007, PAEDIATR RESPIR REV, V8, P212, DOI 10.1016/j.prrv.2007.07.004
   Yamanaka Noboru, 2008, Journal of Infection and Chemotherapy, V14, P180, DOI 10.1007/s10156-007-0599-3
   Zhao QQ, 2003, J NANOPART RES, V5, P567
NR 42
TC 10
Z9 11
U1 0
U2 18
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD APR 16
PY 2014
VL 12
AR 14
DI 10.1186/1477-3155-12-14
PG 9
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA AG5PM
UT WOS:000335470900001
PM 24739467
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU de Bettencourt-Dias, A
   Monteiro, JHSK
   Sigoli, FA
   de Hollanda, LM
   Machado, D
   Lancellotti, M
AF de Bettencourt-Dias, Ana
   Monteiro, Jorge H. S. K.
   Sigoli, Fernando A.
   de Hollanda, Luciana M.
   Machado, Daisy
   Lancellotti, Marcelo
TI Spectroscopy and cell studies of water-soluble lanthanide ion complexes
   with -NH2-bearing ligands
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 247th National Spring Meeting of the American-Chemical-Society (ACS)
CY MAR 16-20, 2014
CL Dallas, TX
SP Amer Chem Soc
C1 [de Bettencourt-Dias, Ana] Univ Nevada, Dept Chem, Reno, NV 89557 USA.
   [Monteiro, Jorge H. S. K.; Sigoli, Fernando A.] Univ Estadual Campinas, Dept Chem, BR-13083970 Sao Paulo, Brazil.
   [de Hollanda, Luciana M.; Machado, Daisy; Lancellotti, Marcelo] Univ Estadual Campinas, Dept Biol, BR-13083970 Sao Paulo, Brazil.
EM abd@unr.edu
RI Sigoli, Fernando A/AAA-6744-2019; de Bettencourt-Dias, Ana/J-4398-2019;
   Sigoli, Fernando A/C-5225-2012
OI de Bettencourt-Dias, Ana/0000-0001-5162-2393; 
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 16
PY 2014
VL 247
MA 491-INOR
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA AZ8HZ
UT WOS:000348457601571
DA 2020-11-30
ER

PT J
AU e Silva, IMP
   Profirio, DD
   de Paiva, REF
   Lancellotti, M
   Formiga, ALB
   Corbi, PP
AF Pereira e Silva, Irlene Maria
   Profirio, Daniel de Moraes
   Ferraz de Paiva, Raphael Enoque
   Lancellotti, Marcelo
   Barboza Formiga, Andre Luiz
   Corbi, Pedro Paulo
TI A silver complex with ibuprofen: Synthesis, solid state
   characterization, DFT calculations and antibacterial assays
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article
DE Ibuprofen; Silver; Solid-state NMR; Mass spectrometry; Theoretical
   calculations; Antibacterial agent
ID MOLECULAR-ORBITAL METHODS; GAUSSIAN-TYPE BASIS; ANTICANCER ACTIVITY;
   CRYSTAL-STRUCTURES; ORGANIC-MOLECULES; DENSITY; DRUGS; ACID;
   NANOPARTICLES; ACETATE
AB The present work describes the synthesis of a silver(I) complex with the non-steroidal anti-inflammatory ibuprofen, Ag-ibu. Elemental and thermal analyses indicate a 1:1 metal/ligand composition. Thermogravimetric analysis shows that Ag-ibu decomposition starts at 180 degrees C, and ends at 400 degrees C (mass loss 64.6%; calcd. 65.5%). UV/Vis kinetic measurements suggest the decomposition of Ag-ibu in dimethyl sulfoxide, with the appearance of a broad band in the spectrum of the complex in the range 300-500 nm. Infrared and solid state C-13 NMR spectra show the coordination of ibuprofen to silver through the carboxylate group. The DFT calculations led us to. propose a dimeric silver bridging structure for the complex. Biological studies show the antibacterial activity of the Ag-ibu complex against Gram-positive and Gram-negative bacterial strains, with MIC values ranging from 6.25 to 12.5 mu g mL(-1). (c) 2013 Elsevier B.V. All rights reserved.
C1 [Pereira e Silva, Irlene Maria; Profirio, Daniel de Moraes; Barboza Formiga, Andre Luiz] Univ Estadual Campinas, Inst Chem, Coordinat Chem Lab, BR-13083970 Campinas, SP, Brazil.
   [Ferraz de Paiva, Raphael Enoque; Corbi, Pedro Paulo] Univ Estadual Campinas, Bioinorgan & Med Chem Res Lab, BR-13083970 Campinas, SP, Brazil.
   [Lancellotti, Marcelo] Univ Estadual Campinas, Inst Biol, Biotechnol Lab, BR-13083970 Campinas, SP, Brazil.
RP Formiga, ALB (corresponding author), Univ Estadual Campinas, Inst Chem, Coordinat Chem Lab, POB 6154, BR-13083970 Campinas, SP, Brazil.
EM formiga@iqm.unicamp.br; pptorbi@iqm.unicamp.br
RI Corbi, Pedro P/B-7639-2012; Paiva, Raphael EF/B-7634-2012; Formiga,
   Andre/G-9755-2011
OI Corbi, Pedro P/0000-0002-7478-0877; Paiva, Raphael
   EF/0000-0003-2549-0344; Formiga, Andre/0000-0001-6773-8083
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/08230-2]; CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)National
   Council for Scientific and Technological Development (CNPq)
FX This study was supported by grants from FAPESP (Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo, proc. no. 2012/08230-2) and CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico).
   Professor Pedro P. Corbi and Andre L.B. Formiga are also grateful to
   Professor Carol H. Collins for English revision of the manuscript.
CR Andini S, 2012, CHEMOSPHERE, V88, P548, DOI 10.1016/j.chemosphere.2012.03.025
   Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010
   Azocar M.I., 2013, COMMUNICATIONS INORG, V1, P19
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Boys S.F., 1966, MOL SOLIDS, P253
   BOYS SF, 1960, REV MOD PHYS, V32, P296, DOI 10.1103/RevModPhys.32.296
   Clinical and Laboratory Standards Institute (CLSI), 2007, 17 INF SUPPL
   Coyle B, 2004, J INORG BIOCHEM, V98, P1361, DOI 10.1016/j.jinorgbio.2004.04.016
   Curran R, 2007, INORG CHEM COMMUN, V10, P1149, DOI 10.1016/j.inoche.2007.06.021
   DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902
   Etcheverry SB, 2002, J INORG BIOCHEM, V88, P94, DOI 10.1016/S0162-0134(01)00368-3
   Fiori ATM, 2011, INORG CHEM COMMUN, V14, P738, DOI 10.1016/j.inoche.2011.02.024
   FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267
   Greenhalgh DG, 2009, CLIN PLAST SURG, V36, P597, DOI 10.1016/j.cps.2009.05.011
   Grodzicki A, 2005, COORDIN CHEM REV, V249, P2232, DOI 10.1016/j.ccr.2005.05.026
   Hackenberg F, 2012, J ORGANOMET CHEM, V717, P123, DOI 10.1016/j.jorganchem.2012.07.006
   HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485
   HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI 10.1063/1.448975
   HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527
   Hindi KM, 2009, BIOMATERIALS, V30, P3771, DOI 10.1016/j.biomaterials.2009.03.044
   Horcajada P, 2006, ANGEW CHEM INT EDIT, V45, P5974, DOI 10.1002/anie.200601878
   Kafarska K, 2009, J THERM ANAL CALORIM, V96, P617, DOI 10.1007/s10973-008-9456-6
   Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4
   Lav P., 2007, [No title captured], Patent No. [WO 2007110755, 2007110755]
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Melaiye A, 2005, J AM CHEM SOC, V127, P2285, DOI 10.1021/ja040226s
   Nomiya K, 2002, J CHEM SOC DALTON, P2483, DOI 10.1039/b200684g
   Olson LP, 2006, CHEM MATER, V18, P1667, DOI 10.1021/cm052657v
   Palacios-Hernandez T.J., 2012, POLYHEDRON IN PRESS, DOI DOI 10.1016/J.P0LY.2012.07.030>(IN
   Puszynska-Tuszkanow M, 2011, J INORG BIOCHEM, V105, P17, DOI 10.1016/j.jinorgbio.2010.09.013
   Rafique S., 2010, BIOTECHNOLOGY MOL BI, V5, P38
   Ruan BF, 2009, J ORGANOMET CHEM, V694, P2883, DOI 10.1016/j.jorganchem.2009.04.020
   Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436
   SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112
   Scott AP, 1996, J PHYS CHEM-US, V100, P16502, DOI 10.1021/jp960976r
   Sun DF, 2004, INORG CHIM ACTA, V357, P991, DOI 10.1016/j.ica.2003.10.010
   Thati B, 2009, EUR J PHARMACOL, V602, P203, DOI 10.1016/j.ejphar.2008.11.020
   Tita B, 2011, REV CHIM-BUCHAREST, V62, P1060
   Valderrama P, 2011, CHEMOMETR INTELL LAB, V106, P160, DOI 10.1016/j.chemolab.2010.05.012
   Zordok WA, 2012, J COORD CHEM, V65, P353, DOI 10.1080/00958972.2011.654203
NR 40
TC 26
Z9 26
U1 1
U2 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2860
J9 J MOL STRUCT
JI J. Mol. Struct.
PD OCT 8
PY 2013
VL 1049
BP 1
EP 6
DI 10.1016/j.molstruc.2013.06.034
PG 6
WC Chemistry, Physical
SC Chemistry
GA 223DQ
UT WOS:000324784700001
DA 2020-11-30
ER

PT J
AU de Souza, AR
   Demonte, ALSSMD
   Costa, KD
   Faria, MAC
   Duraes-Carvalho, R
   Lancellotti, M
   Bonafe, CFS
AF de Souza, Ancelmo Rabelo
   Moreira da Costa Demonte, Ana Luisa Silva Sampaio
   Costa, Karina de Araujo
   Cardoso Faria, Mariana Alcantara
   Duraes-Carvalho, Ricardo
   Lancellotti, Marcelo
   Sampaio Bonafe, Carlos Francisco
TI Potentiation of high hydrostatic pressure inactivation of Mycobacterium
   by combination with physical and chemical conditions
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Mycobacteria; Mycobacterium abscessus; Pressure inactivation; Pressure
   sterilizing
ID TOBACCO-MOSAIC-VIRUS; RAPIDLY GROWING MYCOBACTERIA;
   LISTERIA-MONOCYTOGENES; LOW-TEMPERATURE; NONTUBERCULOUS MYCOBACTERIA;
   ABSCESSUS; DISSOCIATION; DEPENDENCE; PH; GLUTARALDEHYDE
AB Mycobacterium abscessus is an important hospital-acquired pathogen involved in infections associated with medical, surgical, and biopharmaceutical materials. In this work, we investigated the pressure-induced inactivation of two strains [2544 and American Type Culture Collection (ATCC) 19977] of M. abscessus in combination with different temperatures and pH conditions. For strain 2544, exposure to 250 MPa for 90 min did not significantly inactivate the bacteria at 20 A degrees C, whereas at -15 A degrees C, there was complete inactivation. Exposure to 250 MPa at a parts per thousand yen60 A degrees C caused rapid inactivation, with no viable bacteria after 45 min. With 45 min of exposure, there were no viable bacteria at any temperature when a higher pressure (350 MPa) was used. Extremes of pH (4 or 9) also markedly enhanced the pressure-induced inactivation of bacteria at 250 MPa, with complete inactivation after 45 min. In comparison, exposure of this strain to the disinfecting agent glutaraldehyde (0.5 %) resulted in total inactivation within 5 min. Strain 19977 was more sensitive to high pressure but less sensitive to glutaraldehyde than strain 2544. These results indicate that high hydrostatic pressure in combination with other physical parameters may be useful in reducing the mycobacterial contamination of medical materials and pharmaceuticals that are sensitive to autoclaving.
C1 [de Souza, Ancelmo Rabelo; Moreira da Costa Demonte, Ana Luisa Silva Sampaio; Costa, Karina de Araujo; Cardoso Faria, Mariana Alcantara; Duraes-Carvalho, Ricardo; Lancellotti, Marcelo; Sampaio Bonafe, Carlos Francisco] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Bioquim, BR-13083862 Sao Paulo, Brazil.
RP Bonafe, CFS (corresponding author), Univ Estadual Campinas UNICAMP, Inst Biol, Dept Bioquim, Rua Monteiro Lobato,255,Cidade Univ Zeferino Vaz, BR-13083862 Sao Paulo, Brazil.
EM bonafe@unicamp.br
RI Alcantara Cardoso Faria, Mariana/D-6096-2017
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX The authors thank Dr. Paulo P. Juazeiro for the electron microscopy
   analysis and helpful discussion and Stephen Hyslop for editing the
   English of the manuscript. We thank the Instituto Adolfo Lutz of
   Campinas for kindly providing M. abscessus. This work was supported by
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).
CR Bello T, 2006, ENFERM INFEC MICR CL, V24, P319, DOI 10.1157/13089667
   Bigata X, 2001, DERMATOL SURG, V27, P198, DOI 10.1046/j.1524-4725.2001.00020.x
   Bispo JAC, 2007, BIOPHYS CHEM, V125, P341, DOI 10.1016/j.bpc.2006.09.009
   Bonafe CFS, 1998, BIOCHEMISTRY-US, V37, P11097, DOI 10.1021/bi980349n
   Bonafe CFS, 2000, BIOCHEM BIOPH RES CO, V275, P955, DOI 10.1006/bbrc.2000.3402
   Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002
   Cooke RPD, 2003, J HOSP INFECT, V54, P226, DOI 10.1016/S0195-6701(03)00040-9
   Duraes-Carvalho R, 2012, J FOOD SCI, V77, pM417, DOI 10.1111/j.1750-3841.2012.02819.x
   Fonberg-Broczek M, 2005, ACTA BIOCHIM POL, V52, P721
   Fox LP, 2004, J AM ACAD DERMATOL, V50, P450, DOI 10.1016/j.jaad.2003.09.008
   GORMAN SP, 1980, J APPL BACTERIOL, V48, P161, DOI 10.1111/j.1365-2672.1980.tb01217.x
   Griffith DE, 2003, AM J RESP CRIT CARE, V167, P810, DOI 10.1164/rccm.2301001
   HASHIZUME C, 1995, BIOSCI BIOTECH BIOCH, V59, P1455, DOI 10.1271/bbb.59.1455
   Katoch VM, 2004, INDIAN J MED RES, V120, P290
   Le Dantec C, 2002, APPL ENVIRON MICROB, V68, P5318, DOI 10.1128/AEM.68.11.5318-5325.2002
   MACKEY BM, 1994, LETT APPL MICROBIOL, V19, P429, DOI 10.1111/j.1472-765X.1994.tb00973.x
   Masson Patrick, 2001, Journal of Biomedicine and Biotechnology, V1, P85, DOI 10.1155/S1110724301000158
   Mcgaw LJ, 2008, BIOL PHARM BULL, V31, P1429, DOI 10.1248/bpb.31.1429
   Medjahed H, 2010, TRENDS MICROBIOL, V18, P117, DOI 10.1016/j.tim.2009.12.007
   Molina-Gutierrez A, 2002, APPL ENVIRON MICROB, V68, P4399, DOI 10.1128/AEM.68.9.4399-4406.2002
   Moussa M, 2006, APPL ENVIRON MICROB, V72, P150, DOI 10.1128/AEM.72.1.150-156.2006
   Murillo J, 2000, ARCH DERMATOL, V136, P1347, DOI 10.1001/archderm.136.11.1347
   NEUMAN RC, 1973, J PHYS CHEM-US, V77, P2687, DOI 10.1021/j100640a025
   Petrini B, 2006, APMIS, V114, P319, DOI 10.1111/j.1600-0463.2006.apm_390.x
   Ponce E, 1999, FOOD MICROBIOL, V16, P357, DOI 10.1006/fmic.1998.0248
   PORTAELS F, 1982, ANN INST PASTEUR MIC, VB133, P213
   Rikimaru T, 2000, INT J TUBERC LUNG D, V4, P570
   Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660
   Ritz M, 2002, INT J FOOD MICROBIOL, V79, P47, DOI 10.1016/S0168-1605(02)00178-2
   Rivalain N, 2010, BIOTECHNOL ADV, V28, P659, DOI 10.1016/j.biotechadv.2010.04.001
   Rutala WA, 1998, AM J INFECT CONTROL, V26, P393, DOI 10.1016/S0196-6553(98)70034-3
   RUTALA WA, 1991, AM J MED, V91, pS267, DOI 10.1016/0002-9343(91)90380-G
   SALE AJH, 1970, J GEN MICROBIOL, V60, P323, DOI 10.1099/00221287-60-3-323
   Santos JLR, 2004, BIOPHYS CHEM, V111, P53, DOI 10.1016/j.bpc.2004.04.003
   Santos JLR, 2008, BIOPHYS CHEM, V134, P214, DOI 10.1016/j.bpc.2008.02.010
   SILVA JL, 1989, J BIOL CHEM, V264, P15863
   Sohn H, 2009, MICROB PATHOGENESIS, V47, P321, DOI 10.1016/j.micpath.2009.09.010
   Spilimbergo S, 2002, J SUPERCRIT FLUID, V22, P55, DOI 10.1016/S0896-8446(01)00106-1
   Stewart CM, 1997, J FOOD SAFETY, V17, P23, DOI 10.1111/j.1745-4565.1997.tb00173.x
   Sugimoto H, 2010, AURIS NASUS LARYNX, V37, P636, DOI 10.1016/j.anl.2010.01.010
   TAKAHASHI K, 1992, COLLOQ INSE, V224, P303
   Tholozan JL, 2000, J APPL MICROBIOL, V88, P202, DOI 10.1046/j.1365-2672.2000.00917.x
NR 42
TC 5
Z9 5
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD AUG
PY 2013
VL 97
IS 16
BP 7417
EP 7425
DI 10.1007/s00253-013-5067-7
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 191JB
UT WOS:000322408100033
PM 23836348
DA 2020-11-30
ER

PT J
AU Huber, PC
   Reis, GP
   Amstalden, MCK
   Lancellotti, M
   Almeida, WP
AF Huber, Paula C.
   Reis, Gabriella P.
   Amstalden, Maria C. K.
   Lancellotti, Marcelo
   Almeida, Wanda P.
TI Synthesis, spectroscopic characterizations and antimicrobial activity of
   copper and zinc complexes of levofloxacin, ciprofloxacin and
   3-carboxy-4-quinolone
SO POLYHEDRON
LA English
DT Article
DE Copper complexes; Zinc complexes; Quinolones; Antimicrobial activity
ID RAY STRUCTURAL-CHARACTERIZATION; ANTIBACTERIAL ACTIVITY
AB Copper and zinc complexes based on levofloxacin, ciprofloxacin and 3-carboxy-4-quinolone with molecular formula IM(C18H19FN3O4)(2)].2H(2)O, [M(C-17 H17FN3O3)(2)].2H(2)O and [M(C10H6NO3)].2H2O, respectively, were synthesized by the reaction of copper or zinc nitrate and the corresponding ligand. Complexes were not obtained as single crystals. Infrared spectroscopy, high resolution mass spectrometry and thermogravimetric analysis are also performed. Except in the case of copper complexes, H-1 and C-13 NMR spectra were obtained. Antimicrobial activity of complexes and their ligands are carried out against a panel of microorganism from ATCC cultures and strains from clinical isolate were also included. All complexes showed moderate to good antimicrobial activity depending on the concentration. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Huber, Paula C.; Reis, Gabriella P.; Almeida, Wanda P.] Univ Estadual Campinas, Inst Chem, Lab Drug Design, BR-13083970 Campinas, SP, Brazil.
   [Amstalden, Maria C. K.; Lancellotti, Marcelo] Univ Estadual Campinas, Inst Biol, Biotechnol Lab, BR-13083970 Campinas, SP, Brazil.
RP Almeida, WP (corresponding author), Univ Estadual Campinas, Inst Chem, Lab Drug Design, POB 6154, BR-13083970 Campinas, SP, Brazil.
EM wanda@iqm.unicamp.br
RI Almeida, Wanda P/K-2009-2012; Almeida, Waldemar S/N-4641-2015
OI Almeida, Waldemar S/0000-0002-7382-8373; Almeida, Wanda
   Pereira/0000-0002-7154-4668
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2010/20861-2, 2011/21693-9]; Brazilian Research National Council (CNPq)
   for research fellowshipNational Council for Scientific and Technological
   Development (CNPq)
FX This project was supported by FAPESP (2010/20861-2, 2011/21693-9). Wanda
   P. Almeida thanks Brazilian Research National Council (CNPq) for
   research fellowship. Authors are grateful to Michael Joseph Smart and
   Jonathan Bradnick for helpful suggestions concerning English grammar and
   style.
CR Amarante GW, 2010, TETRAHEDRON, V66, P4370, DOI 10.1016/j.tet.2010.04.018
   Anacona JR, 2001, TRANSIT METAL CHEM, V26, P228, DOI 10.1023/A:1007154817081
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Buchtik R, 2012, J INORG BIOCHEM, V116, P163, DOI 10.1016/j.jinorgbio.2012.07.009
   Chohan ZH, 2005, J ENZYM INHIB MED CH, V20, P303, DOI 10.1080/14756360310001624948
   Costa GSM, 2012, POLYHEDRON, V34, P210, DOI 10.1016/j.poly.2012.01.002
   de Lima MRF, 2006, J ETHNOPHARMACOL, V105, P137, DOI 10.1016/j.jep.2005.10.026
   Drevensek P, 2006, J INORG BIOCHEM, V100, P1755, DOI 10.1016/j.jinorgbio.2006.06.011
   Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k
   Fleck M, 2012, POLYHEDRON, V34, P157, DOI 10.1016/j.poly.2011.12.019
   Gaeta A, 2005, BRIT J PHARMACOL, V146, P1041, DOI 10.1038/sj.bjp.0706416
   Hackenberg F, 2012, J ORGANOMET CHEM, V717, P123, DOI 10.1016/j.jorganchem.2012.07.006
   Ma ZY, 2012, J INORG BIOCHEM, V117, P1, DOI 10.1016/j.jinorgbio.2012.08.007
   Mazur L, 2012, J INORG BIOCHEM, V114, P55, DOI 10.1016/j.jinorgbio.2012.04.021
   Novak K.T., 1996, J PHARM BIOMED ANAL, V14, P1405
   Patel M. N., 2008, PHARM CHEM J, V42, P687, DOI [10.1007/s11094-009-0214-2, DOI 10.1007/S11094-009-0214-2]
   Patel MN, 2012, POLYHEDRON, V40, P159, DOI 10.1016/j.poly.2012.03.050
   Rojas G, 2001, J ETHNOPHARMACOL, V74, P97, DOI 10.1016/S0378-8741(00)00349-4
   Sousa I, 2012, J INORG BIOCHEM, V110, P64, DOI 10.1016/j.jinorgbio.2012.02.003
   TAKACSNOVAK K, 1992, INT J PHARM, V79, P89, DOI 10.1016/0378-5173(92)90099-N
   Talancon D, 2013, J INORG BIOCHEM, V118, P1, DOI 10.1016/j.jinorgbio.2012.09.007
   Tan KW, 2012, POLYHEDRON, V38, P275, DOI 10.1016/j.poly.2012.03.014
   Tavares TT, 2012, J INORG BIOCHEM, V115, P13, DOI 10.1016/j.jinorgbio.2012.05.007
   Vranec P, 2012, POLYHEDRON, V39, P118, DOI 10.1016/j.poly.2012.03.046
   WALLIS SC, 1995, POLYHEDRON, V14, P2835, DOI 10.1016/0277-5387(95)00219-I
   Wallis SC, 1996, J INORG BIOCHEM, V62, P1, DOI 10.1016/0162-0134(95)00082-8
   Yang W, 2012, J INORG BIOCHEM, V116, P97, DOI 10.1016/j.jinorgbio.2012.08.001
NR 27
TC 14
Z9 15
U1 1
U2 36
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-5387
J9 POLYHEDRON
JI Polyhedron
PD JUL 2
PY 2013
VL 57
BP 14
EP 19
DI 10.1016/j.poly.2013.04.007
PG 6
WC Chemistry, Inorganic & Nuclear; Crystallography
SC Chemistry; Crystallography
GA 164NN
UT WOS:000320416900002
DA 2020-11-30
ER

PT J
AU Abbehausen, C
   Sucena, SF
   Lancellotti, M
   Heinrich, TA
   Abrao, EP
   Costa-Neto, CM
   Formiga, ALB
   Corbi, PP
AF Abbehausen, Camilla
   Sucena, Suelen F.
   Lancellotti, Marcelo
   Heinrich, Tassiele A.
   Abrao, Emiliana P.
   Costa-Neto, Claudio M.
   Formiga, Andre L. B.
   Corbi, Pedro P.
TI Synthesis, spectroscopic characterization, DFT studies, and
   antibacterial and antitumor activities of a novel water soluble Pd(II)
   complex with L-alliin
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article
DE Pd(II); L-alliin; Infrared; NMR; Antibacterial agent; Antitumor activity
ID MOLECULAR-ORBITAL METHODS; GAUSSIAN-TYPE BASIS; PALLADIUM(II) COMPLEX;
   STRUCTURAL-CHARACTERIZATION; PLATINUM(II); ASSAYS; CYSTEINE; ALLICIN
AB A new water soluble Pd(II) complex with L-alliin (S-allyl-L-cysteine sulfoxide) was obtained and characterized by a set of chemical and spectroscopic measurements. Elemental and mass spectrometric data are consistent with the formula [Pd(C6H10NO3S)(2)]. The H-1 and C-13 nuclear magnetic resonance (NMR) data, [H-1-N-15] two dimensional (2D) NMR and infrared spectroscopic measurements indicate coordination of the ligand to Pd(II) through N and O atoms. DFT studies showed that the trans isomer is the most stable and preferred geometry for the complex. The complex is soluble in water and dimethylsulfoxide. An anti-biogram assay revealed that the complex possess antibacterial activity against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus bacterial strains in the range 125-500 mu g mL(-1). Antitumor assays revealed that the complex presents cytotoxic activity over HeLa cells with an estimated IC50 of 20 mu mol L-1. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Abbehausen, Camilla; Sucena, Suelen F.; Corbi, Pedro P.] Univ Estadual Campinas, UNICAMP, Inst Chem, Bioinorgan & Med Chem Res Lab,LIQI, BR-13083970 Campinas, SP, Brazil.
   [Lancellotti, Marcelo] Univ Estadual Campinas, UNICAMP, Inst Biol, Biotechnol Lab, BR-13083970 Campinas, SP, Brazil.
   [Formiga, Andre L. B.] Univ Estadual Campinas, Inst Chem, Coordinat Chem Lab, LIQI, BR-13083970 Campinas, SP, Brazil.
   [Heinrich, Tassiele A.; Abrao, Emiliana P.; Costa-Neto, Claudio M.] Univ Sao Paulo, USP, Sch Med Ribeirao Preto, Dept Biochem & Immunol, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Abbehausen, C (corresponding author), Univ Estadual Campinas, UNICAMP, Inst Chem, Bioinorgan & Med Chem Res Lab,LIQI, POB 6154, BR-13083970 Campinas, SP, Brazil.
EM camilla.abb@gmail.com; ppcorbi@iqm.unicamp.br
RI Abbehausen, Camilla/AAA-7975-2019; Costa-Neto, Claudio M/K-7291-2015;
   Abbehausen, Camilla/AAD-3050-2020; Abbehausen, Camilla/X-9527-2019;
   Corbi, Pedro P/B-7639-2012; Formiga, Andre/G-9755-2011
OI Costa-Neto, Claudio M/0000-0002-7256-6412; Abbehausen,
   Camilla/0000-0002-8410-2252; Corbi, Pedro P/0000-0002-7478-0877;
   Formiga, Andre/0000-0001-6773-8083
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [Proc. 2012/08230-2]; CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX This study was supported by grants from FAPESP (Proc. 2012/08230-2) and
   CNPq (Brazilian agencies). The authors are also grateful to Professor
   Carol H. Collins for the English revision of the manuscript.
CR Abbehausen C, 2011, POLYHEDRON, V30, P2354, DOI 10.1016/j.poly.2011.06.021
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Bergamini FRG, 2011, J COORD CHEM, V64, P3092, DOI 10.1080/00958972.2011.613463
   Budige G, 2011, CHEM PHARM BULL, V59, P166, DOI 10.1248/cpb.59.166
   Carvalho MA, 2012, J COORD CHEM, V65, P1700, DOI 10.1080/00958972.2012.679660
   Carvalho MA, 2013, J MOL STRUCT, V1031, P125, DOI 10.1016/j.molstruc.2012.07.044
   Cavallito CJ, 1944, SCIENCE, V100, P390, DOI 10.1126/science.100.2600.390
   Cavallito CJ, 1944, J AM CHEM SOC, V66, P1950, DOI 10.1021/ja01239a048
   *CLIN LAB STAND I, 2007, PERF STAND ANT SUS S
   Corbi PP, 2008, J COORD CHEM, V61, P2470, DOI 10.1080/00958970801930005
   Corbi PP, 2007, SPECTROCHIM ACTA A, V66, P1171, DOI 10.1016/j.saa.2006.06.003
   Corbi PP, 2005, CAN J CHEM, V83, P104, DOI 10.1139/V05-003
   Corbi PP, 2000, RUSS J COORD CHEM+, V26, P28
   DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902
   Farrell N, 2002, COORDIN CHEM REV, V232, P1, DOI 10.1016/S0010-8545(02)00100-5
   Fernandez JJ, 2007, EUR J INORG CHEM, P5408, DOI 10.1002/ejic.200700478
   FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267
   Gao EJ, 2009, ANTI-CANCER AGENT ME, V9, P356, DOI 10.2174/1871520610909030356
   Garoufis A, 2009, COORDIN CHEM REV, V253, P1384, DOI 10.1016/j.ccr.2008.09.011
   Ghani NTA, 2011, INORG CHIM ACTA, V373, P249, DOI 10.1016/j.ica.2011.04.036
   Guerra W, 2005, J INORG BIOCHEM, V99, P2348, DOI 10.1016/j.jinorgbio.2005.09.001
   HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485
   Harris JC, 2001, APPL MICROBIOL BIOT, V57, P282, DOI 10.1007/s002530100722
   HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI 10.1063/1.448975
   HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527
   Heinrich TA, 2011, EUR J MED CHEM, V46, P3616, DOI 10.1016/j.ejmech.2011.04.064
   Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j
   Juribasic M, 2011, J INORG BIOCHEM, V105, P867, DOI 10.1016/j.jinorgbio.2011.03.011
   Kazachenko A.S., 2000, PHARM CHEM J, V34, P257, DOI DOI 10.1007/BF02524634
   Kubec R, 1997, J AGR FOOD CHEM, V45, P3580, DOI 10.1021/jf970071q
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Lopez C, 2006, EUR J INORG CHEM, P3974, DOI 10.1002/ejic.200600179
   Macchioni A, 2002, INORG CHEM COMMUN, V5, P319, DOI 10.1016/S1387-7003(02)00391-X
   Massabni AC, 2004, J COORD CHEM, V57, P1225, DOI 10.1080/00958970412331285904
   Minghetti G, 1998, J CHEM SOC DALTON, P4119, DOI 10.1039/a805842c
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nakamoto K., 1997, INFRARED RAMAN SPECT
   Padilla-Camberos E, 2010, ASIAN PAC J CANCER P, V11, P1241
   Salman H, 1999, INT J IMMUNOPHARMACO, V21, P589, DOI 10.1016/S0192-0561(99)00038-7
   SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112
   Spera MBM, 2011, SPECTROCHIM ACTA A, V78, P313, DOI 10.1016/j.saa.2010.10.012
   THEODOROU V, 1985, POLYHEDRON, V4, P1283, DOI 10.1016/S0277-5387(00)84120-0
NR 43
TC 9
Z9 12
U1 0
U2 46
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-2860
EI 1872-8014
J9 J MOL STRUCT
JI J. Mol. Struct.
PD MAR 13
PY 2013
VL 1035
BP 421
EP 426
DI 10.1016/j.molstruc.2012.11.065
PG 6
WC Chemistry, Physical
SC Chemistry
GA 095DS
UT WOS:000315315500056
DA 2020-11-30
ER

PT J
AU Huancahuire-Vega, S
   Correa, DHA
   Hollanda, LM
   Lancellotti, M
   Ramos, CHI
   Ponce-Soto, LA
   Marangoni, S
AF Huancahuire-Vega, Salomon
   Correa, Daniel H. A.
   Hollanda, Luciana M.
   Lancellotti, Marcelo
   Ramos, Carlos H. I.
   Ponce-Soto, Luis Alberto
   Marangoni, Sergio
TI Chemical Modi cations of PhTX-I Myoto in from Porthidium hyoprora Snake
   Venom: Effects on Structural, Enzymatic, and Pharmacological Properties
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID PHOSPHOLIPASE A(2) HOMOLOG; BOTHROPS-ASPER; FUNCTIONAL-CHARACTERIZATION;
   TERMINAL REGION; MECHANISM; TOXICITY; RAT; SUSCEPTIBILITY; DISSOCIATION;
   TOXINS
AB We recently described the isolation of a basic PLA2 (PhTX-I) from Porthidium hyoprora snake venom.. is toxin exhibits high catalytic activity, induces in vivo myotoxicity, moderates footpad edema, and causes in vitro neuromuscular blockade. Here, we describe the chemical modifications of specific amino acid residues (His, Tyr, Lys, and Trp), performed in PhTX-I, to study their effects on the structural, enzymatic, and pharmacological properties of this myotoxin. After chemical treatment, a single His, 4 Tyr, 7 Lys, and one Trp residues were modified. The secondary structure of the protein remained unchanged as measured by circular dichroism; however other results indicated the critical role played by Lys and Tyr residues in myotoxic, neurotoxic activities and mainly in the cytotoxicity displayed by PhTX-I. His residue and therefore catalytic activity of PhTX-I are relevant for edematogenic, neurotoxic, and myotoxic effects, but not for its cytotoxic activity. This dissociation observed between enzymatic activity and some pharmacological effects suggests that other molecular regions distinct from the catalytic site may also play a role in the toxic activities exerted by this myotoxin. Our observations supported the hypothesis that both the catalytic sites as the hypothetical pharmacological sites are relevant to the pharmacological profile of PhTX-I.
C1 [Huancahuire-Vega, Salomon; Ponce-Soto, Luis Alberto; Marangoni, Sergio] State Univ Campinas UNICAMP, Dept Biochem, Inst Biol, BR-13083970 Campinas, SP, Brazil.
   [Correa, Daniel H. A.; Ramos, Carlos H. I.] Univ Campinas UNICAMP, Dept Organ Chem, Inst Chem, Campinas, SP, Brazil.
   [Hollanda, Luciana M.; Lancellotti, Marcelo] Univ Campinas UNICAMP, Biotechnol Lab LABIOTEC, Dept Biochem, Inst Biol, Campinas, SP, Brazil.
   [Ramos, Carlos H. I.] Natl Inst Sci & Technol Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
RP Ponce-Soto, LA (corresponding author), State Univ Campinas UNICAMP, Dept Biochem, Inst Biol, POB 6109, BR-13083970 Campinas, SP, Brazil.
EM poncesoto@yahoo.com.ar
RI Ponce-Soto, Luis Alberto/I-3656-2019; Ponce-Soto, Luis
   Alberto/B-1328-2017; Huancahuire-Vega, Salomon/E-8803-2019; Ramos,
   CH/C-1571-2012; DE HOLLANDA, LUCIANA MARIA/F-7893-2011; Ponce-Soto, Luis
   Alberto/S-5469-2016
OI Ponce-Soto, Luis Alberto/0000-0001-5976-2913; Ponce-Soto, Luis
   Alberto/0000-0001-5976-2913; Ramos, CH/0000-0002-7246-9081; DE HOLLANDA,
   LUCIANA MARIA/0000-0002-6047-4043; Ponce-Soto, Luis
   Alberto/0000-0001-5976-2913; Huancahuire-Vega,
   Salomon/0000-0002-4848-4767
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [09/51207-9]; Mass spectrometry Laboratory at Brazilian Biosciences
   National laboratory, CNPEM-ABTLUS, Campinas, Brazil
FX The authors acknowledge the Mass spectrometry Laboratory at Brazilian
   Biosciences National laboratory, CNPEM-ABTLUS, Campinas, Brazil, for
   their support with the mass spectrometric analyses. They also thank Mr.
   Paulo A. Baldasso for general technical assistance. This work was
   supported by FAPESP (Process 09/51207-9) and is part of Ph.D. thesis by
   S. Huancahuire-Vega.
CR Andriao-Escarso SH, 2000, BIOCHIMIE, V82, P755, DOI 10.1016/S0300-9084(00)01150-0
   Angulo Y, 2005, CELL BIOCHEM FUNCT, V23, P307, DOI 10.1002/cbf.1208
   Araya C, 2007, CELL BIOL INT, V31, P263, DOI 10.1016/j.cellbi.2006.11.007
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   Atanasov VN, 2009, BIOCHEMISTRY-MOSCOW+, V74, P276, DOI 10.1134/S0006297909030055
   Bazaa A, 2009, MATRIX BIOL, V28, P188, DOI 10.1016/j.matbio.2009.03.007
   Beghini DG, 2000, J PROTEIN CHEM, V19, P679, DOI 10.1023/A:1007152303179
   Bonfim VL, 2001, J PROTEIN CHEM, V20, P239, DOI 10.1023/A:1010956126585
   BORENFREUND E, 1984, CELL BIOL TOXICOL, V1, P55, DOI 10.1007/BF00125565
   CHO WH, 1991, METHOD ENZYMOL, V197, P75
   CICALA C, 1993, GEN PHARMACOL-VASC S, V24, P1197, DOI 10.1016/0306-3623(93)90368-8
   Cintra-Francischinelli M, 2010, TOXICON, V55, P590, DOI 10.1016/j.toxicon.2009.10.013
   Correa DHA, 2009, J BIOCH, V3, P164, DOI DOI 10.1038/NPR0T.2006.204
   Costa TR, 2008, PEPTIDES, V29, P1645, DOI 10.1016/j.peptides.2008.05.021
   Cummings J, 2008, MOL CANCER THER, V7, P455, DOI 10.1158/1535-7163.MCT-07-2136
   DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6
   Diz EBS, 2009, TOXICON, V53, P104, DOI 10.1016/j.toxicon.2008.10.021
   Ferreira T, 2009, TOXICON, V53, P69, DOI 10.1016/j.toxicon.2008.10.016
   Francis BR, 1997, TOXICON, V35, P1193, DOI 10.1016/S0041-0101(97)00031-7
   Gebrim LC, 2009, BIOLOGICALS, V37, P222, DOI 10.1016/j.biologicals.2009.01.010
   Gutierrez JM, 2008, TOXICON, V51, P80, DOI 10.1016/j.toxicon.2007.08.007
   HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5
   Holzer M, 1996, TOXICON, V34, P1149, DOI 10.1016/0041-0101(96)00057-8
   Huancahuire-Vega S., 2011, COMP BIOCH PHYSL C, V29, P103
   Huancahuire-Vega S, 2009, TOXICON, V54, P818, DOI 10.1016/j.toxicon.2009.06.008
   HUANG MZ, 1993, TOXICON, V31, P627, DOI 10.1016/0041-0101(93)90117-2
   Jenkins CM, 2009, CARDIOVASC RES, V82, P240, DOI 10.1093/cvr/cvn346
   Jensen LB, 2005, BIOPHYS J, V88, P2692, DOI 10.1529/biophysj.104.056457
   Kao PH, 2008, J PEPT SCI, V14, P342, DOI 10.1002/psc.943
   Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002
   Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008
   Lomonte B, 2009, PROTEIN PEPTIDE LETT, V16, P860, DOI 10.2174/092986609788923356
   Panini SR, 2001, J LIPID RES, V42, P1678
   Petan T, 2007, BIOCHEMISTRY-US, V46, P12795, DOI 10.1021/bi701304e
   Ponce-Soto LA, 2010, PROTEIN J, V29, P103, DOI 10.1007/s10930-010-9229-5
   Ponce-Soto LA, 2007, BBA-GEN SUBJECTS, V1770, P585, DOI 10.1016/j.bbagen.2006.11.015
   Pungercar J, 2007, TOXICON, V50, P871, DOI 10.1016/j.toxicon.2007.07.025
   Rangel J, 2011, CELL BIOCHEM FUNCT, V29, P365, DOI 10.1002/cbf.1758
   Romero-Vargas FF, 2010, COMP BIOCHEM PHYS C, V151, P66, DOI 10.1016/j.cbpc.2009.08.011
   ROSENBERG P, 1989, TOXICON, V27, P137, DOI 10.1016/0041-0101(89)90128-1
   Rudrammaji LMS, 2001, MOL CELL BIOCHEM, V219, P39, DOI 10.1023/A:1011002606505
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SHINA R, 1990, BIOCHEM PHARMACOL, V40, P2233, DOI 10.1016/0006-2952(90)90717-Y
   Soares AM, 2000, ARCH BIOCHEM BIOPHYS, V378, P201, DOI 10.1006/abbi.2000.1790
   Soares AM, 2003, TOXICON, V42, P855, DOI 10.1016/j.toxicon.2003.11.004
   Soares AM, 2004, INT J BIOCHEM CELL B, V36, P258, DOI 10.1016/S1357-2725(03)00237-1
   Soares AM, 2001, ARCH BIOCHEM BIOPHYS, V387, P188, DOI 10.1006/abbi.2000.2244
   SOONS KR, 1986, TOXICON, V24, P679, DOI 10.1016/0041-0101(86)90031-0
   Stabeli RG, 2006, COMP BIOCHEM PHYS C, V142, P371, DOI 10.1016/j.cbpc.2005.11.020
   TAKASAKI C, 1990, TOXICON, V28, P107, DOI 10.1016/0041-0101(90)90012-V
   Teixeira C, 2009, TOXICON, V54, P988, DOI 10.1016/j.toxicon.2009.05.026
   Teixeira CFP, 2003, TOXICON, V42, P947, DOI 10.1016/j.toxicon.2003.11.006
   Toyama DD, 2011, TOXICON, V57, P851, DOI 10.1016/j.toxicon.2011.02.024
   VISHWANATH BS, 1987, TOXICON, V25, P501
   Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2
   YANG CC, 1991, BIOCHEM J, V280, P739, DOI 10.1042/bj2800739
   Yang CC, 1997, VENOM PHOSPHOLIPASE, P185
   Zhao HY, 1998, TOXICON, V36, P875, DOI 10.1016/S0041-0101(97)00169-4
   Zuliani JP, 2005, TOXICON, V45, P335, DOI 10.1016/j.toxicon.2004.11.004
NR 60
TC 5
Z9 5
U1 0
U2 9
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
VL 2013
AR 103494
DI 10.1155/2013/103494
PG 12
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 072PI
UT WOS:000313684300001
PM 23484072
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Sucena, SF
   Paiva, REF
   Abbehausen, C
   Mattos, IB
   Lancellotti, M
   Formiga, ALB
   Corbi, PP
AF Sucena, Suelen F.
   Paiva, Raphael E. F.
   Abbehausen, Camilla
   Mattos, Ives B.
   Lancellotti, Marcelo
   Formiga, Andre L. B.
   Corbi, Pedro P.
TI Chemical, spectroscopic characterization, DFT studies and antibacterial
   activities in vitro of a new gold(I) complex with rimantadine
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
DE Gold(I); Rimantadine; Infrared; NMR spectroscopy; DFT studies;
   Antibacterial assay
ID MOLECULAR-ORBITAL METHODS; SILVER
AB A novel gold(I) complex with rimantadine (RTD) was obtained and structurally characterized by a set of chemical and spectroscopic analysis. H-1, C-13 and N-15 nuclear magnetic resonance (NMR) and infrared (IR) spectroscopic measurements suggest coordination of the ligand to Au(I) through the N atom of the ethanamine group. Theoretical (DFT) calculations confirmed the IR assignments and permit proposing an optimized geometry for the complex. The gold(I)-rimantadine complex (Au-RTD) is soluble in methanol, ethanol, dimethylsulfoxide, acetone and acetonitrile. The preliminary kinetic studies based on UV-vis spectroscopic measurements indicate the stability of the compound in solution. Antibacterial activities of the complex were evaluated by an antibiogram assay. The Au-RTD complex showed an effective in vitro antibacterial activity against the Pseudomonas aeruginosa, Escherichia coli (Gram-negative), and Staphylococcus aureus (Gram-positive) bacterial strains. (C) 2011 Elsevier BM. All rights reserved.
C1 [Sucena, Suelen F.; Paiva, Raphael E. F.; Abbehausen, Camilla; Corbi, Pedro P.] Univ Campinas UNICAMP, Inst Chem, Bioinorgan & Med Chem Res Lab, BR-13083970 Sao Paulo, Brazil.
   [Mattos, Ives B.; Lancellotti, Marcelo] Univ Campinas UNICAMP, Inst Biol, Biotechnol Lab, BR-13083970 Sao Paulo, Brazil.
   [Formiga, Andre L. B.] Univ Campinas UNICAMP, Inst Chem, Coordinat Chem Lab, BR-13083970 Sao Paulo, Brazil.
RP Corbi, PP (corresponding author), Univ Campinas UNICAMP, Inst Chem, Bioinorgan & Med Chem Res Lab, POB 6154, BR-13083970 Sao Paulo, Brazil.
EM pedrocorbi@yahoo.com
RI Abbehausen, Camilla/AAD-3050-2020; Corbi, Pedro P/B-7639-2012;
   Abbehausen, Camilla/X-9527-2019; Abbehausen, Camilla/AAA-7975-2019;
   Paiva, Raphael EF/B-7634-2012; Formiga, Andre/G-9755-2011
OI Abbehausen, Camilla/0000-0002-8410-2252; Corbi, Pedro
   P/0000-0002-7478-0877; Paiva, Raphael EF/0000-0003-2549-0344; Formiga,
   Andre/0000-0001-6773-8083
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2006/55367-2, 2008/56777-5]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [575313/2008-0, 472768/2010-3]
FX This study was supported by grants from FAPESP (2006/55367-2,
   2008/56777-5) and CNPq (575313/2008-0 and 472768/2010-3). Authors are
   also grateful to Professor Carol H. Collins for English revision of the
   manuscript.
CR Abbehausen C, 2011, POLYHEDRON, V30, P2354, DOI 10.1016/j.poly.2011.06.021
   [Anonymous], 1997, 040784 JCPDSICDD
   Bakhtiar R, 1999, GEN PHARMACOL-VASC S, V32, P525, DOI 10.1016/S0306-3623(98)00223-7
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Bonacin JA, 2007, VIB SPECTROSC, V44, P133, DOI 10.1016/j.vibspec.2006.10.007
   Cady SD, 2011, J AM CHEM SOC, V133, P4274, DOI 10.1021/ja102581n
   Canumalla AJ, 2001, J INORG BIOCHEM, V85, P67, DOI 10.1016/S0162-0134(00)00224-5
   Clinical and Laboratory Standards Institute (CLSI), 2007, PERF STAND ANT S S17
   Corbi PP, 2007, SPECTROCHIM ACTA A, V66, P1171, DOI 10.1016/j.saa.2006.06.003
   Corbi PP, 2006, SPECTROCHIM ACTA A, V64, P418, DOI 10.1016/j.saa.2005.07.039
   de Gracia CG, 2001, BURNS, V27, P67, DOI 10.1016/S0305-4179(00)00061-9
   DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902
   Farrell N, 2002, COORDIN CHEM REV, V232, P1, DOI 10.1016/S0010-8545(02)00100-5
   Fiori ATM, 2011, INORG CHEM COMMUN, V14, P738, DOI 10.1016/j.inoche.2011.02.024
   FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267
   HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485
   HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI 10.1063/1.448975
   HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527
   Jakupec MA, 2008, DALTON T, P183, DOI 10.1039/b712656p
   Klasen HJ, 2000, BURNS, V26, P131, DOI 10.1016/S0305-4179(99)00116-3
   Kristopher K.J., 2009, INORG CHEM, V48, P2316
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Luzinova Y, 2009, ORG GEOCHEM, V40, P1143, DOI 10.1016/j.orggeochem.2009.07.015
   Marques LL, 2007, INORG CHEM COMMUN, V10, P1083, DOI 10.1016/j.inoche.2007.06.005
   Nakamoto K., 1997, INFRARED RAMAN SPE B
   Noguchi R, 2006, INORG CHEM COMMUN, V9, P355, DOI 10.1016/j.inoche.2006.01.001
   Nomiya K., 2002, DALTON T, V12, P2483
   Ray S, 2007, J AM CHEM SOC, V129, P15042, DOI 10.1021/ja075889z
   ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0
   Sadler P J, 1994, Met Based Drugs, V1, P107, DOI 10.1155/MBD.1994.107
   SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112
   Silverstein R.M., 2005, SPECTROMETRIC IDENTI
   THURMAN RB, 1988, CRIT REV ENV CONTR, V18, P295
NR 33
TC 6
Z9 7
U1 0
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
EI 1879-2731
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD APR
PY 2012
VL 89
BP 114
EP 118
DI 10.1016/j.saa.2011.12.043
PG 5
WC Spectroscopy
SC Spectroscopy
GA 908DW
UT WOS:000301471600017
PM 22257715
DA 2020-11-30
ER

PT J
AU Bergamini, FRG
   Ferreira, MA
   de Paiva, REF
   Gomes, AF
   Gozzo, FC
   Formiga, ALB
   Corbi, FCA
   Mazali, IO
   Alves, DA
   Lancellotti, M
   Corbi, PP
AF Goulart Bergamini, Fernando Rodrigues
   Ferreira, Marcos Antonio, Jr.
   Ferraz de Paiva, Raphael Enoque
   Gomes, Alexandre Ferreira
   Gozzo, Fabio Cesar
   Barboza Formiga, Andre Luiz
   Andrade Corbi, Fabiana Cristina
   Mazali, Italo Odone
   Alves, Danilo Antonini
   Lancellotti, Marcelo
   Corbi, Pedro Paulo
TI A binuclear silver complex with L-buthionine sulfoximine: synthesis,
   spectroscopic characterization, DFT studies and antibacterial assays
SO RSC ADVANCES
LA English
DT Article
ID MOLECULAR-ORBITAL METHODS; BURN WOUND INFECTIONS; GAUSSIAN-TYPE BASIS;
   METAL-COMPLEXES; HOMOCYSTEINE SULFOXIMINE; RESISTANT-BACTERIA;
   ORGANIC-MOLECULES; GLUTATHIONE; ACID; SULFADIAZINE
AB A binuclear silver(I) complex with the amino acid L-buthionine sulfoximine (BSO) of composition Ag2C8H16N2O3S was synthesized and characterized by chemical and spectroscopic measurements, and DFT (density functional theory) studies. Solid-state C-13 nuclear magnetic resonance (SSNMR) and infrared vibrational spectroscopy (IR) analyses indicate the coordination of the nitrogen and carboxylate groups of the amino acid moiety to one of the silver atoms, while coordination to the second silver atom occurs through the nitrogen of the sulfoximine group. ESI-QTOF-MS measurements show the maintenance of the binuclear structure in solution. DFT studies confirm the proposed structure as a minimum of the potential energy surface (PES) with calculations of the hessians showing no imaginary frequencies. Raman spectroscopic measurements of the [Ag-2(BSO)] complex led to the assignments of the Ag-N bonds. Biological assays of BSO and [ Ag2(BSO)] were performed by the well-diffusion method over Staphyloccocus aureus (Gram-positive), Escherichia coli and Pseudomonas aeruginosa (Gram-negative) bacterial strains. The ligand was inactive under the tested concentration (100 mu g mL(-1)). The [Ag-2(BSO)] complex was active against the Gram-negative and Gram-positive bacteria tested, with MIC values of 3.125 mu g mL(-1).
C1 [Goulart Bergamini, Fernando Rodrigues; Ferreira, Marcos Antonio, Jr.; Ferraz de Paiva, Raphael Enoque; Corbi, Pedro Paulo] Univ Estadual Campinas, UNICAMP, Bioinorgan & Med Chem Res Lab, Inst Chem, BR-13083970 Campinas, SP, Brazil.
   [Gomes, Alexandre Ferreira; Gozzo, Fabio Cesar] Univ Estadual Campinas, UNICAMP, Inst Chem, Coordinat Chem Lab, BR-13083970 Campinas, SP, Brazil.
   [Barboza Formiga, Andre Luiz] Univ Estadual Campinas, UNICAMP, Dalton Mass Spectrometry Lab, Inst Chem, BR-13083970 Campinas, SP, Brazil.
   [Andrade Corbi, Fabiana Cristina; Mazali, Italo Odone] Univ Estadual Campinas, UNICAMP, Solid State Chem Lab, Inst Chem, BR-13083970 Campinas, SP, Brazil.
   [Alves, Danilo Antonini; Lancellotti, Marcelo] Univ Estadual Campinas, UNICAMP, Biotechnol Lab, Inst Biol, BR-13083970 Campinas, SP, Brazil.
RP Bergamini, FRG (corresponding author), Univ Estadual Campinas, UNICAMP, Bioinorgan & Med Chem Res Lab, Inst Chem, POB 6154, BR-13083970 Campinas, SP, Brazil.
EM ppcorbi@iqm.unicamp.br
RI Corbi, Pedro P/B-7639-2012; Inomat, Inct/H-9989-2013; Paiva, Raphael
   EF/B-7634-2012; Bergamini, Fernando Rodrigues Goulart/B-8168-2013;
   Gozzo, Fabio/F-8123-2010; Corbi, Fabiana/T-5854-2019; Mazali, Italo
   O/C-5217-2012; Gomes, Alexandre F/A-9266-2012; Formiga,
   Andre/G-9755-2011
OI Corbi, Pedro P/0000-0002-7478-0877; Paiva, Raphael
   EF/0000-0003-2549-0344; Bergamini, Fernando Rodrigues
   Goulart/0000-0002-8357-3044; Mazali, Italo O/0000-0001-5698-5273;
   Formiga, Andre/0000-0001-6773-8083
FU FAPESP (Sao Paulo State Research Foundation, Brazil)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [proc. 2006/55367-2,
   2008/57805-2, 2012/08230-2, 2009/54066]; CAPESCAPES; CNPq (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)National
   Council for Scientific and Technological Development (CNPq) [proc.
   573672/2008-3, 472468/2010-3, 472067/2010-9]
FX This study was supported by grants from the Brazilian Agencies FAPESP
   (Sao Paulo State Research Foundation, Brazil-proc. 2006/55367-2,
   2008/57805-2, 2012/08230-2 and 2009/54066-Laboratory of Advanced Optical
   Spectroscopy, LMEOA/IQ-UNICAMP), CAPES and CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Brazil-proc. 573672/2008-3;
   472468/2010-3 and 472067/2010-9). The authors are also grateful to MSc.
   Helen Graci C. de Meneses for her valuable contribution in the DFT
   studies and to Professor Carol H. Collins for the English revision of
   the manuscript.
CR Abbehausen C, 2011, POLYHEDRON, V30, P579, DOI 10.1016/j.poly.2010.11.025
   Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Biersack B, 2009, J INORG BIOCHEM, V103, P72, DOI 10.1016/j.jinorgbio.2008.09.005
   Bonacin JA, 2007, VIB SPECTROSC, V44, P133, DOI 10.1016/j.vibspec.2006.10.007
   CARUSO F, 1995, INORG CHEM, V34, P673, DOI 10.1021/ic00107a022
   Carvalho MA, 2013, J MOL STRUCT, V1031, P125, DOI 10.1016/j.molstruc.2012.07.044
   Chartone-Souza E, 2005, J INORG BIOCHEM, V99, P1001, DOI 10.1016/j.jinorgbio.2005.01.004
   CLSI, 2007, PERF STAND ANT SUS S
   Corbi PP, 2010, J COORD CHEM, V63, P1390, DOI 10.1080/00958971003782608
   Corbi PP, 2000, RUSS J COORD CHEM+, V26, P28
   Cuin A, 2011, BIOMED PHARMACOTHER, V65, P334, DOI 10.1016/j.biopha.2011.04.012
   de Lima RG, 2003, TRANSIT METAL CHEM, V28, P272, DOI 10.1023/A:1022967403627
   de Paiva REF, 2012, POLYHEDRON, V36, P112, DOI 10.1016/j.poly.2012.02.002
   DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902
   Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960
   Elander RP, 2003, APPL MICROBIOL BIOT, V61, P385, DOI 10.1007/s00253-003-1274-y
   Fleming A, 1929, BRIT J EXP PATHOL, V10, P226
   FOX CL, 1968, ARCH SURG-CHICAGO, V96, P184
   FOX CL, 1975, INT SURG, V60, P275
   FOX CL, 1974, ANTIMICROB AGENTS CH, V5, P582, DOI 10.1128/AAC.5.6.582
   FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267
   GRIFFITH OW, 1979, J BIOL CHEM, V254, P1205
   GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558
   HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485
   HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI 10.1063/1.448975
   HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527
   Ibrahim M, 2011, J BIOSCI BIOENG, V112, P570, DOI 10.1016/j.jbiosc.2011.08.017
   Jia YS, 2012, CANCER CHEMOTH PHARM, V69, P377, DOI 10.1007/s00280-011-1708-7
   JOHNSON CR, 1974, J ORG CHEM, V39, P2458, DOI 10.1021/jo00930a044
   Jones SA, 2004, WOUND REPAIR REGEN, V12, P288, DOI 10.1111/j.1067-1927.2004.012304.x
   Kasuga NC, 2008, INORG CHIM ACTA, V361, P1267, DOI 10.1016/j.ica.2007.08.020
   Kasuga NC, 2012, INORG CHEM, V51, P1640, DOI 10.1021/ic201950p
   Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4
   Kumar PS, 2005, TETRAHEDRON, V61, P5633, DOI 10.1016/j.tet.2005.03.070
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Li YG, 2011, J COORD CHEM, V64, P1663, DOI 10.1080/00958972.2011.578627
   Lu Y, 2007, FREE RADICAL BIO MED, V43, P1061, DOI 10.1016/j.freeradbiomed.2007.06.021
   Mehrotra R, 2012, EUR J MED CHEM, V50, P149, DOI 10.1016/j.ejmech.2012.01.049
   MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2
   Morzyk-Ociepa B, 1999, SPECTROCHIM ACTA A, V55, P2671, DOI 10.1016/S1386-1425(99)00087-6
   MOYER CA, 1965, ARCH SURG-CHICAGO, V90, P812
   MURRAY P., 2009, MICROBIOLOGIA MED
   NAKAMOTO K, 1997, INFRARED RAMAN SPECT, P59
   Nikolis N, 2003, J INORG BIOCHEM, V95, P177, DOI 10.1016/S0162-0134(03)00102-8
   Noguchi R, 2006, INORG CHEM COMMUN, V9, P107, DOI 10.1016/j.inoche.2005.09.012
   Ouwerkerk-Mahadevan S., 1997, CHEM-BIOL INTERACT, V105, P17
   Pal S, 2010, J ANTIMICROB CHEMOTH, V65, P2134, DOI 10.1093/jac/dkq294
   Pelkonen KHO, 2003, TOXICOLOGY, V186, P151, DOI 10.1016/S0300-483X(02)00743-6
   Pendyala L, 1997, CANCER CHEMOTH PHARM, V40, P38, DOI 10.1007/s002800050622
   ROWE WB, 1970, P NATL ACAD SCI USA, V66, P500, DOI 10.1073/pnas.66.2.500
   Schaftenaar G., 2000, J COMPUT AID MOL DES, P14
   SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112
   Scott AP, 1996, J PHYS CHEM-US, V100, P16502, DOI 10.1021/jp960976r
   Shah MSAS, 2008, CHEM MATER, V20, P2455, DOI 10.1021/cm7033867
   Shen HM, 2000, FREE RADICAL BIO MED, V28, P1115, DOI 10.1016/S0891-5849(00)00206-9
   Silverstein R.M., 2005, SPECTROMETRIC IDENTI, P102
   Spera MBM, 2011, SPECTROCHIM ACTA A, V78, P313, DOI 10.1016/j.saa.2010.10.012
   Stordal B, 2007, IUBMB LIFE, V59, P696, DOI 10.1080/15216540701636287
   TENOVER FC, 1991, AM J MED, V91, pS76, DOI 10.1016/0002-9343(91)90347-Z
   WARD RS, 1995, PHYS THER, V75, P526, DOI 10.1093/ptj/75.6.526
   Wright GD, 2007, TRENDS MOL MED, V13, P260, DOI 10.1016/j.molmed.2007.04.004
NR 62
TC 10
Z9 10
U1 0
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2012
VL 2
IS 27
BP 10372
EP 10379
DI 10.1039/c2ra21433d
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 051PB
UT WOS:000312138400039
OA Green Published
DA 2020-11-30
ER

PT J
AU Mattos, IB
   Alves, DA
   Hollanda, LM
   Ceragiogli, HJ
   Baranauskas, V
   Lancellotti, M
AF Mattos, Ives B.
   Alves, Danilo A.
   Hollanda, Luciana M.
   Ceragiogli, Helder J.
   Baranauskas, Vitor
   Lancellotti, Marcelo
TI Effects of multi-walled carbon nanotubes (MWCNT) under Neisseria
   meningitidis transformation process
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
ID W135 MENINGOCOCCAL CARRIAGE; HOUSEHOLD CONTACTS; HAJJ PILGRIMS; DISEASE;
   CAPSULE; OUTBREAK; TRANSMISSION; HAEMOPHILUS; BACTEREMIA; STRAIN
AB Background: This study aimed at verifying the action of multi-walled carbon nanotubes (MWCNT) under the naturally transformable Neisseria meningitidis against two different DNA obtained from isogenic mutants of this microorganism, an important pathogen implicated in the genetic horizontal transfer of DNA, causing the escape of the principal vaccination measured worldwide by the capsular switching process.
   Materials and methods: The bacterium receptor strain C2135 was cultivated and had its mutant DNA donor M2 and M6, which received a receptor strain and MWCNT at three different concentrations. The inhibition effect of DNAse on the DNA in contact with nanoparticles was evaluated.
   Results: The results indicated an in increase in the transformation capacity of N. meninigtidis in different concentrations of MWCNT when compared with negative control without nanotubes. A final analysis of the interaction between DNA and MWCNT was carried out using Raman Spectroscopy.
   Conclusion: These increases in the transformation capacity mediated by MWCNT, in meningococci, indicate the interaction of these particles with the virulence acquisition of these bacteria, as well as with the increase in the vaccination escape process.
C1 [Mattos, Ives B.; Alves, Danilo A.; Hollanda, Luciana M.; Lancellotti, Marcelo] Univ Campinas UNICAMP, LABIOTEC Biotechnol Lab, Dept Biochem, Inst Biol CP6109, BR-13083970 Campinas, SP, Brazil.
   [Ceragiogli, Helder J.; Baranauskas, Vitor] Univ Estadual Campinas, NanoEng NanoEngn & Diamond Lab, Sch Elect & Comp Engn, Dept Semicond Instruments & Photon,UNICAMP, BR-13083852 Campinas, SP, Brazil.
RP Lancellotti, M (corresponding author), Univ Campinas UNICAMP, LABIOTEC Biotechnol Lab, Dept Biochem, Inst Biol CP6109, BR-13083970 Campinas, SP, Brazil.
EM mlancell@unicamp.br
RI DE HOLLANDA, LUCIANA MARIA/F-7893-2011
OI DE HOLLANDA, LUCIANA MARIA/0000-0002-6047-4043
FU CAPESCAPES; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2008/56777-5]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [575313/2008-0]
FX This study has been financed by CAPES, FAPESP and CNPq. These supports
   helped us to supply reagent and equipments for the entire research
   development. FAPESP (number 2008/56777-5) and CNPq (number
   575313/2008-0) supported the Laboratory of Biotechnology (Coordinated by
   M. L.). CAPES supported NanoEng (Coordinated by VB, Nanobiotechnology
   Program - Effects of carbon nanotubes under biological systems) and the
   personal fellowships for LMH, HJC. Thanks for the English revision to
   Julia N. Varela and Maria Cecilia T. Amstalden.
CR Alcala B, 2004, J ANTIMICROB CHEMOTH, V53, P409, DOI 10.1093/jac/dkh075
   Alcala B, 2002, J MED MICROBIOL, V51, P1102, DOI 10.1099/0022-1317-51-12-1102
   Alonso J M, 2006, Bull Soc Pathol Exot, V99, P404
   Alonso JM, 2003, FEMS MICROBIOL LETT, V222, P99, DOI 10.1016/S0378-1097(03)00252-0
   Caugant DA, 2007, VACCINE, V25, pA8, DOI 10.1016/j.vaccine.2007.04.033
   Davis J, 2001, J BACTERIOL, V183, P4626, DOI 10.1128/JB.183.15.000-000.2001
   Dolan-Livengood JM, 2003, J INFECT DIS, V187, P1616, DOI 10.1086/374740
   Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217
   FROSCH M, 1992, INFECT IMMUN, V60, P798, DOI 10.1128/IAI.60.3.798-803.1992
   Grecco AC, NANOTECHNOLOGY, V22
   HANAHAN D, 1983, METHOD ENZYMOL, V100, P333
   Hollanda LM, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-28
   Kriz P, 2000, EUR J CLIN MICROBIOL, V19, P452, DOI 10.1007/s100960000293
   Kroll JS, 1998, P NATL ACAD SCI USA, V95, P12381, DOI 10.1073/pnas.95.21.12381
   Lancellotti M, 2006, MICROBES INFECT, V8, P191, DOI 10.1016/j.micinf.2005.06.012
   Li MS, 2003, MOL MICROBIOL, V47, P1101, DOI 10.1046/j.1365-2958.2003.03359.x
   NASSIF X, 1995, CLIN MICROBIOL REV, V8, P376, DOI 10.1128/CMR.8.3.376
   Palma BF, 2008, SENSORS, V9
   Perez-Trallero E, 2002, LANCET, V360, P953, DOI 10.1016/S0140-6736(02)11061-0
   Ribeiro H, 2002, ESTUD AV-SAO PAULO, V16, P24
   Rojas-Chapana JA, 2006, J NANOSCI NANOTECHNO, V6, P316, DOI 10.1166/jnn.2006.004
   Spinosa MR, 2007, INFECT IMMUN, V75, P3594, DOI 10.1128/IAI.01945-06
   Sun LL, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/12/125502
   Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271
   Taha MK, 2001, INFECT IMMUN, V69, P1971, DOI 10.1128/IAI.69.3.1971-1973.2001
   Taha Muhamed-Kheir, 2002, Expert Rev Mol Diagn, V2, P143, DOI 10.1586/14737159.2.2.143
   Tonjum T, 1997, GENE, V192, P155, DOI 10.1016/S0378-1119(97)00018-8
   Wilder-Smith A, 2003, EMERG INFECT DIS, V9, P123, DOI 10.3201/eid0901.020131
   Wilder-Smith A, 2003, INT J ANTIMICROB AG, V21, P112, DOI 10.1016/S0924-8579(02)00355-2
   Wilder-Smith A, 2003, J TRAVEL MED, V10, P147, DOI 10.2310/7060.2003.35751
   Wilder-Smith A, 2003, EMERG INFECT DIS, V9, P734
   Wilder-Smith A, 2003, INT J ANTIMICROB AG, V21, P102, DOI 10.1016/S0924-8579(02)00284-4
   Wilder-Smith A, 2003, CLIN INFECT DIS, V36, P679, DOI 10.1086/367858
   Wilder-Smith A, 2002, BMJ-BRIT MED J, V325, P365, DOI 10.1136/bmj.325.7360.365
   Wilder-Smith A, 2007, CURR OPIN INFECT DIS, V20, P454, DOI 10.1097/QCO.0b013e3282a64700
   Zarantonelli ML, 2008, CLIN MICROBIOL INFEC, V14, P467, DOI 10.1111/j.1469-0691.2008.01955.x
   Zarantonelli ML, 2006, J ANTIMICROB CHEMOTH, V57, P924, DOI 10.1093/jac/dkl066
   Zombre S, 2007, VACCINE, V25, pA69, DOI 10.1016/j.vaccine.2007.04.044
NR 38
TC 9
Z9 9
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD NOV 16
PY 2011
VL 9
AR 53
DI 10.1186/1477-3155-9-53
PG 9
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 860JU
UT WOS:000297945400001
PM 22088149
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU de Pace, F
   de Paiva, JB
   Nakazato, G
   Lancellotti, M
   Sircili, MP
   Stehling, EG
   da Silveira, WD
   Sperandio, V
AF de Pace, Fernanda
   de Paiva, Jacqueline Boldrin
   Nakazato, Gerson
   Lancellotti, Marcelo
   Sircili, Marcelo Palma
   Stehling, Eliana Guedes
   da Silveira, Wanderley Dias
   Sperandio, Vanessa
TI Characterization of IcmF of the type VI secretion system in an avian
   pathogenic Escherichia coli (APEC) strain
SO MICROBIOLOGY-SGM
LA English
DT Article
ID ENTERICA SEROVAR TYPHIMURIUM; LEGIONELLA-PNEUMOPHILA; VIRULENCE FACTORS;
   EPITHELIAL-CELLS; BACTERIAL INVASION; INTRACELLULAR GROWTH;
   NONPHAGOCYTIC CELLS; HUMAN MACROPHAGES; BIOFILM FORMATION;
   GENETIC-ANALYSIS
AB The intracellular multiplication factor (IcmF) protein is a component of the recently described type VI secretion system (T6SS). IcmF has been shown to be required for intra-macrophage replication and inhibition of phagosome-lysosome fusion in Legionella pneumophila. In Vibrio cholerae it is involved in motility, adherence and conjugation. Given that we previously reported that two T6SS genes (hcp and clpV) contribute to the pathogenesis of a septicaemic strain (SEPT362) of avian pathogenic Escherichia coli (APEC), we investigated the function of IcmF in this strain. Further elucidation of the virulence mechanisms of APEC is important because this pathogen is responsible for financial losses in the poultry industry, and is closely related to human extraintestinal pathogenic E. coli(ExPEC) strains, representing a potential zoonotic risk, as well as serving as a reservoir of virulence genes. Here we show that an APEC icmF mutant has decreased adherence to and invasion of epithelial cells, as well as decreased intra-macrophage survival. The icmF mutant is also defective for biofilm formation on abiotic surfaces. Additionally, expression of the flagella operon is decreased in the icmF mutant, leading to decreased motility. The combination of these phenotypes culminates in this mutant being altered for infection in chicks. These results suggest that IcmF in APEC may play a role in disease, and potentially also in the epidemiological spread of this pathogen through enhancement of biofilm formation.
C1 [Sperandio, Vanessa] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.
   [Nakazato, Gerson] State Univ Londrina UEL, Londrina, PR, Brazil.
   [Lancellotti, Marcelo] State Univ Campinas Unicamp, Inst Biol, Dept Biochem, BR-6109 Campinas, SP, Brazil.
   [Sircili, Marcelo Palma] Butantan Inst, Bacteriol Lab, BR-05503900 Sao Paulo, Brazil.
   [de Pace, Fernanda; de Paiva, Jacqueline Boldrin; Stehling, Eliana Guedes; da Silveira, Wanderley Dias] State Univ Campinas Unicamp, Inst Biol, Dept Genet Evolut & Bioagents, BR-6109 Campinas, SP, Brazil.
RP Sperandio, V (corresponding author), Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.
EM wds@unicamp.br; vanessa.sperandio@utsouthwestern.edu
RI Nakazato, Gerson/V-3437-2019; Nakazato, Gerson/D-2907-2014; Stehling,
   Eliana G/I-1171-2015; Sircili, Marcelo Palma/M-7823-2014; Stehling,
   Eliana/E-5262-2012; Paiva, Jacqueline/F-2760-2015
OI Nakazato, Gerson/0000-0001-8624-795X; Stehling, Eliana
   G/0000-0002-4362-3203; Sircili, Marcelo Palma/0000-0002-6063-7412;
   Paiva, Jacqueline/0000-0002-4844-0895
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI053067]; FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2008/56739-6, 07/50432-3];
   CAPESCAPES [4062086]; CAPES/PNPDCAPES [041/2009]; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01AI053067,
   R01AI053067, R01AI053067, R01AI053067, R01AI053067, R01AI053067,
   R01AI053067, R01AI053067, R01AI053067, R01AI053067, R01AI053067,
   R01AI053067, R01AI053067, R01AI053067, R01AI053067, R01AI053067] Funding
   Source: NIH RePORTER
FX This work was supported by NIH grant AI053067, grants from FAPESP
   (grants 2008/56739-6 and 07/50432-3), and grants from CAPES (grant
   4062086) and CAPES/PNPD 041/2009. The contents of this work are the sole
   responsibility of the authors, and do not represent the official views
   of the NIH NIAID.
CR Apel D, 2008, BBA-BIOMEMBRANES, V1778, P1851, DOI 10.1016/j.bbamem.2007.07.005
   Barnes HJ, 2003, COLIBACILLOSIS, P631
   Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006
   Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x
   Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131
   Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985
   Clarke MB, 2005, MOL MICROBIOL, V57, P1734, DOI 10.1111/j.1365-2958.2005.04792.x
   Connell I, 1996, P NATL ACAD SCI USA, V93, P9827, DOI DOI 10.1073/PNAS.93.18.9827
   Das S, 2002, BIOCHEM BIOPH RES CO, V295, P922, DOI 10.1016/S0006-291X(02)00782-9
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   de Pace F, 2010, INFECT IMMUN, V78, P4990, DOI 10.1128/IAI.00531-10
   Dho-Moulin M, 1999, VET RES, V30, P299
   FIERER J, 1993, INFECT IMMUN, V61, P5231, DOI 10.1128/IAI.61.12.5231-5236.1993
   Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0
   FINLAY BB, 1991, J CELL SCI, V99, P283
   FRITSCH EF, 1989, MOL CLONING
   Gray CG, 2002, FEMS MICROBIOL LETT, V215, P53, DOI 10.1111/j.1574-6968.2002.tb11369.x
   Gross W. G., 1994, P237
   Gyles C. L., 1993, P164
   Hilbi H, 2001, MOL MICROBIOL, V42, P603, DOI 10.1046/j.1365-2958.2001.02645.x
   Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08
   Khan NA, 2007, CELL MICROBIOL, V9, P169, DOI 10.1111/j.1462-5822.2006.00779.x
   Kirby JE, 1998, MOL MICROBIOL, V27, P323, DOI 10.1046/j.1365-2958.1998.00680.x
   La Ragione RM, 2002, RES VET SCI, V73, P27, DOI 10.1016/S0034-5288(02)00075-9
   LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994
   Marc D, 1998, RES MICROBIOL, V149, P473, DOI 10.1016/S0923-2508(98)80002-8
   Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803
   Mellata M, 2003, INFECT IMMUN, V71, P536, DOI 10.1128/IAI.71.1.536-540.2003
   Mulvey MA, 2002, CELL MICROBIOL, V4, P257, DOI 10.1046/j.1462-5822.2002.00193.x
   Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103
   Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x
   Parsons DA, 2005, INFECT IMMUN, V73, P4338, DOI 10.1128/IAI.73.7.4338-4345.2005
   Pfeifer CG, 1999, INFECT IMMUN, V67, P5690, DOI 10.1128/IAI.67.11.5690-5698.1999
   Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x
   Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010
   Purcell M, 1998, INFECT IMMUN, V66, P2245, DOI 10.1128/IAI.66.5.2245-2255.1998
   Sambrook J, 1989, MOL CLONING LAB MANU
   SCALETSKY ICA, 1984, INFECT IMMUN, V45, P534, DOI 10.1128/IAI.45.2.534-536.1984
   Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x
   Schembri MA, 2001, INFECT IMMUN, V69, P1322, DOI 10.1128/IAI.69.3.1322-1328.2001
   Sexton JA, 2004, INFECT IMMUN, V72, P5983, DOI 10.1128/IAI.72.10.5983-5992.2004
   Shrivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002955
   Solomon JM, 2000, INFECT IMMUN, V68, P2939, DOI 10.1128/IAI.68.5.2939-2947.2000
   VanRheenen SM, 2004, INFECT IMMUN, V72, P5972, DOI 10.1128/IAI.72.10.5972-5982.2004
   VIDOTTO MC, 1990, AVIAN DIS, V34, P531, DOI 10.2307/1591241
   Walters M, 2006, INFECT IMMUN, V74, P5445, DOI 10.1128/IAI.00099-06
   Watarai M, 2001, J EXP MED, V194, P1081, DOI 10.1084/jem.194.8.1081
   Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x
   Yaguchi K, 2007, AVIAN DIS, V51, P656, DOI 10.1637/0005-2086(2007)51[656:VFOAPE]2.0.CO;2
   Zhao LX, 2009, MICROBIOL-SGM, V155, P1634, DOI 10.1099/mic.0.024869-0
   Zink SD, 2002, INFECT IMMUN, V70, P1657, DOI 10.1128/IAI.70.3.1657-1663.2002
NR 52
TC 49
Z9 49
U1 1
U2 22
PU SOC GENERAL MICROBIOLOGY
PI READING
PA MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND
SN 1350-0872
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD OCT
PY 2011
VL 157
BP 2954
EP 2962
DI 10.1099/mic.0.050005-0
PN 10
PG 9
WC Microbiology
SC Microbiology
GA 837FU
UT WOS:000296177300021
PM 21778203
OA Green Published
DA 2020-11-30
ER

PT J
AU Yahn, DM
   Lancellotti, M
   Brocchi, M
   Gimenes, AP
   Dias, VL
   Salgado, AR
   Passos, LC
   Labello, RB
   Kobarg, J
   Corat, M
AF Yahn, D. M.
   Lancellotti, M.
   Brocchi, M.
   Gimenes, A. P.
   Dias, V. L.
   Salgado, A. R.
   Passos, L. C.
   Labello, R. B.
   Kobarg, J.
   Corat, M.
TI In Vivo Characterization of Ki-1/57 Protein
SO JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE
LA English
DT Meeting Abstract
C1 [Yahn, D. M.; Gimenes, A. P.; Dias, V. L.; Salgado, A. R.; Passos, L. C.; Labello, R. B.; Corat, M.] Univ Estadual Campinas, Transgen Unit, Multidisciplinary Ctr Biol Res, Campinas, SP, Brazil.
   [Lancellotti, M.] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil.
   [Kobarg, J.] Natl Lab Synchrotron Light, Campinas, SP, Brazil.
RI Corat, Marcus/M-2301-2013; Corat, Marcus/AAH-2882-2020; Kobarg,
   Jorg/T-4736-2019
OI Corat, Marcus/0000-0002-8801-2318; Kobarg, Jorg/0000-0002-9419-0145
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER ASSOC LABORATORY ANIMAL SCIENCE
PI MEMPHIS
PA 9190 CRESTWYN HILLS DR, MEMPHIS, TN 38125 USA
SN 1559-6109
J9 J AM ASSOC LAB ANIM
JI J. Amer. Assoc. Lab. Anim. Sci.
PD SEP
PY 2011
VL 50
IS 5
BP 804
EP 804
PG 1
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA 835XJ
UT WOS:000296070000384
DA 2020-11-30
ER

PT J
AU Hollanda, LM
   Cury, GCG
   Pereira, RFC
   Ferreira, GA
   Sousa, A
   Sousa, EMB
   Lancellotti, M
AF Hollanda, Luciana M.
   Cury, Gisele C. G.
   Pereira, Rafaella F. C.
   Ferreira, Gracielle A.
   Sousa, Andreza
   Sousa, Edesia M. B.
   Lancellotti, Marcelo
TI Effect of mesoporous silica under Neisseria meningitidis transformation
   process: environmental effects under meningococci transformation
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
ID ELECTROPHORETIC TYPE-37; PATHOGENIC NEISSERIA; SEROGROUP W135;
   HERD-IMMUNITY; BURKINA-FASO; CAPSULE; DISEASE; HAJJ; GONORRHOEAE;
   CARRIAGE
AB Background: This study aimed the use of mesoporous silica under the naturally transformable Neisseria meningitidis, an important pathogen implicated in the genetic horizontal transfer of DNA causing a escape of the principal vaccination measures worldwide by the capsular switching process. This study verified the effects of mesoporous silica under N. meningitidis transformation specifically under the capsular replacement.
   Methods: we used three different mesoporous silica particles to verify their action in N. meningitis transformation frequency.
   Results: we verified the increase in the capsular gene replacement of this bacterium with the three mesoporous silica nanoparticles.
   Conclusion: the mesouporous silica particles were capable of increasing the capsule replacement frequency in N. meningitidis.
C1 [Hollanda, Luciana M.; Cury, Gisele C. G.; Pereira, Rafaella F. C.; Lancellotti, Marcelo] State Univ Campinas UNICAMP, Dept Biochem, Inst Biol CP6109, BR-13083970 Campinas, SP, Brazil.
   [Ferreira, Gracielle A.; Sousa, Andreza; Sousa, Edesia M. B.] Ctr Dev Nucl Energy, Nanotechnol Serv, Nat Commiss Nucl Energy, BR-30123970 Belo Horizonte, MG, Brazil.
RP Lancellotti, M (corresponding author), State Univ Campinas UNICAMP, Dept Biochem, Inst Biol CP6109, CP 6109, BR-13083970 Campinas, SP, Brazil.
EM mlancell@unicamp.br
RI DE HOLLANDA, LUCIANA MARIA/F-7893-2011; Sousa, Edesia/K-5577-2013;
   Pereira, Rafaella F C/M-4418-2017
OI DE HOLLANDA, LUCIANA MARIA/0000-0002-6047-4043; Sousa,
   Edesia/0000-0002-3721-8033; Pereira, Rafaella F C/0000-0003-4928-7631;
   de Sousa Andrada, Andreza/0000-0002-6884-8345
FU CAPESCAPES; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2008/56777-5]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [575313/2008-0]; FAPEMIGMinas Gerais
   State Research Foundation (FAPEMIG)
FX This study has been financier supported by CAPES, FAPESP, CNPq and
   FAPEMIG. These supports help us to reagent supply and equipments for all
   this research development. FAPESP (number 2008/56777-5) and CNPq (number
   575313/2008-0) funding the Laboratory of Biotechnology (Coordinated by
   M. L.). FAPEMIG funding the laboratory coordinated by E. M. B. S. CNPq
   and CAPES funding with the personal fellowships for students: R. F. C.
   P., AS and GAF. Thanks for the English revision for Luiz Paulo Manzo,
   Julia N. Varela and Maria Cecilia T. Amstalden.
CR ABRAHAM J L, 1986, Applied Pathology, V4, P138
   Alcala B, 2004, J MED MICROBIOL, V53, P515, DOI 10.1099/jmm.0.05517-0
   Alonso J M, 2006, Bull Soc Pathol Exot, V99, P404
   Alonso JM, 2003, FEMS MICROBIOL LETT, V222, P99, DOI 10.1016/S0378-1097(03)00252-0
   Barboza Carlos Eduardo Galvão, 2008, J. bras. pneumol., V34, P959, DOI 10.1590/S1806-37132008001100012
   Caugant DA, 2007, VACCINE, V25, pA8, DOI 10.1016/j.vaccine.2007.04.033
   DILLON JR, 1983, LANCET, V1, P779
   Ding M, 2002, INT IMMUNOPHARMACOL, V2, P173, DOI 10.1016/S1567-5769(01)00170-9
   Dolan-Livengood JM, 2003, J INFECT DIS, V187, P1616, DOI 10.1086/374740
   Dull PM, 2005, J INFECT DIS, V191, P33, DOI 10.1086/425927
   FROSCH M, 1992, INFECT IMMUN, V60, P798, DOI 10.1128/IAI.60.3.798-803.1992
   GIORGINI D, 1995, MOL CELL PROBE, V9, P297, DOI 10.1016/S0890-8508(95)91540-0
   GOODMAN SD, 1991, J BACTERIOL, V173, P5921, DOI 10.1128/jb.173.18.5921-5923.1991
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   Harrison J, 2005, AM J IND MED, V48, P10, DOI 10.1002/ajim.20175
   Hearl FJ, 1997, J EXPO ANAL ENV EPID, V7, P279
   IKEDA F, 1986, MICROBIOL IMMUNOL, V30, P737, DOI 10.1111/j.1348-0421.1986.tb03000.x
   Kriz P, 1999, EPIDEMIOL INFECT, V123, P193, DOI 10.1017/S095026889900285X
   Lancellotti M, 2006, MICROBES INFECT, V8, P191, DOI 10.1016/j.micinf.2005.06.012
   Linch Kenneth D, 2002, Appl Occup Environ Hyg, V17, P209, DOI 10.1080/104732202753438298
   Naessan CL, 2008, J BACTERIOL, V190, P387, DOI 10.1128/JB.00765-07
   NASSIF X, 1995, CLIN MICROBIOL REV, V8, P376, DOI 10.1128/CMR.8.3.376
   Perez-Trallero E, 2002, LANCET, V360, P953, DOI 10.1016/S0140-6736(02)11061-0
   Souza KC, 2009, J MATER SCI-MATER M, V20, P507, DOI 10.1007/s10856-008-3592-1
   Spinosa MR, 2007, INFECT IMMUN, V75, P3594, DOI 10.1128/IAI.01945-06
   Stefanelli P, 2003, J CLIN MICROBIOL, V41, P5783, DOI 10.1128/JCM.41.12.5783-5786.2003
   STEPHENS DS, 1982, INFECTION, V10, P192, DOI 10.1007/BF01640777
   Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271
   Taha MK, 2004, J CLIN MICROBIOL, V42, P4158, DOI 10.1128/JCM.42.9.4158-4163.2004
   Taha MK, 2002, J CLIN MICROBIOL, V40, P1083, DOI 10.1128/JCM.40.3.1083-1084.2002
   Taha MK, 1998, MOL MICROBIOL, V28, P1153, DOI 10.1046/j.1365-2958.1998.00876.x
   Taha MK, 2001, INFECT IMMUN, V69, P1971, DOI 10.1128/IAI.69.3.1971-1973.2001
   Taha MK, 2001, PRESSE MED, V30, P1535
   Tonjum T, 1997, GENE, V192, P155, DOI 10.1016/S0378-1119(97)00018-8
   van den Brule S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-84
   Wang JL, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-7
   Wilder-Smith A, 2003, INT J ANTIMICROB AG, V21, P112, DOI 10.1016/S0924-8579(02)00355-2
   Wilder-Smith A, 2003, EMERG INFECT DIS, V9, P734
   Wilder-Smith A, 2002, BMJ-BRIT MED J, V325, P365, DOI 10.1136/bmj.325.7360.365
   Wilder-Smith A, 2007, CURR OPIN INFECT DIS, V20, P454, DOI 10.1097/QCO.0b013e3282a64700
   Zarantonelli ML, 2008, CLIN MICROBIOL INFEC, V14, P467, DOI 10.1111/j.1469-0691.2008.01955.x
   Zarantonelli ML, 2006, J ANTIMICROB CHEMOTH, V57, P924, DOI 10.1093/jac/dkl066
   ZHOU DG, 1994, J BIOL CHEM, V269, P11162
   Zombre S, 2007, VACCINE, V25, pA69, DOI 10.1016/j.vaccine.2007.04.044
NR 44
TC 9
Z9 9
U1 0
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD JUL 25
PY 2011
VL 9
AR 28
DI 10.1186/1477-3155-9-28
PG 8
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 807RE
UT WOS:000293916600001
PM 21787408
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Cury, GG
   Mobilon, C
   Stehling, EG
   Lancellotti, M
   Ramos, MD
   Martinez, R
   Brocchi, M
   da Silveira, WD
AF Cury, Gisele Gentile
   Mobilon, Cristiane
   Stehling, Eliana Guedes
   Lancellotti, Marcelo
   Ramos, Marcelo de Carvalho
   Martinez, Roberto
   Brocchi, Marcelo
   da Silveira, Wanderley Dias
TI Molecular Typing of Methicillin-Resistant Staphylococcus aureus (MRSA)
   Strains Isolated in Two Metropolitan Areas of Sao Paulo State, Southeast
   Brazil
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE MRSA; nosocomial; molecular characterization; PCR
ID SPREAD; CLONE; OUTBREAK
AB One hundred and fifty-one methicillin-resistant Staphylococcus aureus (MRSA) strains have been isolated from patients admitted in tertiary care hospitals in two metropolitan areas (Campinas City and Ribeirao Preto City) in the southeast region of Brazil and analyzed through PCR-based techniques [(PCR amplification of spa, coa, and housekeeping genes (arcC, aroE, gmk, pta, tpi, yqiL)] and further restriction fragment typing of coa and of housekeeping genes. The heterogeneity of spa gene was determined directly by agarose gel electrophoresis migration. The results obtained indicate the existence of three (A, B, C) main clusters. Since the strain distribution in these three clusters is much characteristic, it denotes the existence of three main clones. All strains isolated in Campinas were grouped in clusters A and B, while most of the strains isolated in Ribeirao Preto were grouped in cluster C. This distribution denotes the existence of different founder strains that undergo independent genetic variability. The strains considered representative of the Brazilian Epidemic Clone (BEC) were categorized as cluster A. These results indicate a possible higher variability among Brazilian MRSA strains than currently described and indicate that the techniques herein used can be used as an alternative to Pulsed Field Gel Electrophoresis (PFGE).
C1 [Mobilon, Cristiane; Stehling, Eliana Guedes; Lancellotti, Marcelo; Brocchi, Marcelo; da Silveira, Wanderley Dias] Univ Estadual Campinas, Inst Biol, Dept Microbiol & Immunol, BR-13083862 Campinas, SP, Brazil.
   [Cury, Gisele Gentile; Ramos, Marcelo de Carvalho] Univ Estadual Campinas, Dept Internal Med, Dept Internal Med, BR-13083862 Campinas, SP, Brazil.
   [Martinez, Roberto] Univ Sao Paulo, Sch Med, Dept Internal Med, BR-14049 Ribeirao Preto, SP, Brazil.
RP da Silveira, WD (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Microbiol & Immunol, Rua Monteiro Lobato S-N,POB 6109, BR-13083862 Campinas, SP, Brazil.
EM wds@unicamp.br
RI Stehling, Eliana/E-5262-2012; Dias da Silveira, Wanderley/C-6420-2012;
   Brocchi, Marcelo/E-3723-2012; Stehling, Eliana G/I-1171-2015
OI Stehling, Eliana G/0000-0002-4362-3203
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [03/08407-0];
   CAPESCAPES [832386/1999-5]
FX This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo) grant No. 03/08407-0 and CAPES grant No.
   832386/1999-5. The authors are thankful to Dr. Maria Clara Padoveze [20]
   from Campinas State University for the donation of isolates 257A, 20COA,
   256B, and HC562, and to Dr. Agnes M. Figueiredo [17] from Universidade
   Federal do Rio de Janeiro for the donation of isolates BEC 9393 and HC
   562.
CR AUSUBEL FM, 1988, CURRENT PROTOCOLS MO
   Ayliffe GAJ, 1997, CLIN INFECT DIS, V24, pS74, DOI 10.1093/clinids/24.Supplement_1.S74
   BRANCHINI MLM, 2001, DIAGN MICROBIOL INFE, V17, P275
   Coimbra MVD, 2000, J MED MICROBIOL, V49, P187, DOI 10.1099/0022-1317-49-2-187
   de Sousa MA, 1998, J CLIN MICROBIOL, V36, P2590, DOI 10.1128/JCM.36.9.2590-2596.1998
   deSousa MA, 1996, MICROB DRUG RESIST, V2, P331, DOI 10.1089/mdr.1996.2.331
   Diep BA, 2003, J CLIN MICROBIOL, V41, P4559, DOI 10.1128/JCM.41.10.4559-4564.2003
   DOMINGUEZ MA, 1994, J CLIN MICROBIOL, V32, P2081, DOI 10.1128/JCM.32.9.2081-2087.1994
   Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000
   Feil EJ, 2000, GENETICS, V154, P1439
   Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061
   Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182
   Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004
   Kuhn G, 2006, J BACTERIOL, V188, P169, DOI 10.1128/JB.188.1.169-178.2006
   Mato R, 1998, MICROB DRUG RESIST, V4, P107, DOI 10.1089/mdr.1998.4.107
   Meier PA, 1996, INFECT CONT HOSP EP, V17, P798
   Melter O, 1999, J CLIN MICROBIOL, V37, P2798, DOI 10.1128/JCM.37.9.2798-2803.1999
   Montesinos I, 2002, J CLIN MICROBIOL, V40, P2119, DOI 10.1128/JCM.40.6.2119-2125.2002
   Padoveze MC, 2001, INFECT CONT HOSP EP, V22, P783, DOI 10.1086/501864
   Rohlf FJ, 1997, NTSYS PC 2 1 NUMERIC
   Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102
   Sambrook J., 1989, MOL CLONING LAB MANU
   Sanches IS, 1996, MICROB DRUG RESIST, V2, P319, DOI 10.1089/mdr.1996.2.319
   Soares JMD, 2000, J HOSP INFECT, V44, P301
   Soares MJD, 2001, J MED MICROBIOL, V50, P732, DOI 10.1099/0022-1317-50-8-732
   Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619
   TEIXEIRA LA, 1995, J CLIN MICROBIOL, V33, P2400, DOI 10.1128/JCM.33.9.2400-2404.1995
NR 27
TC 14
Z9 14
U1 0
U2 4
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD JUN
PY 2009
VL 13
IS 3
BP 165
EP 169
DI 10.1590/S1413-86702009000300002
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA 563CZ
UT WOS:000275105600002
PM 20191190
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Lancellotti, M
   Pereira, RFC
   Cury, GG
   de Hollanda, LM
AF Lancellotti, Marcelo
   Carneiro Pereira, Rafaella Fabiana
   Cury, Gisele Gentile
   de Hollanda, Luciana Maria
TI Pathogenic and Opportunistic Respiratory Bacteria-Induced Apoptosis
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Pathogenic bacteria; opportunistic bacteria; apoptosis; bacteria induce
   apoptosis; respiratory bacteria
ID GROWTH-FACTOR RECEPTOR; MYCOBACTERIUM-TUBERCULOSIS;
   LEGIONELLA-PNEUMOPHILA; PORIN PORB; EPITHELIAL-CELLS; INTRACELLULAR
   REPLICATION; NEISSERIA-MENINGITIDIS; MACROPHAGE APOPTOSIS; NEGATIVE
   REGULATOR; HOST-DEFENSE
AB Several pathogenic or opportunistic bacteria have the ability to either induce or inhibit host cell apoptosis. The capacity to modulate cell pathways that result in the induction or delay of host cell apoptosis is considered to be an important bacterial virulence mechanism. These processes could be mediated by different host cell signaling pathways that are subverted by the bacteria. Pathogens are able to activate apoptotic proteins, such as caspases, or inactivate anti-apoptotic proteins, such as NFkB and the MAPKKs, or even up-regulate the endogenous receptor/ligand system that induces apoptosis, generally when the bacteria are bound to the host cell surface. The bacteria-induced apoptotic or anti-apoptotic processes are often related with the fact that the bacteria acquire the ability to reach the host tissues. However, apoptosis is also considered to be a host defense mechanism against infectious agents. Thus, the apoptosis phenomenon plays a central role in host-pathogen interactions.
C1 [Lancellotti, Marcelo; Carneiro Pereira, Rafaella Fabiana; Cury, Gisele Gentile] Univ Estadual Campinas, Inst Biol, Dept Biochem, Campinas, SP, Brazil.
   [de Hollanda, Luciana Maria] Univ Estadual Campinas, Inst Biol, Dept Microbiol & Immunol, Campinas, SP, Brazil.
RP Lancellotti, M (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biochem, Campinas, SP, Brazil.
EM mlancell@unicamp.br
RI Pereira, Rafaella F C/M-4418-2017; DE HOLLANDA, LUCIANA
   MARIA/F-7893-2011
OI Pereira, Rafaella F C/0000-0003-4928-7631; DE HOLLANDA, LUCIANA
   MARIA/0000-0002-6047-4043
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [150800/2005-3]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2006/06058-7]
FX This work was supported by CNPq - Post-Doctoral Fellowship to Marcelo
   Lancellotti Process number 150800/2005-3 and FAPESP Process number:
   2006/06058-7
CR Abu Kwaik Y, 1998, MOL MICROBIOL, V30, P689, DOI 10.1046/j.1365-2958.1998.01092.x
   Abu-Zant A, 2005, INFECT IMMUN, V73, P5339, DOI 10.1128/IAI.73.9.5339-5349.2005
   Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Ali F, 2003, J INFECT DIS, V188, P1119, DOI 10.1086/378675
   Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636
   Bermpohl D, 2005, J CLIN INVEST, V115, P1607, DOI 10.1172/JCI23223
   Braun JS, 2007, INFECT IMMUN, V75, P4245, DOI 10.1128/IAI.00031-07
   Braun JS, 2002, J CLIN INVEST, V109, P19
   Braun JS, 2001, J INFECT DIS, V184, P1300, DOI 10.1086/324013
   Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732
   Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x
   Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689
   Colino J, 2003, J IMMUNOL, V171, P2354, DOI 10.4049/jimmunol.171.5.2354
   Davey M, 2008, J IMMUNOL, V180, P2187, DOI 10.4049/jimmunol.180.4.2187
   DEVOE IW, 1973, J EXP MED, V138, P1156, DOI 10.1084/jem.138.5.1156
   Gao LY, 1999, MICROB PATHOGENESIS, V27, P273, DOI 10.1006/mpat.1999.0308
   Gao LY, 2000, ENVIRON MICROBIOL, V2, P79, DOI 10.1046/j.1462-2920.2000.00076.x
   Gao LY, 1999, INFECT IMMUN, V67, P862, DOI 10.1128/IAI.67.2.862-870.1999
   Gao LY, 1999, INFECT IMMUN, V67, P4886, DOI 10.1128/IAI.67.9.4886-4894.1999
   Grassme H, 2000, SCIENCE, V290, P527, DOI 10.1126/science.290.5491.527
   Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200
   Jain V, 2008, BLOOD, V111, P4637, DOI 10.1182/blood-2007-11-126862
   Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200
   Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8
   Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004
   Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997
   Kirschnek S, 2000, J BIOL CHEM, V275, P27316
   Kornfeld H, 1999, CELL DEATH DIFFER, V6, P71, DOI 10.1038/sj.cdd.4400454
   Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840
   Koziczak-Holbro M, 2007, J BIOL CHEM, V282, P13552, DOI 10.1074/jbc.M700548200
   Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619
   Liu WW, 1996, P NATL ACAD SCI USA, V93, P8258, DOI 10.1073/pnas.93.16.8258
   Massari P, 2000, P NATL ACAD SCI USA, V97, P9070, DOI 10.1073/pnas.97.16.9070
   MCGEE ZA, 1983, REV INFECT DIS, V5, pS708
   MELANCON J, 1983, INFECT IMMUN, V42, P471, DOI 10.1128/IAI.42.2.471-479.1983
   Mikami F, 2005, J BIOL CHEM, V280, P36185, DOI 10.1074/jbc.M503941200
   Mitchell JA, 2007, J ENDOCRINOL, V193, P323, DOI 10.1677/JOE-07-0067
   Molmeret M, 2004, MICROBES INFECT, V6, P129, DOI 10.1016/j.micinf.2003.11.004
   Muller A, 2000, EMBO J, V19, P5332, DOI 10.1093/emboj/19.20.5332
   Muller A, 1996, INFECT IMMUN, V64, P4900
   Muller A, 1999, EMBO J, V18, P339, DOI 10.1093/emboj/18.2.339
   Muller A, 2002, EMBO J, V21, P1916, DOI 10.1093/emboj/21.8.1916
   N'Guessan PD, 2005, THROMB HAEMOSTASIS, V94, P295, DOI 10.1160/TH04-12-0822
   Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0
   O'Connor L, 1999, Results Probl Cell Differ, V23, P173
   Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159
   Rojas M, 2000, J INFECT DIS, V182, P240, DOI 10.1086/315676
   Rojas M, 1999, J IMMUNOL, V162, P6122
   Schmeck B, 2004, INFECT IMMUN, V72, P4940, DOI 10.1128/IAI.72.9.4940-4947.2004
   Schmitz I, 2000, INT J BIOCHEM CELL B, V32, P1123, DOI 10.1016/S1357-2725(00)00048-0
   Shuto T, 2002, J BIOL CHEM, V277, P17263, DOI 10.1074/jbc.M112190200
   Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005
   van Putten JPM, 1998, J EXP MED, V188, P941, DOI 10.1084/jem.188.5.941
   van Putten JPM, 1998, MOL MICROBIOL, V29, P369, DOI 10.1046/j.1365-2958.1998.00951.x
   vanPutten JPM, 1997, INFECT IMMUN, V65, P5028, DOI 10.1128/IAI.65.12.5028-5034.1997
   Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3
   Yang YL, 2000, CELL RES, V10, P169, DOI 10.1038/sj.cr.7290046
   Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073
   Yoshimura A, 1999, J IMMUNOL, V163, P1
   Zhang QB, 2007, J INFECT DIS, V195, P1194, DOI 10.1086/512617
NR 60
TC 11
Z9 18
U1 0
U2 6
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD JUN
PY 2009
VL 13
IS 3
BP 226
EP 231
DI 10.1590/S1413-86702009000300014
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA 563CZ
UT WOS:000275105600014
PM 20191202
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Lancellotti, M
   de Pace, F
   Stehling, EG
   Villares, MCB
   Brocchi, M
   da Silveira, WD
AF Lancellotti, Marcelo
   de Pace, Fernanda
   Stehling, Eliana Guedes
   Barisson Villares, Maria Cecilia
   Brocchi, Marcelo
   da Silveira, Wanderley Dias
TI Ribotyping, Biotyping and Capsular Typing of Haemophilus influenzae
   Strains Isolated from Patients in Campinas, Southeast Brazil
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Haemophilus influenzae; characterization; ribotyping; serotype; biotype
ID FIELD GEL-ELECTROPHORESIS; SEROTYPE-B STRAINS; HEMOPHILUS-INFLUENZAE;
   PCR; VIRULENCE; CHILDREN; DNA
AB Forty-five Haemophilus influenzae strains isolated from patients were characterized based on biochemical characteristics. Their capsular types were determined by polymerase chain reaction (PCR); they were compared, using two molecular methods [ribotyping with a specific DNA probe amplified from the 16S rDNA region from H. influenzae and through restriction fragment length polymorphism (RLFP) of an amplified 16S DNA region]. The strains were better discriminated by the ribotyping technique that used the 16S probe and by the combination of both techniques. Biotypes I and IV were the most common, followed by biotypes VI, VIII and III. Biotypes II and VII were not found. Most of the capsular samples were nontypable (89%), with capsular types a and b found in 2 and 9% of the samples, respectively. We concluded that there is a very close genetic identity among pathogenic and nonpathogenic strains.
C1 [Lancellotti, Marcelo; de Pace, Fernanda; Stehling, Eliana Guedes; Brocchi, Marcelo; da Silveira, Wanderley Dias] Univ Estadual Campinas, Dept Microbiol & Immunol, Inst Biol, Campinas, SP, Brazil.
   [Barisson Villares, Maria Cecilia] Univ Estadual Campinas, Dept Clin Pathol, Med Sch Hosp, Campinas, SP, Brazil.
RP da Silveira, WD (corresponding author), Univ Estadual Campinas, Dept Microbiol & Immunol, Inst Biol, Campinas, SP, Brazil.
EM wds@unicamp.br
RI Dias da Silveira, Wanderley/C-6420-2012; Brocchi, Marcelo/E-3723-2012;
   Stehling, Eliana G/I-1171-2015; Stehling, Eliana/E-5262-2012
OI Stehling, Eliana G/0000-0002-4362-3203; 
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [98/04612-9,
   00/01864-9, 00/01882-7]; Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico-CNPqNational Council for Scientific and Technological
   Development (CNPq) [300121/90-3]
FX This work was supported by Grants no. 98/04612-9; no. 00/01864-9 and no.
   00/01882-7 from Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo-FAPESP and Grant no. 300121/90-3 from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico-CNPq.
CR Aparicio P, 1996, Enferm Infecc Microbiol Clin, V14, P227
   AUSUBEL FM, 1988, CURRENT PROTOCOLS MO
   Clemans DL, 2001, INFECT IMMUN, V69, P7010, DOI 10.1128/IAI.69.11.7010-7019.2001
   FALLA TJ, 1994, J CLIN MICROBIOL, V32, P2382, DOI 10.1128/JCM.32.10.2382-2386.1994
   Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998
   Gomez-De-Leon P, 2000, J CLIN MICROBIOL, V38, P2504, DOI 10.1128/JCM.38.7.2504-2511.2000
   Gonin P, 2000, DIAGN MICR INFEC DIS, V37, P1, DOI 10.1016/S0732-8893(00)00116-4
   KILIAN M, 1976, J GEN MICROBIOL, V93, P9, DOI 10.1099/00221287-93-1-9
   Marrs CF, 2001, FRONT BIOSCI, V6, P41
   Mitsuda T, 1999, J CLIN MICROBIOL, V37, P2548, DOI 10.1128/JCM.37.8.2548-2552.1999
   Moller LVM, 1996, J CLIN MICROBIOL, V34, P1926
   Moor PE, 1999, J CLIN MICROBIOL, V37, P1524, DOI 10.1128/JCM.37.5.1524-1531.1999
   MOXON ER, 1984, J CLIN INVEST, V73, P298, DOI 10.1172/JCI111214
   MOXON ER, 1985, J ROY COLL PHYS LOND, V19, P174
   MOXON RE, 1988, VACCINE, V6, P113
   Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442
   MUSSER JM, 1985, P NATL ACAD SCI USA, V82, P5078, DOI 10.1073/pnas.82.15.5078
   NEI M, 1978, JPN J HUM GENET, V23, P341, DOI 10.1007/BF01908190
   Saito M, 2000, J MED MICROBIOL, V49, P845, DOI 10.1099/0022-1317-49-9-845
   Saito M, 1999, J CLIN MICROBIOL, V37, P2142, DOI 10.1128/JCM.37.7.2142-2147.1999
   Sambrook J., 1989, MOL CLONING LAB MANU
   SMITHVAUGHAN HC, 1995, J CLIN MICROBIOL, V33, P1192, DOI 10.1128/JCM.33.5.1192-1195.1995
   TURK DC, 1982, BRIT MED J, V284, P1634, DOI 10.1136/bmj.284.6329.1634-b
   YEH FC, 1999, POPGENE 1 31 VERSION
NR 24
TC 2
Z9 3
U1 0
U2 1
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD OCT
PY 2008
VL 12
IS 5
BP 430
EP 437
DI 10.1590/S1413-86702008000500015
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA 407OT
UT WOS:000263374900015
PM 19219284
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Zarantonelli, ML
   Lancellotti, M
   Deghmane, AE
   Giorgini, D
   Hong, E
   Ruckly, C
   Alonso, JM
   Taha, MK
AF Zarantonelli, M. L.
   Lancellotti, M.
   Deghmane, A. E.
   Giorgini, D.
   Hong, E.
   Ruckly, C.
   Alonso, J. -M.
   Taha, M. -K.
TI Hyperinvasive genotypes of Neisseria meningitidis in France
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE apoptosis; epidemiology; genetic lineages; invasion; Neisseria
   meningitidis; virulence
ID MENINGOCOCCAL DISEASE; BACTERIAL PATHOGENS; POPULATION; RECOMBINATION;
   VIRULENCE; SEROGROUP; CARRIAGE; CLONES; W135
AB Clinical isolates of Neisseria meningitidis from cases of meningococcal disease, collected between January 2000 and December 2004, were identified and typed at the French National Reference Centre. A representative subset of 546 isolates from among 2882 isolates was further genotyped by multilocus sequence typing to determine their genetic lineages (clonal complexes) and the degree of diversification among different clonal complexes. Representative isolates of the main clonal complexes were tested for their virulence in mice and for proapoptotic effects on human epithelial cells. High genetic diversity in some genetic lineages (ST-32 and ST-41/44) was correlated with heterogeneity in virulence in mice and proapoptotic effects on human epithelial cells. In contrast, the homogeneous genetic structure of isolates of the ST-11 clonal complex, regardless of their serogroup, correlated positively with a fatal outcome of the infection, increased virulence in mice and increased proapoptotic effects on human epithelial cells.
C1 [Zarantonelli, M. L.; Lancellotti, M.; Deghmane, A. E.; Giorgini, D.; Hong, E.; Ruckly, C.; Alonso, J. -M.; Taha, M. -K.] Inst Pasteur, Natl Reference Ctr Meningococci, Neisseria Unit, F-75724 Paris 15, France.
RP Taha, MK (corresponding author), Inst Pasteur, Natl Reference Ctr Meningococci, Neisseria Unit, 28 Rue Dr Roux, F-75724 Paris 15, France.
EM mktaha@pasteur.fr
OI Zarantonelli, Leticia/0000-0002-7170-6102
CR ABDILLAHI H, 1988, MICROB PATHOGENESIS, V4, P27, DOI 10.1016/0882-4010(88)90045-9
   Achtman M, 2004, INT J MED MICROBIOL, V294, P67, DOI 10.1016/j.ijmm.2004.06.028
   Alonso JM, 2003, FEMS MICROBIOL LETT, V222, P99, DOI 10.1016/S0378-1097(03)00252-0
   BONMARIN I, 2002, EUROSURVEILLANCE WEE, V6, P5
   Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x
   Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590
   Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061
   Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561
   Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182
   Hotchkiss RS, 2003, SCAND J INFECT DIS, V35, P585, DOI 10.1080/00365540310015692
   Jolley KA, 2000, J CLIN MICROBIOL, V38, P4492, DOI 10.1128/JCM.38.12.4492-4498.2000
   KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963
   Lancellotti M, 2006, MICROBES INFECT, V8, P191, DOI 10.1016/j.micinf.2005.06.012
   Levy-Bruhl D, 2002, Euro Surveill, V7, P74
   Maiden MCJ, 2000, INT J MED MICROBIOL, V290, P183
   Maiden MCJ, 2004, ADV EXP MED BIOL, V549, P23
   Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140
   MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384
   Schoen C, 2007, INT J MED MICROBIOL, V297, P601, DOI 10.1016/j.ijmm.2007.04.003
   Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242
   Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2
   Taha MK, 2004, J CLIN MICROBIOL, V42, P4158, DOI 10.1128/JCM.42.9.4158-4163.2004
   Taha MK, 2002, TRENDS MICROBIOL, V10, P376, DOI 10.1016/S0966-842X(02)02402-2
   Taha MK, 2000, LANCET, V356, P2159, DOI 10.1016/S0140-6736(00)03502-9
   Trotter CL, 2007, FEMS MICROBIOL REV, V31, P27, DOI 10.1111/j.1574-6976.2006.00060.x
   Trotter CL, 2002, J MED MICROBIOL, V51, P855, DOI 10.1099/0022-1317-51-10-855
   Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155
   Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004
   Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0
NR 29
TC 40
Z9 40
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1198-743X
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD MAY
PY 2008
VL 14
IS 5
BP 467
EP 472
DI 10.1111/j.1469-0691.2008.01955.x
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA 285PU
UT WOS:000254789500009
PM 18294240
DA 2020-11-30
ER

PT J
AU Zarantonelli, ML
   Antignac, A
   Lancellotti, M
   Guiyoule, A
   Alonso, JM
   Taha, MK
AF Zarantonelli, ML
   Antignac, A
   Lancellotti, M
   Guiyoule, A
   Alonso, JM
   Taha, MK
TI Immunogenicity of meningococcal PBP2 during natural infection and
   protective activity of anti-PBP2 antibodies against meningococcal
   bacteraemia in mice
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
DE Neisseria meningitidis; vaccine; penicillin-binding proteins; animal
   model
ID RESISTANT STAPHYLOCOCCUS-AUREUS; PENICILLIN-BINDING PROTEINS;
   NEISSERIA-MENINGITIDIS; REDUCED SUSCEPTIBILITY; BACTERICIDAL ACTIVITY;
   IMMUNE-RESPONSE; SEROGROUP; VACCINE; GONORRHOEAE; SEQUENCE
AB Objective: To evaluate the immunogenicity of the meningococcal penicillin-binding protein 2 (PBP2) and its potential as a vaccine candidate.
   Methods: The immunogenicity of meningococcal PBP2 was investigated using acute and convalescent sera from patients who recovered from meningococcal disease. Sera were tested against purified recombinant PBP2s corresponding to meningococcal isolates of different genetic lineages, of different serogroups and with various susceptibility levels to penicillin G. Mice were vaccinated with recombinant PBP2 and challenged with Neisseria meningitidis. A purified anti-PBP2 rabbit IgG was also used for passive protection experiments in mice.
   Results: Convalescent patients' sera recognized PBP2s from different strains, showing that this protein is immunogenic in meningococcal disease. Vaccination with purified recombinant PBP2 and purified anti-PBP2 rabbit IgG antibody conferred protection against experimental meningococcaemia in mice.
   Conclusion: These data argue for considering meningococcal PBP2 as a vaccine candidate.
C1 Inst Pasteur, Dept Mol Med, Neisseria Unit, Natl Reference Ctr Meningococci, F-75724 Paris 15, France.
RP Zarantonelli, ML (corresponding author), Inst Pasteur, Dept Mol Med, Neisseria Unit, Natl Reference Ctr Meningococci, 25-28 Rue Dr Roux, F-75724 Paris 15, France.
EM lzaranto@pasteur.fr
OI Zarantonelli, Leticia/0000-0002-7170-6102
CR Abdillahi H, 1988, J Med Microbiol, V26, P177
   Antignac A, 2003, CLIN INFECT DIS, V37, P912, DOI 10.1086/377739
   Antignac A, 2003, J BIOL CHEM, V278, P31529, DOI 10.1074/jbc.M304607200
   Antignac A, 2001, J ANTIMICROB CHEMOTH, V47, P285, DOI 10.1093/jac/47.3.285
   BARBOUR AG, 1981, ANTIMICROB AGENTS CH, V19, P316, DOI 10.1128/AAC.19.2.316
   Claassen I, 1996, VACCINE, V14, P1001, DOI 10.1016/0264-410X(96)00020-5
   Deghmane AE, 2003, MOL MICROBIOL, V47, P135, DOI 10.1046/j.1365-2958.2003.03259.x
   Dessen A, 2001, J BIOL CHEM, V276, P45106, DOI 10.1074/jbc.M107608200
   FREDRIKSEN J H, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P67
   Holst J, 2003, VACCINE, V21, P734, DOI 10.1016/S0264-410X(02)00591-1
   KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963
   MAIDEN MCJ, 1993, FEMS MICROBIOL LETT, V112, P243, DOI 10.1111/j.1574-6968.1993.tb06457.x
   NIETO JAS, 1990, LANCET, V336, P54, DOI 10.1016/0140-6736(90)91567-T
   Ohwada A, 1999, J ANTIMICROB CHEMOTH, V44, P767, DOI 10.1093/jac/44.6.767
   PARGE HE, 1990, J BIOL CHEM, V265, P2278
   Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655
   Quagliarello VJ, 1997, NEW ENGL J MED, V336, P708, DOI 10.1056/NEJM199703063361007
   Rokbi B, 1997, INFECT IMMUN, V65, P55, DOI 10.1128/IAI.65.1.55-63.1997
   Sabhnani L, 2003, INT IMMUNOPHARMACOL, V3, P1413, DOI 10.1016/S1567-5769(03)00138-3
   Sambrook J., 1989, MOL CLONING LAB MANU
   Senna JPM, 2003, VACCINE, V21, P2661, DOI 10.1016/S0264-410X(02)00738-7
   SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195
   SPRATT BG, 1988, REV INFECT DIS, V10, P699
   SPRATT BG, 1994, SCIENCE, V264, P388, DOI 10.1126/science.8153626
   Taha MK, 2004, J CLIN MICROBIOL, V42, P4158, DOI 10.1128/JCM.42.9.4158-4163.2004
   Taha MK, 2002, TRENDS MICROBIOL, V10, P376, DOI 10.1016/S0966-842X(02)02402-2
   Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809
   Vazquez JA, 2003, ANTIMICROB AGENTS CH, V47, P3430, DOI 10.1128/AAC.47.11.3430-3434.2003
   Welsch JA, 2003, J INFECT DIS, V188, P1730, DOI 10.1086/379375
NR 29
TC 15
Z9 15
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
EI 1460-2091
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD MAY
PY 2006
VL 57
IS 5
BP 924
EP 930
DI 10.1093/jac/dkl066
PG 7
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 032XQ
UT WOS:000236810300019
PM 16513914
OA Bronze
DA 2020-11-30
ER

PT J
AU Brocchi, M
   Ferreira, A
   Lancellotti, M
   Stehling, EG
   Campos, TA
   Nakazato, G
   de Castro, AFP
   Silveira, WD
AF Brocchi, Marcelo
   Ferreira, Alessandra
   Lancellotti, Marcelo
   Stehling, Eliana G.
   Campos, Tatiana A.
   Nakazato, Gerson
   Pestana de Castro, Antonio F.
   Silveira, Wanderley D.
TI Typing of avian pathogenic Escherichia coli strains by REP-PCR
SO PESQUISA VETERINARIA BRASILEIRA
LA English
DT Article
DE avian Escherichia coli; typing; REP-PCR
ID REPETITIVE INTERGENIC CONSENSUS; DNA-SEQUENCES; BROILER-CHICKENS;
   GENOMES; EPIDEMIOLOGY; POLYMORPHISM; PRIMERS; DISEASE; CLONES; FAMILY
AB In the present study the repetitive extragenic palindromic (REP) polymerase chain reaction (PCR) technique was used to establish the clonal variability of 49 avian Escherichia coli (APEC) strains isolated from different outbreak cases of septicemia (n = 24), swollen head syndrome (n = 14) and omphalitis (n = 11). Thirty commensal strains isolated from poultry with no signs of these illnesses were used as control strains. The purified DNA of these strains produced electrophoretic profiles ranging from 0 to 15 bands with molecular sizes varying from 100 bp to 6.1 kb, allowing the grouping of the 79 strains into a dendrogram containing 49 REP-types. Although REP-PCR showed good discriminating power it was not able to group the strains either into specific pathogenic classes or to differentiate between pathogenic and non-pathogenic strains. On the contrary, we recently demonstrated that other techniques such as ERIC-PCR and isoenzyme profiles are appropriate to discriminate between commensal and APEC strains and also to group these strains into specific pathogenic classes. In conclusion, REP-PCR seems to be a technique neither efficient nor universal for APEC strains discrimination. However, the population clonal structure obtained with the use of REP-PCR must not be ignored particularly if one takes into account that the APEC pathogenic mechanisms are not completely understood yet.
C1 Univ Estadual Campinas, Dept Microbiol & Immunol, Inst Biol, Cidade Univ, BR-13081862 Campinas, SP, Brazil.
   Univ Sao Paulo, Inst Ciencias Biomed 2, Dept Microbiol, BR-05508900 Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular Mol & Bioagentes Patogen, BR-14049900 Ribeirao Preto, Brazil.
RP Silveira, WD (corresponding author), Univ Estadual Campinas, Dept Microbiol & Immunol, Inst Biol, Cidade Univ, Cx Postal 6109,Zeferino Vaz S-N, BR-13081862 Campinas, SP, Brazil.
EM wds@unicamp.br
RI Stehling, Eliana/E-5262-2012; Nakazato, Gerson/V-3437-2019; Dias da
   Silveira, Wanderley/C-6420-2012; Brocchi, Marcelo/E-3723-2012; Stehling,
   Eliana G/I-1171-2015; Nakazato, Gerson/D-2907-2014
OI Stehling, Eliana G/0000-0002-4362-3203; Nakazato,
   Gerson/0000-0001-8624-795X
CR ACHTMAN M, 1983, INFECT IMMUN, V39, P315, DOI 10.1128/IAI.39.1.315-335.1983
   Aycardi J., 1969, Bulletin de l'Office International des Epizooties, V72, P351
   Chansiripornchai N, 2001, VET MICROBIOL, V80, P75, DOI 10.1016/S0378-1135(00)00380-1
   da Silveira WD, 2003, J VET MED B, V50, P63, DOI 10.1046/j.1439-0450.2003.00607.x
   da Silveira WD, 2002, VET MICROBIOL, V85, P47, DOI 10.1016/S0378-1135(01)00482-5
   da Silveira WD, 2002, VET MICROBIOL, V89, P323, DOI 10.1016/S0378-1135(02)00256-0
   Dalla-Costa LM, 1998, J MED MICROBIOL, V47, P227, DOI 10.1099/00222615-47-3-227
   de Moura AC, 2001, AVIAN DIS, V45, P173, DOI 10.2307/1593025
   DHO M, 1982, AVIAN DIS, V26, P787, DOI 10.2307/1589865
   Dho-Moulin M, 1999, VET RES, V30, P299
   Dombek PE, 2000, APPL ENVIRON MICROB, V66, P2572, DOI 10.1128/AEM.66.6.2572-2577.2000
   FANTINATTI F, 1994, VET MICROBIOL, V41, P75, DOI 10.1016/0378-1135(94)90137-6
   GILSON E, 1984, EMBO J, V3, P1417, DOI 10.1002/j.1460-2075.1984.tb01986.x
   Gomis SM, 1997, AVIAN DIS, V41, P234, DOI 10.2307/1592464
   GROSS WB, 1961, AVIAN DIS, V5, P431, DOI 10.2307/1587774
   GROSS WB, 1994, NATURE, V298, P760
   HULTON CSJ, 1991, MOL MICROBIOL, V5, P825, DOI 10.1111/j.1365-2958.1991.tb00755.x
   Janssen T, 2001, INT J MED MICROBIOL, V291, P371, DOI 10.1078/1438-4221-00143
   La Ragione RM, 2002, RES VET SCI, V73, P27, DOI 10.1016/S0034-5288(02)00075-9
   LIPMAN LJA, 1995, VET MICROBIOL, V43, P13, DOI 10.1016/0378-1135(94)00070-D
   MORLEY AJ, 1984, AVIAN DIS, V28, P238, DOI 10.2307/1590147
   Olive DM, 1999, J CLIN MICROBIOL, V37, P1661, DOI 10.1128/JCM.37.6.1661-1669.1999
   Pourbakhsh SA, 1997, MICROB PATHOGENESIS, V22, P331, DOI 10.1006/mpat.1996.0116
   Pourbakhsh SA, 1997, AVIAN DIS, V41, P221, DOI 10.2307/1592463
   RANDALL CJ, 1984, VET REC, V114, P246, DOI 10.1136/vr.114.10.246
   Sambrook J., 1989, MOL CLONING LAB MANU
   SELANDER RK, 1980, SCIENCE, V210, P545, DOI 10.1126/science.6999623
   SELANDER RK, 1986, APPL ENVIRON MICROB, V51, P873, DOI 10.1128/AEM.51.5.873-884.1986
   SILVEIRA WD, 1994, BRAZ J GENET, V17, P9
   SOJKA W. J., 1961, RES VET SCI, V2, P340
   Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006
   VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991
   VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823
   WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213
   Yeh F.C, 1999, POPGENE VERSION 1 31
NR 35
TC 4
Z9 4
U1 0
U2 5
PU REVISTA PESQUISA VETERINARIA BRASILEIRA
PI RIO JANEIRO
PA EMBRAPA-SAUDE ANIMAL, KM47 SEROPEDICA, 23851-970 RIO JANEIRO, BRAZIL
SN 0100-736X
EI 1678-5150
J9 PESQUI VET BRASIL
JI Pesqui. Vet. Bras.
PD APR-JUN
PY 2006
VL 26
IS 2
BP 69
EP 73
DI 10.1590/S0100-736X2006000200002
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA 057DE
UT WOS:000238575700002
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Lancellotti, M
   Guiyoule, A
   Ruckly, C
   Hong, E
   Alonso, JM
   Taha, MK
AF Lancellotti, M
   Guiyoule, A
   Ruckly, C
   Hong, E
   Alonso, JM
   Taha, MK
TI Conserved virulence of C to B capsule switched Neisseria meningitidis
   clinical isolates belonging to ET-37/ST-11 clonal complex
SO MICROBES AND INFECTION
LA English
DT Article
DE Neisseria meningitides; capsule; vaccination; typing; virulence
ID MENINGOCOCCAL-DISEASE; VACCINATION CAMPAIGN; CHEMICAL PROPERTIES;
   SEROGROUP-B; POLYSACCHARIDE; SUSCEPTIBILITY; IDENTIFICATION; OUTBREAK;
   SEQUENCE; STRAINS
AB Capsule switching in Neisseria meningitidis is thought to occur by horizontal DNA exchange between meningococcal strains. Antigenic variants may be generated by allelic replacement of the siaD gene; the variants may then be selected by specific immunity against the capsular antigen. There were several vaccination campaigns against serogoup C in France in 2002, following an increase in the prevalence of invasive isolates of serogroup C of the phenotype C:2a:P1.5 and C:2a:P1.5,2 belonging to the ET-37/ST-11 clonal complex. We evaluated the emergence of capsule variants by the detection of B:2a:P1.5 and B:2a:P1.5.2 meningococcal isolates of the ET-37/ST-11 clonal complex. These isolates were significantly more frequent after the year 2002. Pulsed field gel electrophoresis profiles of the serogroup B (ET-37/ST-11) isolates differed from that of serogroup C (ET-37/ST-11) isolates by the bands that harbor the siaD genes responsible for the serogroup specificity. However, serogroup B and C, ET37/ST-11 isolates both express similar virulence as assessed from colonization and invasiveness in a mouse model. Our results indicate that capsule switching events within the same clonal complex can arise frequently with no alteration in virulence. This justifies an enhanced system of surveillance by molecular typing Of Such isolates, particularly after serogroup-specific vaccination. (c) 2005 Elsevier SAS. All rights reserved.
C1 Inst Pasteur, Natl Reference Ctr Meningococci, Neisseria Unit, F-75724 Paris 15, France.
RP Alonso, JM (corresponding author), Inst Pasteur, Natl Reference Ctr Meningococci, Neisseria Unit, 25-28 Rue Dr Roux, F-75724 Paris 15, France.
EM jmalonso@pasteur.fr
RI English, Peter Mark Bandele/E-1341-2014
OI English, Peter Mark Bandele/0000-0001-6914-9127
CR Alonso JM, 2003, FEMS MICROBIOL LETT, V222, P99, DOI 10.1016/S0378-1097(03)00252-0
   Antignac A, 2003, CLIN INFECT DIS, V37, P912, DOI 10.1086/377739
   BONMARIN I, 2002, EUROSURVEILLANCE WEE, V6, P5
   Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x
   Claus H, 1997, MOL GEN GENET, V257, P28, DOI 10.1007/PL00008618
   Davison K L, 2002, Commun Dis Public Health, V5, P213
   FROSCH M, 1989, P NATL ACAD SCI USA, V86, P1669, DOI 10.1073/pnas.86.5.1669
   KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963
   Kertesz DA, 1998, J INFECT DIS, V177, P1754, DOI 10.1086/517439
   Kriz P, 1999, RES MICROBIOL, V150, P273, DOI 10.1016/S0923-2508(99)80052-7
   Krizova P, 1995, Cent Eur J Public Health, V3, P189
   Levy-Bruhl D, 2002, Euro Surveill, V7, P74
   Lipsitch M, 1997, P NATL ACAD SCI USA, V94, P6571, DOI 10.1073/pnas.94.12.6571
   LIU TY, 1971, J BIOL CHEM, V246, P2849
   LIU TY, 1971, J BIOL CHEM, V246, P4703
   Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140
   NIKOSKELAINEN J, 1978, LANCET, V2, P403
   Perez-Trallero E, 2002, LANCET, V360, P953, DOI 10.1016/S0140-6736(02)11061-0
   POOLMAN JT, 1988, EUR J CLIN MICROBIOL, V7, P291, DOI 10.1007/BF01963104
   Salleras L, 2003, VACCINE, V21, P729, DOI 10.1016/S0264-410X(02)00590-X
   Sambrook J., 1989, MOL CLONING LAB MANU
   Shlush LI, 2002, J CLIN MICROBIOL, V40, P3565, DOI 10.1128/JCM.40.10.3565-3571.2002
   Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271
   Taha MK, 2004, J CLIN MICROBIOL, V42, P4158, DOI 10.1128/JCM.42.9.4158-4163.2004
   Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000
   Taha MK, 2000, LANCET, V356, P2159, DOI 10.1016/S0140-6736(00)03502-9
   Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809
   Trotter C L, 2002, Commun Dis Public Health, V5, P220
   Trotter CL, 2002, J MED MICROBIOL, V51, P855, DOI 10.1099/0022-1317-51-10-855
   van Furth A M, 2001, Ned Tijdschr Geneeskd, V145, P1716
   Vogel U, 2000, NEW ENGL J MED, V342, P219, DOI 10.1056/NEJM200001203420319
NR 31
TC 37
Z9 41
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD JAN
PY 2006
VL 8
IS 1
BP 191
EP 196
DI 10.1016/j.micinf.2005.06.012
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 013WW
UT WOS:000235441700022
PM 16182586
DA 2020-11-30
ER

PT J
AU da Silveira, WD
   Lancellotti, M
   Ferreira, A
   Solferini, VN
   de Castro, AFP
   Stehling, EG
   Brocchi, M
AF da Silveira, WD
   Lancellotti, M
   Ferreira, A
   Solferini, VN
   de Castro, AFP
   Stehling, EG
   Brocchi, M
TI Determination of the clonal structure of avian Escherichia coli strains
   by isoenzyme and ribotyping analysis
SO JOURNAL OF VETERINARY MEDICINE SERIES B-INFECTIOUS DISEASES AND
   VETERINARY PUBLIC HEALTH
LA English
DT Article
ID VIRULENCE FACTORS; GENETIC-RELATIONSHIPS; BROILER-CHICKENS;
   PATHOGENICITY; RESISTANCE; INFECTION; DIARRHEA; APEC
AB Forty-nine avian Escherichia coli strains isolated from different outbreak cases of septicemia (24), swollen head syndrome (14) and omphalitis (11), and 20 strains isolated from poultry with no signs of the mentioned illnesses, for a total of 69 strains, were typed by isoenzyme profile and ribotyping analysis by restriction fragment length polymorphism (RFLP). Isoenzyme analysis discriminated better among strains (0-0.07 degree of genetic dissimilarity) than ribotyping analysis (0- 0.02 degree of genetic dissimilarity). The enzyme profiles of the E. coli isolates allowed the identification of 33 clones that were organized into six main clusters (A-F). Cluster A comprised 87% of the pathogenic strains and had no commensal strains, while commensal strains were assigned to clusters B-F. The ribotyping analysis resulted in a more heterogenous distribution of strains but most of those that cause the same type of infection were kept close together. Taken as a whole, these results demonstrate that pathogenic clones are more similar to one another when compared with commensal strains and suggest a correlation between the genetic background and the pathogenic characteristics of avian pathogenic E. coli strains.
C1 Univ Estadual Campinas, Dept Microbiol & Immunol, Campinas, SP, Brazil.
RP da Silveira, WD (corresponding author), Univ Estadual Campinas, Dept Microbiol & Immunol, CP 6109, Campinas, SP, Brazil.
EM WDS@obelix.unicamp.br
RI Stehling, Eliana/E-5262-2012; Solferini, Vera/E-9121-2012; Stehling,
   Eliana G/I-1171-2015; Brocchi, Marcelo/E-3723-2012; Dias da Silveira,
   Wanderley/C-6420-2012
OI Solferini, Vera/0000-0001-6582-1449; Stehling, Eliana
   G/0000-0002-4362-3203; 
CR ACHTMAN M, 1983, INFECT IMMUN, V39, P315, DOI 10.1128/IAI.39.1.315-335.1983
   ARP LH, 1980, AVIAN DIS, V24, P153, DOI 10.2307/1589774
   ARTHUR M, 1990, INFECT IMMUN, V58, P471, DOI 10.1128/IAI.58.2.471-479.1990
   BEUTIN L, 1990, J INFECT DIS, V162, P1329, DOI 10.1093/infdis/162.6.1329
   BINNS MM, 1979, NATURE, V279, P778, DOI 10.1038/279778a0
   CAMPOS LC, 1994, INFECT IMMUN, V62, P3282, DOI 10.1128/IAI.62.8.3282-3288.1994
   da Silveira WD, 2002, VET MICROBIOL, V85, P47, DOI 10.1016/S0378-1135(01)00482-5
   de Moura AC, 2001, AVIAN DIS, V45, P173, DOI 10.2307/1593025
   Dho-Moulin M, 1999, VET RES, V30, P299
   Doetkott DM, 1996, AVIAN DIS, V40, P927, DOI 10.2307/1592319
   Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124
   FANTINATTI F, 1994, VET MICROBIOL, V41, P75, DOI 10.1016/0378-1135(94)90137-6
   Gomis SM, 1997, AVIAN DIS, V41, P234, DOI 10.2307/1592464
   Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x
   Janssen T, 2001, INT J MED MICROBIOL, V291, P371, DOI 10.1078/1438-4221-00143
   LEVINE MM, 1987, J INFECT DIS, V155, P377, DOI 10.1093/infdis/155.3.377
   MASLOW JN, 1995, INFECT IMMUN, V63, P2409, DOI 10.1128/IAI.63.7.2409-2417.1995
   Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943
   MORLEY AJ, 1984, AVIAN DIS, V28, P238, DOI 10.2307/1590147
   NEI M, 1978, GENETICS, V89, P583
   ORSKOV F, 1990, J INFECT DIS, V162, P76, DOI 10.1093/infdis/162.1.76
   Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999
   Pourbakhsh SA, 1997, MICROB PATHOGENESIS, V22, P331, DOI 10.1006/mpat.1996.0116
   Pourbakhsh SA, 1997, AVIAN DIS, V41, P221, DOI 10.2307/1592463
   RANDALL CJ, 1984, VET REC, V114, P246, DOI 10.1136/vr.114.10.246
   Rodrigues J, 1996, INFECT IMMUN, V64, P2680, DOI 10.1128/IAI.64.7.2680-2686.1996
   Sambrook J, 1989, MOL CLONING LAB MANU
   SELANDER RK, 1986, APPL ENVIRON MICROB, V51, P873, DOI 10.1128/AEM.51.5.873-884.1986
   SILVEIRA WD, 1994, BRAZ J GENET, V17, P9
   SOJKA W. J., 1961, RES VET SCI, V2, P340
   STENDERUP J, 1983, J INFECT DIS, V148, P1019, DOI 10.1093/infdis/148.6.1019
   TRUSCOTT RB, 1973, CAN J COMP MED, V38, P160
   VIDOTTO MC, 1990, AVIAN DIS, V34, P531, DOI 10.2307/1591241
   VIDOTTO MC, 1991, BRAZ J MED BIOL RES, V24, P677
   WHITTAM TS, 1988, INFECT IMMUN, V56, P2458, DOI 10.1128/IAI.56.9.2458-2466.1988
   WHITTAM TS, 1993, INFECT IMMUN, V61, P1619, DOI 10.1128/IAI.61.5.1619-1629.1993
   WOOLEY RE, 1993, AVIAN DIS, V37, P1092, DOI 10.2307/1591919
   YAM WC, 1994, J MED MICROBIOL, V40, P229, DOI 10.1099/00222615-40-4-229
   Yeh F.C, 1999, POPGENE VERSION 1 31
   ZarkoPostawka M, 1997, GENE, V185, P231
NR 40
TC 11
Z9 11
U1 0
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0931-1793
J9 J VET MED B
JI J. Vet. Med. Ser. B-Infect. Dis. Vet. Public Health
PD MAR
PY 2003
VL 50
IS 2
BP 63
EP 69
DI 10.1046/j.1439-0450.2003.00607.x
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA 647TD
UT WOS:000181109400003
PM 12675896
DA 2020-11-30
ER

PT J
AU da Silveira, WD
   Ferreira, A
   Lancellotti, M
   Barbosa, IAGCD
   Leite, DS
   de Castro, AFP
   Brocchi, M
AF da Silveira, WD
   Ferreira, A
   Lancellotti, M
   Barbosa, IAGCD
   Leite, DS
   de Castro, AFP
   Brocchi, M
TI Clonal relationships among avian Escherichia coli isolates determined by
   enterobacterial repetitive intergenic consensus (ERIC)-PCR
SO VETERINARY MICROBIOLOGY
LA English
DT Article
DE Escherichia coli; typing; ERIC-PCR
ID DNA-SEQUENCES; STRAINS; GENOMES; FAMILY
AB Forty-nine avian Escherichia coli isolates isolated from different outbreak cases of septicemia (24 isolates), swollen head syndrome (14 isolates) and omphalitis (11 isolates), and 30 commensal isolates isolated from poultry with no signs of illness were characterized by enterobacterial repetitive intergenic consensus (ERIC)-PCR technique and their serotypes were determined. The ERIC-PCR profile allowed the typing of the 79 isolates into 68 ERIC-types and grouped the isolates into four main clusters (A-D), with the omphalitis isolates being grouped with the commensals and separated from the septicaemia and swollen head syndrome. These results indicate that ERIC-PCR is a technique that could replace other molecular characterization techniques such as random amplification of polymorphic DNA (RAPD)-PCR and restriction fragment length polymorphism (RFLP), reinforce previous observations that omphalitis isolates are just opportunistic agents, and are consistent with many reports that specific genotypes are responsible for causing specific diseases. Most of the isolates were either nontypable or rough, supporting the need for alternative methods for typing these isolates. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Estadual Campinas, Dept Microbiol & Immunol, Inst Biol, BR-13083970 Campinas, SP, Brazil.
   Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil.
   Univ Sao Paulo, Dept Cellular Mol Biol & Pathogen Bio Agents, BR-14049 Ribeirao Preto, SP, Brazil.
RP da Silveira, WD (corresponding author), Univ Estadual Campinas, Dept Microbiol & Immunol, Inst Biol, CP 6109, BR-13083970 Campinas, SP, Brazil.
EM wds@obelix.unicamp.br
RI Brocchi, Marcelo/E-3723-2012; Leite, Domingos S/D-4365-2012; Dias da
   Silveira, Wanderley/C-6420-2012; Leite, Domingos/L-4531-2013
OI Leite, Domingos/0000-0002-0946-4165; Da Silva Leite,
   Domingos/0000-0003-4737-7852
CR Blanco JE, 1998, VET MICROBIOL, V61, P229, DOI 10.1016/S0378-1135(98)00182-5
   Chansiripornchai N, 2001, VET MICROBIOL, V80, P75, DOI 10.1016/S0378-1135(00)00380-1
   da Silveira WD, 2002, VET MICROBIOL, V85, P47, DOI 10.1016/S0378-1135(01)00482-5
   Dalla-Costa LM, 1998, J MED MICROBIOL, V47, P227, DOI 10.1099/00222615-47-3-227
   de Moura AC, 2001, AVIAN DIS, V45, P173, DOI 10.2307/1593025
   Dho-Moulin M, 1999, VET RES, V30, P299
   GILSON E, 1984, EMBO J, V3, P1417, DOI 10.1002/j.1460-2075.1984.tb01986.x
   Gross W. G., 1994, P237
   GUINEE PAM, 1972, APPL MICROBIOL, V24, P127
   HULTON CSJ, 1991, MOL MICROBIOL, V5, P825, DOI 10.1111/j.1365-2958.1991.tb00755.x
   LEVINE MM, 1987, J INFECT DIS, V155, P377, DOI 10.1093/infdis/155.3.377
   Maurer JJ, 1998, AVIAN DIS, V42, P431, DOI 10.2307/1592670
   MORLEY AJ, 1984, AVIAN DIS, V28, P238, DOI 10.2307/1590147
   Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403
   RANDALL CJ, 1984, VET REC, V114, P246, DOI 10.1136/vr.114.10.246
   Sambrook J, 1989, MOL CLONING LAB MANU, P19891584
   SOJKA W. J., 1961, RES VET SCI, V2, P340
   VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991
   VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823
   WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213
   Yeh F.C, 1999, POPGENE VERSION 1 31
NR 21
TC 24
Z9 25
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1135
EI 1873-2542
J9 VET MICROBIOL
JI Vet. Microbiol.
PD NOV 6
PY 2002
VL 89
IS 4
BP 323
EP 328
AR PII S0378-1135(02)00256-0
DI 10.1016/S0378-1135(02)00256-0
PG 6
WC Microbiology; Veterinary Sciences
SC Microbiology; Veterinary Sciences
GA 607QZ
UT WOS:000178803400007
PM 12383641
DA 2020-11-30
ER

PT J
AU da Silveira, WD
   Ferreira, A
   Brocchi, M
   de Hollanda, LM
   de Castro, AFP
   Yamada, AT
   Lancellotti, M
AF da Silveira, WD
   Ferreira, A
   Brocchi, M
   de Hollanda, LM
   de Castro, AFP
   Yamada, AT
   Lancellotti, M
TI Biological characteristics and pathogenicity of avian Escherichia coli
   strains
SO VETERINARY MICROBIOLOGY
LA English
DT Article
DE Escherichia coli; adhesion; invasion; pathogenicity
ID VIRULENCE FACTORS; HELA-CELLS; ADHERENCE; SEROTYPES; CHICKENS; PATTERNS;
   DIARRHEA
AB Fifty avian (chicken) pathogenic Escherichia coli strains (APEC) isolated from individuals suffering from omphalitis, septicaemia and swollen head, syndrome, and 30 strains isolated from healthy chickens were studied regarding their biological characteristics such as serogroups, haemolysin, colicin, cytotoxin, toxin and siderophore production, adhesion capacity to in vitro cultivated cells, and absorption of Congo red dye. Serotyping demonstrated that most of the omphalitis and normal strains were untypable, whereas most of the septicaemic strains were either untypable or rough. There was no prevalent serogroup among the pathogenic strains studied. The capacity for adhesion and invasion of in vitro cultured cells (HeLa, HEp-2, KPCC), as well as the agglutination of different types of red blood cells and the LD50 Of each strain were also evaluated. No correlation was observed between the biological characteristics and pathogenicity, except that colicin was characteristically produced by swollen head syndrome E. coli strains. No correlation was found between adhesion or haemagglutination patterns and pathogenicity. only six of the 50 strains revealed invasive capacity and the strain that best invaded the cell lines was the one with the lowest LD50. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Estadual Campinas, Inst Biol, Dept Microbiol & Immunol IB, BR-13081970 Campinas, SP, Brazil.
   Univ Sao Paulo, FMRP, Sch Med, Dept Cellular & Mol Biol & Pathogen Bioagents, Ribeirao Preto, Brazil.
   Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.
   Univ Estadual Campinas, Inst Biol, Dept Histol, BR-13081970 Campinas, SP, Brazil.
RP da Silveira, WD (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Microbiol & Immunol IB, CP 6109, BR-13081970 Campinas, SP, Brazil.
EM wds@obelix.unicamp.br
RI Brocchi, Marcelo/E-3723-2012; DE HOLLANDA, LUCIANA MARIA/F-7893-2011;
   Yamada, Aureo T/F-7752-2012; Dias da Silveira, Wanderley/C-6420-2012
OI DE HOLLANDA, LUCIANA MARIA/0000-0002-6047-4043; Yamada, Aureo
   T/0000-0003-3620-9685; 
CR Blanco JE, 1998, VET MICROBIOL, V61, P229, DOI 10.1016/S0378-1135(98)00182-5
   CARBONETTI NH, 1985, VIRULENCE ESCHERICHI, P419
   CLOUD SS, 1985, AVIAN DIS, V29, P1084, DOI 10.2307/1590463
   Dho-Moulin M, 1999, VET RES, V30, P299
   EMERY DA, 1992, AVIAN DIS, V36, P504, DOI 10.2307/1591741
   FANTINATTI F, 1994, VET MICROBIOL, V41, P75, DOI 10.1016/0378-1135(94)90137-6
   Germani Y, 1996, J INFECT DIS, V174, P1124, DOI 10.1093/infdis/174.5.1124
   GUINEE PAM, 1972, APPL MICROBIOL, V24, P127
   Jouve M, 1997, INFECT IMMUN, V65, P4082, DOI 10.1128/IAI.65.10.4082-4089.1997
   Martins MD, 2000, VET MICROBIOL, V76, P51, DOI 10.1016/S0378-1135(00)00223-6
   NATARO JP, 1985, INFECT IMMUN, V48, P378, DOI 10.1128/IAI.48.2.378-383.1985
   NATARO JP, 1987, PEDIATR INFECT DIS J, V6, P829, DOI 10.1097/00006454-198709000-00008
   PAYNE SM, 1977, INFECT IMMUN, V18, P94, DOI 10.1128/IAI.18.1.94-98.1977
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Sambrook J, 1989, MOL CLONING LAB MANU
   SCALETSKY ICA, 1984, INFECT IMMUN, V45, P534, DOI 10.1128/IAI.45.2.534-536.1984
   SILVEIRA WD, 1994, BRAZ J GENET, V17, P9
   VIDOTTO MC, 1990, AVIAN DIS, V34, P531, DOI 10.2307/1591241
NR 18
TC 35
Z9 40
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1135
EI 1873-2542
J9 VET MICROBIOL
JI Vet. Microbiol.
PD FEB 26
PY 2002
VL 85
IS 1
BP 47
EP 53
DI 10.1016/S0378-1135(01)00482-5
PG 7
WC Microbiology; Veterinary Sciences
SC Microbiology; Veterinary Sciences
GA 517FD
UT WOS:000173599700006
PM 11792491
DA 2020-11-30
ER

EF